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Abstract

This dissertation research explores how values regarding sexuality, morality,
responsibility, protection, trust, and risk – expressed through parent, daughter, and
healthcare provider relationships and interactions – inform parental decisions regarding
the Gardasil® vaccine. In particular, the research examines the competing and conflicting
meanings that parents and providers ascribe to vaccination and how actors position the
vaccine within a wider set of negotiated, value-laden discourses. Because these narratives
are situated within a larger structural field that shapes the landscape in which providers
and parents interact, relevant historical and structural factors, including vaccine policy,
cost, and compensation are discussed. In-depth, semi-structured interviews with 17
healthcare providers and 26 parents were conducted to explore these relationships.
Results suggest that in considering the Gardasil vaccine, parents balance concerns
regarding the newness of the vaccine with assessments of their daughters’ sexual maturity
and vulnerability. The primary vaccine frame that parents ascribe to Gardasil – as a
cancer-prevention technology or vaccine to prevent a sexually transmitted disease – shifts
the angle from which parents approach the decision. Trust in government and public
health establishments, pharmaceutical companies, healthcare providers, daughters, and
their social environments operate at multiple levels to both inform and complicate
decisions. In making decisions to accept, refuse, or defer Gardasil uptake,
parents rely on different vaccine frames that focus upon specific aspects of the vaccine or
of HPV risk.
ix

Chapter One – Background

Human Papillomavirus
Human papillomavirus (HPV) is the name of a group of viruses belonging to the
family Papovaviridae (WHO 2007). In the United States alone, more than 20 million
people are currently infected with HPV, and there are 6.2 million new cases each year
(Frazer 2006). Over 100 types of HPV have been described molecularly and 40 of these
types infect the genital tract (Munoz, et al. 2003). Each genital HPV type is categorized
as high or low risk, depending on the strength of the association between an HPV type
and lower genital tract cancer (Frazer 2006). Between 2003 and 2005, sentinel
surveillance for cervical infection with high-risk HPV types (16, 18, 31, 33, 35, 39, 45,
551, 52, 56, 58, 59, or 68) was conducted in 26 STI, family planning, and primary care
clinics in six cities nationwide. Results indicated a high-risk HPV prevalence of 23%
(CDC 2009a). The prevalence rate was higher in STI (26%) and family planning clinics
(26%), compared to primary care (15%) clinics. Similarly, rates were highest in younger
age groups. Females ages 14 to 19 years of age carried the greatest burden (35%),
followed by women ages 20 to 29 (29%), 30 to 39 (13%), 40 to 49 (11%), and 50 to 65
years of age (6.3%) (CDC 2009a).
High risk HPV types are associated with up to 99.7 percent of cervical cancers
(Frazer 2006), as well as with cancer of the cervix, vagina, vulva, anus, and penis (Cox
2006; Organization 2007; WHO 2007). Recent studies have also linked HPV infection to
head and neck cancers; high-risk HPV infection has been found in 15-20 percent of head
1

and neck cancers independent of smoking and alcohol use (D'Souza, et al. 2007; Pintos,
et al. 2008; Pintos, et al. in press; Smith, et al. 2004a). In 2007, 12,280 women in the U.S.
were diagnosed with cervical cancer and 4,021 died from it (CDC 2011c). It is estimated
that at least 2,900 new cases of HPV-associated vulvar and vaginal cancer, 1,700 incident
cases of HPV-associated head and neck cancers, and 1,600 new cases of HPV-associated
anal cancers will be diagnosed among females in the United States each year (CDC
2011d). While there are at least 15 high-risk genital HPV types (Frazer 2006), types 16
and 18 are responsible for the greatest disease burden. HPV type 16 is responsible for
more than half of all invasive cancers, and HPV types 16 and 18 account for between 70
and 75 percent of all cervical cancer cases worldwide (Frazer 2006; Pollack, et al. 2007;
WHO 2007).
While low-risk HPV types are usually clinically benign and rarely progress to
neoplasia (Frazer 2006), they are a significant source of morbidity and economic cost in
the U.S., accounting for five percent of all visits to sexually transmitted infection (STI)
clinics (Insigna, et al. 2003; Wiley, et al. 2002). Genital warts are also highly infectious;
the transmission rate from an infected to non-infected sexual partner is approximately 65
percent (Lacey, et al. 2006). HPV types 6 and 11 are the two most common low-risk
HPV types, responsible for approximately 90 percent of genital warts (Cox 2006; Frazer
2006). National Health and Nutrition Examination Survey (NHANES) results from 1999
to 2004 reveal that 5.6 percent of sexually active adults between the ages of 18 and 59
year self-reported a lifetime diagnosis of genital warts (CDC 2009a) and recent data
from the National Disease and Therapeutic Index (NDTI) suggest that the incidence of
genital warts might be increasing (CDC 2009a). Results from the NDTI show an overall
2

increase in the number of American seeking initial treatment for genital warts. For
example, in the year 2000, approximately 220,000 people were initially seen for genital
warts, compared to 357,000 in 2009 (CDC 2009a). Treatment is often complicated,
expensive, and ineffective: up to 75 percent of cases recur within six months of treatment
(Frazer 2006; Lacey, et al. 2006).
The economic costs associated with low and high-risk HPV infection are high.
Each year in the United States, approximately $200 million are spent on managing genital
warts, $300 to $400 million are spent on care associated with invasive cervical cancer,
and a staggering $3.5 billion is spent annually on follow-up for abnormal Pap tests and
the management of pre-invasive cervical disease (Dempsey and Freed 2008).
HPV infection disproportionately affects young people; 15 to 24 year olds
comprise only 25 percent of the sexually active population (usually defined as those
between 15 and 44 years of age) in the U.S., but they account for nearly half of the STIs
(Frazer 2006). Approximately 75 percent of incident HPV infections (4.6 million) occur
among 15 to 24 year olds (Frazer 2006). By the age of 50, an estimated 80 percent of
U.S. women will have acquired HPV in the genital tract (SAM 2006).

HPV Vaccines
Immunization is arguably one of the greatest public health successes in history.
The Centers for Disease Control and Prevention (CDC) list vaccination first on a list of
the top ten public health achievements in the twentieth century (1999a). The widespread
distribution of vaccines has led to the worldwide eradication of smallpox and the near
eradication of polio in the Western hemisphere (CDC 1999b). Despite their successes,
vaccines have always been a controversial public health intervention, fueling ethical
3

debates about the rights of parents and the State vis-à-vis children’s bodies and about
ethical obligations to protect one’s own health (or the health of a child) and the health
and welfare of the community (Blume 2006; Colgrove and Bayer 2005; Fenner, et al.
1986; Spier 2001; Stern and Markel 2005). Recently, parental concerns regarding the
safety, effectiveness, and necessity of vaccines have grown, or at least been illuminated
through increased media coverage, celebrity interest, and political battles regarding
vaccine mandates (Leask 2002; Offit 2008; Smith, et al. 2008; Stern and Markel 2005).
In the past, controversies focused on vaccines administered during infancy and
early childhood, with discussions of long-term side effects and State control of vaccines
dominating the debates (Freed 2005; Isaacs, et al. 2004; Link 2005). More recently,
discussions regarding the risks and benefits of vaccines have coalesced around the HPV
vaccine. Developed to provide protection against four types of HPV that are the leading
causes of cervical cancer and HPV in the population, the Gardasil® vaccine introduced
vaccine-specific concerns into the general vaccine debate, while fanning the flames of
historically rooted cultural and political tensions regarding vaccine campaigns, vaccine
mandates, and state and parental rights.
While vaccines against STIs can drastically reduce the stigma, suffering, and
death associated with these infections, development of these particular vaccines has been
slow. For example, until a few years ago, the Hepatitis B vaccine was the only Food and
Drug Administration (FDA) approved vaccine in the United States to prevent an STI
(FDA 2006). Two pharmaceutical companies have independently developed vaccines to
prevent HPV. Cervarix®, the name of the HPV vaccine developed by GlaxoSmithKline,
protects against HPV types 16 and 18; Cervarix received FDA approval for use in
4

females ages 10 through 25 in October 2009, three years after the Gardasil vaccine was
initially FDA approved (FDA 2009a).
Manufactured by Merck, Gardasil1 is a quadrivalent vaccine that protects against
four HPV strains: 6, 11, 16, and 18. The vaccine is administered in a series of three doses
delivered over the course of six months (the additional doses are delivered two and six
months after the initial dose) (Merck 2011). Common side-effects associated with the
vaccine include “pain, swelling, itching, bruising, and redness at the injection site,
headache, fever, nausea, dizziness, vomiting, and fainting” (Merck 2011). Since sexual
contact is the primary mode of transmission and Gardasil is most beneficial as a
prophylactic, it is important to vaccinate individuals before sexual debut (Pollack, et al.
2007; SAM 2006; Siddiqui and Perry 2006).
Initial FDA approval for Gardasil was granted in 2006 for use among females
ages 9 to 26 in the United States, but the Advisory Committee on Immunization Practices
(ACIP) to the CDC recommended that 11 and 12 year old girls be specifically targeted
for vaccination (CDC 2007). Given the young age of vaccination, parents play a
significant role in determining the vaccination status of their daughters. It is therefore
important to understand the factors that shape and influence parental vaccine decisionmaking, particularly in regards to STI-related vaccines.
The primary goal of this dissertation research was to examine the contextual
landscape in which parents make HPV vaccine decisions: how (and from whom) parents
ascertain, value, and weigh information regarding HPV and the vaccine to prevent it, and

1

The vaccine contains the following ingredients: proteins of HPV Types 6, 11, 16, and 18, amorphous
aluminum hydroxyphosphate sulfate, yeast protein, sodium chloride, L-histidine, polysorbate 80, sodium
borate, and water for injection (Merck 2011)
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how such information is positioned vis-à-vis daughters and within wider structural and
historical frames to inform decision-making.
The introduction of the Gardasil vaccine in 2006 evoked new moral and ethical
questions surrounding vaccination. Conflagrations regarding morality spread as parents
and religious leaders questioned the need, or even appropriateness, of a vaccine to protect
individuals from a disease that is primarily sexually transmitted. That the vaccine would
target children and young adults only further fueled debate (Colgrove 2010; Epstein and
Huff 2010).
Apart from the fact that it has become an object of moral and ethical debate, the
HPV vaccine is also a relatively new technology. And while any new technology can
induce feelings of anxiety and fear, the events surrounding the development and roll out
of the Gardasil vaccine increased anxiety regarding the vaccine, as will be discussed in
Chapter Six.
The controversies coloring the moral landscape of HPV vaccination were also
layered with ethical concerns regarding the target age group. At the time of its approval
in 2006, Gardasil was the only STI-vaccine offered during adolescence – a period of time
when many youth begin to explore their own sexuality and can potentially take a more
active role in the vaccine decision-making process. What role, if any, would (or should)
girls have in the vaccine decision-making process? If girls knew what the vaccine
protected against, would they interpret it as parental or societal permissiveness of
adolescent sex? Would adolescents misinterpret the breadth of protection provided by
the vaccine and have a false sense of security?

6

In 2009, the FDA later extended Gardasil approval for boys within the same 9 to 26 year age range (FDA 2009b). At the time that I conducted this dissertation research,
Gardasil had not yet been approved for use in males. However, in anticipation of
possible FDA approval, and recognizing the role that universal versus genderedavailability might have on decisions, I asked parents and providers to discuss their views
regarding a future HPV vaccine for boys.
Although there is potential for adolescent girls to participate in vaccine decisions,
parents remain the primary Gardasil vaccine decision-maker (Constantine and Jerman
2007; Dempsey, et al. 2006; Friedman and Shepeard 2007). Even before Gardasil
became available to the public, public health practitioners, economists, reproductive
health advocates, and healthcare practitioners were trying to predict the cost-effectiveness
of a vaccine, provider acceptability of a vaccine, and parental intentions to have
daughters vaccinated (Davis, et al. 2004; Goldie, et al. 2004; Kulasingam and Myers
2003; Mays, et al. 2004; Mays and Zimet 2004; Olshen, et al. 2005; Raley 2004; Sanders
and Taira 2003; Zimet, et al. 2005; Zimet, et al. 2005b). Efforts to predict parental HPV
vaccine decisions had to do not only with the potential economic costs of implementing
such an expensive and massive vaccination campaign, but also with the likelihood of
transforming the epidemiology of HPV-related diseases as a result of it. The vaccine’s
potential to reduce the rates of cervical and other HPV-related cancers, as well as genital
warts, largely depended upon –and continues to depend on – the willingness of parents to
vaccinate their daughters.
Despite significant efforts to identify factors associated with HPV vaccine
acceptance, an examination of the HPV vaccine acceptance literature – both prior to and
7

following approval in the United States - reveals little consensus about the significance of
different attitudes, beliefs, values, knowledge, or perceptions on HPV vaccine acceptance
(Allen, et al. 2010; Boehner, et al. 2003; Dempsey, et al. 2006). A detailed discussion of
the variability in past findings will be presented in Chapters Two and Three of the
dissertation, but for now, it suffices to say that researchers have not demonstrated a
predictive relationship between HPV knowledge and vaccination. Demographic
variables are commonly measured in parental HPV vaccine acceptance studies, but like
other measures, the association (the strength and direction) between variables and
acceptance varies widely.
Like parents, healthcare providers are part of the social and interactive experience
through which vaccines are discussed and decisions are made. Provider
recommendations appear to be key factors influencing parent vaccine decisions (Kahn, et
al. 2005; Klein and Wilson 2002 ; Mays and Zimet 2004; Millstein, et al. 1996; Raley
2004; Riedesel, et al. 2005; Sussman, et al. 2007; Torkko, et al. 2000); therefore it is
important to understand when and how providers initiate vaccine conversations, what
they discuss or leave out of conversations, and to whom conversations are directed.
Studies describing variations in provider recommendations by patient and provider
attributes are presented in the following chapter.
An Anthropological Approach to HPV Vaccine Decision Processes
As I will also argue more thoroughly Chapter Two, the parental vaccine
acceptance literature has been, and continues to be, largely shaped by the Health Belief
Model (HBM) and the Theory of Reasoned Action (TRA). Like all theories, the HBM
and TRA approach a phenomenon from a particular angle; as such, analyses will always
8

be limited in what they reveal. The problem is not that all theoretical models are limited,
rather, the problem arises when one or two theories or models underlie the bulk of the
literature regarding a phenomenon. The countless studies of parental vaccine acceptance
based on HBM and TRA models provide compelling evidence that the factors shaping
parental vaccine decisions vary significantly. That so many studies have revealed so little
consistency suggests that parental vaccine decisions are complex; no single set of factors
or beliefs can predict parental vaccine choices. While these two models help to identify
vaccine acceptance factors that need to be explored in greater detail, they cannot
adequately answer the “how” or “why” questions.
One of my goals in selecting this dissertation topic was to use an anthropological
perspective to explore the “how’s” and “why’s” of parental HPV vaccine decisions,
without reducing the complexity of decisions down to single, quantifiable variables.
Rather than viewing an HPV decision as a dichotomous outcome – such as a final choice
to accept or refuse the vaccine – I viewed parental vaccine decisions as processes that
often unfolded over extended periods of time, in the context of particular events, and
shaped by various actors. In order to describe the contextual landscape within which
parental vaccine decisions occur, I sought to understand the roles that daughters,
healthcare providers, spouses, the media, and other actors may have in directly or
indirectly shaping vaccine decisions. At the same time, I tried to position parental
vaccine decisions within their larger historical and socio-political context, for many of
the fears, risks, and hopes shaping HPV vaccine decisions result from and speak to
deeply rooted ideas and understandings of a world beyond Gardasil or vaccines in
general.
9

In order to achieve these goals, I chose a research design plan based on the
theoretical and methodological assumptions outlined in the Local Vaccines Culture
approach (LVC) (Nichter 1996c; Streefland, et al. 1999). An in-depth discussion of the
LVC approach is provided in Chapter Two; here, I highlight only that the approach calls
for a heavily qualitative analysis of both provider and parental perspectives, especially in
relation to the provider-patient interaction, in order to understand acceptance from
multiple levels. In brief, I conducted 26 semi-structured, in-depth interviews with parents
residing in Pennsylvania and Florida to elicit how they situate vaccines within their larger
social worlds. Perspectives were sought both from parents who had already made
definitive HPV vaccine decisions and from others who had not yet made a final vaccine
decision.
To develop an understanding of provider perspectives, semi-structured, in-depth
interviews were conducted with 16 providers in Pennsylvania and Florida, including
pediatricians, nurse practitioners, school nurses, and a chiropractor who work with
adolescent girls and who have discussed the Gardasil vaccine with parents. Interviews
were designed to elicit information about providers’ personal approaches to and beliefs
about vaccination, their perspectives toward this particular vaccine, their perceptions of
parental vaccine concerns, and the meanings that they ascribe to parental vaccine choices.
Additional factors, such as vaccine protocols, procedures, and billing were also explored
during provider interviews.
In order to couch both provider and parental narratives within their larger
sociocultural milieu, a literature review was conducted to better understand historical
developments in vaccine policy, mandates, and resistance; the economics of vaccination,
10

both generally and pertaining specifically to the HPV vaccine; the process by which the
Gardasil vaccine was developed and marketed to the general population; and the wider
media representations of vaccines.
Contributions
While anthropologists possess the perspective and tools necessary to provide indepth, thorough understandings of complex decisions that exist within larger structural
fields, anthropological contributions to the vaccine acceptance literature are almost nonexistent. The few anthropological studies that do exist primarily focus on infant and
early childhood immunization programs in developing countries (Cassell, et al. 2006b;
Fairhead, et al. 2004; Fairhead, et al. 2006a; Feldman-Savelsberg, et al. 2000; Kaljee, et
al. 2004; Millimouno, et al. 2006; Pool, et al. 2006; Samuelsen 2001a; Streefland, et al.
1999) or in the United Kingdom (Casiday, et al. 2006; Casiday 2007; Poltorak, et al.
2004; Poltorak, et al. 2005). At the time that I began this study, there existed, to my
knowledge, no anthropological literature that explored the values, meanings, and
processes underlying decisions regarding uptake of an adolescent vaccine, particularly
one that protects against a sexually transmitted infection.2
Providing socioculturally-informed research on parental HPV vaccine acceptance
that expands the scope of inquiry beyond parental beliefs, values, and perceptions can
positively contribute to the vaccine literature. Inhorn and Brown (1997:21) note that
anthropologists can make some of their greatest contributions to public health by

11

“helping to explain why people behave as they do.” An anthropological contribution can
also provide new ways of conceptualizing parental HPV vaccine decisions, which can
expand the scope of HPV prevention strategies and generate new research questions.
By using anthropological methods and theories to inform a public health issue, I
hope to expand the scope and perceived utility of anthropological perspectives, while
simultaneously providing useful and practical recommendations pertaining to HPV
vaccination protocols, communication, and education. The lack of anthropological
attention to this particular topic also offers an opportunity to contribute meaningfully to
anthropological theory. Specifically, this research question provides an opportunity to
further explore and explain how parents conceptualize issues of autonomy, power,
responsibility, and control in making HPV vaccine decisions, and how such processes are
shaped by and reproduce ideas about the maintenance, performance, and construction of a
child’s body.

12

Chapter Two – Theories of Vaccine Acceptance

“Nothing in science – nothing in life, for that matter – makes sense without theory. It is
our nature to put all knowledge into context in order to tell a story, and to recreate the
world by this means” (Pasick and Burke 2007:4.2).

The story of parental vaccine acceptance has largely been a single- authored
work, shaped predominantly by psychologically-based understandings of the world.
However, the story, as currently conceived, is incomplete and researchers with other
theoretical perspectives are beginning to suggest some revisions. In the first part of this
chapter I attempt not to tell the story of parental vaccine acceptance, but to critically
discuss the biographies of its contributors – the theoretical orientations that give shape
and form to the parental vaccine acceptance literature. After considering the strengths
and limitations of available theoretical approaches, I present a research framework that
offers theoretical flexibility.

Rational Actor Approaches
To begin, we need to examine how the word “theory” is used and what it is used
for. Researchers interested in health promotion and public health often conceptualize
theory differently from anthropologists. From an anthropological perspective, the
definition of theory commonly used in public health is rather limited. Many of the most
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commonly used health behavior theories are concerned with explaining and predicting
associations between attitudes, beliefs, and behaviors (Lupton 1995). The purpose of
these models is not “an overarching attempt to construct an epistemology of public
health” but to “produce a particular result under specific conditions” to more effectively
target interventions and improve public health (Lupton 1995:55). Model-building is
normalized and valued in public health and researchers strive to produce models that can
explain the relationship between beliefs and behaviors in multiple contexts. In public
health, the terms “theory” and “model” are often used interchangeably, as illustrated by
the names of the two most common theories used in the vaccine acceptance literature:
Health Belief Model (HBM) and Theory of Reasoned Action (TRA).
While the HBM and TRA differ in important ways, which will be discussed
shortly, they also share a set of common epistemological and ontological assumptions
that need to be recognized. Both prominent models of behavior change used in health
promotion, the HBM and TRA share roots in social psychology, drawing from Stimulus
Response Theory (SRT) and Cognitive Theory (CT)3 (Lupton 1995; Rosenstock, et al.
1988). Because of their historical roots in SRT and CT, the HBM and TRA are theories
within a larger cognitive/learning perspective (CLP). The CLP is a rational-choice
framework, underpinned by value-expectancy (VE) and subjective expected utility (SEU)
theories (Connor and Norman 1996; Mellers, et al. 1998). In models drawing from the
CLP, rationality refers to the reasoning process in which people engage to make

3

SRT combines assumptions from classical conditional and instrumental conditioning theories to posit that
people learn from “reinforcements” (i.e. events) that then reduce the physiological stimuli that induce
behaviors. Within this framework, human behavior can be explained by reinforcements alone without
accounting for human thought or reason (Rosenstock et al. 1988). Cognitive theory emphasizes the
importance of an individual’s subjective expectations in explaining her behavior, where her perception of
an outcome and the probability of it occurring will lead to behavior.
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decisions, which is thought to be deliberate, systematic, and rule-driven – and hence,
measurable and explainable (Connor and Norman 1996; Vernberg 1998; Vernberg and
Murphy 1996).
Rational actor approaches like the HBM and TRA are “value-expectancy models”
(VEM) (Prentice-Dunn and Rogers 1986; Weinstein, et al. 1998). Fundamental to VEMs
is the assumption that the expected benefits to risk reduction must be measured against
the expected costs of acting, although the particular components included as benefits or
risks, and their relative weights, vary by model (Weinstein 1993). This cost-benefit
analysis revolves around the individual. Drawing from SEU theory, the CLP assumes
that the “maximization or optimization of utility [and] strict methodological
individualism” primarily motivate human action (Taylor-Gooby and Zinn 2006:398).
Cognition is central to CLPs because behaviors are seen to be the result of individuallevel processes that are volitional (Vernberg 1998). However, the study of cognition is
limited to cognitive perceptions that are assumed to contribute to a rational cost-benefit
approach to choice (Vernberg 1998: 34). Theories drawing from the CLP are structural,
in the sense that structures (cognition) determine behavior (Kippax and Crawford 1993).
While the TRA and HBM are underpinned by many of the same theoretical assumptions,
there are important differences between the two.
The Health Belief Model (HBM)
The HBM is by far the most utilized theory within the vaccine acceptance
literature (Brewer and Fazekas 2007; Chan, et al. 2007; Gerend, et al. 2007; Keane, et al.
2005; Lazcano-Ponce, et al. 2001; Mays, et al. 2004; Niederhauser, et al. 2001; Rhodes
and Hergenrather 2002; Rosenthal, et al. 1995; Smailbegovic, et al. 2003; Sturm, et al.
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2005). The HBM essentially posits that if a person perceives a disease to be a threat to
her health, then she will be motivated to take actions to avoid or minimize that threat
(Noar 2005). The perceived threat (e.g., cervical cancer, genital warts, or HPV) is
measured by two factors: perceived susceptibility to the disease and perceived severity of
the disease (Hornick 1991). The action (e.g., vaccination) is more or less likely to occur
depending on the individual’s perception of two additional factors: the perceived benefits
and perceived barriers associated with the action (Coreil, et al. 2001). The model also
assumes that demographic variables affect how a person perceives these four factors, and
cues to action (e.g. media, a specific experience) are stimuli that trigger the decisionmaking process (Noar 2005).
While self-efficacy is not an original component of the HBM, it is often added to
the model to assess a person’s belief that she can initiate a behavior (Garcia and Mann
2003). By examining the relative weight of each factor in the model, researchers can
determine which factors appear to be most important to parental vaccine acceptance.
However, unlike other health-behavior models, the HBM provides no clear combinational
rules for analyzing the relationship among factors (Montano 1986). Researchers
generally use multiple regression equations to explore the relationship between factors,
where behaviors are outcomes and components are predictors (Prentice-Dunn and Rogers
1986).
The Theory of Reasoned Action (TRA) and the Theory of Planned Behavior (TPB)
Both the TRA and TPB assert that individual beliefs are the motivators of
individual action and that behavioral intentions to perform an action are the most
proximal prediction of whether a behavior will actually occur (Noar 2005). In the TRA,
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intentions are comprised of attitudes and subjective norms. Attitudes are made up of
behavioral beliefs (i.e., beliefs that a behavior has positive outcomes) and an evaluation
(i.e., the value one associates with a given outcome). Subjective norms are comprised of
normative beliefs (social norms about a behavior) and motivation to comply (how
motivated one is to comply with these norms). The more positive one’s attitudes and
subjective norms, the more likely one is to form a behavioral intention (Noar 2005).
While not traditionally part of the TRA, self-efficacy is often added to the model (Garcia
and Mann 2003).
The Theory of Planned Behavior includes the same components as the TRA, but
adds perceived behavioral control as a third major contribution in predicting intention.
Perceived behavioral control includes two components: control beliefs, which refer to the
perceived factors and resources that facilitate or impede a behavior, and perceived power,
which refers to the impact that each factor has on behavioral intention. Many researchers
also add a construct of self-efficacy to the TPB, which has been shown to increase the
model’s predictive abilities4 (Garcia and Mann 2003). The TPB asserts that behavior is
most likely to occur when the TRA requirements are met and when there is a high degree
of perceived behavioral control (Noar 2005).
Because the TRA and TPB include a normative component, they require that the
researcher conduct pilot testing, usually in the form of focus groups, to elicit the basic
concerns of the group that will then be integrated into a survey instrument (Brewer, et al.
2007a; Weinstein 1993). The use of pilot testing, advocates argue, allows for the model

4

In the TPB, self-efficacy is usually measured in terms of one’s confidence to complete a behavior while
behavioral control is measured in terms of the difficulty or ease associated with completing the behavior.
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to be used in cross-cultural settings, although this is questionable because these models
are still based on utilitarian, individualistic assumptions that do not always hold in the
United States, let alone cross-culturally (Kippax and Crawford 1993; Poss 2000).
The TRA and TPB are commonly used in the vaccine acceptance literature,
although rarely as the sole theoretical perspective. Nearly all of the studies using the
TRA or TPB use it in conjunction with the HBM (Dempsey, et al. 2006; Gerend, et al.
2007; Kahn, et al. 2005; Mays, et al. 2004; Paulussen, et al. 2006; Rosenthal, et al. 1995).
Most commonly, researchers use the basic constructs of the HBM, adding a normative
component from the TRA/TPB models (Poss 2000). The primary difference between
studies using the HBM model compared to the hybrid HBM/TRA model is that analyses
based on the latter hybrid model often include an evaluation of the relative importance of
social network norms on acceptance.
Several studies of HPV vaccine acceptance using these models indicate that for at
least a subset of parents, social norms regarding vaccine acceptability would affect their
likelihood of vaccinating (Kwan, et al. 2008; Marlow, et al. 2007a; Ogilvie, et al. 2007).
For example, in a study of HPV vaccine acceptance conducted among mothers in
England, Marlow and colleagues (2007a) found that mothers who perceived vaccine
acceptance to be more normative were also more likely to anticipate vaccinating their
daughters. In another study conducted with Chinese adolescent girls in Hong Kong,
researchers reported that perceived peer and family support of the vaccination was
associated with higher intention to vaccinate (Kwan, et al. 2008).
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The HBM and TRA – What they Tell Us, What they Don’t
Results from individual studies using the HBM/TRA in the vaccine literature do
suggest that certain factors are more important to parents than other factors; however,
there is little consistency in the findings across studies. A review of studies that used the
HBM to examine parental acceptance of an HPV vaccine yields varying results. The
most important factor related to parental acceptance of an HPV vaccine in some studies
has been perceived susceptibility (Brabin, et al. 2006; Friedman and Shepeard 2007;
Marlow, et al. 2007a; Olshen, et al. 2005; Riedesel, et al. 2005; Waller, et al. 2006),
although other studies have found no association between susceptibility and vaccination
(Litton, et al. 2011). Perceived severity has been significantly associated with vaccine
acceptance in some studies (Zimet 2005), but not in others (Dempsey, et al. 2006; Kahn,
et al. 2003). Several studies report that higher perceived vaccine effectiveness is
associated with greater parental vaccine acceptability (Davis, et al. 2004; Dempsey, et al.
2006; Gerend, et al. 2007; Zimet, et al. 2000; Zimet, et al. 2005b). However, perceptions
regarding what the vaccine protects against varied in these studies. For example, Fazekas
and colleagues (2008) found that vaccine effectiveness against cervical cancer was
related to parental vaccine acceptance, but perceived effectiveness against HPV infection
was not. Perceived barriers associated with sexuality have been a significant predictor of
non-acceptance, but only for small portions of the sample population (Constantine and
Jerman 2007; Davis, et al. 2004; Moraros, et al. 2006; Zimet, et al. 2005).
Demographic factors are also assessed in the HBM, although the association (the
strength and direction) vary widely. Education level, maternal employment, clinic type,
income level, insurance type, household type, parent age, and ethnicity have all been
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positively, negatively, and not associated with vaccine acceptance (see Table A1). I have
included a detailed description of these diverse associations, along with findings related
to the other HBM/TRA factors in the appendix. The results are simply too diverse to
include here in anything other than a brief summary. The variability found in different
studies likely results from multiple factors, including the use of different methodologies;
different state or national laws related to immunization services, health care coverage,
and mandates; the type of vaccine explored in the study; and the complexity of factors
that account for childhood vaccination status (Bardenheier, et al. 2004; Rosenthal, et al.
2004).
The primary feature that distinguishes research using the HBM from those using a
combined HBM and TRA approach is an emphasis on social influence. Studies using a
combined approach highlight the important role that family, friends, and partners have in
shaping vaccine perceptions. Multiple studies suggest parental vaccine acceptance is
affected by what other family members, including partners and parents (Dinh, et al. 2007;
Friedman and Shepeard 2007; Marlow, et al. 2007a) and other parents or peers
(Dempsey, et al. 2006; Rosenthal, et al. 2004) think about a vaccine.
Perhaps more than any other group, healthcare providers appear to exert a
significant degree of social influence on parental vaccine perceptions. The importance of
a healthcare provider recommendation appears to be one of the most consistently reported
factors associated with parental vaccine acceptance (Dempsey, et al. 2006; Dinh, et al.
2007; Esposito, et al. 2007; Rosenthal, et al. 1995).
Despite the suggested importance of the clinician recommendation, relatively few
studies have examined provider perceptions of the HPV vaccine and factors associated
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with recommending it. Several studies using the TRA have identified professional
medical associations as influential in providers’ HPV vaccine perceptions; pre-licensure
studies found that providers would be more likely to recommend a vaccine that was
endorsed by a professional medical association (Mays and Zimet 2004; Raley 2004;
Riedesel, et al. 2005).
Patient age continues to be associated with clinician recommendation practices;
providers are more likely to routinely endorse vaccination as a girl’s age increases
(Esposito, et al. 2007; Kahn, et al. 2005; Mays and Zimet 2004; Raley 2004; Riedesel, et
al. 2005; Tissot, et al. 2007; Vadaparampil, et al. In press). A healthcare provider’s own
comfort discussing sexual health concerns may also affect when providers talk about the
vaccine, the types of information they share about it, how they share it, with whom, and
when (Cheng, et al. 1999; Esposito, et al. 2007; Keating, et al. 2008; Rupp, et al. 2005).
Clinician specialization can also influence recommendation practices. Results from
nationally-representative (Daley, et al. 2010b; Ishibashi, et al. 2008a; Vadaparampil, et
al. In press) and smaller studies (Barnack, et al. 2010) indicate that pediatricians are
more likely than OB/GYN, family, and general practitioners to routinely recommend the
HPV vaccine to patients and are more likely to begin recommending the vaccine at
younger ages. More recent post-licensure studies have noted an association between
HPV vaccine reimbursement policies and provider recommendations. Providers
reporting insufficient insurance reimbursement were less likely to recommend the
vaccine to patients (Kahn, et al. 2009; Vadaparampil, et al. In press; Young, et al. In
press).

21

Knowledge and awareness about HPV infection, cervical cancer, and the HPV
vaccine are commonly assessed, although neither is a formal construct of the HBM or
TRA. However, their incorporation into these models reflects researchers’ beliefs that
knowledge and awareness are “prerequisites for making informed decisions about
vaccination” (Brewer and Fazekas 2007:2). It remains unclear how important knowledge
and awareness actually are in vaccine acceptance, because despite many studies on HPV
knowledge, few researchers have demonstrated a predictive relationship between
knowledge and vaccination. In several studies, knowledge of HPV was found to have a
significant effect on parental willingness to vaccinate (Chan, et al. 2007; Davis, et al.
2004; Fazekas, et al. 2008), but in several others, adults with very little biomedical
knowledge about HPV were willing to accept an HPV vaccine for themselves or their
daughters (Chan, et al. 2007; Friedman and Shepeard 2007; Lazcano-Ponce, et al. 2001;
Lenselink, et al. 2008; Zimet, et al. 2000). None of these studies measured a change in
knowledge (e.g. baseline compared to post-education scores), which makes them difficult
to validate.
Other studies show no association between knowledge and acceptance (Boehner,
et al. 2003). In a randomized intervention study (Dempsey, et al. 2006), 1,600 parents
with children between the ages of 8 and 12 completed a survey on HPV vaccine
acceptance. The researchers hypothesized that parents in the group that received HPV
information would not only score higher on knowledge scales about HPV, but also be
more likely to report vaccine acceptance. While there was significant improvement in
knowledge among this group compared to others, there was no significant change in
parents’ ratings of vaccine acceptance.
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When compared, the HBM and TRA each have relative strengths and weaknesses.
One of the main criticisms of the TRA and TPB is that they measure behavioral
intentions rather than actual behavior. Proponents of these models argue that intentions
are the best predictors of actual behavior (Montano 1986), but anthropologists have long
noted the discrepancy between ideal and real behavior. The assumption that intentions
are adequate proxies for behavior has seldom been tested and when tested, reveals
inconsistencies (Weinstein 1993). Perkins and colleagues (2010), for example, found that
in studies of HPV vaccine intentions, anywhere from 46 to 75 percent of parents reported
the intention to vaccinate their daughters, but a subsequent assessment of actual vaccine
rates found that only 38 percent of vaccine eligible girls had received at least one HPV
dose. Unlike the HBM, the TRA does not include any measure of vulnerability or
susceptibility, which likely affects behavioral choices. This reflects the original purpose
of the TRA, which was to explain behavior generally, not simply behavior under
conditions of uncertainty (Cameron 1997).
One of the main strengths of the TRA, compared to the HBM, is the inclusion of
social factors, although many researchers argue that by reducing social norms to
cognitions (beliefs) in the TRA, they are relegated to subjective, individualized factors
(Kippax and Crawford 1993). Unlike the HBM, the TRA also includes a priori
interaction rules which specify how variables in the model interact and how statistical
tests of the model should be performed. These rules provide for more uniform
comparison of studies using the TRA (Vernberg 1998).
A primary weakness of the HBM is that, in its original form, the HBM does not
account for behavioral intentions, perceived control, or other factors that have been
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demonstrated to influence vaccine acceptance, such as previous experience or social
network factors (Hausmann-Muela, et al. 2003). Another weakness relates to its lack of
specificity. Because the HBM does not articulate any clear combinational rules to
explain how cognitive factors translate into behavior, there is no unified way to measure
the strength, direction and interaction of factors (Abraham and Sheeran 1997; Pack, et al.
2006). Critics argue that without delineating the relationship between beliefs and action,
the HBM is more akin to a short list of variables, rather than a theoretical model (Connor
and Norman 1996; Weinstein 1993). On the other hand, the flexibility of the HBM
allows researchers to easily incorporate factors from other theories into the model –
which might explain why researchers tend to add elements of the TRA into the HBM,
rather than the other way around.
The summary of findings from the HBM and hybrid models tends to support this
characterization. Few of these studies provide a probabilistic model to explain how
factors relate to one another and are thus limited in their predictive abilities (Sturm, et al.
2005; Weinstein 1993). Sturm and colleagues (2005), who have published extensively on
parental vaccine choices using the HBM and TRA models, have recently questioned the
utility of assessing parental attitudes, beliefs, and knowledge using the HBM, pointing to
the weak predictive power of attitude measures in the HBM and outdated measures to
assess parental perceptions of children’s susceptibility. The HBM has also been
criticized for lacking a social norm component, which is a comparative strength of the
TRA and TPB. Despite these criticisms, the HBM continues to be a popular model
among vaccine acceptance researchers.
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The HBM and TRA also share similar strengths and weaknesses. As discussed
earlier, the HBM and TRA developed from similar assumptions about human behavior
and those shared underpinnings are the target of many criticisms that apply to both the
HBM and TRA. One of the main criticisms of the models is the over-emphasis on the
role of psychological and individual factors on behavior at the expense of social and
structural factors (Hausmann-Muela, et al. 2003). The focus on perceived risks, benefits,
attitudes, intentions, and susceptibility can lead to a somewhat narrow understanding of
the context within which parental vaccination choices occur. The models tend to portray
people as autonomous agents existing in a social vacuum (Lupton 1995). While the TRA
and TPB acknowledge the role of one’s social network in decision-making, the
conclusion that individuals ultimately make their own decisions about health behaviors
reflects cultural assumptions: researchers have demonstrated that in many cases,
individuals do not make their own healthcare decisions (Good 1994; Kippax and
Crawford 1993).
The theoretical preoccupation with the individual’s role in preventive health care
choices often leads researchers to search for “discrete, measurable variables” that relate
to particular behavioral outcomes. Often a population is segmented by personal
characteristics, such as mother’s education level, income, or ethnic identity, which
presumably make some individuals more or less likely to engage in a particular behavior.
Unfortunately, such distinctions, when significantly correlated with specific health
behaviors, reveal little about why, for example, a mother’s education level predisposes
her to seek or decline vaccination (Millimouno, et al. 2006; Nichter 1996c). In addition,
the emphasis and preoccupation with behavioral outcomes (e.g. acceptor/non-acceptor),
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neglects the “pathways and processes associated with vaccination acceptance” (Nichter
1996c:337).
Researchers with very different theoretical positions criticize the lack of emphasis
that the TRA and HBM place on process. Some cognitive theorists – who agree that
individual cognition leads to behavior – argue that the TRA and HBM are inadequate
because they fail to articulate the cognitive processes that shape particular attitudes or
beliefs. For these cognitive theorists, it is not enough to say, for example, that intentions,
which are shaped by attitudes, predict behavior. While the HBM/TRA can help target
interventions for behavior change, the models cannot specify how the underlying
cognitive processes work. As Mathews (1998:190) observes, “Predicting the points at
which people will make decisions based on assessment of cost or likelihood of cure,
however, is not the same as understanding how they do so.” This point has not only
theoretical, but practical importance. One must understand how particular cognitive
processes (or biases) influence attitudes or beliefs for interventions to work effectively5
(Connor and Norman 1996).
Many anthropologists are critical of the assumption that the processes
underpinning behavior change are the result of individual cognitive factors (Coreil, et al.
1994; Garro 1998a; Garro 1998b; Kippax and Crawford 1993). The inattention to
process denies the importance of context in decision-making. Decisions do not occur in
vacuums, but are shaped by broader social, economic, and political circumstances, as
well as individual experiences and emotions, that provide the context and meaning in

5

In Chapter Three, I describe the particular cognitive biases that these theorists use to explain particular
risk responses.
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which individual behavior takes place (Cameron 1997; Kippax and Crawford 1993).
Additionally, “thought (or cognitive activity) may not occur until after the behavior in
question has been enacted” (Kippax and Crawford 1993: 255). These concerns related to
the causal effect of cognition on behavior are legitimate – most studies using the HBM
and TRA are cross-sectional and therefore unable to measure a causal relationship
between cognition and subsequent behavior (Sheeran and Abraham 1997).
Like all theories, the HBM and TRA provide a limited understanding of a social
phenomenon. They help to identify factors that need to be explored in greater detail, but
do not adequately answer the “how” or “why” questions. Studies of parental vaccine
acceptance using the HBM/TRA models reveal that the factors – and the relative weight
of these factors – affecting parental vaccine decisions vary significantly. The lack of
consistent findings using these models suggests that parental vaccine decisions are
complex, and that no single set of factors or beliefs can predict parental vaccine choices.
The findings also suggest that the exclusive focus on subjective, individual beliefs, as
conceptualized in these models, is insufficient.
Yet the use of the HBM and TRA within the vaccine acceptance literature is
nearly monopolistic; researchers from diverse disciplinary backgrounds overwhelmingly
frame their vaccine research using theories of the HBM and TRA. As a result, current
findings in the literature reflect one perspective. One of public health’s strengths is its
multi-disciplinary heritage, and drawing on this heritage to incorporate other theories that
emphasize social and cultural factors can provide important information on vaccine
acceptance that both situates some of the individual-level findings and encourages a
reexamination of previously held assumptions.
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Anthropological Theories and Contributions
A more nuanced understanding of parental vaccine acceptance can be achieved by
expanding our scope of inquiry, particularly through the application of anthropological
theories and approaches. Anthropologists sometimes argue that culture is the factor
underlying behavior, though it is more likely that cultural factors, like cognitive factors,
shape behavior, rather than determine it (D'Andrade 1999). While anthropological
approaches have been used to understand many public health issues, anthropologists have
had a more limited role in vaccination research. Therefore, to understand how
anthropologists can (but have not necessarily) contributed to vaccine studies, it is helpful
to examine how anthropological theories have been applied to related fields, including
parental acceptance of oral rehydration therapy (ORT) and parental decisions regarding
fetal genetic screening, breastfeeding, and the use of certain childhood medications.
Attempting to parse out theoretical approaches to parental acceptance of
technological innovations within the anthropological literature is a sticky and somewhat
interpretive affair. Unlike many of their public health counterparts, many anthropologists
do not explicitly articulate the theoretical orientations that frame their research questions.
In addition, anthropological results are often descriptive and theoretically ambiguous.
While anthropologists often espouse theoretical rhetoric which is polemic –
suggesting that anthropologists strictly adhere to specific theoretical approaches – in
practice anthropologists tend to borrow from several theoretical traditions. For this
reason, any attempt to group theoretical contributions under one rubric or another is
artificial and limiting. However, in order to make general sense of these theories, I have
chosen to organize them into two very broad categories: meaning-centered and critical
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approaches. Within the meaning-centered category, I discuss cognitive and
symbolic/interpretive theories. I discuss political economy, Foucauldian, and feminist
approaches within the critical category.
Meaning Centered Approaches
While cognitive anthropological theory draws from diverse schools of thought,
theorists from this tradition generally agree with Goodenough’s assertion that culture
consists of a set of shared mental models that includes “whatever it is that one has to
know or believe in order to operate in a manner acceptable to its members” (Geertz 2001:
345). Because culture is located in the mind, anthropologists need to examine the
“organizing principles underlying behavior” to understand “how different people
organize and use their cultures” (Tyler 1996:353). Cognitive anthropologists are
particularly interested in the relationships between linguistic units and units of cognition,
which leads to a heavy emphasis on linguistic analysis (Agar 1974; McGee and Warms
1996).
In the 1980s, cultural models were understood as “pre-supposed, taken-forgranted models of the world that are widely shared . . . by members of a society and that
play an enormous role in their understanding of that world and their behavior in it”
(Garro 2004:18). These studies were largely descriptive and concerned with
understanding the emic perspective. Medical anthropologists using this approach tended
to focus on categorizing and classifying semantic illness categories, folk taxonomies, and
cognitive illness domains that people used to organize information about disease etiology,
symptoms and treatments (Agar 1974; Farmer and Good 2007; Trotter 1997).
Anthropologists working in the international health arena during this period drew heavily
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from cognitive approaches (Chowdury, et al. 2002; Good 1994; Nichter 1996b). For
example, Nichter (1996b) found that the ethnosemantic classification of a respiratory
condition as either “weak lungs” or “tuberculosis” affected local perceptions of the
purpose of tuberculosis medication, which contributed to delays in health care treatment
and drug misuse.
Cognitive anthropology in this vein was criticized for several reasons, one of
which related to the supposed homogeneity of cultural models. Anthropologists focused
on the shared elements of cultural maps but largely neglected to account for intra-cultural
variation (Garro 2004). Other criticisms of cognitive theory are shared with the HBM
and TRA: anthropologists focused on the end product (cultural maps) without explaining
the processes that contributed to these shared models (Garro 2004). In addition, findings
exclusively derived from descriptive cultural maps were often used to explain conflicts
between biomedical and traditional illness categories (Good 1994). However, like
researchers using the HBM and TRA, few cognitive anthropologists observed actual
behavior to see if it coincided with mental models (Chavez, et al. 2001).
More recently, however, cognitive anthropologists have attempted to address
some of these limitations. New techniques, such as cultural consensus analysis, allow
anthropologists to examine cultural homogeneity and cultural dissonance (Dressler
2001). Cognitive anthropologists also shifted their attention from the “formal properties
of illness models to their relation to natural discourse, and thus to context and
performance characteristics of illness representations” (Farmer and Good 2007). By
focusing on illness narratives and exploring them in the context of decision-making,
some cognitive anthropologists have sought to understand how people use cultural
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knowledge to make health care choices. As Garro (2004:19) explains, “narrative is an
active and constructive form of cognitive engagement that reflects participation in
specific social and moral worlds and depends upon personal experience and cultural
resources, including culturally available models.” This approach recognizes that
decision-making is affected by individual and cultural factors – many decisions cannot be
understood or predicted based on shared cultural models. However, advocates of this
approach argue that in cases where recurring decisions take place and there are
alternative choices, group members develop a set of shared standards and criteria for
making choices (Garro 2004:16).
The reshaping of cognitive anthropology has aligned cognitive interests more
closely with those of interpretive anthropologists. Indeed, much of the recent literature
on acceptance of health innovations draws both from cognitive theory and
interpretive/symbolic theory, making it difficult to separate examples into one school or
the other (Green, et al. 1994).
Symbolic and interpretive theories, to which I now turn, are also meaningcentered anthropological approaches. Margaret Lock argued that neither technologies nor
the human need for them are independent of culture – we need to analyze the “attribution
of meaning to technologies and their application” (Lock 2004:86). Anthropologists
drawing from symbolic and interpretive traditions (SI) are particularly interested in the
multiple meanings that technologies embody. SI approaches have been hugely influential
in medical anthropology, particularly in understanding medical innovation, compliance
issues, and physician/patient communication (Blume 2006; Good 1994; Kauchali, et al.
2004; MacCormack and Draper 1988; Mull and Mull 1988; Nichter 1988; Nichter 1996a;
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Princeton 1988; Samuelsen 2001b; Vecchiato 1997). Like cognitive anthropologists,
anthropologists from the SI tradition largely treat culture as a mental phenomenon.
However, SI anthropologists reject the assertion that culture can be modeled or studied by
searching for cognitive domains within people’s minds. While SI theorists agree that
culture cannot exist apart from individuals, they argue that it is better studied by
examining how people interpret the events and materials around them. Geertz, a pioneer
in interpretive theory, explained that “Whatever sense we have of how things stand with
someone else’s inner life, we gain through their expressions, not through some magical
intrusion into their consciousness.” Culture is “embodied in public symbols and actions”
where symbols work to transmit meaning (McGee and Warms 1996:430).
Rather than studying linguistic taxonomies, Geertz asserted that the study of
culture was a study of everyday life. In Geertz’s (2001:341) opinion, “behavior must be
attended to, and with some exactness, because it is through the flow of behavior – or,
more precisely, social action – that cultural forms find articulation.” Axiomatic to this
approach is that humans imbue the world with meaning and significance. Social groups
are connected to one another through a system of shared meanings and symbols and
social life is seen as the process by which people create and negotiate meaning (Moore
and Sanders 2006). By observing social life and everyday activities, one can study
culture. In this sense, culture is used as an analytic concept to explain “an ordered system
of meaning and symbols, within which actors interpret their experience and order their
actions” (Moore and Sanders 2006:10).
This approach has been used to understand how vaccines develop multiple
meanings in a cultural group and how these meanings affect the success or failure of a
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program. Two examples will illustrate this point. In The Gambia (Fairhead, et al.
2006b), blood is powerful and health-promoting – to lose blood is risky. While vaccines
do not draw blood, locals connected vaccines with past health programs that did draw
blood samples. Coupled with suspicions about the uses of African blood (to help white
people at the expense of Africans), vaccines took on multiple meanings among locals that
complicated vaccine decisions. Conversely, in the village of Kéru in Burkina Faso,
vaccines were generally accepted not because of what they contained but because of how
they were administered. Local incision techniques require healers to penetrate the skin in
order to mix medicine with blood – the medicine becomes meaningful when it is
dispensed in this manner to infuse with the blood. Because of their similar route of
penetration, vaccines were widely accepted by healers and parents (Samuelsen 2001a).
Arthur Kleinman’s “explanatory models” (EM) approach draws largely from a
meaning-centered perspective (as well as cognitive anthropology) and is a commonly
used framework to understand physician/patient interactions and health care seeking
behavior. EMs originally developed as a framework to improve provider-patient
communication in clinical settings. Kleinman posits that both the patient and the
provider bring their own EMs to the clinical encounter and that EMs include explanations
of etiology, onset of symptoms, pathophysiology, the severity of type of sickness, and
treatment. Additionally, Kleinman argues that “EMs are tied to specific systems of
knowledge and values centered in the different social sectors and sub-sectors of the
health care system” (Hausmann-Muela, et al. 2003:6). Kleinman insists that explanatory
models cannot be ascertained through formal elicitation techniques; rather, EMs emerge
through discourses and often change depending on the illness event (or stage of an
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illness). Therefore, health behaviors need to be understood as responses to a “particular
episode of illness within specific clinical and life-world contexts” (Hunt and Arar
2001:349). Kleinman’s approach has been used in many studies of patient-provider
interactions to examine risk communication practices (Lazarus 1988), health seeking
behavior (Hausmann-Muela, et al. 2003), and “compliance” issues6 (Hunt and Arar
2001).
Despite differences between cognitive and interpretive theoretical perspectives,
the meaning-centered anthropological theories have been criticized on similar grounds.
Theorists within these schools have been accused of casting individuals as “supremely
knowledgeable” – aware of an association between their beliefs and their actions and
capable of articulating these connections (Moore and Sanders 2006:11). While
individuals are supremely knowledgeable (in the sense that anthropologists can learn
everything about a culture from individuals), they simultaneously lack agency – a
difference from the HBM and TRA models. In cognitive and SI theories, individuals are
largely conceptualized as vessels through which culture flows – their interpretations,
thoughts, and ideas are largely structured by cultural values and beliefs. While Geertz
might argue for the importance of observing how meaning is interpreted in everyday life,
the underlying assumption is that the cultural script with which people are acting has
already been written (Roseberry 1982).

6

The EM approach can be used to explore broader issues beyond the physician-patient dyad. For example,
Princeton (1988) contrasted the EM’s of public health officials and members of a small Colorado cult to
understand why a diphtheria vaccine intervention failed in the midst of a community epidemic. After
examining the incompatibility of epistemological beliefs held by the group members and public health
officials, the broader meanings that each group associated with particular health practices, and the way that
the intervention was approached, Princeton concluded that the public health campaign was bound to fail.
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One of the primary critiques of these anthropological approaches is that they fail
to articulate the relationship between “systems of ideas and patterns of behavior” (Moore
and Sanders 2006: 11). In other words, how are meanings and values transmitted between
groups and individuals and how do group values and beliefs relate to individual actions?
While few anthropologists would likely dispute the importance of meanings and symbols,
many anthropologists are interested in understanding the importance of these meanings
and symbols in action.
Some critics of the meaning-centered theories dispute their application in studies,
many of which focus on the differences between public health and lay population beliefs
about the body, disease, and treatment. These studies, critics argue, conceptualize
cultural groups as discrete and bounded wholes that have particular, somewhat
homogenous health beliefs that vary to a relative degree from the biomedical disease
model (Brodwin 1997; Good 1994; Streefland, et al. 1999). This criticism is directed
both at the theory, for failing to explicitly examine or expose power differences, and at
the ways that anthropologists have used these theories. To examine this latter point, it is
worth discussing the history of medical anthropology’s engagement in public health
interventions, especially internationally.
In the 1950s, public health programs were introduced in developing countries
with the overarching goal of altering local behaviors to improve population health (Good
1994). Despite well-meaning, if ethnocentric intentions, innovations were met with
apathy or resistance, falling victim to the fallacy of the empty vessel (Scotch 1963).
Anthropologists argued that the internal logics of a cultural system had to be understood
before public health interventions could be successfully implemented (Good 1994).
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These early anthropological works developed an adversarial model to explain local
resistance to technologies where “scientific and traditional medicine were locked in a
battle, each trying to win (or hold on to) the allegiance of the community” (Foster
1977:528). While early anthropological work was often sharply critical of health
planners’ naiveté and ethnocentrism, it nonetheless was framed upon assumptions about
the validity and superiority of biomedical technologies. The anthropologist’s job was to
understand how cultural beliefs interfered with the transplantation and acceptance of
biomedical knowledge, which was largely unquestioned as superior. Moreover,
anthropologists focused nearly exclusively on the local beliefs that could interfere with a
public health program, while ignoring service-level factors. As Foster (1977:528) noted,
“many of the apparent resistances to acceptance of health services commonly attributed
to villagers’ apathy and their cultural barriers, are, in fact, the result of administrative and
professional inadequacies.”
While anthropologists have become more aware of biomedicine’s western,
epistemological foundations and are more skeptical of innovation and development,
critics argue that the same assumptions guide research today. Viewing resistance to
technology as a product of cultural miscommunication, anthropologists often become
cultural mediators, who attempt to identify the disparate beliefs in order to “negotiate
between the two cultural worlds and craft the health-education messages recommended
by biomedical science in appropriate, locally acceptable idioms” (Brodwin 1997:71).
These goals are clearly stated in Kauchali and colleagues’ (2004:82-83) examination of
diarrhea care-seeking behavior among parents in a rural district of South Africa. As the
authors noted in their paper,
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The purpose of this study was to contrast caregiver’s beliefs and concepts
pertaining to childhood diarrhoea with bio-medical concepts and care guidelines
used by health workers and researchers. The aim was also to identify possible
differences that could lead to delayed care-seeking, improper diagnoses and
treatments by health workers or which could invalidate data on diarrhoea
prevalence and severity in research.
The issue highlighted here is the adoption of an uncritical “liberal reformist position,”
which assumes “that health development provides practical and apolitical tools for
solving specific human problems” (Brodwin 1997:72). Critics argue that innovations and
interventions cannot simply be seen as altruistic attempts to improve the lives of others;
rather, they need to be viewed within a larger historical and political context that
recognizes shared and competing interests. While I agree that interventions need to be
considered critically before anthropologists decide whether to contribute to their
implementation, I would also oppose a wholesale rejection of such involvement on the
supposition that it might advance biomedicine or the interests of particular political
players. Such criticisms should not lead us to reject applied or interdisciplinary work, nor
meaning-centered approaches.
As Good explains, post-interpretive theoretical developments demand a more
complex understanding of culture: “Given the emergence of practice theories and wideranging forms of critical analysis, it is little surprise that some formulations in this
tradition now seem dated or that the very term ‘meaning-centered’ now seems best placed
in quotes” (1994:56). Most contemporary applied anthropologists, regardless of their
main theoretical orientation, are aware that their work contributes to certain types of
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knowledge production and think carefully about how to best approach a research topic
given these fundamental issues.
Critical Medical Anthropology, Political Economy, Foucault, and Feminist
Approaches
Critical medical anthropology is perhaps more of an over-arching approach than a
theory. While there is no one definition of critical medical anthropology, Morgan
(1987:135) defines it as a “radical critique . . . concerned with illness as a metaphor for
internalized, somaticized exploitative social relations. The foci of intellectual inquiry are
the body, which absorbs and reflects social dissonance, and medical institutions, the
histories of which reveal societal attempts to cope with dis-ease.” Critical medical
anthropologists, drawing from political economy, Foucauldian, and feminist theory, have
used this approach to challenge western epistemology and anthropologists’ roles in
reproducing the power relationship inherent in western epistemology (Kincheloe and
McLaren 2003).
While symbolic and interpretive theories focus heavily on the meaning-centered,
ideational role of culture, political economy (PE) approaches predominantly focus on
structural, macro-level forces in shaping culture. The PE of health is primarily a macrolevel theory focused on the relationship between modes of production, class-based
division of labor, and inequality. PE is a materialist position whereby material conditions
of unequal access to wealth and power are assumed to condition social relationships
(Erickson and Murphy 1998). Anthropologists using this approach tend to examine the
ways in which societies group individuals (e.g. by class, gender, or ethnicity) and how
power and wealth are distributed within the society. Within this framework, culture is
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conceptualized as a system of objective and concrete forces, or ideologies, that reflect
specific interests among members in society (Erickson and Murphy 1998). Cultural
beliefs become resources that people use to “address the major social and economic
contradictions affecting their lives” (Brodwin 1997:73).
Anthropologists using a PE approach draw on a historical perspective to inform
their research and tend to employ dialectic or conflict models of social change in their
analyses (Morgan 1987). Unlike meaning-centered approaches (which have been
categorized as reformist), a conflict-based ideology is central to the PE model (and all
critical theories). Here, anthropological research is used primarily to critique the
“dominant reformist ideology, “to expose health inequities and domination, and to link
local, national, and global entities in “webs of political influence” (Brodwin 1997:73).
PE approaches contribute to the broader research on parental acceptance of
innovations (Greenough 1995a; Greenough 1995b; Obadare 2005; Turnbull 1989).
Historical examinations of parental resistance to the smallpox vaccine in Victorian
England reveal how mandatory immunization laws disproportionately affected the
working class, who were also more likely to be harmed by vaccination (Durbach 2000;
Durbach 2002; Fenner, et al. 1986). Viewed through this lens, compulsory vaccine
campaigns are exposed as symbols of class oppression intended to homogenize and
regulate the bodies of working class citizens (Baker 2003; Hobson-West 2007). More
recent cases of vaccine resistance, such as opposition to the pertussis vaccine, have been
analyzed as expressions of class-based tensions (Baker 2003). In another recent example,
resistance to the oral polio vaccine among parents in Nigeria is analyzed as the result of
religious and political conflicts between Islam and the West (Yahya 2006; Yahya 2007).
39

By examining the events unfolding in several Nigerian villages, the author ultimately
questions the roles, motivations, and actions of several global and national actors who
were associated with the immunization program, concluding that the 16-month vaccine
standstill was ultimately a “play of political might between the international community
and the federal government on one hand and the northern Muslim states on the other”
(Yahya 2006:7). In this case, parental resistance to the vaccine was not understood as the
outcome of individual choices or shared local meanings, but as the consequence of
macro-level dynamics.
Political economy approaches are not without critics. While symbolic
anthropologists are criticized for failing to account for structures, political economists are
assailed for focusing too heavily on structures (Erickson and Murphy 1998). Further,
many anthropologists argue that political economy approaches are too deterministic,
often relegating individual actors to obscurity (Knauft 1996). When agency is discussed,
it is often narrowly defined as explicitly political actions that either reinforce or resist
overt types of domination (Brodwin 1997).
Critics argue that by focusing exclusively on the role of an innovation (e.g.
vaccines) in advancing or diminishing the power of specific interest groups,
anthropologists tend to overlook the benefits that local people might perceive from such
programs (Brodwin 1997). Other anthropologists reject the PE theory as ethnocentric
because of its roots in Marxist philosophy, which is premised on the assumption that
“culture is the product of materialist power struggles – a uniquely Western form of
analysis” (Erikson and Murphy 1998:139). The assertion that there is only one “cause of
configuration between industrial capitalism, colonialism, and the post-Enlightenment
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ideal of scientific progress” has caused many anthropologists to question some of the
basic assumptions of the approach (Erickson and Murphy 1998:139).
Foucauldian examinations of power and discourse are another strand of analysis
that can be included with the vein of critical medical anthropology. Foucault was
particularly interested in the relationship between power and knowledge and the process
by which some forms of knowledge become legitimate. Foucault argued that one way in
which power is exerted over bodies is through particular knowledges of the body. When
power is exercised onto bodies, the bodies become objects and effects of knowledge. The
individual body, rather than the disease, becomes the dangerous entity (Nettleton 1988).
In the context of vaccine-preventable diseases, it is the unvaccinated body, rather than the
disease, that must be controlled. Dew (1999) reveals how UN conventions, national
policies, and state laws use coercive measures, through ideological, legal and financial
means, to compel parents to vaccinate their children, exemplifying the way in which
dissenting bodies, rather than diseases, are targeted.
While some regulations are externally-driven, Foucault argued that bio-power, or
control over the body, was most effective when bodies became disciplined; that is, when
regulation of the body was internalized, rather than imposed by external forces (Gaines
and Davis-Floyd 2004). From this perspective, mass immunization campaigns,
especially voluntary campaigns with high coverage rates, are understood as effective
mechanisms of the state that function to regulate, surveil and control individual bodies.
Researchers have commonly used this Foucauldian perspective to understand why so
many parents routinely vaccinate their children without putting much thought into it
(Brownlie and Howson 2006; Streefland, et al. 1999).
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For Foucault, power and knowledge are inseparable. For example, biomedical
knowledge about the body (contagion) led citizens in many European countries to accept
increased state control over the regulation of individual bodies (e.g., through quarantine,
vaccines, etc.). This act authorized and legitimized the expansion of state power into the
domain of public health. The success of vaccination programs further legitimated
biomedical knowledge about disease, while illegitimating other forms of knowledge.
Through this process “the exercise of power perpetually creates knowledge and,
conversely, knowledge constantly induces the effects of power . . . Power was exercised
on bodies and thereby rendered them both the object and effect of knowledge” (Nettleton
1988:160).
Nations and Rebhun (1988) explored the relationship between power and
knowledge to explain why oral rehydration therapy (ORT) was underutilized by parents
in northeastern Brazil. The authors argued that the Brazilian biomedical institution, as
embodied by physicians and nurses, created a set of rituals surrounding ORT in an
attempt to mystify the treatment event. By dramatizing the rituals associated with ORT
administration, by admonishing parents who used alternative treatment techniques, and
by limiting the use of ORT to the clinic (rather than distributing stockpiles of unused
ORT for home use), biomedical practices gained ascendancy and legitimacy over other
forms of healing. New knowledge about diarrhea and dehydration was created – ORT
became a biomedical entity requiring expert supervision in a clinic-setting for proper
delivery. As a result, few parents felt confident that they could manage to deliver ORT to
their own children. A similar situation was described in Jamaica, where aid agencies
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advertised and sold ORT as a biomedical medicine, even though the ingredients were
common household items that most parents had (MacCormack and Draper 1988).
While these analyses provide an alternative and challenging view of biomedicine
that raises important questions about technological innovation, social justice, and
competing stakeholders’ interests, it simultaneously challenges parents’ abilities to make
health care decisions. The anthropologists assume that the parents would prefer to
administer the ORT themselves if they had access to it, or if physicians presented it
differently – or that parents would resist vaccine programs if they understood them as a
disciplining discourse of control. This might be the case, or it might not. Interpreting
others’ cultural beliefs and practices as mystification or false consciousness raises
questions about knowledge and differences in what anthropologists and lay people can
know. As Good (1994:61) explains, “it risks making actors be dupes – of a hegemonic
system, in this case – even as it authorizes the perspectives of the observer over the
claims of those we study.” When people’s knowledge claims are analyzed as
mystification they become the subject of the anthropologist’s epistemological judgments,
“with some version of a distinction between science and ideology” (Good 1994:61). The
anthropologist/physician/scientist “knows better” critique once again rears its head.
As a final critique, some anthropologists also question the applicability of critical
approaches to the “real” world. While critiques of biomedical, public health, and
physician processes (as well as anthropology as a discipline with western-epistemological
roots) provide an alternative way to view health care and the role of structures in
disciplining such interactions, one also has to question how applicable these critiques are
to the applied anthropologist who hopes to work within the public health system to effect
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change. As Good (1994) correctly notes, approaches that are critical of biomedicine and
public health exist at the same time that children die of vaccine-preventable diseases.
Feminist theories, as they relate to medical anthropology and vaccine research,
have been injected into larger theoretical frameworks to approach an analysis of the
medicalization of motherhood, whereby mothers face increasing pressure to make
decisions regarding an expanding number of technological innovations (Malacrida 2002;
Rapp 2000; Rothman 1982; Viisainen 2000). Mothers, as opposed to parents, are often
the targets of health interventions, reflecting social expectations about the roles and
responsibilities of the mother (Petersen and Lupton 1996). Perhaps as a result of this
disproportionate focus on maternal accountability for childhood health, many mothers
express feelings of responsibility, liability, and blame when making vaccine decisions on
behalf of their children (Sporton and Francis 2001; Tickner, et al. 2007). These decisions
are no doubt complicated by value-laden meanings and implications, thus tying them to
meaning-centered approaches. Certain types of choices and the responses that those
choices elicit from mothers, physicians, the state, and the public “embody both positive
and negative feelings about women, motherhood, and sexuality” (Zeitlyn and Rowshan
1997:66).
The literature on the medicalization of motherhood tends to focus on differential
power relationships between mothers, physicians, and the state, often through the lens of
authoritative knowledge (Jordan 1997). Mothers who refuse biomedical treatments are
often stigmatized or blamed for their decision (Craven 2005). For example,
pharmacological treatment of Attention Deficit Disorder (ADD) is disproportionately
valued by most physicians, many educators, and the state. Mothers who refuse to treat
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their children with ADD drugs are often the subject of targeted interventions that portray
them as non-compliant, ignorant, or irresponsible (Malacrida 2002). Women who choose
unassisted births face similar stigma – women are often described as “calculating
criminals”, “unnatural”, and “callous murderers” in narratives (Lupton 2003:166). While
examining the meaning of motherhood, it is important not to conflate motherhood with
womanhood, or to assume that all mothers experience motherhood, or decisions related to
it, in the same way (Lewin 2006). One must be careful not to strip gender from other
social categories that undoubtedly interact with gendered-beings – such as class,
ethnicity, sexuality and religion. As several studies on mothers’ decisions regarding
prenatal screening have noted, the meanings of motherhood and how expectant mothers
make choices about pre-natal screening vary by class and ethnicity (Hunt, et al. 2006;
Rapp 2000).
Recently, researchers have explored the intersection between medicalization and
marginalization, where particular kinds of mothers, such as single mothers, teen mothers,
or welfare mothers are singled out (or doubled out?) – not only because of their health
care choices, but because of their sociocultural positions (Ellison 2003; Malacrida 2002;
Solinger 2005). In a study of vaccine acceptance in India, researchers found that mothers
in lower castes experienced significant obstacles to vaccination –forced to wait outside of
a vaccination house until all of the children of higher castes had been immunized
(Streefland, et al. 1999). Other studies reveal the important role that gender can play in
the success and implementation of vaccine programs (Millimouno, et al. 2006; Nichter
1996c). In Bangladesh, for example, vaccine discussions occurred from behind a curtain
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because male vaccinators were prohibited from having face-to-face discussions with
mothers.
The normalization of feminist approaches within the larger anthropological
discipline has expanded its application so that gender analyses can be incorporated into
diverse theoretical frameworks (Lewin 2006). Because the analysis of gender has
become so widely accepted in anthropology, many anthropologists write “gendered
ethnographies,” where women’s lives are not an area of inquiry of themselves, but a lens
through which broader topics are examined (Knauft 1996). While the lives and
experiences of women – as mothers who are socioculturally positioned in multiple and
overlapping ways – is an important component of my study, it is not in itself adequate to
understand HPV vaccination decisions. As Knauft (1996) notes, the goal is to bring
gender into the equation rather than to make it the equation.

Theory in the Middle: The Local Vaccine Culture Approach
“We need to know, not only what use the answer will be to someone else, but what use it
will be to us. Are the questions we ask worth having answers to? This is a pragmatic
view” (Herzfeld 2001:24).
Meaning-centered and critical approaches all provide important contributions to
the parental vaccine acceptance literature. These approaches, which begin with
assumptions about the importance of sociocultural factors in shaping individual
behaviors, provide an important balance to the more individualistic HBM and TRA
models. However, while the anthropological frameworks offer more holistic
examinations of vaccine acceptance than are often present in the health behavior
literature, they also tend to limit the role of human agency. On one extreme, the
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psychological health behavior theories focus so narrowly on the individual actor that they
lose sight of the larger social and cultural contexts that shape individual decisions. On
the other end are the anthropological theories, which focus so widely on the role of
sociocultural factors in shaping individual behavior that individuals are largely irrelevant.
While anthropologists chastise public health officials for perpetuating the fallacy of the
empty vessel, many anthropologists could be accused of perpetuating a similar fallacy,
although in this case we could call it the fallacy of the culturally (or structurally) sinking
vessel. In reality, I should note, it is unlikely that many anthropologists do perpetuate
this fallacy. Rather, it exists in the meta-theorizing and grand debates that still occupy
much of the discipline but not much of the work. As Knauft (2006) notes, most
anthropological work “sits in the middle” – borrowing from theoretical traditions to
inform specific research questions. Many of the examples that I used to illustrate one
theoretical perspective could probably be used to highlight other theoretical approaches.
In actual writing, there is extreme hybridization that reflects a post-post modern current
in anthropology.
Knauft (2006:412) states concisely what I have found in my own review of the
literature that “increasingly, theory in anthropology emerges not in itself but as a modifier
of specific topics and issues to which theoretical articulations are applied, explored, and
expressed.” The most useful approach that I have found for my own research, the “Local
Vaccine Culture” framework, fits within this category. The approach combines strengths
of the HBM and meaning-centered and critical theories to provide the flexibility to
examine individual, symbolic and structural issues surrounding the HPV vaccine and
parental acceptance.
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This approach was largely developed by Nichter (1996c), who proposed that in
order to understand vaccine acceptance a distinction needed to be made between active
demand, passive acceptance, and non-acceptance. According to Nichter, active demand
“entails adherence to vaccination programs by an informed public which perceives the
benefits of and need for specific vaccinations” (1996c:330). Passive acceptance, on the
other hand, “denotes compliance,” it is the “passive acceptance of vaccinations by a
public which yields to the recommendations and social pressure, if not prodding, of
health workers and community leaders” (1996c:330). Examples of passive acceptance
include cases in which mothers vaccinate their children to avoid being blamed or overcharged if their children fall ill in the future (Millimouno et al. 2006).
In order to distinguish between active demand and passive acceptance, Nichter
emphasizes the need to examine supply and service factors, social factors, and cultural
factors that shape vaccine decisions (1996c). Therefore, Nichter argues that structural
and symbolic perspectives need to be explored by examining the perspectives of parents,
as well as other actors, including service providers, in the local and historical context. In
addition, he argues for the need to explore cultural factors related to a specific vaccine
and vaccines in general, since both affect vaccine demand (Gore, et al. 1999; Ogilvie, et
al. 2007; Slomovitz, et al. 2006; Sturm, et al. 2005). Finally, he calls for a shift from
exclusively focusing on “predictors of non use [of vaccinations]” to studies that also
examine predictors of demand and self-regulation which “pay credence to the agency of
community members” (1996c:336).
Nichter’s original framework underpins most of the recent anthropological
research on parental vaccine acceptance, because his work provides the basis for the
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“Local Vaccine Culture” (LVC) approach. The LVC approach was proposed by
Streefland and colleagues (1999) as a more comprehensive version of Nichter’s original
framework. They argued that in practice, the concepts of active demand and passive
acceptance lacked sensitivity to assess actual vaccine behavior. In response, they
proposed three general conceptual categories: acceptance, social demand, and nonacceptance. The authors argue that there are “gradations of acceptance” (1999:1710),
pointing to cases where parents might fully vaccinate one child, partially vaccinate
another, and choose not to vaccinate a third. To account for these cases, they suggest a
continuum rather than a dichotomy to understand acceptance. In Nichter’s original
framework, active demand results from people’s recognition of an association between
the vaccine and specific therapeutic effects. Streefland and colleagues (1999) created
another concept, called “social demand” to account for vaccine demand that is associated
with general vaccine benefits or general trust in biomedicine. This category is helpful to
describe instances in which there is a demand for a vaccine, but the demand does not
relate wholly to the vaccine’s biomedically-defined therapeutic effect7.
In the LVC approach, there are three modes of non-acceptance to describe the
various reasons why vaccination does not occur. In one mode, mothers are willing but
unable to vaccinate because of inclement weather, transportation constraints, or work
requirements. In the second mode, mothers simply refuse to go to the vaccination site,
which reflects resistance to the program rather than the technology itself. Provider
attitudes, misinformation about vaccine availability, and concerns about side effects are

7

For instance, studies have shown that some mothers accept vaccines because they feel that the vaccine
will generally improve a child’s health or prevent general illness, rather than because they associate a
particular vaccine with the prevention of a specific disease.
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included in this mode, although the authors mainly attribute refusals in this mode as a
response to the perception that services are inadequate or malfunctioning. In Malawi and
Ethiopia, for example, mothers responded that vaccinators rarely showed up to the clinics
to give the injections, and in cases when they did show up, there were not any vaccines to
dispense (Streefland, et al. 1999). In the third mode, mothers question the need for
vaccination itself. In this mode, the challenge is directed at the technology rather than its
delivery. The authors attribute cases of collective and organized resistance to this mode.
While past anthropological studies tended to emphasize either the cultural
acceptability of a vaccine itself (meaning) or the delivery of a vaccine program
(structural), the LVC framework allows for the exploration of both by examining them
through the lens of service-delivery (Greenough 1995b). Fairhead et al. (2004:4) note the
importance of exploring the interactions between parents and healthcare providers,
arguing that these interfaces involve “communicative processes, creative exchanges and
negotiations of knowledge and meaning which are both framed by, and in turn shape,
people’s broader perspectives on the technologies, issues and agencies concerned.” The
framework provides an integrated and dynamic approach to explore vaccine acceptance
that connects individual practices to larger community processes, without pre-supposing
the specific means through which such connections are enacted.
Though some have made minor changes8 to it, the LVC approach has remained
popular among anthropologists conducting research in diverse parts of the world (Cassell,
et al. 2006b; Fairhead, et al. 2004; Feldman-Savelsberg, et al. 2000; Kaljee, et al. 2004;

8

Millimouno et al. (2006:1), added “significant lateness” to the category of “non-acceptance” and replaced
“non-acceptance” with the word “default” to allow for cases in which mothers accept vaccines in principle,
but in practice are incapable or unwilling to complete the vaccine schedule.
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Millimouno, et al. 2006; Poltorak, et al. 2004; Pool, et al. 2006; Samuelsen 2001b;
Streefland, et al. 1999). The approach has primarily been used to examine vaccine
acceptance in developing countries, but it has also served as a framework to examine
parental acceptance of the MMR vaccine in the U.K. (Casiday, et al. 2006; Leach 2005;
Poltorak, et al. 2004; Poltorak, et al. 2005). The strength of the framework (and a
potential weakness) is its breadth – it allows researchers to examine the individual
experiences and emotions, shared (or contested) meanings surrounding vaccination, and
political and economic factors shaping vaccine policy and delivery as part of an
integrated system. As a framework, the approach provides parameters through which the
problem can be explored, without stifling the ability to engage in inductive theorizing.
The approach has yielded complex, in-depth accounts of vaccine acceptance that
encourage diverse and more nuanced theoretical understandings of vaccination behaviors
and acceptance.
Incorporating elements from multiple theoretical perspectives into a coherent
structure provides a dynamic, adjustable lens, which can be focused for both close-up and
panoramic views of a research question. By capturing multiple levels of data, the
resulting collage of information is more likely to capture the rich and complex layers of
vaccine acceptance decisions than a narrowly-focused, single-theory snapshot may do.
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Chapter Three – Theories of Risk

A large body of literature drawing from multiple theoretical strains attempts to
explain how and why people identify, process, and respond to risks. Much of the risk
literature draws extensively from psychological, cognitive, and economic theories, which
tend to explain risk perceptions and decision-making from a rationalistic, individualistic
orientation. More recently, however, many researchers have shifted their attention to
sociocultural risk theories, suggesting an increasing consensus that social and cultural
factors play a significant role in how people identify, perceive, and respond to risks. In
this section, I will provide a brief overview of the theoretical schools that influence risk
perception studies, along with the strengths and limitations of each perspective. I will
then illustrate how our current understanding of parental risk perceptions and decisionmaking reflects these different strains, primarily drawing on examples from the vaccine
literature. In reviews of the risk literature, authors tend to distinguish between cognitivescience approaches and sociocultural approaches (Berry 2004; Lupton 1999). I will use
the same general distinction to discuss risk theories, recognizing however, that there are
substantial variations within each category, as well as some overlap between categories.

Cognitive-Science Approaches to Risk
Most of the general risk literature is underpinned by a cognitive science approach
(CSA). Like all approaches, the cognitive science approach is predicated on a set of
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epistemological and ontological assumptions that frame the way that researchers examine
and seek to answer specific research questions. Cognitive science approaches share
fundamental components, including values placed on rationality, objectivity, and
measurement (Lupton 1999). Within the CSA approach, risks are seen as objective
hazards or threats that exist in the world (Berry 2004; Lupton 1999) that can be identified
and controlled using scientific measurements and calculations (Lupton 1999). Risk, as a
concept, is largely unquestioned by researchers using this approach (Lupton 1999).
The most common CSA used to understand vaccine risk perceptions and decisionmaking is the cognitive/learning perspective (CLP), which draws largely from
psychology (Taylor-Gooby and Zinn 2006). In Chapter Two, I discussed two theories
that are included within the CLP – the HBM and TRA. Rather than repeating all of the
attributes of the HBM and TRA as CLPs, I will focus on other theories in this section,
particularly those that study the cognitive process of risk conceptualization (as opposed to
the outcome). As discussed in Chapter Two, CLPs are rational actor approaches and
value-expectancy models, where a deliberate, self-maximizing assessment of the
likelihood and severity of outcomes leads to behavior. Serious limitations in this
approach were demonstrated when slight changes to the range of values, wording, or
order of questions – factors that should be theoretically insensitive – were found to
significantly alter the way that people estimated risks (Taylor-Gooby and Zinn 2006).
Rather than questioning the underlying assumption of rationality, researchers
sought to understand what kept people from perceiving risks rationally. In other words,
the findings led researchers to explore why these “errors” in judgment occurred. Many
researchers turned their focus to the role of cognitive heuristics, or mental shortcuts that
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people employ when assessing a risk, to explain seemingly irrational decisions. Several
studies of parental vaccine decision-making focus on the influence of specific heuristics,
such as biases of omission, availability, and control on risk perceptions and decisions
(Asch, et al. 1994; Baron and Ritov 2004; Brown, et al. 2010; Gellin, et al. 2000;
Meszaros, et al. 1996). Table A2 (see appendix) contains a more detailed description of
each bias and how they are used to understand parental vaccination decisions. These
studies emphasize the need to address specific heuristics that parents use with the goal of
“completing and correcting mental models” so that parents can make “correct” vaccine
decisions (Ball, et al. 1998:456; Bostrom, et al. 1994).
Studies examining risk heuristics often use hypothetical scenarios that require
parents to numerically estimate an acceptable risk score based on alternative risk choices.
A question might ask, “Imagine that a new HPV vaccine is developed. How safe would
the vaccine have to be before you would vaccinate your daughter?” Often, parents are
asked to provide a risk percentage response. Connelly and Reb (2003) provide an
excellent review of studies attempting to measure parental vaccine acceptance using
numeric risk scenarios. Most of the studies that were reviewed found that at least some
respondents are hesitant to vaccinate when there is a significant risk involved. However,
all of the reviewed studies involved one or more measurement problems that are
discussed in Chapter Four.
Other researchers are more interested in understanding the specific cognitive
processes that parents undergo when making risk decisions. Referred to as the mental
modeling approach (MMA), this perspective is framed upon the assumption that people
“develop representations of issues in their minds as part of the process of constructing
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explanations” (Taylor-Gooby and Zinn 2006:399). Researchers guided by this approach
tend to examine how mental models relate to risk communication, searching for “critical
gaps in cognitive understanding of risk in the minds of the lay public” (2006:399). The
approach could be used to examine physician and researcher mental maps as well,
although it is seldom used in this regard. Ball et al. (1998:456) urge physicians to
recognize their own use of heuristics, since “professional training does not preclude
biases and errors in judgment.” The authors’ suggestion could equally be applied to
researchers, but to my knowledge no one has attempted to explore this area, likely
because the entire CLP framework is based upon the assumption that there is some real,
wholly-rational way to make decisions that scientists already employ.
Some cognitive researchers argue that emotional and affective factors, as well as
cognitive heuristics, are important to risk decisions. Researchers have shown that the
weight (e.g., relevance) and value (e.g., positive or negative) that people ascribe to
previous experiences can significantly influence their immediate risk decisions.
Moreover, an individual’s mood, or what happened to the person a few minutes before a
risk decision is made, can significantly influence the ultimate decision that one makes
(Mellers, et al. 1998). Recently, psychometric studies have attempted to combine an
affect (e.g. emotion) heuristic with other heuristics to understand how each might
influence a risk decision (Lupton 1999; Taylor-Gooby and Zinn 2006; Wroe, et al. 2004).
While these models vary slightly from one another, they all try to identify deficiencies in
the ways that people use cognitive (and affective) heuristics, searching for “the
imperfections of learning, especially in complex social situations, or the weaknesses of
[lay] mental models” (Taylor-Gooby and Zinn 2006:399). While “risks” are perceived as
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objective, independent phenomena, individuals’ reactions to these phenomena are seen as
subjective and dependent (Lupton 1999).
A fundamental component of such frameworks is the value placed on science,
which elevates the expertise and knowledge held by particular groups of people, such as
physicians, researchers, and public health practitioners, whose training and perspective
generally reflects a scientific understanding of risk (Berry 2004). As a consequence,
when people react to a risk in a manner at odds with scientific risk assessments, their
perspective is often viewed as inaccurate, invalid, and irrational. In an article examining
risk comprehension, Weinstein (1999:15) acknowledges that “decisions and behaviors are
not determined by knowledge alone,” noting that other factors, such as “emotions,
personal values, social pressures, environmental barriers, and economic constraints” can
also play a role. Despite the multitude of variables that can shape decisions, the author
seems to suggest that these values are impediments to “appropriate” decision-making
when he concludes that even “educated individuals do not always make wise decisions”
(Weinstein 1999:15).
The belief that medical and scientific ways of knowing are (or should be)
paramount to parental vaccine decisions and calculations of risk underlie much of the
literature on vaccine acceptance (Allen, et al. 2010; Chan, et al. 2007; Davis, et al. 2004;
Fazekas, et al. 2008). In a systematic review of HPV studies, Allen and colleagues
(2010) reported that knowledge of HPV health consequences was measured in more than
45 studies, which was significantly more than any other construct. Assumptions
regarding the superiority of scientific ways of knowing not only pervade the scholarly
literature. A recent and widely publicized article from the Associated Press reported that
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an increasing number of non-religious parents in the U.S. were using religious
exemptions to avoid vaccinating their children (LeBlanc 2007). While parents’ narratives
included a variety of reasons for claiming the exemption, the position of physicians and
public health officials was largely uniform. Dr. Paul Offit, a prominent vaccine
researcher, represented this view clearly in the article, criticizing parents’ actions as an
“irrational, fear-based decision” (LeBlanc 2007:1).
In order to correct lay perceptions, researchers and health educators often
advocate the need to educate the public about a risk, to “better inform the public and
reduce what is seen as ‘irrational’ thinking” (Leask 2002:125). Successful education
campaigns are measured by changes in public risk perceptions to conform more closely
to “expert” risk assessments (Berry 2004). The underlying assumption is that individuals
can become rational decision-makers if they are provided with sufficient scientific risk
information that is communicated in an effective manner (Crawford 2000).
Yet, if it were the case that the general public was simply ignorant of scientific
ways of knowing, then one would expect that once informed of scientific risks, the
general public would adopt behaviors more congruent with those of medical
professionals. However, as already discussed, scientific knowledge about a vaccine or
disease often has an insignificant effect on a parent’s decision to vaccinate (Alaszewski
and Horlick-Jones 2003).
In one particular study, non-vaccinating parents were presented with the type of
risk-benefit information that leads many medical and public health experts to conclude
that not vaccinating is far more risky than vaccinating. After viewing the materials, the
non-vaccinating parents became even more committed to non-vaccination, rather than
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less committed (Meszaros, et al. 1996). Another study found the same effect among
vaccinating parents – after viewing scientifically presented anti-vaccination materials
mothers were more absolute in their acceptance of vaccines (Leask, et al. 2006). The
findings suggest that parents focus on information that supports their previously held
position while filtering out other information, lending support to the argument that other
factors, unrelated to knowledge (e.g., trust, beliefs, moral values, etc.) play a role in these
decisions.
Another problematic assumption of the CSA is that people will weigh the risks
and benefits of actions to make a decision that is in their individual best interest. The
assumption that parents are self-interested beings who act individually is problematic for
two reasons. As discussed in Chapter Two, parents neither perceive vaccine risks as
isolated actors, nor make vaccine decisions in isolation. In addition, parents are not
making vaccine decisions for themselves, but for their children.
One of the major weaknesses of the CSA, and the psychometric approach in
particular, is the inability to explain why some people employ different heuristic devices
based on class, gender, or ethnicity, and how risks are conceptualized within shifting
political, economic, and social contexts. Mary Douglas (1992:13)aptly articulates many
of the problems with the underlying assumptions framing cognitive science approaches:
“Warm-blooded, passionate, inherently social beings though we think we are, humans are
presented in this context as hedonic calculators calmly seeking to pursue private interests.
We are said to be risk-aversive, but, alas, so inefficient in handling information that we
are unintentional risk-takers; basically we are fools.” Among other previously discussed
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limitations, Douglas’ remark also highlights the lack of emphasis that cognitive science
approaches place on the social and cultural factors that frame parental risk perception.

Sociocultural Approaches to Risk
Researchers using a sociocultural approach (SCA) are more interested in
understanding the ways in which groups identify and react to particular risks than in
identifying, measuring, or predicting the probability of a risk or its outcome (Berry 2004).
The divergent focus on risk between the CSA and SCA partially relates to ontological
differences underpinning the two perspectives. If risk theorists were placed along a
constructionist/realist continuum, sociocultural theorists would generally fall on the
social constructionist side of the continuum (although at different points), while
cognitive-scientists would position themselves nearer to the realist side of the continuum
(Mythen 2004; Taylor-Gooby and Zinn 2006). Sociocultural theories all share the
assumption that risks can “never be fully objective or knowable outside of belief systems
and moral positions: what we measure, identify and manage as risks are always
constituted via pre-existing knowledge and discourses” (Lupton 1994:29). Because risks
are culturally constructed, they are perceived differently among individuals who identify
with particular social worlds. Risk is understood as a central “cultural and political
concept by which individuals, social groups and institutions are organized, monitored,
and regulated” (Lupton 1999:25). Within this framework, parental risk perceptions are
not – and cannot – be limited to the individual, because they are, to some extent, products
of shared meanings, experiences, and understandings about the world.
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The Risk Society Perspectives
Risk society theories have become influential during the last fifteen years and
generally draw on works by Ulrich Beck (1992) and Anthony Giddens (1991; 1999).
Fundamental to both Giddens and Beck’s theories is the assertion that risk is a key
feature of modern society that emerged through processes of modernization (Lupton
1999). Both men focus on the political aspects of risk and the processes by which risk is
generated and dealt with at the “macro-structural level of society,” and both identify
reflexivity as the principal response to increasing levels of uncertainty and insecurity
(Lupton 1999:81). However, Beck and Giddens disagree about the relationship between
risk and reflexivity. Giddens believes that a heightened degree of risk reflexivity resulted
not from a quantitative increase in the number of risks that actually existed in the world,
but an increase in sensitivity and focus on risk. Beck, on the other hand, sees risk
reflexivity as the response to an actual quantitative increase in the number of risks to
which people had to respond (Lupton 1999). Additionally, Beck sees reflexivity as
rooted in distrust of expert knowledge systems, while Giddens sees reflexivity as taking
place “through expert systems” and “reliant upon lay people’s trust in expertise” (Lupton
1999:82).
Beck proposes that people living in western societies are in a transitional period,
where the proliferation of wealth and risk are simultaneous (Lupton 1999). With the
generation of “goods” also come “bads” – or unanticipated, negative consequences that
result from modernization (Taylor-Gooby and Zinn 2006). Beck argues that these
unintended risks simultaneously erode “the framework of ideas and institutions
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fundamental to modernity” (Taylor-Gooby and Zinn 2006:403). Reducing and managing
risk has become central to political survival.
Giddens is also interested in the uncertainty characterizing people’s lives in
modern western society, although compared to Beck he is more interested in the impact
that cultural changes have on individual lives and the role of trust in risk mitigation
(Lupton 1999; Taylor-Gooby and Zinn 2006). As societies become progressively
complex, people increasingly rely on others to complete everyday activities. However,
the “others” on which people must rely are abstract entities (e.g., organizations),
symbolic objects (e.g., money), and “absent others” – unknown and unseen individuals
whose decisions and actions affect individual lives and consequently, on whom people
must rely. To rely on these “others” involves substantial trust (Casiday 2005). Trust,
however, is difficult to maintain in a society where scientific knowledge production,
political decision-making, and expert authority are often associated with increasing risks.
When expert systems fail, as they sometimes do, uncertainty in the system
increases. As a result, “People are required to be more challenging of expert knowledges,
requiring of them that they win their trust” (Lupton 1999:77). As people increasingly
focus on risks, they become less confident in the abilities of expert authorities,
government officials, and scientists to manage risk (Taylor-Gooby and Zinn 2006). Two
patterns emerge in response to this lack of confidence. Individuals return to face-to-face
relationships in an effort to re-establish trust in people whom they personally know
(Lupton 1999). Additionally, individuals increasingly link trustworthiness with likeness:
trust is strongest among members of the same social group (e.g. parents), while distrust
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becomes more pronounced between people of different social groups (e.g., parents and
providers).
Trust offers a sense of reliability or assuredness in the face of risk – providing
individuals with a way to diminish concerns about possible risk; therefore, trust itself
always presupposes an awareness of a risk (Lupton 1999). Giddens argues that trust is
“vital to establish ontological security from infancy onwards” (Lupton 1999:78).
Ontological security is conceptualized as an emotional and psychological phenomenon
that provides individuals with a sense of continuity not only in their own self-identity, but
in the continuity of the larger social and material world. Trust is seen as key to
establishing and maintaining ontological security by offering a way to preserve
confidence in the reliability of people and things. Trust can be viewed as a psychological
tool that people use to deal with
risks that would otherwise paralyze action or lead to feelings of engulfment, dread
and anxiety. Without trust, people could not engage in the ‘leap of faith’ that is
required of them in dealing with these expert knowledge systems of which they
themselves have little understanding or technical knowledge of because they have
not been training in them (Lupton 1999:78).
Risk society approaches have been used, though minimally, to explain some
aspects of vaccine decision-making. Parents in several studies reported increased
confidence in a provider’s vaccine recommendation when the provider talked about his or
her own experiences making vaccination decisions as a parent. In doing so, the provider
was repositioned as a parent who could recognize the individuality of each child’s health,
allaying fears that providers were only concerned with population health (Brownlie and
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Howson 2005; Casiday 2007). The level of distrust that people of one group (e.g.,
parents) feel towards people of another group (e.g., providers) varies. Findings from one
study are illustrative of this point. Casiday et al. (Casiday, et al. 2006: 177) found that
both parents who accepted and rejected the MMR vaccine were highly distrustful of the
government, but less distrusting of providers. The authors suggest that the MMR
campaign could be undermined if the government directly promoted the vaccine to
parents, suggesting instead that providers take the initiative. In the latter half of this
chapter I will provide a more thorough discussion of these factors.
Giddens argues that people in “risk societies” become reflexive citizens who
increasingly manage their own risks. Through this conscious and reflexive process, risk
becomes a fundamental feature to individual interactions and the construction of the self
(Petersen 1997). As expert knowledge is questioned, people look to alternative sources
of information and advice. Alternative advice can come from other parents, vaccine
resistance groups, scientists with dissenting opinions, the media, and anti-vaccine
medical providers. Poltorak et al. (2005:717-718) draw on the risk society approach to
explain parent narratives that suggest “links between personalised approaches to
immunisation, and a personalisation of responsibility . . . where distrusting the capacity
of public institutions to manage technological risks, parents feel they have no one to
blame but themselves”. Distrustful of expert knowledge, mothers sought information
from other sources, most notably, other mothers. Through informal discussions with
fellow mothers about MMR, women were introduced to other techniques and therapies –
such as homeopathy, infant massage, and cranial osteopathy – that helped build their
confidence to accept or reject specific health strategies (Poltorak, et al. 2005).
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For citizens of a risk society, risk and risk management are central components of
individual subjectivity. Themes of responsibility, accountability, and blame are central
discourses that are directed at the self or at others (Lupton 2000). For example, the
media portrayed the outbreaks of mad cow disease (bovine spongiform encephalopathy)
as a “‘natural’ outcome of ‘unnatural’ practices” (Lupton 2000:208). In this case, the risk
of mad cow disease was perceived as an external and unnatural threat and the government
and beef industry were largely singled out as being responsible for creating the threat
(Lupton 2000). In other cases, risks are internalized and framed as personal
responsibility. This is particularly the case within medical and public health discourses
where the onus is on the individual to seek care, such as vaccination (Lupton 2000). As I
will discuss shortly, there are numerous ways in which vaccine risks are internalized.
There are limitations to the risk society approach. Both Beck and Giddens tend to
see risk perceptions as largely rational responses to modernization – they say little about
the ways that risk discourses “operate at a more latent, extra-rational level of meaning.”
(Lupton 2000:210). The risk society approach also tends to paint a relatively universal
portrayal of risk perceptions that can be applied to nearly all risks occurring in western
societies. The theory is largely insensitive to cultural, social, and geographic variations
that undoubtedly affect risk perceptions. While the risk society approach does
acknowledge differences in risk conceptualization among sectors of society, the
distinction is largely drawn between a public and an opposing group, such as physicians
(Casiday 2007; Mythen 2004).
What is lacking, Mythen (2004:116) argues, is consideration of the “mélange of
social, economic and cultural factors which underpin public perceptions of risk.”
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Focusing beyond the individual requires a less compact and “messier idea of social
reality than the risk society model” but such an approach may nonetheless “provide a
more accurate reflection of the complex nature of public perceptions of risk” (2004:116).
The Cultural Approach to Risk
Douglas and Wildavsky’s Risk and Culture (1982) is a key work in sociocultural
theories of risk. According to Wildavsky, one of the underlying assumptions of this
theory is that “people construct their culture in the process of decision-making” (Selle
1991:102). He further argues that when people make choices, they “discover their
preferences by deciding whether they will reaffirm, modify, or abandon their way of life”
(1991:102). The choices that people make are not inconsequential; through decisionmaking people endlessly construct and reconstruct their culture. Shared values reinforce
particular types of behaviors, which together comprise cultures or social orders (Selle
1991).
A finite number of these social orders or cultures exist and develop from two
basic dimensions mapped in a grid/group model. The model is built on the assumption
that there are essentially two different social organization-types that affect how people
order themselves. The “group” index connotes differences between groups with high and
low group ethos. The high group ethos values within-group cohesion and makes strong
distinctions between “us” and “them”. The low group ethos values individuality but not
group cohesion. The “grid index” refers to social constraints that are imposed on the
individual. A high grid index emphasizes a greater number of cultural constraints. When
these two indices are combined, there are four ideal cultures: hierarchists, egalitarians,
individualists, and fatalists (Lupton 1999).
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The model itself has been criticized on many levels (see Selle 1991 for an
excellent critique). One of the most often cited limitations of the approach is
methodological and operational – it is unclear on what basis people are categorized into
particular groups or how they can move from group to group (Casiday 2007; Lupton
1999). While few anthropologists strictly adhere to the grid/group classification system,
many of the approach’s underlying concepts have been influential in reshaping the way
that social scientists think about risk.
The cultural risk theory focuses on risk perceptions, but at the group level, asking
why people view some things and not others as risky. Wildavsky and Douglas (1982)
assert that risks become risks when they threaten values associated with shared social
orders. The specific weight and attention that a particular risk manifests at any given
point in time have to be understood contextually, because risks are culturally constructed
over time (Lentzos 2006).
Much of Wildavsky and Douglas’ (1982) work on risk developed from Douglas’
(1966) earlier work on pollution, purity, and danger. Douglas was interested in
comparing non-western proscriptions (danger) against pollution with western notions of
“risk”. Like “danger”, risks are not only threatening to the individual, but to the broader
social order (Lupton 1999). Therefore, the concept of “risk” is used to hold individuals
and institutions responsible for behaviors that do not conform to cultural expectations.
Sometimes classified as a structural functionalist, Douglas is interested in understanding
how systems and structures maintain social order, define boundaries, and maintain social
regularities and norms (Lupton 2000).
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Controversies surrounding a risk are symptoms of competing values in a society.
Risk narratives often express values and meanings that go well beyond the superficial to
expose underlying themes of “accountability, responsibility, liability, and blame”
(Casiday 2007:1062). The anthropologist’s task is to understand how groups identify and
order risks, as well as identify the symbolic basis of anxieties connected to a perceived
risk. Are risks symbolically associated to fears regarding government control, the loss of
personal control, the permeation of boundaries, or something else?
For example, in the late 1950s Arnold Green (1961) applied aspects of this
approach to understand why town leaders resisted water fluoridation. Leaders against
fluoridation often used the argument that it was toxic, however concerns regarding poison
related far more to concerns about the larger social order. As Green (1961:24) explained,
fluoridation became “emblematic of an ultimate aim to smother personal identity in a
homogenous mass . . . [the risk of poisoning] latently labels the damage done to
individual autonomy and self-esteem by a social order that is felt to be increasingly
manipulative.”
In this vein, Douglas was particularly concerned with the human body. She saw
the human body as a metaphor for society, capable as standing in for any type of
boundary that is threatened. While Douglas was particularly interested in food taboos,
vaccines can also be seen as particularly risky because they bridge the boundary between
internal and external. Through vaccination, substances from the outside are injected into
the body “from that which is ‘alien’ or ‘other’ to that which is ‘self’” (Lupton 2000:210).
Nichter’s (1996c) analysis of vaccine programs in India reflects the ways in which the
body and the vaccine come to reflect larger societal concerns. Parents associated
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vaccines with Christian expansion, medical experimentation, government family planning
initiatives, and western forms of technology. Nichter argues that vaccines became
emblematic of foreign intervention, revealing concerns about national boundaries and
conveying a sense of moral geography.
Although no authors have explicitly used a cultural risk theory in describing HPV
vaccine decisions, such an approach could be used to explain how risks associated with
the HPV vaccine reflect larger societal concerns related to chastity, morality, sexual
abstinence and the adolescent body. For example, Waller and colleagues (2006) reported
that mothers in one focus group associated the Gardasil vaccine with their children’s
health and well-being, but also with declining morality. As several mothers explained, by
giving children a vaccine to prevent STI’s they were essentially "teaching them ... that it's
okay to be promiscuous" (1259). Some mothers did not want to consider vaccinating
their daughters because the act of vaccination against HPV would serve as symbolic
“acceptance of the fact that the child would one day be sexually active” (1260).
The risk society and cultural approaches differ in important ways. Douglas aims
to demonstrate the continuities and similarities in risk perceptions among industrialized
and non-industrialized settings, but these comparisons are incompatible within the risk
society approach, which argues that risks of modernity are unique to industrialized
societies. The risk society and cultural approaches also seek to explain different aspects
of “risk”: Douglas is interested in understanding why certain things are perceived as risks
in some groups and not others, or at some points in times and not others; Beck is
interested in “how the definition of risk is a reflection on and a critique of modernity
itself” (Casiday 2007:1062).
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Foucault and Governmentality
A Foucauldian perspective9 on risk focuses on discourses10 of risk, particularly
those conveyed and controlled by experts (e.g. public health officials, scientists,
physicians). The approach provides a lens to examine the ways in which “discourses,
strategies, practices and institutions” around risk bring it into being and construct it as a
phenomenon (Lupton 1999:84). It is essential to analyze the discourses, strategies,
practices, and institutions that create a risk because they are the means through which the
‘truths’ about a risk are defined, which then become the basis for action. From this
perspective, risk is conceptualized not as a thing in itself, but as a “calculative rationality”
(Lupton 1999:85).
Like Becks and Giddens, Foucault sees expert systems as central to the character
of late modern subjectivity. However, Foucault does not perceive expert knowledge as a
transparent means by which individuals engage in reflexivity, but rather as central to the
strategy of governmentality. Through surveillance, observation, measurement, and
monitoring, experts not only construct understandings of normal bodies but use these
understanding to regulate them. Experts from a variety of disciplines collect and analyze
information to problematize, calculate, and manage risk. In using expert knowledge to
identifying problem groups in need of education or interventions, risk becomes a “moral
technology” to regulate, alter, and control individual practices (Lupton 1999).

9

Because Foucault was discussed in Chapter Two of this paper, I only briefly address this approach here.
Discourse can be viewed as a “set of ideas, beliefs and practices that provide ways of representing
knowledge. Discourse enables the presentation of certain forms of knowledge and precludes the
construction of others” (Gabe 2004:167).
10
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In neo-liberal states, strategies of governmentality include direct and coercive
techniques, but rely even more heavily upon indirect tactics that focus on self-discipline
and regulation, dependent upon individual self-regulation, whereby individuals
voluntarily comply with the needs of the state. Self-regulation becomes a subtle and
powerful form of governmentality (Crawford 2004; Osbourne 1997). Regulation is not
primarily enacted upon passive subjects by external policing agents, but rather selfenacted by individuals who police themselves as “normalized subjects who are in pursuit
of their own best interests and freedom, who are interested in self-improvement, seeking
happiness and healthiness” (Lupton 1999:88).
For example, Petersen (1997) argues that one manifestation of this type of
discipline can be seen in “healthism”, which posits that people have a choice in
preserving their health and protecting themselves from disease. According to Crawford,
health and fitness are ways in which individuals express agency and “constitute
themselves in conformity with the demands of a competitive world.” (Petersen
1997:198). One’s ability to maintain a healthy body becomes a marker used both by the
individual and by others to “separate those who deserve to succeed from those who will
fail” (Petersen 1997:198). Individuals who fail to live healthy lifestyles are often viewed
as lacking self-control; terms like ‘healthy’ and ‘unhealthy’, Petersen argues, “have
become signifiers of normal and abnormal identity; of one’s moral worth” (1997:198).
Risk becomes an important tool in self-regulation when individuals begin to shape
their own behaviors, practices, and beliefs in order to minimize their own risk level. The
governmentality approach seeks to explain “how risks shape the way we experience our
own realities” (Mythen 2004:168). Directed at the regulation of the body, risk discourses
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dictate how bodies interact with other bodies and things, and contribute to the panoply of
“technologies of the self” that contribute to one’s constitution of selfhood (Lupton 1999).
In an attempt to become healthier or happier, to live longer, or to improve oneself in
some way, individuals seek expert knowledge from institutionalized government
agencies.
By controlling risk through mystifying discourses, experts have produced both the
language and the data that inform broader bodies of ideas (Mythen 2004). Experts and
institutions are seen as filters that sieve out information to reinforce dominant norms and
invalidate alternative perspectives. Individuals are expected to follow expert advice to
mitigate risk; when individuals reject expert advice or adopt alternative practices, they
are often blamed for problems that result. On the other hand, when problems arise from
conforming to expert advice, blame is often deflected and risk described in relative terms
(expert technologies and advice reduce, rather than eliminate risk).
Several anthropologists and sociologists have used this perspective to critically
examine the role of public health and health promotion in shaping risk perceptions (see
Lupton 1995; Petersen and Lupton 1996). Specifically, they argue that these experts
advance the notion of a reflexive subject who undertakes “self-surveillance and selfreform [as] an essential part of a ritual act that serves a disciplinary social order.” As an
effect of this discipline, public health ensures that “new forms of power-knowledge
move, more or less continuously, towards incorporating more of life within nets of
surveillance and control” (Crawford 2000:220). To my knowledge, a Foucauldian lens
has not specifically been applied to examine parental vaccine practices, though
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vaccination, as a technology controlled by experts and benefiting the state, but
implemented by parents, certainly lends itself to this type of analysis.

Risk Perceptions Related to Vaccination
As detailed above, risk theories differ substantially from one another, yet many of
the risks associated with parental vaccine acceptance can be understood within multiple
theoretical frameworks. Consider risks associated with a child’s immune system, for
example. From a risk society perspective, some vaccine risks can be viewed as products
of vaccine innovations and success. The increasing number and combinations of
vaccines that children receive have led to specific fears about their effect on the immune
system. From a cultural theory approach, the unique perceived vaccine risks to the
child’s immune system symbolize broader conceptualizations about the incompleteness
of children as human beings (Prout 2000). Using a CSA, risks associated with a child’s
immune capabilities can be understood as cognitive biases that result from one of many
incorrect suppositions.
The risk theories detailed above are used by researchers to explain and understand
parents’ perspectives on vaccine risk, though parents themselves likely think little about
these theoretical differences. In the remainder of this section I summarize the risks that
parents associate with vaccination, while recognizing that these risks are filtered through
particular theoretical lenses.
Many parents perceive vaccine risks associated with the child’s state of immunity
and their concerns are diverse, overlapping, and often contradictory to scientific
evidence. Because so many of the risks that parents associate with vaccines are
contingent upon other risks and assumptions about health, illness, trust, and
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immunization, it is difficult to organize these risks into discernible categories. I have
arranged these risks into specific categories for heuristic purposes only and recognize that
many of these risks exist simultaneously for parents.
Freeloading, Bandwagoning, and Herd Immunity
Issues of compulsory vaccination and opt-out clauses are intricately tied to herd
immunity. One of the reasons that opt-out clauses are tolerated vis-à-vis community
health is because of herd immunity, which suggests that unvaccinated individuals will be
protected from disease when a critical portion of a population is vaccinated against the
disease (Fine 1993). While individuals on both side of the ethical debate regarding
compulsory vaccination seem to agree about the importance of herd immunity, they
disagree about its ethical implications. One perspective is that herd immunity constitutes
“a kind of moral hazard, allowing individuals to “free load” on others’ willingness to
accept vaccination. Where high levels of immunity have been achieved, cases of adverse
reactions of a vaccine, although inherently rare, may actually exceed cases of the disease
against which it protects” (VHPB 2000:5). From this perspective, one might conclude
that it is better to rely on the risk of others – on herd immunity – than take a chance at
individual vaccination. Of course, if too many people adopt this perspective then no one
benefits from herd immunity.
Freeloading or freeriding logic is sometimes used to explain why parents do not
vaccinate their children. Parents who base their assumption on this supposition assume
that their child will be protected against a vaccine-preventable disease as long as other
children receive the vaccine. This phenomenon was noted in several parent studies
(Benin, et al. 2006; Kimmel and Wolfe 2005; Meszaros, et al. 1996).
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In some cases, heuristics can work in favor of vaccine acceptance.
Bandwagoning refers to the tendency of parents to vaccinate their own children if they
perceive that everyone else is doing it. Under this heuristic, the normative effect plays
the largest role in the parental decision and little thought is put into the decision. Several
studies show a strong bandwagoning effect related to vaccine acceptance (Hershey, et al.
1994; Meszaros, et al. 1996; Tickner, et al. 2007).
Natural Immunity
Several studies have documented parental concerns related to the “naturalness” of
vaccines and their effects on the immune system and immunity. In the case of the MMR
vaccine, some parents thought that their children would elicit stronger and more “natural”
immune responses if the children contracted measles, mumps, or rubella naturally
(Dannetun, et al. 2005; Evans and Watson 2003; McMurray, et al. 2004). In another
study, some parents saw the immune system and disease-status as phenomena under
God’s control – in this case, vaccines were risky because they interfered with a “natural”
process (Princeton 1988; Wilson 2000).
In Ashland, Oregon, for example, one third of parents are not vaccinated. Allen
(2007) notes that many of these parents ascribe to a natural, holistic view of health and
see vaccination as a potentially dangerous intervention that parents unnecessarily give
their children. One public health official explained the way that many parents in Ashland
viewed decisions to vaccinate, “if you get your kids vaccinated it means that you are a
dupe, that you haven’t done your research” (Allen 2007).
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Health States and Immunization
For many parents, vaccination is not necessarily risky itself, but becomes risky in
association with a child’s particular immune character. Multiple studies have shown that
parents are less likely to immunize a child when the child is ill (Freed, et al. 2004; Offit,
et al. 2002; Tarrant and Gregory 2003), which reflects a general perception that the
child’s immune system is less able to handle, or respond to a vaccination during an
illness. Some parents speak of acute illness where a child’s immune system is viewed as
momentarily compromised, thus prohibiting vaccination temporarily but not indefinitely
(Pruitt, et al. 1995; Taylor, et al. 2002; Tickner, et al. 2007; Wilson 2000). For other
parents who perceive that their child has a chronically fragile or vulnerable immune
system, vaccination might never occur. For example, parents who reported that their
children suffered from asthma, allergies, digestive disorders, or recurrent ear, chest, or
urinary tract infections attributed such illnesses to a weakened immune system and were
therefore fearful of giving these children vaccinations (Casiday 2007; Hilton, et al.
2006b).
Parental concerns about vaccinating children while they are ill reflect deeper fears
about vaccine immuno-suppression, vaccine susceptibility, vaccine overload, and
immune system maturation. Some parents fear that vaccines can cause ill health – either
in the short or long term, although there are many ways in which parents express this
concern. Some parents worry that vaccines can compromise the immune system, thus
making it vulnerable to outside infections (Freed, et al. 2004; Sporton and Francis 2001).
Other parents fear that vaccines may actually cause diseases, either the diseases that the
vaccines are intended to prevent or other diseases. For example, Niederhaus et al. (2001)
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reported that 40 percent of parents were concerned that their children would contract
chickenpox from the varicella vaccine. In a study on the meningitis vaccine, parents
most feared that their children would contract meningitis from the vaccine (Timmermans,
et al. 2005).
While many current vaccines consist of virus-like particles or dead viruses that
cannot cause disease, the use of live-attenuated viruses has led to cases in which vaccines
do cause the diseases that they are intended to prevent, most notably in the case of polio
(Link 2005; Offit 2005; WHO 2007). There are also fears that vaccines can cause other
diseases or conditions. Many parents associate the MMR vaccine with a risk of autism
(Benin, et al. 2006; Casiday 2007; Raithatha, et al. 2003; Smailbegovic, et al. 2003;
Taylor, et al. 2002), and parents have associated the DTP and hepatitis B vaccines with
multiple sclerosis, autism, and other neurodevelopmental disorders (Link 2005; VHPB
2000).
Parents also express fear that vaccines will not prevent diseases. Some parents
believe that their children are likely to get the vaccine-preventable disease, regardless of
whether they receive an immunization, so vaccination, along with its discomfort and
risks, seems unjustified. These concerns are more pronounced with particular vaccines,
most notably varicella and influenza (Benin, et al. 2006), as well as pertussis and measles
vaccines (Tarrant and Gregory 2003).
For many parents, the risks associated with an immunization event relate to the
content and type of vaccine that is being administered. One common risk that parents
associate with vaccination is vaccine or immune overload, which refers to the fear that a
child’s immune system will be overwhelmed by a vaccination or series of vaccinations.
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Many of the fears related to vaccine overload are associated specifically with
combination vaccines and receiving more than one injection at a time (Casiday 2007;
Evans, et al. 2001; Marlow, et al. 2007a; Pruitt, et al. 1995). Combination vaccines, such
as DTaP and MMR, provide immunization against multiple diseases with one injection
(Gregson and Edelman 2003). From a public health perspective, combination vaccines
are a welcomed innovation – decreasing the number of injections and the number of
clinic visits required, while increasing vaccination coverage (Chen, et al. 1995).
However, parents generally perceive combination vaccines as riskier than single
vaccines. While research (Black, et al. 1991; Chen, et al. 1995; Miller, et al. 2003)
suggests that combination vaccines do not induce immuno-suppression – and may
actually induce a heightened protective effect – many parents continue to express anxiety
about combination vaccines.
Parental concerns about combination vaccines tend to relate to the immature
nature of the infant or child’s immune system and beliefs about its capacities and
limitations (Casiday 2007; Hilton, et al. 2006b; Miller, et al. 2003). In one U.S. study, 25
percent of parents believed that children’s immune systems would be weakened if they
received too many vaccinations (Gellin, et al. 2000). In other studies, fears of vaccine
overload have been a significant reason that parents either delay or refuse to vaccinate
children (Bond, et al. 1998; Bostrom 1997; Niederhauser, et al. 2001; Salmon, et al.
2005). As one parent explained when voicing her concerns about the combination MMR
vaccine, “the worry is putting all three in at one time, into that wee body. Individual ones
for me is the way, it makes sense to not bombard it with too much chemicals all at one
go” (Hilton, et al. 2006b:4324). Underlying this mother’s concern is a belief that the
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child’s immune system is vulnerable, immature, and fragile. A mother from a separate
study echoed this concern, explaining that receiving four shots in one study was “a lot for
a tiny baby to handle. I don't necessarily think that when they're tiny is the best time to
give them their shots …. I think that when they're robust and they can take it is a much
better time” (Niederhauser, et al. 2001:19).
Some parents believe that combination vaccines – but not single vaccines – are
unnatural, requiring an immune response that would not likely occur through natural
infection. The perception of “naturalness” in this case refers to the likelihood that a child
would naturally contract, and consequently elicit an immune response to multiple
diseases at once. Since, for example, it is unlikely that a child would simultaneously
contract measles, mumps, and rubella, these parents reason that encouraging an immune
response to these three diseases is unnatural. As one mother explained, combination
vaccines are like a “sudden onslaught to the body’s immune system” (Hilton, et al.
2006b:4324).
Parents also express concerns about the content of vaccines and risks associated
with specific vaccine suspending fluids, preservatives, and adjuvants. For example,
parents in the U.S. have expressed concerns about the safety of thimerosal-containing
vaccines (TCVs), fearing that these vaccines contain dangerous levels of mercury and can
cause autism (Link 2005). While multiple well-conducted, population-based studies
(Heron, et al. 2004; Madsen, et al. 2003; VHPB 2000) have found no association between
TCVs and autism, many parents still perceive TCVs (and the vaccines from which TCVs
have since been removed ) as risky. Parents also perceive more general risks associated
with vaccine ingredients, as this mother’s quote suggests: “When I look at the
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ingredients they’re preserved with mercury, heavy metals and formaldehyde, and DNA
from other animals that would be getting into my daughter’s system doing some sort of
genetic engineering with her body. I just can’t justify doing that …” (Niederhauser and
Markowitz 2007:19-20).
Risk and Disease Experience
In the studies I reviewed, many of the risks that parents associate with vaccination
relate to their past experiences. Parents often embedded risk statements within personal
illness experiences and drew from their own disease history to make vaccination choices
for their children. Some parents, who were never vaccinated against a disease and never
developed the disease, questioned whether vaccines were necessary, and were less likely
to vaccinate their children (Sporton and Francis 2001). Other parents, who had naturally
contracted a disease and perceived few side-effects from it were less likely to perceive
the disease as severe (Sporton and Francis 2001). In one study, parents who had
naturally acquired measles immunity perceived measles as less severe and less dangerous
than other parents. Similarly, parents who had experienced whooping cough perceived it
as less threatening than other parents (Hilton, et al. 2006a). In another study, parents who
had a child or knew someone who had a child with autism were less likely to vaccinate
their children with the MMR vaccine. From their perspective, the risks of getting
measles, mumps, and rubella were far less than the risks of developing autism
(McMurray, et al. 2004)
Conversely, parents who knew someone who died or was seriously injured (e.g.
blinded) by a vaccine-preventable disease, such as measles, were more likely to vaccinate
their children and perceived vaccination as less risky than the disease (McMurray, et al.
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2004; Tarrant and Gregory 2003). Mothers with a history of cancer in their families were
more likely to accept an HPV vaccine for their daughters than other mothers (Marlow, et
al. 2007a), although these findings have been challenged in another HPV study.
Dempsey et al. (2006) found that women who had experienced a past abnormal Pap
smear or cervical cancer perceived HPV to be less severe, but also perceived their
daughters to be at increased risk of infection and perceived an increased benefit to
vaccination.
However, these women were no more likely to vaccinate their daughters than
women who had not had an abnormal screening or cervical cancer. On the other hand,
women who had genital warts were more likely to vaccinate their daughters, which the
authors suggest is attributed to the social stigma that is associated with genital warts but
not with cervical cancer or with an abnormal Pap: “Unlike cervical cancer and abnormal
Pap smears, genital warts are a visually apparent condition with the potential to be
recognized by the lay person as a sexually transmitted disease” (Dempsey, et al.
2006:1492).
Parents also associated their risk perceptions with previous vaccine experiences.
In these cases, the risk is in the way that the vaccine is administered, not in the vaccine
content itself. Parents who reported negative prior vaccine experiences, either for
themselves or their children, were less likely to vaccinate their children than other parents
(Tickner, et al. 2007; Wilson 2000). In one study, several mothers described experiences
where providers administered the wrong vaccine to their children, leading them to doubt
physician competence (Benin, et al. 2006). In other studies, the trauma associated with a
vaccine experience deterred parents from immunizing their children. For example,
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mothers in one study commonly used the analogies of cattle being herded, the conveyor
belt effect, and “just another number” to refer to the vaccine experience (Harrington, et
al. 2000:396). Many parents perceived the process as cold, insensitive, and traumatic.
As one parent explained, “It’s very hard now, kind of, they just took her arm and took her
leg and dump the needle in . . .” (2000:396).
Distrust, Incompetence, and Competing Interests
Parents often associate vaccine risks with competing interests and skepticism of
physicians, pharmaceutical companies, and government motivations. In an analysis of
Australian antivaccination print coverage during the 1990s, Leask and Chapman (1998)
identified a recurrent theme of distrust in governmental transparency and fears of
governmental conspiracies and cover-ups. In many studies, parents had concerns about
physician bias, especially regarding the vaccine information that physicians provided
(Dannetun, et al. 2005; Kimmel and Wolfe 2005; Raithatha, et al. 2003). Some parents
questioned physician allegiance, worrying that physicians might encourage a vaccine,
even if they did not think it was safe, because of economic incentives, monetary
partnerships, or political positions (Benin, et al. 2006). In one study, mothers questioned
whether official statistics were accurate and reliable, explaining that physicians either
wanted to make measles appear to be more severe than it is (by under-reporting cases in
which there are few serious complications), or rarer than it is (suggesting that doctors
inflate the vaccine’s efficacy) (Hilton, et al. 2006a). Very similar fears were expressed in
another study, where parents felt that physicians were too heavily influenced by
governmental policies and vaccine statistics. They feared that physicians would withhold
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or under-report information questioning the safety of a vaccine (Smailbegovic, et al.
2003).
Parents sometimes expressed more general distrust of the government and
pharmaceutical industry (Raithatha, et al. 2003; Serpell and Green 2006). In one study,
parents questioned whether the government received monetary incentives from the
pharmaceutical industry for including vaccines on the schedule and were skeptical that all
of the vaccines on the schedule were safe and necessary (Salmon, et al. 2005). In another
study, parents questioned the safety of new vaccines, expressing fears that their children
were guinea pigs of the state and pharmaceutical industry (Wilson 2000). Other parents
suspected that the government over-emphasized the threat of contracting certain diseases,
such as MMR, which led to a distrust of government motivations in promoting
immunization (McMurray, et al. 2004).
Issues of trust appear to be a particularly important issue among African
Americans, who have specifically referred to the Tuskegee Syphilis Trials when
expressing hesitation about vaccines (Friedman and Shepeard 2007; Scarinci, et al. 2007;
Tissot, et al. 2007). As one African American woman cautioned, when expressing fears
about the HPV vaccine, “They [the government] may not be telling the full story, which,
of course, we found out about syphilis, we found out about AIDS” (Friedman and
Shepeard 2007:477). While mistrust of the medical community and medical
interventions might well be higher among African Americans, it is important to note that
other factors, such as access issues and structural disparities, might lead to lower uptake
of vaccines among African Americans.
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At the same time, it is worth noting that racial differences in vaccine uptake result
from, are associated with, or are confounding by, other factors, such as socioeconomic
status, healthcare access, and insurance coverage. For example, a U.S. study of children
ages 19 to 35 months indicated significant differences in the sociodemographic
characteristics of children who were underimmunized compared to those who had not
received any vaccinations (Smith, et al. 2004b). Children who were underimmunized
tended to be African American and to have mothers who were younger, unmarried, and
had less than a college degree. These children typically lived within households near the
poverty line and within the central city. On the other hand, nonimmunized children
typically were white males whose mothers were married, college-educated, and living
within households exceeding annual incomes of $75,000. Parents in the latter group
typically abstained from vaccinating due to safety concerns and in these cases, provider
recommendation had little effect on decisions.
In another study, Gellin and colleagues (2000) reported that African American
and Hispanic parents, as well as those with a high school education or less, were more
likely to express concerns about vaccine side effects. Due to the methodology employed
in the study, it is unclear why there are educational and ethnic differences in concerns.
To further complicate issues regarding trust, ethnicity, and vaccine perceptions, several
studies of HPV vaccine acceptability find that some providers personally observe what
they perceive to be ethnic and racial differences in HPV vaccine acceptability. Tissot and
colleagues (2007), for example, conducted qualitative interviews with healthcare
providers and noted that while some providers felt that African American parents were
less trusting or accepting of the HPV vaccine, other providers reported that from their
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own experiences, African American parents appeared to be more open and receptive to
discussions of sexuality and STI prevention.
Social Stigma as Risk
Parents associate social risks, along with biological risks in vaccine decisions.
Parents commonly associate vaccine decisions with social values related to responsibility
and good parenting (Niederhauser and Markowitz 2007; Petts 2005). Many parents are
concerned that providers will think that they are bad parents if they question the need for
a vaccination. This fear not only affects vaccine choices, but also the scope of vaccine
communication that occurs between parents and providers (Evans, et al. 2001). Some
mothers felt a sense of shame after refusing a vaccine. One mother who decided not to
vaccinate her child against MMR explained that when her physician learned that she was
not going to have her daughter vaccinated, “she really put this huge guilt trip on me . . .
So, I felt quite dejected when I came out and felt I was a bad parent” (Casiday
2007:1065). Other mothers believed that providers would treat them differently if they
questioned vaccines or refused them. For example, one mother who did accept the MMR
vaccine but spent substantial time researching it and discussing the choice with her
provider reflected that “I’m sure they’ve got it on my file, ‘neurotic mother’” (Evans, et
al. 2001:907). Another mother, who refused to vaccinate her child with the MMR
vaccine explained that “They put red all over the notes, red pen, they write REFUSED in
big red letters all the way across the child’s medical notes so they’ve sort of got ‘difficult
parent’ in their minds” (Evans, et al. 2001:907).
Social values pertaining to vaccine decisions are not only directed at parents by
physicians but also at parents by other parents. Comments made during one focus group
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discussion of mothers who all vaccinated their children illustrate this point. The women
in the group referred to anti-vaccination women as “burn your bra types,” “hysterical,”
“new agers,” “alternative lifestylers,” “naturals,” and “go against it for rebellion’s sake”
types who were “very irresponsible” and lacking “common courtesy” (Leask, et al.
2006:7241). A study of U.S. pediatricians suggests that parental vaccine decisions may
not only lead to social judgments about parenting skills, but may also lead to differential
access to healthcare: 28 percent of the pediatricians surveyed said that they would no
longer treat children whose parents refused key vaccinations (Flanagan-Klygis, et al.
2005).
Studies also suggest that parents associate the HPV vaccine, and why one would
need it, with stigma. As one woman explained, “Maybe some people will be
embarrassed to go and get the shot . . . People are going to say she sleeps around and she
needs the shot” (Friedman and Shepeard 2007:477). In another study, some women said
that family members and partners might react poorly to knowledge that a woman wanted
the vaccine. One woman explained, “My mother would really think, well, why would
you really need the vaccine? You’re not really supposed to be out doing nothing like this”
(Scarinci, et al. 2007:1230). Referring to many partners’ reactions, one woman said, “I
can hear one of them [men] right now: so what, you’re trying to say I have something? It
automatically makes them think that you’re assuming that they have something, but
you’re just doing this to protect yourself” (2007:1230).
One mother’s association between vaccine choices and moral judgments went
even farther: she would not vaccinate her son against tetanus because she perceived that it
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was “her job to keep him out of harm” (Tickner et al. 2007:7401). As long as she was
acting as a responsible mother she did not think her son was at risk of getting tetanus
Other studies suggest that the medicalization of motherhood has consequences for
mothers who refuse or delay vaccination. The stigmatization associated with failing to
accept vaccine innovations is produced and reinforced not only by providers, but also by
other mothers who do accept vaccines for their children (Casiday 2007; Flanagan-Klygis,
et al. 2005; Leask, et al. 2006; Niederhauser and Markowitz 2007), illustrating, again, the
social nature/context of vaccine decision-making.
Risks Associated with Specific Vaccines
Because most studies only examine parental decisions regarding a specific
vaccine, there is a perception that parents are universal vaccine rejecters or accepters.
However, many studies have shown that this is far from the case. Parents who are
generally supportive of vaccines may choose not to immunize their children against a
particular disease. As one mother explained, “I’m not actually anti-vaccines, I’m quite
sort of pro-vaccines. It’s MMR in particular that I have a problem with” (Evans, et al.
2001:905-906). Specific vaccine risks can be associated with a vaccine because of its
content or combination, factors associated with the disease or the child, or the relative
newness of a vaccine.
Few studies have compared parental-perceived risks associated with multiple,
specific vaccines, although a comparison across studies does suggest that parents
perceive the risks associated with some vaccines differently from others. In one study
where parents did compare risks associated with several vaccines, parents were generally
supportive of all vaccines, except MMR and meningitis (Smailbegovic, et al. 2003). In
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another study, however, parents perceived meningitis as the most severe and lifethreatening disease to their infants and also the most important vaccine for infants to
receive (Hilton, et al. 2006a).
Most of the studies conducted on parental vaccine acceptance are related to DTP
and MMR vaccines, both because of their controversial histories in the U.S. and U.K
respectively, and because they are combination vaccines. Hilton et al. (2006a) asked
parents to describe their perceptions of several diseases associated with these vaccines
and found that parents associated different risks and vulnerabilities with each disease,
which influenced their perception of the need to vaccinate. Most mothers in the study
recalled receiving a rubella vaccine check during their pregnancy and because of the risk
to the fetus, generally perceived rubella as more severe than epidemiologists or clinicians
would say that it is. While groups perceived meningitis as the most severe disease and
the most important to vaccinate against, none of the parents mentioned an association
between viral meningitis and mumps. Diphtheria was seen as a disease of the past – an
old plague that one participant compared to the Latin language (Hilton et al. 2006a).
MMR has been perceived as the most risky vaccine among parents in many
studies. Even among parents who generally support vaccination, a lack of confidence in
scientific support for the vaccine’s safety is a recurrent source of fears (Raithatha, et al.
2003; Smailbegovic, et al. 2003). The risk of autism is mentioned by parents in many
studies and is often considered a serious and likely risk (Andrews 2006; Bellaby 2003;
Casiday, et al. 2006; Casiday 2007; Frankel and Nielsen 2003; Hilton, et al. 2007; Taylor,
et al. 2002; Woo, et al. 2004).
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Risks Associated with the Child’s Age
Several studies have found that parents are more likely to vaccinate their children
at one age rather than another. Many parents perceive greater risks associated with
vaccinating infants than older children. In a study of parental acceptance of a flu vaccine,
Daley et al. (2007) reported that 20 percent of parents felt it was unsafe to administer the
vaccine to infants under one year of age. In a Swedish study, 60 percent of parents would
postpone the MMR vaccination until their children were at least four years of age,
believing that children (and presumably their immune systems) need to mature before
coping with the vaccine (Dannetun, et al. 2005). Concerns about a child’s vaccination
age generally related to the infant’s immune system and its inability to cope with
vaccines. However, parents had other reasons for preferring specific immunization ages.
Some parents who did not want to vaccinate their children as infants but would
eventually vaccinate them explained that infants could not communicate distress and
parents could not explain what was happening to the infant and why. This perspective
was especially common among first-time parents (Tickner, et al. 2007). Other studies
have also reported that first-time parents are significantly more likely to postpone
vaccination than other parents (Dannetun, et al. 2005; Leask 2002). Parents with older
children, on the other hand, felt that it was more difficult to vaccinate children when they
were in pre-school because they had a greater understanding of the situation, which made
parents feel a greater sense of responsibility and guilt about the vaccine experience
(Tickner, et al. 2007). In a similar vein, parents from another study preferred that their
children receive vaccinations at younger ages, because older children had developed a
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fear of needles, screaming during the vaccination and causing the parents to feel a greater
sense of guilt, distress, and embarrassment (Tarrant and Gregory 2003).
Parents not only associate vaccine decisions with the child’s age and capacities,
but with their own experiences as parents and what they face at particular points in their
child’s development. For example, Hilton et al. (Hilton, et al. 2006b) observed that many
parents who rejected an MMR combination vaccine, opting for the single disease
vaccines instead, had earlier vaccinated their children with a combination DTP vaccine.
When asked about the contradiction, many parents explained that vaccine timing played a
role in determining their own willingness to accept a vaccine. Several parents explained
that because DTP was administered during infancy, when parents felt emotionally
overwhelmed or exhausted, they were less able to fully consider the vaccine decision. As
one woman explained, “I’m sure if the timing of diphtheria, tetanus, whooping cough and
Hib was later like MMR, there would be a lot more discussion about it” (Hilton, et al.
2006b:4324).
Nearly all of the aforementioned studies have occurred among parents with
infants and young children and relate to vaccines that are required by the time that
children enter school in the U.S. It is less clear how age-of-vaccination preferences affect
parental decisions for other vaccines that are not required for school enrollment. Several
studies of the HPV vaccine report relationship positive correlation between child’s age
and vaccine acceptability; vaccine acceptability increases as does the child’s age
(Dempsey, et al. 2006; Fazekas, et al. 2008; Kahn, et al. 2003; Slomovitz, et al. 2006).
From these quantitative studies, it is unclear why parents are more accepting of the
vaccine with increasing age. However, results from qualitative studies, which find that
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many parents are unwilling to accept an HPV vaccine until they think their children are
sexually active, suggest that parents might relate vaccine-age to perceptions of their
child’s sexual activity (Mays, et al. 2004).
Gender, Sex, and Disease Transmission Route
There is some evidence to suggest that parents consider a child’s sex when
evaluating the risks associated with certain diseases and the vaccines developed to
prevent them. In a study of MMR vaccine decision-making, parents of daughters were
more to likely to accept the vaccine than were parents of sons, an association that the
authors attribute to parental knowledge that autism is four time more likely to occur in
males than in females (Taylor, et al. 2002). In another study (Hilton, et al. 2006a),
parents believed that it was more important for daughters to be vaccinated against rubella
than sons. Mothers questioned why it was necessary to vaccinate boys against a disease
that they associated with pregnancy, which raised suspicions among some mothers about
the goals and motivations of clinicians in vaccinating boys against rubella. Conversely,
the same parents believed sons were more susceptible than daughters to mumps. Parents
described mumps as a disease that only affects boys and could cause male infertility – an
outcome that was often discussed through humor and jokes, which could indicate that
male infertility is not seen as a particularly severe outcome (Hilton, et al. 2006a).
Diseases that can differentially threaten males’ and females’ future reproductive
potential can affect the risk evaluation undertaken by parents. The modes through which
diseases are primarily acquired can also factor into parents’ risk evaluations. Several
studies have examined parental acceptance of vaccines for gonorrhea, Chlamydia, HIV,
herpes, and Hepatitis B, which are sexually transmitted (Liddon, et al. 2005; Mays, et al.
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2004; Zimet, et al. 2000). Each study focused on predictive variables in vaccine
acceptance, although the significance of associations varied in each study. Liddon and
colleagues (2005) reported that parent’s sex, ethnicity, and marital status were associated
with vaccine decision. Zimet et al. (2000) found significant variation in parental
vaccination acceptance by recruitment site (urban versus private clinics), perceived
severity of the disease, and perceived efficacy of the vaccine. In a study that compared
parental acceptance of four hypothetical vaccines to prevent HIV, gonorrhea, Chlamydia,
and HPV, researchers found that HPV was the least accepted of the vaccines, although
reasons for the lower approval rates was unclear (Mays et al., 2004).
Several studies suggest that a disease’s route of transmission is an important
factor to some parents, who associate sexually transmitted diseases with multiple
meanings, including morality, self-responsibility, and self-discipline. The association
between risk and morality is clearly illustrated in one father’s response to whether he
would accept a hypothetical gonorrhea or HPV vaccine for his 14 year old son: “I
wouldn’t be too insistent about it. Sounds to me like something a careful person . . . a
responsible person wouldn’t have to worry about. Again, it’s a matter of responsibility.
It’s not something you’re going to catch off a doorknob” (Mays, et al. 2004:1420).
During U.S. Congressional testimony on the safety of the hepatitis B vaccine, one parent,
who thought the vaccine resulted in his daughter’s death, further exemplified the
moralistic nature of sexually transmitted diseases and vaccines to prevent them: “Almost
every newborn baby is now greeted on its entry into the world by a vaccine injection
against a sexually transmitted disease because they couldn’t get the junkies, prostitutes,
homosexuals, and promiscuous heterosexuals to take the vaccine (Colgrove 2006:231).
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In a general study (Zimet, et al. 2005) to examine variations in acceptance by
transmission route, the sexual route of transmission was not a significant factor for the
overall sample of parents. However, it was a significant factor for a subset of parents
(6% of the sample), who strongly opposed vaccines that prevented sexually transmitted
infections. In a study of Californian parents’ intentions to vaccinate their daughters
against HPV, less than 3% of parents cited moral sexual behavior concerns as a reason to
refuse the vaccine (Constantine and Jerman 2007). In other studies, parents have
expressed concerns that vaccinating their children against sexually transmitted infections
might lead to unsafe sexual practices and a false sense of protection (Brabin, et al. 2006;
Davis, et al. 2004), promiscuity (Liddon, et al. 2005), and earlier sexual debut (Brabin, et
al. 2006; Davis, et al. 2004; Olshen, et al. 2005).
In a nationally representative study of Canadian parents, slightly more than onefifth of parents had concerns that the HPV vaccine might affect their daughters’ sexual
behaviors, in terms of expediting the age at which they become sexually active or
encouraging daughters to practice unsafe sex or have sex with a greater number of
partners (Ogilvie et al. 2007).
Prior to HPV vaccine licensure, 35 CDC-funded focus groups were conducted in
order to better understand how a hypothetical HPV vaccine might be perceived and
introduced to the public. The focus groups contained 314 ethnically diverse men and
women from six urban and rural sites across the country. Though the authors did not
specify the frequency with which concerns regarding adolescent sexuality were raised
(nor the number of participants who were also parents), they noted that when asked about
whether a vaccine should be administered to children, “strong concerns were voiced by
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parents about giving children a false sense of security and implicitly condoning unsafe or
promiscuous sexual behaviors” (Friedman and Shepeard 2007: 478).
Although HPV is also associated with cancers that affect both males and females,
the vaccine was initially only available to females. Unlike other sexually transmitted
diseases, which are often viewed as equally detrimental for boys and girls11, HPV was
originally marketed, manufactured, and targeted as a cervical-cancer prevention
technology12. It is likely that the strong association between HPV with cervical cancer
affects the ways in which parents perceive risks for their sons and daughters (Brabin, et
al. 2006; Slomovitz, et al. 2006). Moreover, because the vaccine protects against a
sexually transmitted disease and sexual norms are gendered, notions of risk and gender
may intersect to produce different risk perceptions (Crawford and Popp 2003; Schalet
2000).
The few studies that have included parents of sons or that specifically ask
questions about the need for sons and daughters to be vaccinated suggest that there are
important differences in how parents conceptualize vaccination based on the child’s sex
(Brabin, et al. 2006; Lenselink, et al. 2008; Olshen, et al. 2005; Slomovitz, et al. 2006).
Zimet and Rosenthal (2010) provide a comprehensive review of studies that included parental
attitudes toward vaccinating boys.

11

While the symptoms and associated risks for each STI vary, to at least some extent by individual’s sex, it
is likely that STI’s such as syphilis, herpes, and now HIV are seen as having significantly harmful effects
regardless of sex.
12

The Gardasil vaccine is not advertised as a vaccine that protects against 90% of genital warts, even
though it does. In addition, the fact that the vaccine was only available to women originally might lead
parents or the lay population to associate HPV as a disease of women. The association that the public
makes between HPV and women might be even stronger for the Cervarix vaccine, which does not protect
against genital warts and whose name references the cervix. I discuss the representation of the vaccine and
its important to my research question more under “Goals”.
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In one of the few studies that included a qualitative component, Olshen et al.
(2005) reported that while most participants believed that vaccinating boys was important
to protect future partners and reduce disease transmission, at least two parents of sons did
not think the vaccine should be given to boys. Unfortunately, the authors provide no
narrative or explanation to contextualize the reason for these parents’ perspective.
Another study of parents in Galveston, Texas found no significant differences in parent’s
willingness to vaccinate sons and daughter. However, among parents of sons, a primary
reason not to vaccinate related to perceived lack of direct benefit to boys (Slomovitz et al.
2006).
Other variables associated with vaccine acceptance in some studies, but not
others, include parents’ comfort discussing sexuality with children (Askelson, et al. 2010;
Brabin, et al. 2006; Marlow, et al. 2007a; Waller, et al. 2006). Parents’ willingness to
discuss protective sexual health behaviors with daughters appears, at least in some cases,
to inform HPV vaccine decisions (Brabin, et al. 2006; Marlow, et al. 2007a; Romo, et al.
2011)). Brabin and colleagues (2006) found that parents who discussed HPV-related
information with their children were more likely to support vaccination. Conversely,
parents who were least comfortable discussing sex with their children were least likely to
anticipate having their daughters vaccinated. Marlow and colleagues (2007) reported that
mothers willing to talk about cervical cancer, sexuality, STIs, or HPV with their
daughters at younger ages were also more likely to express willingness to have their
daughters vaccinated in general, and at earlier ages.
HPV-information sharing appears to be both content and age specific (Askelson,
et al. 2010). Parents in one study, for example, felt more comfortable discussing the
94

cervical cancer prevention aspects of the HPV vaccine with daughters, but less
comfortable discussing the relationship between the vaccine and HPV disease of STIs,
especially with younger daughters (Marlow et al. 2007). The results from this study
support broader findings that suggest that mothers are more likely to talk about sexual
health-related issues with older children (Byers, et al. 2008; Pluhar, et al. 2008).
Fewer studies have examined adolescent perspectives regarding STI vaccines and
sexual behavior. Webb and colleagues (1999) surveyed 140 primarily female, African
American youth, ages 13 to 18 to understand how they would perceive a hypothetical
HIV vaccine to influence their peer’s sexual behavior. More than three-quarters of youth
believed that adolescents would engage in riskier sexual behavior (including decreased
condom use, increased number of partners, and less selectiveness in choosing partners) if
an HIV vaccine with 90% efficacy were available. In a London-based study, Forster and
colleagues (2010) surveyed 162 girls between the ages of 14 and 15 attending a “highachieving, state-funded, single-sex” secondary school. Girls were asked to rate their own
intention to receive the HPV vaccine, but also asked a series of statements to assess
whether they thought their parents would allow them to be vaccinated and what they
thought it would mean if their parents permitted them to be vaccinated. Ten percent of
girls strongly or slightly agreed that parental consent implied that they felt it was okay for
their daughters to be sexually active or that girls were old enough to engaging in sexual
activity (8%).
Does “Risk” Matter?
To determine how important the concept of “risk” is in parental vaccine
acceptance requires consideration of what constitutes a risk. The HBM constructs of
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perceived susceptibility and perceived severity are essentially risk measures. They are
designed to elicit one’s self-risk appraisal. However, susceptibility and severity are
measures of risk defined by public health and epidemiology. The “perceived barriers”
factor can include other “risks” – such as fear of promiscuity or immune overload, but
these variables are lumped with a whole host of other factors, such as economic and
structural barriers, that are deliberately factored into a risk assessment.
Given the predominance of the HBM in the vaccine literature, it is no surprise that
much of the literature of vaccine acceptance relates to risk perceptions. Many of the
instruments that are used to explore parental vaccine acceptance begin with the
assumption that “risk” is a key component in decision-making. What is unclear,
however, is whether the focus on risk is a product of the instruments used to asses
vaccine acceptance or because parents frame their decisions as risks. As Hobson-West
(2003:279) explains, “Research into public attitudes to a technology may talk about
perception of risk, simply because it has been assumed that this is the meaning of the
debate to the public. In other words, research often looks for risk, and finds it, when it
isn’t necessary there.” For these reasons, and because of its association with rational,
probabilistic, cost-benefit measurements, the term “risk” does not necessarily describe the
way that parents understand vaccine-related anxieties and concerns.
Qualitative studies that do not begin with the assumption that “risk” matters,
suggest that there are many important issues, such as trust, responsibility, accountability,
and the meaning of alternative health beliefs, that underlie parents’ understandings of
vaccines (Hobson-West 2004). In one qualitative study on vaccine risk, mothers were
asked to define, evaluate, and process vaccination decisions in their own terms, rather
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than in terms dictated by a survey instrument. The results revealed that mothers have
complex and multiple ways of understanding a risk, which can reproduce and/or
challenge biomedical conceptions of risk. Some mothers explained that the risks that
they associated with vaccines were generated through maternal instinct and intuition.
From this perspective, mother’s used subjective knowledge, or knowledge from the self,
to understand a risk (Rogers and Pilgrim 1995). For other mothers, risks are understood
within an explanatory model that prioritizes fate over intervention.
“Given the renewed enthusiasm for the concept [of risk] it may prove tempting to
build aspects of social theory on the back of risk, without empirical justification. In other
words, look for risk (and find it), when it isn’t necessarily there” (Hobson-West
2003:279). While the risk appraisal is absolutely essential to scientific, medical, and
public health understandings of the relative merits of vaccination, there is less evidence to
suggest that parents use the same process to consider the relative merits of vaccination for
their own children. In fact, studies that examine risk communication between providers
and parents suggest that the relative importance of the scientifically understood risk
appraisal has little relevance for most parents (Hobson-West 2003; Hunt, et al. 2006;
Rapp 2000).
These findings remind us that the relative importance of risk perceptions should
not be taken for granted. As previoiusly discussed, researchers using the HBM have not
convincingly demonstrated that risk perceptions can adequately account for variability in
parental vaccine acceptance. The failure to demonstrate the relevance of risk perceptions
relates both to theoretical assumptions (as already discussed), and to methodological
issues, to which I will now turn.
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Chapter Four – Methods

As illustrated in the theoretical and topical reviews presented in the previous two
chapters, the HBM and TRA dominate the vaccine literature and subsequently, the
methodological literature. Several primarily quantitative methods have been used in
specific ways to generate most of the findings that constitute the vaccine acceptance
literature. In this chapter, I review the predominant methods used in the vaccine
acceptance literature, as well as other methods that can contribute to a broader, more
holistic view of vaccine decision-making.
I begin the chapter with a brief definition of research methodologies that includes
a set of criteria that I later use to assess the utility of given methods within the larger
vaccine literature and within my own study. I then examine how various research
methods have informed the structure and composition of the current vaccine acceptance
literature. Based on conclusions drawn from this review, my research questions, and
theoretical orientation, I conclude with an outline of the methodological strategy I
employed to collect and analyze data.
Methodologies are simply a body of methods, rules, and postulates employed by a
discipline (Merriam-Webster 2007). As such, they are useful tools when appropriately
applied to investigate specific questions, but it is only within the context of a particular
question, topic, or issue that the strengths and weaknesses of these tools can be assessed.
Just as a chainsaw is a tool better suited to cutting through wood than to driving a nail
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into the wall, a research method can work exceptionally well for tackling one question,
while proving incredibly ineffective at addressing another. And even when methods are
appropriately selected, their abilities are largely dependent on the user. Continuing the
above analogy, a chainsaw can effectively slice through wood, but only if the user can
operate the chainsaw. If one holds the blade rather than the handle, the chainsaw will still
be effective (in lopping off a hand, for example), although not at solving the original
problem (the wood is still uncut). In a less dramatic example, tools can be used more or
less effectively: one might not apply correct pressure to the wood, resulting in an
imperfect, albeit sliced, piece of wood. In short, methodologies are not, in and of
themselves, good or bad; rather, they are more or less useful depending on the specific
research question and what one hopes to learn about a given topic.
With these points in mind, I have organized each methodological section to
address several points. First, I provide a brief description of a method in terms of its
strengths and weaknesses. I then discuss its use in the parental vaccine acceptance
literature. When applicable, I will examine how researchers from different theoretical
orientations have used the method and the effects that those uses have on our
understanding of the parental vaccine acceptance literature. I will conclude by proposing
a methodology that fits within the Local Vaccines Culture (LVC) approach (see Chapter
Two) and illustrate how this methodology will allow me to collect data that contributes to
the general literature on vaccine acceptance.
Before discussing the various uses of the relevant methods, it is important to note
the variability in what constitutes one method or another, both in definition and use of
terms. Two examples will illustrate this point. In the first case, Gerend and colleagues
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(2007:469) use a face-to-face, close-ended instrument to elicit information from
participants on pre-defined, sequentially arranged questions, and describe their method as
“semi-structured interviews.” While this method is an interview in the sense that the
discussion is a “conversation with a purpose” (Marshall and Rossman 2006:101), I would
classify it as a survey or structured interview. In the second case, Brewer and Fazekas
(2007) classify a study (Constantine and Jerman 2007) which used a telephoneadministered instrument consisting of sequentially arranged questions as a “qualitative
study” because one question on the instrument allowed for an open-ended response. I
would not classify this study as qualitative, especially given the way that the data were
analyzed. In Tables A3 and A4, which include lists of some of the studies that I have
examined, I have used my methodological definitions. I am certain that other reviewers
and some of the researchers themselves would disagree with my categorization, but it is
necessary to have a common set of criteria to classify and compare methods.

Interviews
Interviewing strategies are commonly used to understand parental vaccine
acceptance, although the scope and depth of an interview, the number of people involved
in the interview, and the structural constraints framing the interview vary widely
(Marshall and Rossman 2006).
Survey Interviews
Following Schensul and colleagues (1999b), I define surveys as structured,
primarily close-ended, instruments that are administered by a researcher in a face-to-face
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interaction13. Generally speaking, the great strength of the survey interview is that it is
highly structured14 – every informant is exposed to the same stimuli (Bernard 2000). As
a result, structured interviews are often more amenable to quantitative data analysis.
The survey is the most common instrument used in studies of parental vaccine
acceptance. For example, 47 out of 70 (67%) studies that I reviewed prior to developing
my own methodology included a questionnaire or survey instrument. In 43 of these
studies the survey was the only instrument used. Eighteen of 22 (82%) studies on
parental HPV vaccine acceptance used a survey (see Table A3 for details). These studies
using survey methodology have been quite adept at revealing that immunization – a
behavior that has traditionally been identified as noncomplex15 – is actually quite
complex. Based on results presented in previous chapters I would argue that these
studies reveal the limitations of a primarily quantitative survey instrument to find “a
magic bullet” factor that can capture this complexity or produce any particularly relevant
factor predicting vaccine decisions.
Several researchers who are proponents of survey methods have been especially
critical of their use in the vaccine literature. The criticism largely relates to ambiguities
underlying survey construction and difficulties testing hypotheses, both of which are tied
to use of the HBM or hybrid –HBM models. Nearly all of the studies on parental vaccine
acceptance use survey-based models to operationalize HBM or hybrid HBM models.

13

I use the term telephone survey to distinguish surveys that are still administered to someone by a
researcher, though not through face-to-face interaction. Questionnaires refer to surveys that are selfadministered by a respondent. While there are relative strengths and weaknesses to each of these
approaches, my review treats them generally.
14
Other structured interview techniques, such as free-listing, triads, and pile-sorts also share this strength.
15
Many researchers, when arguing against the use of the HBM for particular behaviors such as condom
use, have argued that the HBM is only effective at explaining “simple” behaviors, citing immunization as a
good example.
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The way in which model factors are operationalized is no small point. If a model is
intended to explain or predict behavior, then the survey items used to assess the model
need to measure the factors that the model posits are important (Bernard 2000).
Unfortunately, many studies on vaccine acceptance are crippled by problems with
construct validity (Brewer, et al. 2007a).
For example, the HBM posits that individual perceptions of susceptibility,
severity, benefits, and barriers will affect health behavior. Because the model assumes
that individual perceptions are paramount to behavioral responses, the instrument needs
to frame vaccine questions to specifically probe for individual-level perceptions. In
practice, however, items to assess individual risk perceptions often fail to differentiate
between individual and population risk events. For example, many surveys ask the
question “how serious is X disease” rather than asking “how serious would it be if you (or
your daughter) got X disease?” (Brewer, et al. 2007a). If the first question is used to
measure perceived individual susceptibility then there will be inferential problems in
determining the locus of susceptibility (Brewer et al. 2007a). A parent might think, for
example, that HPV is not generally a serious disease. However, a parent might think that
HPV would be very serious if her daughter got it.
As mentioned in Chapter Two, the HBM and hybrid models assume that beliefs,
perceptions, and intentions lead to actual behavior. This behavior motivation hypothesis
“describes the effects of perceptions of risk on changes in behavior” (Brewer, et al.
2004:126). Specifically, the hypothesis states that individuals who currently have
elevated risk perceptions will be more likely to engage in preventive behaviors in the
future, which is a cause and effect hypothesis. In order to test this hypothesis, a research
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design needs to include a temporal dimension – some type of longitudinal design that can
measure both intentions (or perceptions) and behavior (Brewer, et al. 2004). Only one of
the surveys that I reviewed (Wroe, et al. 2004) used a longitudinal16 research design. In
my opinion, this particular weakness relates not to the method but to its application.
Granted, nearly all of the HPV vaccine acceptance studies have been necessarily limited
to intentions because they were conducted prior to vaccine availability. However, a
review of the larger vaccine acceptance literature contains few cases in which researchers
actually test this hypothesis (Brewer, et al. 2007a; Weinstein 2007; Weinstein, et al.
2007).
Additionally, many of the surveys fail to adequately condition risk questions. As
Brewer (2004) notes, risk questions need to be conditioned when researchers hypothesize
that a risk perception will change one’s behavior. If a researcher expects that perceived
susceptibility to a disease will motivate vaccine behavior, then questions related to
susceptibility need to be conditioned on whether one does or does not get vaccinated.
While this particular problem is not a concern in the HPV literature (because all studies
included in my review occurred prior to FDA approval), it has been a significant problem
in the larger parental vaccine acceptance literature (Brewer et al. 2004; Brewer et al.
2007a).
For example, in order to assess whether a particular factor, such as perceived
likelihood of HPV infection, actually affects intention, surveys need to assess an
individual’s risk perception with and without the intervention (vaccine). A survey should

16

Benin et al. (2006) also used a longitudinal research design, but to conduct qualitative interviews that did
not attempt to statistically test an association between beliefs and behaviors.
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include both of the following questions about likelihood: “What is the likelihood that
your daughter will get HPV if she does not get vaccinated?” (unconditioned) and “What
is the likelihood that your daughter will get HPV if she is vaccinated?” (conditioned).
Without knowing both pieces of information, it is difficult to test whether a risk
perception, or efficacy, motivates a vaccine action (Brewer et al. 2007a).
Another methodological problem with many studies relates to the use of
unconditioned questions in cross-sectional research where parents are separated into
groups based on whether their child has or has not been vaccinated. The use of
unconditioned risk questions, while inappropriate, is common in these studies. The
answer to the question “What is the likelihood that your daughter will get cervical
cancer?” will likely be conditioned by whether the child received the vaccine or not. If
parents in the “acceptance” group rate their child’s susceptibility as lower because they
have vaccinated their child and see the vaccine as effective, then a negative association
will likely appear. However, this negative association cannot be interpreted to mean that
parents who perceive that their children are at low risk for a disease are more motivated
than other parents to vaccinate (Brewer et al. 2007a).
These construct problems are not minor issues. Rather, such errors have the
potential to completely skew results. In a meta-analysis of health behavior theories,
researchers questioned whether many studies could even be examined given their
methodological biases (Brewer et al. 2007a). While these problems stem more from
misapplication than the tenets of the method itself, they also exemplify the ease with
which entire models can be dismissed on legitimate statistical grounds.
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So what about the survey method of interviewing itself? Suppose that researchers
used longitudinal survey-based designs (and statistical analyses) that could actually test
the model’s assumptions? How useful would survey-based research be in understanding
vaccine acceptance and decision-making? The answer to this question largely depends
on one’s epistemological and ontological assumptions. Many researchers, particularly
those leaning more towards the relativist side of the ontological continuum, are skeptical
of using structured surveys to study risk events because risks are seen as constructed.
Douglas argues that the attempt to objectify and generalize responses leads to
profound limitations and inaccuracies because risks do not occur in neutral or unbiased
contexts (1992). In survey-based research, people are disconnected from social networks
and sociocultural contexts – the designs of many studies assume that people, not
populations, carry social risk (Brehmer 1994). This is an interesting point. One of the
strengths of surveys is that they can be used with large sample sizes, which allows
researchers to generalize results to populations. Yet I have to agree that there is a danger
in using surveys built on individual-risk theories to generalize out to populations. The
result is that certain individuals, who can be grouped into particular risk categories, can
be targeted for interventions. While populations do carry social risks, the effects of
interventions (which are supported by this survey data), can easily lead to victimblaming, where particular kinds of people (Douglas or Foucault could argue) become the
sources of danger and targets of control.
Mythen (2004:104) argues that the survey-based design of vaccine studies
“reproduces a realist understanding of risk and embodies a rationalist interpretation of
human motivations.” This type of approach does not account for politicization of risk and
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the importance of political issues on the meaning of a risk. The public politicizes risk
and it would be inaccurate to preclude such topics from a risk analysis (Douglas 1992).
This critique illustrates another main problem with quantitative survey instruments – that
they cannot measure many types of information, even when developed from extensive
ethnographic research. For example, in a study of mothers’ immunization practices in
Haiti, Coreil and colleagues (1994) used a mixed method approach, conducting extensive
ethnographic interviews and participant observation before developing a quantitative
survey. From the interviews and participant observation, the researchers found that the
main reasons that mothers did not get children immunized – maternal negligence,
embarrassment, and shyness – could not be measured at all quantitatively, while other
variables – maternal time use and previous negative clinic experience – were
“incompletely assessed due to limitations in the survey design” (237). The limits of
translating qualitative findings into quantitative measures raises a critical question about
findings from quantitative surveys – specifically about what they can and cannot tell us.
This is of special concern given that the findings from surveys are often used to develop
interventions and policies, and to identify target groups. As the authors explain,
“One variable which was easy to measure – knowledge of immunizations – was found to
be the most significant predictor of immunization use after controlling for socioeconomic
factors. While this finding is consistent with results of studies in other parts of the world,
it tells us little about the relative importance of cognitive factors compared to other
psychosocial variables which are difficult to measure in quantitative studies” (Coreil, et
al. 1994:237).
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Even though the ethnographic descriptive data led the researchers to conclude that
fears of embarrassment, shyness, and maternal negligence were important predictors of
immunizations, perhaps even more so than other variables, they were lost in the
predictive model because they could not adequately be measured in the survey.
What surveys – even ethnographically informed surveys – fail to capture then, is often
the most important and interesting aspects of any phenomenon: the meaning and context
behind the numbers. As I discussed in preceding chapters, many quantitative, surveybased studies on HPV suggest that X, Y, or Z group is more or less likely to accept a
vaccine, but there is limited information about why parents make these decisions,
especially as situated actors within a larger sociocultural milieu.
Due to the lack of consistent findings revealed through the use of surveys, and the
unlikeliness that even the most carefully designed ethnographic survey would capture the
type of information I hoped to explore, I opted against the use of survey-based
instruments for this study.
Qualitative Interviews
While qualitative interviewing is a staple of most anthropological research,
anthropologists have no proprietary claim to the method. Researchers in diverse
disciplines use qualitative interviews, although the way that researchers design, conduct,
and analyze qualitative interviews varies depending on the disciplinary lens that they
apply to the method. As Warren explains, “ethnography’s lens is that of lived
experience, set in an eternal present. The lens of the intensive interview is verbal – what
people say and mean – but its temporal range is biographical, extending into the past and
future” (2002:85).
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Given the richness and depth of information potentially accessible using this
method, which is typified by open-ended and less-structured questions, qualitative
interviews are sometimes employed as the default method for capturing a population’s
“real views” on a subject. Of course, what is “real” is open to debate and has been a
matter of much philosophical, theoretical, and methodological discussion. It is well
accepted among anthropologists that their own identities, positions, and roles vis-à-vis
the participant will influence the types of information the participant shares and how it is
communicated. Further, no individual’s responses, no matter how many interviews she
completes on a topic, will encapsulate all of what she thinks and feel about an issue,
event, or concept. Rather, individuals filter out information based on what they think
their audience wants to know (and hear), what they (don’t) want to share, and what they
think they can tell their audience. Add to this variation in the individual’s (and
researcher’s) particular mood during the interview, the larger events, issues, or stresses
someone experiences around the time an interview takes place, and the interview setting,
and one can easily understand why the notion of a “real view” must be problematized.
Interview data, as expressed to researchers, is always partial – in the sense that it
is incomplete and because it is biased. As Pool notes “these variations in expression
cannot be viewed as mere deviations from some underlying “true” opinion, for there is no
neutral, non-social, uninfluenced situation to provide that baseline” (Gubrium and
Holstein 2002:14).
Despite the situated, contextual nature of these communications, there remains a
“romantic impulse” among researchers to extract some fundamental truth or genuine
voice from the interviewee. In an effort to do this, many researchers have turned to open108

ended, in-depth interviewing, which is assumed to be a better way to explore “emotional
enclaves of the self” (Gubrium and Holstein 2002:11). The assumption in creating this
type of research interaction is that the “true, internal voice of the subject comes through
only when it is not externally screened or otherwise communicatively constrained”
(Gubrium and Holstein 2002:11). The quest for authenticity, however, is a concept that
has been defined and is validated by the researcher. Authenticity is an invention, a
reflection of our own assumptions about the body, the self, and the way it is expressed
and communicated.
As with more quantitative survey methods, recognizing the underlying
assumptions and weaknesses of the method does not invalidate the method; rather, it
provides boundaries that are a helpful check when designing research and interpreting
findings. Again, the specific research question and the researcher’s skill and
disciplinary/theoretical background mediate the usefulness of any particular method.
As an anthropologist, the lens I bring to the conduct and analysis of qualitative
interviews is one of interest in meaning and context, and the connection of individuals to
a broader sociocultural context. This perspective on qualitative research is partially
responsible for my dissatisfaction with the current qualitative literature on parental
vaccine acceptance. In health research, qualitative methods are often employed to
deconstruct complex phenomena into more straightforward concepts to be included in
survey questions or interventions (Pasick and Burke 2007). Most of the qualitative
findings from research studies, for example, result from interview guides based on the
HBM (Bond, et al. 1998; Raithatha, et al. 2003). While there is nothing inherently wrong
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with crafting an interview guide on the HBM constructs, there are consequences to
framing questions about vaccine acceptance based on the model.
First, conversations tend to be limited to factors that are already presumed to be
important to parents, which can limit the possibility of learning about other significant
factors. Second, questions, when posed as factors relevant to the HBM, tend to
encourage free-listing responses rather than contextualized answers (see Olshen, et al.
2005). Finally, focusing exclusively on HBM factors limits conversations largely to the
individual-level. When particular beliefs about vaccination are expressed, researchers
seldom probe (or at least do not publish the data) about the meaning of those beliefs and
how they are connected to larger questions.
For example, the only qualitative question included in a telephone survey on
parental acceptance of a hypothetical HPV vaccine (Constantine and Jerman 2007) asked
parents to explain why they rated their acceptance of the vaccine as they did (using a
Likert scale). Rather than providing descriptions of the narrative, the authors grouped the
items into categories, such as “health and safety,” “vaccine concerns,” and “pragmatic
prevention,” which stripped any contextual attributes or meaning from the responses.
Again, however, the usefulness of a tool depends largely on its purpose. If the goal of
using a qualitative, open-ended question is to generate a set of items to include in a
quantitative scale, then the method adequately served its function. However, if the goal
is to understand the meanings, experiences, emotions, and concerns that converge to
shape parental perceptions on vaccines, then the application of qualitative methods in the
study was inadequate.
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Individual Qualitative Interviews
Despite the limitations of interviewing and the method’s diverse application
reviewed above, individual interviews17 can provide a rich source of information about a
topic, experience, or way of life. Individual interviews can be more or less structured (or
open-ended) and more or less in-depth (Schensul, et al. 1999b). In the vaccine literature,
anthropologists have used a biographical, in-depth interview technique to elicit parent
narratives.
“Child health and immunization biographies” have been applied in several
anthropological studies to obtain information from parents about vaccination experiences
(Fairhead, et al. 2004; Jegede 2005; Kamara 2005; Millimouno, et al. 2006; Poltorak, et
al. 2004). These interviews are open-ended and in-depth, designed to “explore thinking
and decision-making about vaccination in relation to other forms of health protection” for
a particular child (Leach and Fairhead 2005:4). Parent biographies, rather than asking
solely for beliefs or decisions specifically related to a particular vaccine, decision-point,
or outcome, attempt to understand how parents access and interpret specific
immunization knowledge, experiences, and events related to their own recollections and
observations. Underlying this approach is an assumption that vaccine decisions are not
singular, detached events, but meaningful, contextualized processes. As Poltorak et al.
(2004:8) explain,

17

I will use the word individual interview in this section to refer to individual interviews where at least a
third of the research questions appear to be qualitative (to distinguish these from survey instruments, where
there are very few or no qualitative items in an instrument). I also recognize that during an interview
session, however, that multiple qualitative and quantitative instruments can be combined. For ease of
discussion, however, I separate these.
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When parents do not vaccinate they are not necessarily merely making a
statement about their scientific reading, but also to varying degrees about what
they regard as valued parenthood, their responsibility to their child, the right of
parents to choose, their trust in the medical establishment and their position in
their trajectory of interest in the issue, how they place themselves with respect to
their friends, and so on.
These biographies have, to my knowledge, only been used with parents of young
children, often under three years of age. However, they can just as easily be used with
parents of adolescent girls, although the types of experiences parents are likely to recall
and the way that they frame these vaccine histories will vary.
Not all of the in-depth individual interviews in the vaccine literature take a
necessarily biographical approach. Tarrant and Gregory’s (2003) interviews with FirstNations’ mothers in north-western Ontario produce a rich set of historically-couched
narratives, although the interview guide (which they included) and researcher intentions
were not specifically focused on obtaining mothers’ biographies. Unstructured (or
loosely structured) interviews are an excellent tool for learning about someone’s lived
experience and for understanding how people frame their own experiences (Bernard
2000).
Semi-structured Interviews
According to Schensul and colleagues (1999b:149), semi-structured interviews
“combine the flexibility of the unstructured, open-ended interview with the directionality
and agenda of the survey instrument to produce focused, qualitative, textual data at the
factor level” (149). In many studies, qualitative interview questions are used within a
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larger survey framework so that respondents can justify why they answered a close-ended
question in one way or another (Brabin, et al. 2007; Constantine and Jerman 2007; Mays,
et al. 2004). For example, Mays et al. (2004) assessed parental knowledge related to four
STIs and then asked parents to rate the likelihood (using a Likert scale) that they would
vaccinate their child against each disease if a vaccine was available. After parents
responded, the interviewer asked parents to explain why they responded as they did. This
approach is useful in identifying the multiple reasons that parents use to arrive at a
particular shared response. It can also be helpful to identify problems with the validity of
close-ended measurements in a survey. Semi-structured interviews can also provide
material for future hypothesis testing and be useful in understanding the various terms or
phrases that are used to refer to particular topics or items.
As they relate to the vaccine acceptance literature, key informant interviews, a
type of semi-structured interview, have been used extensively in ethnographic studies
(but in other studies as well) to interview a range of stakeholders believed to influence
vaccine acceptance, including traditional healers (Fairhead, et al. 2004; Jegede 2005),
health workers (Fairhead, et al. 2004; Jegede 2005; Kamara 2005; McCormick, et al.
1997; Poltorak, et al. 2004), community leaders (Millimouno, et al. 2006; Jegede 2005;
Kamara 2005), religious leaders (Millimouno, et al. 2006; Jegede 2005), traditional
birthing attendants and midwives (Fairhead, et al. 2004), NGO representatives (Kamara
2005); health clinic coordinators and representatives (McCormick et al. 2004), and
national policy makers (Kamara 2005).
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Group Interviews
Schensul and colleagues (1999a) define group interviews as any discussion that
occurs between a researcher and more than one other person, regardless of whether the
conversation is formal or informal, or arranged or impromptu. Group interviews have
several advantages. First, they allow the researcher to obtain a large quantity of
information in a short amount of time. In addition, group conversations can partially
recreate the types of discourses that are likely to occur in a “natural” setting. Group
interviews also provide the opportunity to examine how group members interact with one
another and the subject matter (Morgan 1988). They can be useful in generating research
questions for individual interviews, or to further examine themes that emerged through
individual interviews. This method is especially useful for generating hypotheses
because it generally requires less input and direction from the interviewer than individual
interviews (Morgan 1988).
I specifically discuss the strengths and limitations of focus groups here, because
they are, by far, the most common type of group interview used in vaccine studies. Focus
groups were included in 17 of 70 studies that I reviewed on parental vaccine acceptance
(see Table A5). While these 17 studies generally provided a clear and thorough
justification regarding focus group composition (i.e. sampling), few of the studies
included information regarding the role of the facilitator (or interview guide) in the
group. These are important features because facilitators and guides can constrain or
expand the topics of conversation. Facilitators can have more or less control in a group
interview setting. A more structured interview is helpful if the researcher wants to
compare data across groups or explore clearly defined issues. Most of the focus groups
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to study vaccine acceptance appear to be relatively structured, which makes sense if the
goal of the group is to develop questions to use in future surveys. The focus group guide
provided by Olshen et al. (2005), for example, is relatively restrictive. Even though
parents in the groups could provide open-ended responses, the questions specifically
related to constructs in the HBM and only encouraged discussions about HPV and the
tetanus vaccine.
While increased structure yields greater control over the data generated from the
group, it also limits opportunities for generating new information and encouraging group
interaction. In less structured interviews, group interaction increases and new or
unexpected topics are more likely to emerge, but the emergent data might be less
amenable to comparison (Morgan 1988). In studies by Evans et al. (2001) and Casiday
(2007) group interviews were relatively unstructured, which led to discussions framed
around trust, responsibility, and politics, rather than (for example) the risk perceptions
probed for in studies using a more structured focus group approach.
The focus group method is a good tool for examining commonly held views and
how those views are discussed in a social situation, but the method tends only to reveal
how people who share some similar characteristic interact with one another and a topic.
This is not a problem so much as a limitation, since much of human interaction occurs
with people who we see as similar to ourselves. The method is not generally used to
understand how people from different groups (such as doctors and parents) or who have
made different decisions (vaccinate or not) interact. In the first case, issues related to
authority, respect, and power might lead some parents to feel uncomfortable expressing
their views about vaccination in front of providers. In the second example, the
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environment could become charged, accusatory, and defensive if either set of parents
perceives that they are being judged negatively because of their vaccine perspectives
(Morgan 1988).
Like surveys and individual qualitative interviews, focus groups rely on verbal,
self-reported data. This information is valuable, but also limiting. Interviewees can talk
about perceptions, beliefs, attitudes, and knowledge all day long, and they can tell us how
these factors relate to behavior. However, without observing actual behavior or
interactions, it is difficult to know anything beyond the emic perspective.
Participant Observation
Participant observation (PO) is often the initial step in ethnographic research
because it aids in establishing relationships, helps anthropologists understand how a
system is organized (how people interact, how boundaries are defined), and provides the
researcher with experiences and insights that can be incorporated into interviews
(Schensul, et al. 1999a) In addition, repeated POs can reveal “patterns of etiquette,
political organization and leadership, social competition and cooperation, socioeconomic
status and hierarchies in practice, and other cultural patterns that are not easily addressed
or about which discussions are forbidden” (Schensul, et al.1999a:91).
In the parental vaccine acceptance literature, participant observation has been
used in several studies, but mostly in developing countries (Coreil 1994; Fairhead, et al.
2004; Jegede 2005; Kamara 2005; Kishore, et al. 2003; Millimouno, et al. 2006). One
ethnographic study on parental MMR vaccine acceptance in the U.K. includes clinic
observations (Poltorak et al. 2004). In a U.S.-based time-motion study on provider risk
communication, researchers recorded the amount of time that providers spent discussing
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vaccination with parents (Davis, et al. 2004b). Silverman and colleagues (2002) also
used participant observation methods to exam adult perceptions regarding influenza
immunization.
PO exists along a continuum from full (or nearly full) participation to exclusive
(to the extent possible) observation. There are strengths and limitations of situating
oneself at any point along the PO continuum; however, I will speak directly towards
issues related to less participatory, more observational strategies, because observation
lends itself more easily to studies of vaccine acceptance.
Whiting and Whiting (Johnson and Sackett 1998) write that behavior observation
is a time intensive method. Behavior observations take time to collect and greater time to
analyze. They argue that to justify such an investment, behavior observation must be
able to significantly contribute to the understanding of key research questions (though I
would suggest that for any method to be justified, it should help to answer key questions).
Johnson and Sackett (1998) argue that behavior observation is appropriate when the study
is about behavior and when activity descriptions are helpful to understand what activities
are like, who participates in activities, in what capacities, and in what contexts. Perhaps
the most significant advantage of direct observation over retrospective reporting of
behavior is that direct observations nearly always yield more accurate documentation of
activities and behaviors than do retrospective participant recollections (Bernard 2006). In
study after study, researchers found that individuals were poor reporters of prior
behavior, even when those behaviors occurred the previous day (Bernard 2006).
While vaccine decisions result in specific behaviors (vaccination or not), the
processes by which decisions are made are likely, in large part, cognitive in nature. At
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the same time, a core underpinning of the LVC is that interactions are important
components of vaccine decisions, and thus should be understood. Although the use of
observation could have provided valuable information regarding the nature of parent,
adolescent, and health care provider interactions and conversations, I opted against using
the method due to logistical, time, and practical constraints.
As is true with any form of participant observation, one must consider the effects
that observations will have on a particular exchange (Johnson and Sackett 1998).
Observations characterized by little to no researcher participation can make the
researcher’s presence more obvious to participants, who in turn might alter their behavior
as a consequence. This is especially true in more obtrusive forms of observation, such as
shadowing, where a researcher observes an individual (e.g., a physician) as they complete
daily activities (LeCompte and Schensul 1999). In the case of the provider-parentadolescent triad, and their healthcare interactions, I felt my presence would not only be
quite obvious – given the average size of an examination room – but could also
discourage parents or their daughters from discussing important health concerns they
might have with their provider.
Because I did not feel the benefits of observations would outweigh the limitations
and risks of using the method, I opted against conducting observations; as a result, I
needed to obtain information about the healthcare interaction through other means. In
cases where researchers cannot observe interactions, they often rely on retrospective
descriptions of an exchange. This is a useful approach regardless of whether
observations are conducted, because people’s recollection of events can highlight
tensions, meanings, or interpretations of the exchange that were relevant to the
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individual. There are, of course, limitations to relying on retrospective recollections of
events, which I highlight when discussing my interview methods.
Decision-Making Tools
Most studies attempt to determine what factors lead parents to accept or reject a
vaccine for their child. Although nearly all of the studies use the HBM or a hybrid-HBM
model to predict these decisions, and most use a survey-based research design, some
researchers have tried to model decisions using other methods (Sturm, et al. 2005; Zimet,
et al. 2005). These include vaccine vignettes and scenarios, free-listing and pile-sorting
activities, and triads. I focus only on vignettes and scenarios in this section because the
other methods are seldom used within the vaccine acceptance literature (though certainly
could be helpful to explore aspects of vaccine decision-making).
Vignettes and hypothetical scenarios are common methods used to assess risk
perceptions and to understand how people will respond to particular situations under
alternative conditions (Marshall and Rossman 2006). Researchers with diverse interests
have used these methods to examine aspects of parental vaccine acceptance (see Tables
A3 and A4). The critiques of these methods largely depend on their purpose, although
they also share some limitations.
First, these scenarios are often used in cases where a technology (e.g., a vaccine)
is not yet available. Responses to these vignettes are dependent upon a very limited
understanding of a technology that is far removed from the person’s reality. Vignettes
have commonly been used to examine parental acceptance of STI-related vaccines.
However, in most of these studies the vaccines do not exist in reality and parents are left
to imagine how they might respond to a vaccine of the future based on a very limited
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amount of de-contextualized information. For example, while it is unclear what effect
the marketing of Gardasil and efforts to mandate the vaccine (or its association with
Vioxx, Merck, or any other host of factors) had on acceptance, it is likely that parental
perceptions of the vaccine have been affected by its introduction. It is impossible to
capture (or anticipate) the social and political context into which new technologies will
be introduced, which dramatically limits what one can learn from these scenarios.
As I discussed in Chapter Three, hypothetical scenarios have been enormously
popular in mental-modeling cognitive studies that ask parents to use numeric risk
estimations to rate vaccine acceptability under various conditions. There are several
important limitations to using these scenarios to calculate risk perceptions. First, the
approach assumes that parents can respond to a risk scenario based solely on the facts
presented, without allowing background assumptions to bias their response. Second, the
approach assumes that parents can represent acceptability using a numeric scale, usually
from 1 to 100. Finally, researchers assume that the risk-benefit scenarios include
information that is relevant to parental decision-making (Connolly and Reb 2003).
Studies designed to test these assumptions indicate that this particular method of
assessing risk perception is problematic (Connolly and Reb 2003).
Context is another problem, regardless of the scenario. Even when vignettes
relate to technologies or decisions that people are familiar with, they are still asked to
respond to vignettes in a context far removed from the wider political and social context
in which individuals make real decisions. A possible consequence is that, “under
controlled conditions and outside of an everyday social context, respondents may feel
compelled to make sense of risk using analytical techniques as opposed to habitual
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anchors” (Mythen 2004:105). Mythen’s critique is targeted at the use of vignettes in
cognitive research, where response options are limited, but the critique could also be
applied more generally.
Results from these studies indicate, over and over again, that context matters.
Paradoxically, the method produced findings that illustrated the limitations of the method
itself. If context matters, then we need to question how useful scenarios and vignettes are
in predicting or even understanding actual behavior. Findings from hypothetical
scenarios are unlikely to reveal preferences or perceptions that represent real life
decisions.
However, vignettes and scenarios can still provide valuable information. Garro
(2004) suggests that they are especially helpful in promoting discussions related to
sensitive topics (by speaking hypothetically about some other person). They can also
reduce the likelihood that people will try to explain their own behaviors using “post hoc
rationalizations” (Garro 1998a:325). Using hypothetical scenarios, researchers can ask
people to evaluate alternative actions associated with a decision that is independent of
their own past actions.
I incorporated the use of hypothetical scenarios and vignettes into parent and
provider interviewers in order to delineate how perspectives or behaviors might change
under different conditions and to better understand the nuances surrounding vaccine
decisions. I provide a more detailed discussion of these methods when outlining my
research methodology.
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A Methodology for Examining HPV Acceptance
As presented earlier, conceptualizing an HPV vaccine decision as an isolated
event has been challenged on multiple theoretical grounds (Baker 2007; Casiday 2007;
Hobson-West 2007; Poltorak, et al. 2004). I propose that the Local Vaccines Culture
approach (LVC) provides a more nuanced and holistic strategy to examine vaccine
decisions within their sociocultural context. To review, the LVC approach calls for an
examination of supply and demand-side factors, as well the service interface. The
delivery of a vaccine program (supply-side) is affected by broader political and economic
forces, and the way that macro-level processes shape the current vaccine practices
generally and related to the HPV vaccine. The meanings (demand-side) ascribed to a
vaccine by parents, while important, do not exist in isolation either. Rather than limiting
conversations with parents to the HPV vaccine, and associated knowledge and risks, the
approach requires methods that explore how parents’ vaccine practices and beliefs are
associated with the wider social world. The service-delivery interface, as embodied by
the pediatric practice and interactions occurring within it, is of particular interest because
it is a border zone, where multiple meanings are translated, negotiated and performed.
The strength and consequential weakness of the LVC framework is its breadth in
calling for the examination of the individual experiences and emotions, shared (or
contested) meanings surrounding vaccination, and political and economic factors shaping
vaccine policy and delivery as part of an integrated system.
By capturing these multiple levels, the resulting collage of data is more likely to
capture the rich and complex layers of vaccine acceptance decisions than a narrowlyfocused, single-theory snapshot may do. At the same time, producing such a complex
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and organized analysis is challenging. The goals of the approach are lofty and necessitate
the use of qualitative methods that are sometimes difficult to implement, time-intensive
to analyze, and yield overwhelming quantities of data. In developing a research
methodology, I struggled to balance the requirements of the framework with practical,
economic, and time limitations. While I was unable to use specific methods that would
have provided a deeper understanding of the topic, I was able to construct a research
methodology that still allows for a deep, rich, and insightful analysis of HPV vaccine
decision-making in line with the goals of the LVC approach. In the following sections, I
describe my rationale for choosing particular research methods, sampling techniques, and
analytical strategies.
Research Methods
In brief, demand-side factors were explored using semi-structured, in-depth
interview methods that examined how parents situate vaccination within their larger
social worlds. Several methods contributed to an understanding of supply-side factors. I
conducted an extensive literature review on the economic, political, and structural
features of vaccine policy in order to situate the current HPV vaccine program in its
wider, historically-situated context. In addition, I conducted interviews with service
providers to elicit information about their personal approaches to vaccination, their
perceptions of parental concerns, and the meanings that they ascribe to parental vaccine
choices.
While I planned to conduct key informant interviews with health care
administrators and site managers to ascertain information about vaccine policies,
protocols, and procedures, both generally and related to the HPV vaccine, I was unable to
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successfully recruit any to participate. I originally planned to use direct observations and
shadowing as methods to collect information regarding the service-delivery interface.
However, concerns regarding the obtrusiveness of observations and the difficulty of
obtaining consent and assent from health practices, individual providers, parents, and
their daughters led me to seek other ways to collect information about the patientprovider relationship. Specifically, I incorporated questions, vignettes, and scenarios into
both provider and parent interviews to capture elements of the service-delivery interface.
Semi-Structured Interviews
I used semi-structured interviews to talk to both parents and providers. Semistructured interviews provide most of the same openness and flexibility offered by an
unstructured interview, but with the use of an interview guide that ensures that specific
topics are covered. Bernard (2006) notes that semi-structured interviews are especially
appropriate when participants will only be interviewed once, as was the case in this study.
Additionally, semi-structured interviews work well when interacting with members of
communities who are “accustomed to efficient use of their time” such as healthcare
providers (Bernard 2006:212).
One of the goals of this study was to better understand the meanings of
vaccination to parents – how parents frame their own stories and make connections
between vaccinations, personal experiences, and larger social processes. To explore
these connections, I conducted in-depth, semi-structured, one-on-one interviews with 26
parents. Within the larger semi-structured interview framework, I incorporated elements
from the biographical vaccine interview approach by asking parents to recall past vaccine
experiences and earlier decisions as related to specific children. I also used probes,
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vaccine scenarios, and vignettes to discuss aspects of the healthcare visit, including
typical provider-patient care interactions, how parents describe typical and non-typical
clinic visits, if and how the structure of visits changes through time (from childhood to
adolescence, for example), and how vaccination conversations occur. I also provided
parents with different scenarios to understand if, when, and how they discuss specific
vaccine recommendations. Other themes I explored during parent interviews included
general healthcare attitudes and decision-making and general perspectives towards
vaccines. Of course, a significant amount of time was spent discussing the HPV vaccine
in particular, and probing themes related to sexuality, responsibility, trust, risk, and
timing that emerged from these discussions.
I also conducted semi-structured in-depth interviews with 16 providers, who as
primary actors in both public health and biomedical systems, are well situated to
understand how larger structural, economic, and political aspects of healthcare provision
and vaccine coverage relate to HPV vaccine availability, coverage, and acceptance.
Providers are also key actors in the service-delivery interface; exchanges that occur
between parents, providers, and youth during healthcare visits link supply- and demandside factors and provide spaces where value conflict, consensus, and negotiation are
enacted.
It is important to include providers in studies of vaccine acceptance, not only
because they are part of the social/interactive experience of vaccine acceptance, but
because studies have found that provider recommendations can influence parental
vaccine decisions (Dempsey, et al. 2006; Dinh, et al. 2007; Esposito, et al. 2007;
Rosenthal, et al. 1995). It is important to understand if, how and when providers discuss
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the HPV vaccine and under what conditions they feel comfortable (and why)
recommending the vaccine. It is also critical to understand how they perceive parental
response to the HPV vaccine and how, if at all, this influences their own present and
future interactions with parents and patients.
Finally, providers can provide aggregate-level data about parental vaccine
perceptions. While parents provide the contextual richness that helps to frame and give
meaning to decisions, their narratives are specific and individual. Providers’ accounts of
typical parental concerns and interactions lack contextual richness, but help to situate
individual narratives within what providers view as normative, typical, and generalized
vaccine responses. Thus, together, parental and provider interviews provide two different
lenses by which to position and make sense of Gardasil decisions.
To examine these multiple facets, I designed a semi-structured interview guide
that provided a way to consistently probe specific areas, but was flexible enough to allow
me to explore emergent themes. In order to understand facets of the service-delivery
interface, I used scenarios and vignettes to understand how providers structure clinic
visits and how procedures, protocols, and perceptions vary depending on the age of the
infant, child, or adolescent and the type of visit (acute, sports physical, annual check-up,
etc.). I also asked providers to describe the typical structures of clinic visits with preadolescents, adolescents and parents. In addition, I asked questions to elicit information
about providers’ general perceptions towards vaccination and particularly vaccines for
adolescents, including HPV.
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Sampling Strategy and Recruitment of Research Population
The goal of my research was to understand the wide range of experiences and
perspectives that come to shape the way that parents make HPV vaccine decisions for
their pre-adolescent and adolescent daughters. I cast a fairly wide sampling net in an
effort to include parents who already made HPV vaccine decisions for (or with) their
daughters, as well as parents who have not yet made final vaccine decisions. The dearth
of anthropological, qualitative and descriptive literature on this research topic suggested
that a selective convenience sampling approach would be useful given the exploratory
nature of the research (Schensul, et al. 1999b)
Because of the limited amount of contextualized data on HPV vaccination
decisions and the overabundance of quantitative material on the subject, I felt it was
important not to limit the sample population, or set pre-defined sampling quotas based on
any particular demographic variable. As previously discussed, the quantitative literature
on parental vaccine acceptance yields no consistent evidence to suggest that demographic
variables are strong or reliable predictors of vaccine decision-making (Brabin, et al. 2006;
Constantine and Jerman 2007; Davis, et al. 2004; Fazekas, et al. 2008; Friedman and
Shepeard 2007; Marlow, et al. 2007a; Marlow, et al. 2007b; Moraros, et al. 2006; Olshen,
et al. 2005; Riedesel, et al. 2005; Waller, et al. 2006; Zimet, et al. 2005). While no single
demographic variable seems to be predictive of vaccine acceptance, parents’ own
personal demographic characteristics, such as education, age (of self and daughter),
ethnicity, and socioeconomic status, likely shape to some extent the way that they
understand and experience vaccine decision-making. In an effort to promote diversity in
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the study sample, I posted and distributed recruitment fliers in multiple locations18,
serving diverse groups of individuals; however, I did not require that a specific number of
parents meeting particular demographic characteristics be sampled.
I used both passive recruitment and a snowball sampling strategy to recruit study
participants; fliers were used for initial and ongoing recruitment of parents and providers,
while a snowball strategy was used to recruit additional participants. Participants who
learned about the study through a flier were passively recruited. Each individual needed
to contact me him- or herself to learn more about the study. Parent fliers were placed in
private pediatric healthcare clinics, community centers, and recreational centers
throughout the Tampa Bay area (Hillsborough, Pasco, and Sarasota counties) and in
central Pennsylvania (York and Cumberland counties) with permission from on-site
representatives. I posted fliers in rural, suburban, and urban areas, as well in venues
serving both younger and older girls, such as youth recreational facilities, libraries, and
after-school program sites. Using an online phone directory, I randomly selected 100
medical provider practices in the Tampa Bay area and 20 practices in central
Pennsylvania. I sent each of these practices, by mail, an envelope that contained several
copies of the parent flier, several copies of the provider flier, and a summary letter
explaining the purpose of my research. Providers were asked to place parent fliers in
their practice waiting rooms (if desired/permissible) and to share provider fliers with
colleagues. They were also invited to participate personally in the study. Fliers
targeting healthcare providers were placed in private healthcare clinics and at other sites
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For example, I posted fliers at youth after-school program sites for underserved and/or at-risk youth, at
recreational sites (e.g., YMCA), in coffee shops, libraries, convenience stores, and at clinics and healthcare
practices accepting youth with public and private types of insurance
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where healthcare providers congregate (e.g., workshops). In all cases, I obtained
approval from recruitment sites before posting fliers; no fliers were posted in sites where
prior approval was not obtained.
Snowball sampling was used as a secondary recruitment strategy, whereby
interviewed participants were asked to refer other eligible participants to the study.
Participants who wished to refer another person to participate in the study were given
additional research fliers and contact information to share with eligible individuals.
Sample Populations: Rationale, Inclusion and Exclusion Criteria
Initially, I planned to conduct interviews with providers and parents living (or
working) in the Tampa Bay area, including Hillsborough, Pinellas, and Pasco counties.
There were several reasons for selecting this research population. First and foremost, as a
resident of the Tampa Bay area at the time, the research population was accessible, which
was key given that I hoped to conduct face-to-face individual interviews with providers
and parents. I chose to include three Florida counties as part of the Florida sample
because these counties represent a diverse group of individuals from urban, suburban, and
rural areas (EDA 2007).
After nearly a year of data collection, I was having difficulty recruiting
individuals – especially parents – to participate in the study. Nearing the end of a year,
the secondary snowball sampling strategy had not led to any new participants, perhaps
because many of the parents that I initially interviewed were newer to the area
themselves. I decided to expand my sample to include parents and providers living (or
working) in central Pennsylvania, where I was born and raised and would spend several
months in which I could collect data. While splitting my sample between two
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geographically distinct areas of the country required additional analysis, legwork, and
state-level policy research, it also served to diversify my sample. Including participants
from two distinct geographic regions of the country, however, does not itself allow for a
comprehensive geographic comparison of vaccine perspectives. Even with the addition
of a second research site, my sample was never intended to be random or representative,
nor would the requirements that I sample to saturation likely result in sample sizes large
enough to conduct any type of statistical comparisons between or across groups.
To participate in parent interviews, individuals had to be between the ages of 24
and 65 and be the parent of legal guardian of a female between the ages of 9 and 16. It is
important to note that non-English speaking parents, who comprise an important segment
of the U.S. population, were ineligible to participate in the study, due to my limited
language skills19, the nature of the research, and economic constraints.
Licensed healthcare providers between the ages of 18 and 65 were invited to
participate in the study if the provider had contact with a pediatric population between 9
and 16 years of age and had discussions with parents or youth regarding the HPV
vaccine. Because a wide range of providers discuss vaccines with parents, and because
provider recommendations appear to influence parental vaccine perspectives, I attempted
to recruit providers with a wide range of specialization and training. I sent fliers and
research material to practices that employed medical doctors, doctors of chiropractic
medicine, osteopaths, naturopaths, nurses (nurse practitioners, registered nurses, etc.),
and physician’s assistants. Additionally, I sent material to practices and clinics that

19

Most notably, I did not feel that I could adequately or equally analyze interview data that were collected
and transcribed by another individual, when I was solely responsible for conducting, transcribing, and
analyzing all English-language interviews.
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specialized in acute care (such as walk-in clinics), primary and family care, pediatric
care, gynecological care, chiropractic, and naturopathic medicine.
Parent and provider interviews, on average, took between 45 minutes and two
hours to complete, depending on the breadth and depth of the participant’s responses.
The majority of interviews (n=37) were conducted in-person. Face-to-face interviews
were conducted at participants’ homes, in participants’ offices or work place, in the
researcher’s office (if preferred by the participant), or in another mutually agreed upon
location that was convenient, safe and private. Due to the distance between research
sites, scheduling conflicts, and weather-related cancellations, several telephone
interviews (n=5) had to be conducted. In order to compensate participants for their time,
I provided honorariums in the form of Target gift cards to parents ($10) and providers
($20) who initiated an interview.
Sample Size
As Schensul and colleagues (1999b:262) explain, the objective of exploratory
research “is to reach the informational saturation point, which is the point at which
additional data collection, including interviews and observations, produces no new
information about cultural domains, subdomains, or factors.” This point, termed
“sufficient redundancy” is reached when “patterns of response begin to repeat themselves
and generate no new information” (261). Based on this principle, and because my goal
was not to collect a statistically representative sample, I did not begin with the goal of
completing a specific number of interviews. Rather, I planned to conduct interviews with
parents and providers until I reached the point of sufficient redundancy.
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While there was no specific number associated with achieving redundancy, most
qualitative, ethnographic samples are relatively small (Schensul et al. 1999a). For
example, in one study where the concept of saturation was operationalized to determine
the point at which saturation occurred, researchers found that saturation occurred within
the first twelve interviews and basic elements for meta-themes emerged in as few as six
interviews (Guest, et al. 2006).

Data Analysis
Unlike quantitative analysis, which usually occurs at one point in time after all of
the data are collected, qualitative analysis is an ongoing and iterative process (LeCompte
and Schensul 1999). The systematic, but flexible nature of qualitative data analysis
allows us to rework questions and methods as we go, to adjust our focus and sharpen our
view of a problem. While statistical analysis gives us a snapshot, qualitative analysis
allows us to explore other dimensions as well – to add layers and depth and nuance to
contextualize findings.
I employed a data analysis strategy that consisted of several interrelated and
overlapping steps that included three primary levels of analysis: item, pattern and
constitutive analysis (LeCompte and Schensul 1999). Item-level analysis, which gives
the “researcher analytic scaffolding on which to build” was both an initial and ongoing
step in the analysis process (Charmaz 2005:517). Item-level analysis refers to the process
of isolating specific elements or items from the data that are related to the research
questions (LeCompte and Schensul 1999). These related items are then grouped into the
same “code” or descriptive unit in order to make sense of the data (Ryan and Bernard
2000). The process of identifying items and codes was simultaneously inductive and
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deductive and I drew from several code-identification procedures reviewed by LeCompte
and Schensul (1999:69-70) when conducting my own item-level analysis. The process
was also flexible: data could simultaneously represent elements of more than one code
and the same data were sometimes re-coded more than once throughout the research
process to provide “multiple readings and renderings” of a phenomenon (Charmaz
2005:517).
Once a substantial number of item-level codes had been created, I compared
codes to one another to identify patterns or themes. I drew from eight methods outlined
by LeCompte and Schensul (1999) to identify themes: declaration, frequency, omission,
similarity, co-occurrence, corroboration, sequence, and a priori hypothesizing. While
searching for similarities and patterns, I also used the process of analytic induction to
search for negative or disconfirming cases to explore the variation within narratives and
to highlight the nuances and multiple dimensions of experience (LeCompte and Schensul
1999).
In the constitutive (or structural) analysis phase, I began to find “consistent
relationships among patterns, components, constituents, and structures” (LeCompte and
Schensul 1999:177). For example, the importance of trust, vaccine timing, and
responsibility were identified during this phase as important components in parental
narratives. Using structural categories, I connected pattern-level themes to one another
and back to the research questions in an effort to gain a more complete and nuanced
understanding of the research problem. In this phase, for example, I identified
connections between trust in vaccines and trust in daughters with decisions regarding
vaccine timing. Finally, in the interpretive stage, I attempted to bring meaning to the data
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by locating them (and my study) within the broader field of research, which I intend to do
in the following chapters.

Ethical Considerations and Participant Confidentiality
The original research proposal and all modifications were approved by the
University of South Florida Institutional Review Board. The informed consent document
was written using lay language. All participants were given ample time to read the
informed consent document; in addition, I verbally discussed the content of the document
with participants in order to en sure that participants fully understand the document. After
reading the informed consent document, participants were encouraged to ask questions
about the scope and/or breadth of the project, specific risks or benefits of participating,
and information in the document that they did not understand or about which they wanted
more information or hand concerns. Participants who had reviewed the document,
discussed it with me, asked relevant questions, and were judged to be capable of
providing informed consent and willing to participate in the study were asked to sign the
informed consent document.
Participants were interviewed only once. Interviews were conducted at
participants’ homes, in participants’ offices or work place, in the researcher’s office (if
preferred by the participant), or in another mutually agreed upon location. Every effort
was made to accommodate the participant to find a safe and private location to conduct
the interview. In order to ensure confidentiality, all locations had to provide a reasonable
amount of privacy. Whenever possible, interviews were conducted in-person. However,
due to the distance between research sites, participants’ limited availability, inclement
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weather20, and economic constraints, five of the 42 interviews had to be conducted over
the telephone. In cases where a face-to-face interview was not possible, an initial
telephone call was used to discuss the research and to verbally review the informed
consent documents; participants who were still interested in participating then received,
via postal mail, a copy of the informed consent document, a Target gift card (a $20
honorarium for providers and a $10 honorarium for parents), and return envelope and
postage. After receiving and reviewing the packet of information, a second phone call
was set up to discuss, in detail, the informed consent document and answer any questions
that potential participants might have had regarding the study or their participation within
it. Participants who still wanted to participate sent the signed informed consent document
back to me, along with receipt that they received the incentive, and upon receiving this
information, I contacted participants to arrange a time to conduct the interview.
Snowball sampling was only used to recruit participants within groups (e.g.,
parents to recruit other parents or providers to recruit other providers). I did not ask
providers for any direct referrals of patients to avoid exerting undue pressure on parents
to participate. All electronic data (digital audio recordings of interviews, transcribed
interviews, and other data-related files) have been (and continue to be) stored on a
password-protected computer that is not part of a larger computer network. Hardcopy
data (field notes, informed consent documents) are stored in a locked office on the USF
campus. Post-interview, all audio-recorded data were saved in a digital format on a
password protected computer and erased from the audio-recording device. Typed
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For example, one face-to-face interview in Pennsylvania had to be cancelled due to a blizzard; due to the
parent’s work schedule, it was impossible to reschedule the interview before I had to return to Florida.
Therefore, we agreed to conduct the interview by phone.
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transcriptions of the interviews, as well as coding and analysis files, are also stored on a
password protected computer.
Parents discussed their own vaccination choices and perspectives about a vaccine
that is delivered to their daughters. Therefore, it was possible that through these
discussion parents could provide information that could directly identify their daughters
and other individuals, such as spouses, grandparents, or healthcare providers, who might
be mentioned in relation to vaccine decision-making. Providers sometimes discussed
information that could lead to their own or their colleagues’ identification. In order to
protect the confidentiality and privacy of all individuals who were either directly or
indirectly discussed during the course of an interview, I removed all information that I
felt might lead to the identification of individuals.
To ensure further protection of parent and provider confidentiality, I have
assigned all participants pseudonyms. In many cases, I use pseudonyms to identify
which parents and providers express specific ideas. In some cases, however, I felt that
including a participant’s pseudonym with some quoted material could potentially lead to
his or her identification, especially were someone to examine all of his or her quoted
material collectively. I do not use parent’s names when they are describing specific
information about their children that could lead to their identification and I refrained from
including specific information about some disorders due to their rarity. I also avoid using
provider names in association with quoted material that might lead their colleagues or
clients to identify who they are or where they work, especially because some of the
information that they shared with me was critical of their clients. I have used my best
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judgment in attempting to protect confidentiality while providing the reader with a sense
of participant profiles.
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Chapter Five – Setting and Participants

National and State-Level Vaccine Coverage and State Laws
Each state has its own laws specifying which vaccines are mandated for school
entry, in what dosages, and at what ages or grades. Vaccine-related policies and
requirements are not straightforward, but often politically charged issues for states, as
exemplified by recent presidential debates, in which Michelle Bachmann questioned Rick
Perry’s previous efforts as the governor of Texas to mandate the HPV for school entry.
Similarly, each state defines the conditions under which a child attending public schools
can be exempt from vaccinations. Finally, the ways in which states contribute to and use
federal vaccine funds through VFC, Medicaid, and 317 differ, which will be discussed
below. In this section, I briefly discuss Florida and Pennsylvania vaccine-related laws.
To attend public schools in Pennsylvania or Florida, children must have proof of
diphtheria, tetanus, poliomyelitis, measles, rubella, mumps, hepatitis B, and chickenpox
vaccines (or proof of immunity) (Florida 2008; Pennsylvania 2011). In addition to early
childhood vaccines, students entering the seventh grade must receive a vaccine against
tetanus and diphtheria toxoid and acellular pertussis (TdaP). In both states, students may
also require a chickenpox booster vaccine for seventh grade (Florida 2011). In
Pennsylvania, children entering the seventh grade are also required to receive the
meningococcal conjugate vaccine (MCV), though this law was enacted in 2010
(Pennsylvania 2010), after I completed interviews with parents. In addition to state
required vaccines, children ages 11 and 12 are also eligible to receive a series of catch-up
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vaccines, including Hep A and B, polio, and MMR, as well as the annual flu vaccine
(CDC 2011b).
Both Pennsylvania and Florida allow for medical exemptions. In both states,
parents submit a form signed by a physician or the physician’s designee stating that the
immunization(s) may be detrimental to the child’s health. Both Pennsylvania and Florida
law also permit religious exemptions, but Pennsylvania’s definition of a religious
exemption is more expansive than Florida law. In Pennsylvania, an exemption can be
granted “if the parent, guardian or emancipated child objects in writing to the
immunization on religious grounds or on the basis of a strong moral or ethical conviction
similar to a religious belief” (PA §23.84, 2008). In Florida, parents can request a religious
exemption by filling out a form issued by the county health department. The parent
submits a signed form that states in writing that a religious conflict exists. Under Florida
law, exemptions for personal or philosophical reasons are not permitted (Florida 2008).
At the national level, American Indian or Alaska Native (AIAN) girls were most
likely (64.8%) to have received at least one dose of HPV vaccine, followed by Hispanic
(56.2%), Asian, non-Hispanic (50.1%), and Black, non-Hispanic (48.9%) girls. Initiation
rates were lowest among White, non-Hispanic girls (NIST 2010a). However, a different
trend characterized three dose vaccine completion rates. Asian, non-Hispanic (86%) and
White, non-Hispanic (74.7%) girls were most likely to complete the series, followed by
girls identifying as Black, non-Hispanic (65.4%) or of American Indian or Alaska Native
(64%) descent. Rates of series completion were lowest among Hispanic girls at 56.1
percent (NIST 2010a). In Pennsylvania, 2010 indicators reveal that Black, non-Hispanic
girls (ages 13 to 17) were most likely to have initiated the series (63.6%), followed by
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Hispanic (54.5%) girls. Only half of White girls (50.2%) initiated the series (NIST
2010a). However, White, non-Hispanic girls who initiated the series were more likely
(87.4%) than non-Hispanic Black girls (65.4%) to complete the series (no data existed for
other race/ethnicity completion rates) (NIST 2010a). In Florida, 2009 data comparing
rates of one-dose coverage were slightly higher among Latina/Hispanic girls (40%) than
Whites (38%); data were unavailable for coverage rates among African Americans (NIST
2009).
National statistics indicate that a slightly greater percentage of girls below the
poverty line have had at least one dose of HPV vaccine. Approximately 52 percent of
girls below the poverty line began the series, compared to 48 percent of other girls.
However, girls at or above the poverty line (73.2%) were more likely to complete the
series than other girls (57.3%) (NIST 2010b; NIST 2010c; NIST 2010d). State-level
indicators for HPV coverage by poverty level were unavailable in Florida; however in
Pennsylvania girls living below the poverty line were more likely to both initiate (57.8%
vs. 50.4%) and complete (86.8% vs. 82.9%) the HPV series (NIST 2010).
Although national and Pennsylvania state indicators suggest that girls below the
poverty line are more likely to at least begin the HPV series, it is unclear whether Florida
patterns are similar. The 2010 national average is based on information collected from
eleven states and the District of Columbia; it is unclear what types of differences are
appearing in other states (NIST 2010d). Moreover, and as will be discussed in greater
detail below, structural differences in state-level management of its CHIP, Medicaid and
VFC programs can lead to differential uptake rates even among girls enrolled in or
eligible for these services. For example, a comparison of HPV vaccine uptake in Texas
140

between 2006 and 2008 revealed lower rates among girls enrolled in Medicaid and CHIP
programs, compared to those with private insurance (Staras, et al. 2010). Moreover,
uptake was higher among girls enrolled in Medicaid, as opposed to CHIP, programs
(Staras, et al. 2010a)
HPV vaccine coverage among 13 to 17 year old girls is higher in Pennsylvania
than in Florida. Based on results from the 2010 National Immunization Teen Survey, 41
percent of girls in Florida have received at least one dose of HPV (either Gardasil or
Cervarix), compared to 52 percent of Pennsylvanian girls (NIST 2010e). A greater
proportion of Pennsylvanian girls had received three or more HPV vaccine doses as well
(42% compared to 25%). Pennsylvania’s HPV vaccine rates are above and Florida’s
rates below the national average. Pennsylvania has the 19th highest initial vaccine rate
and the 9th highest 3-dose completion rate in the country (NIST 2010e). Florida has the
12th lowest uptake rate and 7th lowest 3-dose completion rate in the country (CDC
2011c).
Many factors likely contribute to variations in HPV vaccine coverage; one factor
is vaccine availability. Providers surveyed in several studies report that vaccine
reimbursement is a significant barrier to vaccination (Boodman 2007; Freed, et al. 2008;
Keating, et al. 2008; Kelley 2010) and there appears to be regional variations in vaccine
availability. In a national survey of family and pediatric physicians, 89 percent of
respondents in the northeast administered the vaccine in their office, compared to only 79
percent of providers in southern states (Daley, et al. 2010a). The cost of a single Gardasil
vaccine averages $120; a complete series costs an average of $360 (Kaiser 2008). While
the cost of the vaccine is the highest of any recommended vaccine currently on the
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market, its status as an ACIP-recommended vaccine (the vaccine approval and
recommendation process is discussed thoroughly in the following chapter) guarantees
that Gardasil is available for low or no cost through Medicaid and Vaccines for Children
(VFC) programs (KFF 2008). It is significant that the vaccine is covered through VFC
and Medicaid programs given that nearly a quarter (23%) of girls ages 9 to 18 are
publically insured and 13 percent have no insurance. Although the majority of girls are
privately insured (63%), it is unclear exactly what percentage of private plans currently
cover Gardasil vaccination (Kaiser 2008).
While many girls have private insurance, they still might be underinsured.
Underinsured children, defined as those who have “commercial (private) health insurance
but the coverage does not include vaccines, whose insurance covers only selected
vaccines (VFC-eligible for non-covered vaccines only), or whose insurance caps vaccine
coverage at a certain amount” can receive VFC vaccines only through Federally
Qualified Community Health or Rural Health Centers (CDC 2011c). While there are
ways in which underinsured girls can obtain the Gardasil vaccine at low or no cost,
factors such as awareness of eligibility and site location can potentially limit access to
these centers.
For example, the number of community and rural health centers in the five
counties sampled in this study varied. In Hillsborough County, there are 14 federally
qualified community health clinics (FACHC 2011). There are seven community health
clinics located in Pinellas County and three operating in Pasco County (FACHC 2011).
Cumberland County has one community health center, while York County contains four
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(PACHC 2011). Of the five counties included in this study, Hillsborough County is the
only one that contains federally qualified rural health centers (RAC 2011).
In Florida, approximately 18 percent of girls under age 19 are uninsured, while an
estimated 7 percent of girls in Pennsylvania lack any type of health insurance. These
girls can also receive Gardasil at low or no cost through the Vaccines for Children Fund
(VFC) (KFF 2011). Data from 2008 and 2009 indicate that approximately 30 percent of
children in Florida (29%) and Pennsylvania (30%) are insured through Medicaid or other
public programs, specifically the Children’s Health Insurance Program (CHIP) (KFF
2011).
The Children’s Health Insurance Program (CHIP) was created to expand
insurance coverage and services to underinsured families (Kaiser 2008). At the federal
level, CHIP is administered by the U.S. Department of Health and Human Services,
which provides matching funds to states for health insurance to families and children.
Individual states are responsible for implementing the program and have some degree of
flexibility in deciding how to administer CHIP. CHIP programs can take one of three
overarching forms. States can create CHIP programs that are completely independent
from state Medicaid programs, they can use CHIP funds to expand Medicaid programs,
or they can take a combined approach where some funds are used to expand Medicaid
programs while others are funneled into an independent program (Kaiser 2008)..
The structure of each state’s CHIP program affects a child’s eligibility to receive
vaccines through the VFC program. Children who are enrolled in a separate CHIP
program are not eligible for vaccines through the VFC because they are considered to
have insurance coverage and have access to ACIP-recommended vaccines through their
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CHIP insurance program. Pennsylvania has a CHIP program completely separate from
Medicaid, while Florida uses a combined approach. In Pennsylvania, children enrolled in
the CHIP program can receive ACIP-recommended vaccines, such as Gardasil, as part of
their program benefits, but are not eligible to receive the same vaccines through the VFC
program. Children enrolled in Medicaid expansion CHIP programs, on the other hand,
are Medicaid eligible, and therefore entitled to VFC program benefits. Though families
can obtain free or low cost vaccines through CHIP, Medicaid, and VFC, program types
affect aspects of service-delivery (e.g., locations from which vaccines can be obtained)
and provider reimbursement.
The structure of Florida’s combined program offers a good example of the ways
in which insurance coverage can affect vaccine uptake. Through the combined CHIP and
Medicaid programs in Florida, children are enrolled in one of six programs. Enrollment
options depend on the specific needs of the child and county of residence. In a two-year
Florida study of HPV vaccine uptake among girls (ages 11 to 17) enrolled in these
programs, researchers found that HPV vaccine uptake varied by Medicaid program type
and by length of enrollment (Staras, et al. 2010b).
While a significant percentage of Pennsylvanian and Floridian children can or do
receive vaccines through federally and state-sponsored programs (due to CHIP/Medicaid
coverage and/or being uninsured), they are underrepresented in this study sample. All 15
of the parents interviewed from Pennsylvania had private insurance plans that covered all
childhood vaccines. In the Florida sample, two of 11 parents had children covered under
Medicaid/CHIP programs and two parents currently had no insurance.
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County-Level Demographics
Approximately two and a half million people reside in Hillsborough, Pasco, and
Pinellas counties. Hillsborough County is the largest and most ethnically diverse of the
three counties (1,229,226; 71% White, 17% Black, and 25% Hispanic). Pinellas County
is slightly smaller, has an older population, and is less ethnically diverse (916,542; 82%
White, 10% Black, 8% Hispanic). Pasco County is the smallest of the three counties,
largely rural, and predominantly White (464,697; 88% White, 5% Black, 12% Hispanic).
These three counties include urban, suburban, and rural areas as well as linguistic, ethnic,
and income diversity.
The population sampled from central Pennsylvania is smaller and more
homogenous in comparison. Collectively, less than 700,000 people reside in Cumberland
and York counties and the majority of residents are White (91% in Cumberland County;
86% in York County). While York County does include a large metropolitan area, none
of the providers or parents who participated in this study lived or worked in this region of
the county.

Provider Characteristics
Sixteen healthcare providers participated in this study. Eleven of the providers
worked in Florida and five worked in Pennsylvania. The five Pennsylvania providers
included two school nurses, two pediatricians (one MD and one DO), and one family
nurse practitioner. While the sample of healthcare providers from Pennsylvania is small,
the population in the sample area is also relatively small. The nurse practitioner and
physicians worked in three practices that see more than 35,000 children in the area.
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Florida providers included eight nurse practitioners, two pediatricians, and one
chiropractor.
Providers in both sites worked in a variety of healthcare settings and several (n=7)
worked in more than one setting, providing them with comparative insights regarding
differences in vaccine uptake and perceptions. Nine providers worked in physicianowned practices: seven in pediatric practices, one in a family practice, and one in an
OB/GYN practice. Four providers worked in university affiliated, publically funded
teaching clinics. Two providers worked in non-profit family planning and STI clinics,
two in private retail clinics, and two in public and private elementary, middle, or high
school settings. The chiropractor worked in chiropractor-owned office. The OB/GYN
office was the only setting in which Medicaid or other publically-funded insurance was
not accepted. Most providers worked in settings where both public and private insurance
were accepted, though some settings dealt primarily with privately insured patients (n=2),
and others primarily with Medicaid insured or uninsured clients (n=5).
With the exception of the chiropractor, all providers were female. The genderbias is surprising given that slightly more than half of research fliers were sent to male
healthcare providers. In two cases, male providers who received the fliers passed them
on to females in their practices, who contacted me to be interviewed. I asked several of
the providers with whom I spoke why they thought male providers had not volunteered to
participate. Four providers speculated that males were simply less enthusiastic about a
vaccine that was targeted to and benefited females. One pediatrician said, “I think female
practitioners are more sensitive to the topic, and therefore more willing to invest time to
talk about it.” Another provider, whose male colleague passed the flier onto her,
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reflected, “I almost feel like they don’t really want to touch it yet. Because they don’t – I
don’t know, maybe they don’t understand it as much or they don’t sympathize as much. I
know people – my friends have HPV. I know about it.”
It is possible that males were more likely to pass fliers along to female colleagues,
not because they were disinterested in women’s health, HPV, or the Gardasil vaccine, but
because they knew some of their female associates were more passionate about the topic.
One pediatrician explained how she came to learn about the study: “[The flier] was sent
to the president of our office, who is male. And he said, ‘We received this, is anyone
interested in doing this? And he kind of [said to me], ‘I think this would be good for you,
you’re really interested in this.’ And I was like, ‘Yeah, I’ll do it.’”.
It is also possible that males were less likely to participate because they felt they
had limited experience regarding the topic, or that female providers would have greater
breadth of experience to draw from concerning vaccine interactions. Several providers
noted that in their healthcare setting, female providers saw the majority of pre-adolescent
and adolescent females, while male providers tended to work with most of the young
males.
Providers also thought that broader gender differences might explain the absence
of participation among males. One pediatrician thought that even if males participated in
the study, they would not (presumably unlike females) represent the general male
provider: “The males that are interested in doing it are not going to be your typical male
population anyway.” A nurse practitioner was not at all surprised that men had not
responded to research fliers, explaining, “I think most guys have a good bit of ADD.
They just don’t sit down and do anything that’s not going to immediately benefit them.
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Men just tend to be a little more selfish (laughs).” She went on to speculate that women,
as nurturers, are more likely to take time to help others. “I think it’s the nature of the
beast. Women tend to like to be helpful to other people.”
It is unfortunate that the chiropractor is the only male perspective presented here,
especially given that chiropractors’ typical vaccine discussions, interactions, and roles
differ markedly from those of medical doctors and nurse practitioners, regardless of
gender. The absence of male perspectives is especially disappointing because studies
suggest that there are some gender differences in HPV-vaccine approaches. Daley and
colleagues (2010) reported that in a national sample of family providers, female
physicians (95%) were more likely than male physicians (83%) to report giving Gardasil
in their offices.
Several of the female providers in this study also suspected that men viewed the
vaccine differently. As one pediatrician reflected, “you wonder if [male providers] just
feel uncomfortable. You wonder what they’re saying to patients.” Two providers
thought male providers would be less likely to push the vaccine, especially to parents of
younger girls. One provider thought the males with whom she worked would spend less
time discussing or promoting the vaccine with parents or young women. She said,
“They’ll just slap a pamphlet in front of them and say, ‘I think this is a good thing.
Here’s the information. Read it and let me know if you want it.’ In my experience, that’s
been the guys I’ve worked with.” Two pediatricians suspected that they pushed Gardasil
more heavily than their male counterparts and wondered how different their approaches
were. Another provider knew that males in her office were not routinely initiating
Gardasil conversations with younger girls, “They’ve told me at meetings with our reps
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and they’ve told me themselves that they sometimes don’t even bring it up to the 11 year
olds. They don’t even mention it. . . I’d love to hear a man’s take on it and if it’s
different from my take.”
I present the reflections of these few female providers not to suggest that male
providers are selfish, disinterested, or unlikely to recommend the vaccine, but to point out
some of the gender differences female providers perceive in male/female practice and
attitudes towards Gardasil. If differences exist in the ways that male and female
providers approach the vaccine – as is likely – it is critical to use caution when
interpreting the results of this study. The small sample of providers already precludes
wide generalization of findings, as does the analytic techniques employed, but the lack of
male voices certainly restricts any generalized interpretations that might be made even
further.
All of the healthcare providers in this study were generally supportive of
vaccination. However, the pediatricians tended to be more staunchly pro-vaccine,
making blanket statements in support of vaccination, while nurse practitioners were more
likely to convey overall support for vaccination but express specific concerns or
ambivalence towards certain vaccines. The differences in nurse (n=11) and physician
(n=4) perspectives towards vaccines are discussed throughout the dissertation, although it
is important to stress that variation in physician and provider vaccine perspectives may be
the result of sampling-bias. For example, while two physicians I interviewed described
their colleagues as pro-vaccine, both providers also noted that compared to their
colleagues they were the most supportive of vaccines, and the least likely to allow parents
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to split21 vaccines. These two physicians were also the most likely to initiate vaccine
conversations with every parent at every visit, regardless of previous vaccine refusals.
One of the physicians thought that while all of the other physicians in her practice were
“very pro HPV vaccine” she was not “sure that everyone is as forceful about it” as she is.
The other physician admitted that she was the most enthusiastic supporter of all vaccines,
especially Gardasil, in her practice. Of the difference in her own and colleagues stance
towards Gardasil she said, “I’m the only woman in the practice, so I think I’m a little bit
more for it than the men are. They’re a little bit more cautious because it’s a new
vaccine.”

Parent Population
In total, 26 parents completed interviews. Parent characteristics are presented in
Table 1 below. The majority of parents (n=22, 85%) who participated were mothers.
Slightly more than half of parents (n=15, 58%) resided in central Pennsylvania, while the
remainder (n=11, 42%) lived in the Tampa Bay area.

Table 1. Parent Sample Characteristics
Variable
Parent Age

Parent Sex

Under 36
36-40
41-45
46-50
Over 50
Female
Male

N
1
6
5
10
4
22
4

%
8%
23%
19%
38%
15%
85%
15%

21

In common usage, vaccine splitting can refer to two different practices: choosing to administer each
component of combination vaccines separately (e.g., vaccinating a child against measles on one visit, and
mumps on another) or to having children vaccinated, but at times that diverge from those recommended on
the CDC Recommended Vaccine Schedule (Sears 2009).
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Residence
Employment

Income

Race/Ethnicity

Religion

# of Children

# of Daughters

# of Sons

Daughters’ Ages

HPV Vaccine
Decision (for all
daughters ages 9-17)

Florida
Pennsylvania
Full-time
Part-time
Household
Under $50,000
$50,000-$99,999
$100,000-$149,999
$150,000+
Prefer not to answer
White/Caucasian
Black/African
American
Hispanic/Latino
Mixed
Christian
Jewish
Spiritual
None
1
2
3
4
5
1
2
3
0
1
2
3
4
<9
9
10
11
12
13
14
15
16
≥17
All girls vaccinated
None vaccinated
Deferring
decision/Undecided
Decision varied by
daughter

11
15
16
6
4
4
8
10
3
1
21
1
1
1
2
20
1
2
1
7
8
7
3
1
17
4
5
10
13
2
0
1
2
4
1
6
3
1
7
7
6
3
14
2
7

42%
58%
62%
23%
15%
15%
31%
38%
12%
4%
81%
4%
4%
4%
8%
76%
4%
8%
4%
27%
31%
27%
12%
8%
65%
15%
20%
38%
50%
8%
0%
4%
8%
15%
5%
23%
12%
4%
27%
27%
23%
12%
54%
8%
27%

3

12%
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The sampling strategy used to obtain interviews differed by state. In both states,
initial participants were recruited passively using study research fliers. The goal was then
to use a snowball sampling strategy to recruit eligible friends, family, and colleagues of
participants. As discussed in the previous chapter, I chose to include Pennsylvania as a
study site after experiencing low parent response in the Tampa area. With one exception,
all of the parents that I interviewed in Florida were passively recruited. On the other
hand, the majority of parents with whom I spoke in Pennsylvania were recruited using a
snowball method.
The different strategies are important to note. As an effect of the heavy reliance
on snowball sampling used to recruit parents in Pennsylvania, there is more homogeneity
in parents’ socioeconomic and occupational attributes. The demographic profiles of
Florida parents are more diverse because parents were not recruited by friends or
colleagues. I also bring up differences in sampling strategy to highlight the importance of
social cohesiveness and participant-researcher rapport when conducting research. In
Florida, the parents with whom I spoke were strangers, willing to take a few hours out of
their lives to speak with me. These parents were likely less likely to feel comfortable
encouraging their friends to do the same, especially for a stranger. In Pennsylvania, on
the other hand, parents were more willing to contact their friends to participate in the
study because even if they did not know me personally, they knew of me (e.g., that I was
born and raised in the area, that I had attended a local high school, etc.).
The majority of parents (n=21, 81%) self-reported as White. Three parents (12%)
identified themselves as mixed race/ethnicity, one parent (4%) as African
American/Black, and one parent (4%) as Latino. Sixty-two percent (n=16) of parents
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worked full time, 23 percent (n=6) had part time positions, and 15 percent (n=4) took
care of the household. Fifteen percent of parents (n=4, 15%) reported a household
income of fewer than $50,000 per year, a third (n=8, 31%) between $50,000 and
$100,000 annually, and half (n=13, 50%) reported household incomes of $100,000 or
more. Three quarters of parents (n=20, 76%) identified themselves as Christian, one as
Jewish, two as spiritual, and one as having no religious or spiritual affiliation. Most
parents had between one and three children (n=22, 85%). All parents had at least one
daughter between the ages of 9 and 16. Approximately one third of parents had only one
daughter (n=17, 65%); the remaining parents had either two or three daughters. More
than half of the parents interviewed also had at least one son (n=16, 62%). Most parents
(n=22) had private health insurance plans that covered their daughters. The children of
two parents were Medicaid-insured, and two parents did not have any type of health
insurance coverage.
Few Americans completely abstain from vaccinating their children. It is much
more common that parents resist specific vaccines, especially those which are not
required for school attendance. The vaccine practices reported by parents in this study
mirror those seen in the wider population, providing us with an opportunity to understand
how ‘typical’ parents view vaccines. All of the parents I interviewed were generally
supportive of vaccination. With the exception of one mother, who refused to have her
children vaccinated against chicken pox, all parents reported that their children had
received vaccines required for school entry. Two parents home schooled their children.
One was home schooling because she did not want to have her children vaccinated
against chicken pox. The other mother’s children had received all school-required
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vaccines, but were home-schooled for other reasons. One couple waited until their eldest
daughter was five to give her all school-mandated vaccines, but followed the normal
vaccine schedule with their subsequent three children. As discussed in the analysis,
vaccine practices for chicken pox, flu, hepatitis A, and HPV were more variable.
Participant Quotes
Brackets used within participant quotes indicate that originally quoted material
was altered. When phrases or words are contained within brackets, I have altered the
actual quote either to protect the identity of an individual (for example changing an actual
name in a quote to [my daughter]) or to improve the flow of narrative. No substitutions
were made that, in my estimation, altered the meaning of the quote. Italics are used to
indicate that a participant stressed a certain syllable, word, or phrase when speaking.
Parentheses are used to note when participants whispered, laughed, gesticulated, or used
other non-verbal cues to express an idea.
Bernard (2006:505) argues that while “there is a case to be made for recording
people’s statements verbatim,” there is often no such case to justify reporting those
statements verbatim. While I transcribed participant’s narratives verbatim, the quotes
used throughout the dissertation have been lightly edited to flow more seamlessly.
Bernard argues that editing out the run-ons, false starts, pauses, fillers, (e.g., “um”, “uh”,
“you know”, “like”) is not only acceptable practice, but advisable, when one is not doing
a linguistic, conversation, or narrative analysis. In Bernard’s estimation, “unexpurgated
speech is terrible to read [. . .] If you don’t edit that stuff, you’ll bore your readers to
death” (505). I agree. I removed unnecessary fillers, pauses, false starts, and run-ons in
an effort to create a more fluid text that highlights the importance of participant’s actual
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ideas, rather than their stutters or filler syllables. No speech was edited or removed from
quoted material that I deemed to alter or significantly contribute to the conveyed
meaning.
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Chapter Six – Context

In organizing the analysis of the data collected for this dissertation, I move from
distal to proximate factors related to Gardasil vaccine decisions. Distal factors include an
analysis of institutions, bodies, and legislation. Distal factors also include what Giddens
(Cassell 1993) refers to as experts systems of knowledge, abstract entities such as
biomedicine and science that are removed from and beyond identifiable individuals.
I have chosen to begin the analysis chapters with a discussion of structural factors
associated with vaccination. Aside from being an important consideration, as outlined in
the Local Vaccines Culture approach, there are strong epistemological reasons for
beginning with this discussion because these factors constrain, limit, and shape other
factors, such as the ways in which parents approach the vaccine or how providers choose
to discuss it. Different evaluations of vaccines and the diverging pathways that lead to
these assessments can be attributed to differences in the ontological status of processes,
factors, etc.; for instance, the differences in the creation of vaccine-related legislation
with the formation of a parent’s thoughts about vaccine risk. In many cases, these things
can be said to operate at different temporal scales, and take place within different entities
and between different actors (FDA board meeting vs. provider/parent interface vs.
spousal discussion) resulting in and reproducing social processes that pertain to different
ontological realms. Certainly it is true that parents’ ideas about sexuality, for example,
exist concurrently with legislation and pedagogical strategies for training health
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professionals, but ultimately the difference in scale—the social manifestation and
emergence of each of these processes – will respond to different units of a larger social
system. A careful study of the steps involved in parents’ decisions concerning the
vaccine needs to attend to the fact that the behavior under study is situated within a larger
system, and that this system is comprised of different levels (pertaining to temporal and
spatial scales), actors and interfaces.
I begin the structural analysis with a historical review of salient developments in
vaccine development, legislation and vaccine adoption and resistance. I then present the
processes leading up to and defining the availability of Gardasil to the public in 2006. In
the following chapter I shift the analytical lens from examining legislative factors
towards an examination of pedagogical models of health care delivery and factors
relevant to the provision of vaccines. Using nurse practitioner narratives that
differentiate their own nursing model of care from the medical model of care, I hope to
avoid an atomistic discussion of vaccine delivery. Instead, I present these differences in
care models in an attempt to immerse provider interactions within a larger conceptual
system and in a larger system of practice.
Moving towards a discussion of proximate factors, I then discuss sources of HPV
knowledge, trust relationships, perception of risks and benefits related to Gardasil, HPV
and daughters’ sexuality. To frame an analysis according to distal and proximate ends
entails a center. I have chosen to define this center through interconnectivity, humanness,
sociality, and tangible relationships; that is, as a psychological and socio-culturally
bounded individual, in this case, the parent. I try to illustrate, throughout this analysis,
how interconnectedness threads its way along the distal-proximate continuum. In human
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form, such interconnections between distal and proximate entities reveal themselves
through the parent/provider interface, and through parents’ narratives about their
daughters. Healthcare providers encapsulate “contradictory” manifestations; they have
faces, they have kids of their own, they interface with parents and children. They care for
their individual patients (thus are not quite public health officials), and they are also
intimately associated with expert knowledge systems (science, biomedicine), institutional
entities (government regulatory bodies, public health system), and industries (e.g.,
insurance, pharmaceutical) which parents may not necessarily trust. In essence, the
interactions with providers act as the distal-proximate interface, in which abstract entities,
and processes of temporal scope that far supersede those usually associated with an
individual, emerge and gain saliency in people’s lives.
Provider narratives, perception, and behaviors flow throughout the different
sections of this analysis. The provider embodies a Janus-faced dual-dimensionality,
capable of providing two different, but related perspectives on vaccination. Providers can
be seen as key experts, who can speak to typical parental vaccine perspectives as opposed
to the singular, though contextualized perspective of parents themselves. In this way,
providers present aggregate information on parental concerns, parental decisions, and
typical interactions. At the same time, providers through their interfaces and interactions
with public health, pharmaceutical, insurance, biomedical, and scientific communities,
offer an alternative lens through which parent vaccine decisions can be framed.
In the final sections of the analysis, I specifically examine the patient-provider
interaction as a situated event, from both parent and provider perspectives. I highlight
some of the challenges, tensions, and opportunities that arise through interactions and that
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emerge from different perspectives on the constitution of knowledge, conceptualizations
of risk, and trust relationships.

The Legal, Economic, and Political Vaccine Landscape
HPV vaccine decisions cannot be understood without first examining the
historical, political, and cultural vaccine landscape. Many of the tensions surrounding the
HPV vaccine apply broadly to all vaccines, and stem, at least partially, from historical
events and developments. Moreover, many parental concerns regarding vaccine use
cannot be understood outside of vaccine policies and laws that limit the ways in which
parents can conceive of vaccines themselves. The information presented in this section
provides necessary contextualization in understanding the findings that emerge of this
research project.
While parents have some decision-making power when it comes to vaccinating
their children against diseases, other stakeholders shape the landscape in which parental
vaccine decisions are made. In order to understand why specific themes gain saliency in
contemporary HPV vaccine discussions, one must first situate vaccines, and vaccine
campaigns, within their historical and sociocultural context. At both the federal and state
level, the U.S. government plays a pivotal role not only in approving and monitoring the
safety of vaccines, but in assuring that new vaccines are developed, current vaccines are
manufactured, and available vaccines are administered to the public. Political decisions
regarding compulsory vaccination laws, vaccine funding, and school exemptions are
shaped by epidemiological factors and public opinion regarding vaccine safety and the
rights of individuals and the state to guarantee individual and collective well-being.
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Vaccine financing, federal regulations and oversight, and litigation influence
which companies will engage in vaccine manufacturing, which diseases will be targeted
for vaccine development, and how much vaccines will cost. Insurance reimbursement
influences whether private physicians carry vaccines. The ease with which vaccine
waivers (for school entry) can be sought and whether vaccines are covered by insurance
will factor into parental economic decisions. All of these factors will affect, either
directly or indirectly, parental choices.
In this chapter, I provide an historical overview of vaccination in the United
States, focusing on the roles that public opinion, vaccine safety, economics, and
legislation have played in shaping the current vaccine landscape. I then describe the
processes by which vaccines are approved and recommended for general use. Finally, I
discuss the legal, economic, and social issues surrounding the approval and
recommendation of the Gardasil vaccine in 2006.

Historical Overview
Government involvement in the dissemination and regulation of vaccines can be
traced to the turn of the nineteenth century with initial federal efforts to improve
smallpox vaccine accessibility. In 1801, President Thomas Jefferson and several hundred
of his friends and their families became some of the first individuals in the U.S. to be
vaccinated against smallpox (Hodge and Gostin 2002). A year later, Jefferson attempted
to transport vaccines to the southern states, while also increasing their overall availability.
Despite his efforts, vaccination largely remained a technology of the elite. Among the
working class and poor, safety concerns and accessibility issues generally led to low
uptake (Hodge and Gostin, 2002). Thus, while the vaccine could protect individuals from
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contracting smallpox, it did little to curb the larger epidemic, especially among the
working class. In 1813, the U.S. Congress passed a bill to encourage vaccination, which
gave President James Madison authority to appoint an agency to oversee the safe
distribution of the vaccine throughout the country. Though well intended, the bill had
little effect given the fragmented and uncoordinated healthcare system and lack of
transportation (Hodge and Gostin, 2002).
While the federal government attempted to promote voluntary vaccination,
compulsory immunization efforts were underway in individual states. Unlike many
countries, where compulsory vaccination is enforced and regulated at the federal level, in
the U.S. individual states control vaccination policies (Tobey 1926). In the United States,
regional outbreaks of disease became the catalyst for introducing state vaccine
legislation. In 1809, Massachusetts became the first state to legislate vaccination
requirements and other states followed suit (Tobey 1926), but as an increasing number of
states adopted mandatory immunization policies, resistance to vaccination also mounted.
Colgrove (2010) argues that mounting vaccine resistance can be in part
understood as a response to broader public health initiatives developed in the latter half of
the nineteenth century. During the period, a flurry of legislative activity resulted in the
passage of an increasing number of laws directed at protecting public health through the
regulation of industrial practices, quarantine, isolation, vaccination, and sanitation. The
new regulations forced both individuals and commercial entities to modify their
behaviors and people did not respond well to what they perceived as government’s
increasingly regulatory role. The public was especially resistant to vaccine regulations
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because while most public health laws prohibit an individual from engaging in a specific
activity, vaccination requires an individual to submit to a bodily invasive procedure.
While resistance to larger public health regulation and government control did
little to help the case of compulsory vaccination, Colgrove (2010) suggests that
vaccination laws ultimately became victims of their own success. As rates of smallpox
declined generationally, people no longer witnessed the devastating effects of the disease.
In the face of expanding regulatory public health measures, people saw vaccination less
as a necessity and more as another example of governmental control. Vaccine laws were
challenged and while the courts often upheld the constitutionality of compulsory
vaccination campaigns, especially for school entry, the court of public opinion was a
different matter. Sensitive to the sentiments of constituents leery of public health
regulation, and in response to anti-vaccination activists, many legislators were persuaded
to repeal compulsory vaccine laws. During this period, vaccine opponents were
instrumental in repealing compulsory vaccination laws in eight states (Wolfe and Sharp
2002).
Questions regarding the constitutionality of compulsory vaccination were put to
rest in the 1905 Supreme Court Ruling of Jacobson v. Commonwealth of Massachusetts,
197 U.S. 11 (Court 1905). The impetus for the case began in 1902 when the city of
Cambridge, Massachusetts passed a statute mandating that all city residents who had not
been infected with “natural” smallpox be vaccinated, or re-vaccinated (if vaccinated
before March 1897) to protect against an outbreak (Court 1905). The city argued that
vaccination was a matter of public health and safety, and moreover, that because the
vaccine was offered free of charge and required of everyone, it was not putting undue
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burden on any individual (Court 1905). Henning Jacobson, a resident of the town,
refused to be vaccinated and was consequently prosecuted. In a seven to two ruling, the
Court sided with the state. Justice Henson wrote in the decision:
The liberty secured by the Constitution of the United States does not import an
absolute right in each person to be at all times, and in all circumstances wholly
freed from restraint, nor is it an element in such liberty that one person, or a
minority of persons residing in any community and enjoying the benefits of its
local government, should have power to dominate the majority when supported in
their action by the authority of the State (1905:1).
By 1905, eleven states had adopted compulsory vaccination policies and thirteen
states had specific laws for excluding unvaccinated children from attending public
schools22 (Hodge and Gostin 2002). Despite court rulings in support of compulsory
smallpox vaccination, compulsory vaccine laws were rarely enforced. In the early
twentieth century, three new vaccines became available, but states were in no rush to
mandate their use. Legislators were weary of the political fallouts and the public was
weary of governmental interference and vaccine safety. The problems associated with
early vaccines helped to explain, at least partially, why many people were distrustful of
government public health initiatives and compulsory vaccination programs (Sturm, et al.
2005; Wolfe and Sharp 2002). Unsanitary vaccination techniques leading to disease
outbreaks throughout Europe were not lost on the American public. In England, for
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Compulsory vaccination policies existed in Connecticut, Georgia, Kentucky, Maryland, Massachusetts,
Mississippi, North Carolina, Pennsylvania, South Carolina, West Virginia, and Wyoming. Schoolexclusion policies existed in California, Georgia, Iowa, Maine, Massachusetts, New Hampshire, New
Jersey, New York, Oregon, Pennsylvania, Rhode Island, South Dakota, and Virginia.
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example, most working class individuals had to obtain the smallpox vaccine at public
vaccination stations where one syringe was used to inoculate many children. By using
the same needle to vaccinate multiple people, other disease, especially erysipelas,
syphilis, and hepatitis B were spread (Fenner, et al. 1986). Similar cases led to a jaundice
epidemic among factory workers in Germany and a syphilis outbreak among children in
Italy (Fenner, et al. 1986).
In the United States, tragedies in Kentucky and New Jersey heightened public
fears regarding the safety of vaccines. By the turn of the century a diphtheria vaccine
manufactured by many private and public companies was being widely administered to
U.S. children (Offit 2005). The vaccine was manufactured by injecting the diphtheria
toxin into horses and then extracting the serum to inject into children. In 1901, during the
St. Louis diphtheria outbreak, a five year old girl who had received the vaccine died of
tetanus. Thirteen more children died of tetanus soon after receiving the diphtheria
vaccine. All of the vaccines involved in the deaths were traced to one batch of serum
produced by the St. Louis city health department. A subsequent investigation revealed
that one of the horses used to obtain the serum was infected with tetanus (Offit 2005). In
Camden, New Jersey a similar disaster occurred – nine children died of tetanus following
vaccination for smallpox (Offit 2005).
As a result of the St. Louis deaths and in an effort to address public concerns
about the safety of drug manufacturing, Congress enacted the Biological Control Act on
July 2, 1902 (Colgrove 2005; Offit 2005). The bill gave the U.S. Public Health Service
the authority to regulate “any virus, therapeutic serum, toxin, antitoxin, or analogous
product applicable to the prevention and cure of disease of man” (Offit 2005:59).
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Government regulation of vaccine safety led to a general unwillingness to acknowledge
vaccine-related injuries (Colgrove 2005; Offit 2005). The government, especially the
U.S. Public Health Service, had a vested interest in reducing the number of vaccinerelated injuries since any increase in injuries would reflect poorly on the agency.
Practitioners were also less likely to attribute diseases to vaccination, perhaps reflecting
their own confidence in the new regulatory requirements. Often when disease did
develop following vaccination, officials blamed the infection on poor hygiene. As such,
blame was shifted from vaccine manufacturers, physicians, or regulatory agencies, onto
the individuals who were vaccinated (Colgrove 2005). In deflecting blame from
themselves to individuals in an attempt to preserve public trust in vaccine safety,
government agencies and healthcare providers paradoxically caused many individuals to
distrust not only vaccines, but those that regulate and administer them. Thus,
governmental oversight of vaccine production gave some Americans a sense of security,
while heightening others’ fear and distrust not only of vaccines, but of government as
well.
Over the next few decades, vaccine-related fear would intensify for several
reasons, including epidemiological disease shifts, pharmaceutical company expansion,
the growth of preventive healthcare, and government reform. One shift in vaccine
perception resulted from shifts in the epidemiology of smallpox disease. In 1907, the
milder form of smallpox, variola minor, appeared in the U.S. Variola minor shared many
of the same symptoms with variola major, but the disease left fewer scars and was
associated with a much lower case fatality rate (Colgrove 2005). Within twenty years it
had surpassed the more virulent strain as the most common form of smallpox in the
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country. As more people developed the less virulent form of smallpox, the public
perceived fewer risks associated with developing smallpox and public resistance to the
vaccine increased (Colgrove 2005). Similarly, as the fatalities associated with smallpox
declined, the public became more critical of fatalities and adverse effects associated with
the vaccine.
Pharmaceutical companies were also expanding during the early part of the
twentieth century, forming partnerships with universities, the medical community, and
pharmacies, employing large staffs of scientists to research and develop products
(Colgrove 2005). By 1910 the term vaccine, which originally referred exclusively to
smallpox inoculation, was applied to a broader host of diseases (Colgrove 2005).
Companies developed vaccines against diseases such as cholera, typhoid, and plague.
New developments were met both with excitement and anxiety. Media sources devoted
widespread coverage to vaccine development and there was a general sense of hope that
vaccines would contribute to an improvement in overall health (Colgrove 2005). Yet
vaccine developments also elicited concern. Anti-vaccination groups worried that the
development of new vaccines would lead to an increasing number of compulsory
vaccinations – something that many anti-vaccinationists vehemently opposed, not only
because of perceived infringement on individual rights, but because of the unknown side
effects associated with vaccines (Colgrove 2005).
Broader social changes during this period, particularly related to health, also
influenced vaccine policy and public opinion. Many individuals perceived the increasing
number of social workers, visiting nurses, and educators employed within the private and
public sectors as a threat to family privacy (Colgrove 2005). After 1910, new workers’
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compensation programs led many employers to require employee physical examinations.
At the same time, life insurance companies started requiring physical examinations of
policyholders (Colgrove 2005). These changes represented a new focus on preventive
care, which previously had not been a significant component of healthcare. In an effort
to deliver preventive care, healthy individuals needed to see physicians; earlier perceived
as experts of sickness, physicians were now also experts in health. The increasing role of
physicians, nurses, and social workers in everyday life made many Americans
uncomfortable. When health reforms permeated the school system, parents feared that
the government and physicians were usurping parents’ rights23 (Colgrove 2005).
The establishment of the federal Children’s Bureau exacerbated concerns in 1912.
In an effort to control tuberculosis, the Bureau “distributed millions of health education
pamphlets aimed at teaching scientifically based methods of child rearing to mothers
around the country,” (Colgrove 2005:172). Many people interpreted the educational
materials as the government’s attempt to control how mothers parented their children.
Protests over state control culminated with the 1920 Sheppard-Towner Act, which
emerged as a “lightning rod for criticism” (Colgrove 2005:173). To opponents of
burgeoning state medicine programs, the Sheppard-Towner Act was a definite act of state
control, representing “the creeping expansion of a distant, centralized government, a
trend that was especially threatening amid the postwar backlash against socialism”
(Colgrove 2005:173).
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The reforms also affected public school inspections, which originally related only to infectious disease
control. In the early 1900s, however, the inspections were expanded to include screenings for chronic or
hidden conditions. The expanding role that physicians played, especially in child health, sparked concerns
over parental rights. Opponents of such measures argued that physicians and schools were slowly and
covertly “removing children from the control of their parents” (Colgrove, 2005, p. 172).
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In 1921, a member of Congress described the fears felt by many Americans:
“Government supervision of mothers; Government care and maintenance of infants;
Government control of education; Government control of training for vocations;
Government regulation of employment, the hours, the holiday, wages, accident insurance
and all.” (Colgrove 2005:173). To this litany of fears, the anti-vaccinationists added
vaccination as a form of government control. The process of medicalization and the
emphasis on preventive care continued through the 1920s led to changes in antivaccination arguments, which now asserted that vaccination, as well as larger healthcare
reform, were part of a “well-laid plan to medically enslave the nation” (Colgrove,
2005:172).
The emergence of polio tempered public reactions to health based social reforms.
In the summer of 1916, the first major U.S. polio outbreak struck New York City (Offit
2005). At that time, it was the largest polio epidemic ever recorded, paralyzing 9,000 and
killing 2,400 (Offit 2005). While polio undoubtedly caused widespread pain and
suffering, it paled in comparison to the toll of the 1918 influenza epidemic, which killed
675,000 Americans. To put it in perspective, more Americans were killed in this one
epidemic than in World War I, World War II, and the Vietnam War combined (Offit
2005). While polio caused fewer deaths than other U.S. epidemics, its effects on the
American psyche were far more profound. Those who contracted paralytic polio and
survived rarely recovered fully; it did not help that most of polio’s victims were young
children. As Offit (2005:9) explains, “The sight of small children trying to use withered
arms or struggling to walk with crutches or lying helplessly in breathing machines (called
iron lungs) was a constant, crushing reminder of the infection.”
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The devastating effects of polio prompted government and private support for
polio vaccine research. By 1935 two researchers, Maurice Brodie and John Kolmer, had
independently developed two different polio vaccines. Both of the vaccines were
produced using pulverized spinal cord fluid from monkeys that had been infected with
polio, but the processes varied slightly. With the hope of protecting their children from
polio, parents enrolled their children to participate in vaccine trials (Offit 2005).
Kolmer’s vaccine was administered to ten thousand children in 36 states and Canada.
The study had no control group which made it difficult to estimate the vaccine’s efficacy,
but the vaccine caused paralysis in ten children and the deaths of five others. When
pressed about the association between his vaccine and the deaths, Kolmer denied any
association, which led to public anger and likely increased public fear and distrust of
vaccination (Offit 2005). Brodie conducted his own study in North Carolina, Virginia,
and California, but with a control group. The vaccine was shown to be 88% effective: 5
of the 4,500 children without the vaccine developed polio compared to 1 in 7,000
vaccinated children. However, there were still risks associated with vaccination. One
vaccinated child died four days after receiving the inoculation and two infants developed
polio within two weeks of their first vaccination. The price for the public was too high
and both Kolmer and Brodie were vilified. Both had trouble finding work for the
remainder of their careers and their fate led to a significant decline in polio vaccine
research, both in terms of researchers and funding interests.
Eventually, however, funds and public interest for a polio vaccine reappeared. As
polio exacted higher annual tolls, the public became increasingly desperate for an answer.
In 1943, there were 10,000 U.S. cases of polio. In 1948 the annual total jumped to
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27,000. By 1952 fear of polio, more than polio itself paralyzed the nation. One U.S.
national poll reported that Americans feared polio second only to the atomic bomb (Offit
2005). During the preceding years, physician Jonas Salk had been working to perfect a
polio vaccine. In the spring of 1953, Salk vaccinated himself, his wife, and his three
children with an inactive form of the polio virus suspended in a mineral oil adjuvant.
While Salk clearly had confidence in the vaccine, the National Foundation for Infant
Paralysis (NFIP) (Dimes 2011)24 was concerned with the mineral oil adjuvant. Joseph
Bell, an epidemiologist at the National Institutes of Health, was hired by the NFIP to
design the test of Salk’s vaccine. Bell resisted the adjuvant, arguing that mineral water
occasionally caused pain at the injection sight and “running abscesses” (Offit 2005:39).
The restriction against mineral water was more than minor – the adjuvant was extremely
important in stimulating a prolonged immune response25. Finding a suitable replacement
was not a simple proposition. By the time that Salk was told he would need to find
another adjuvant the prospect of a vaccine had already been leaked to the press and Salk
found himself under tremendous pressure to produce a vaccine for large scale trials26.
As Salk struggled to find a new vaccine, Parke-Davis, the pharmaceutical
company originally set to manufacture the vaccine, pulled out. Salk’s lack of
comprehensive production protocol made Parke-Davis nervous. Without a manufacturer,
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The National Foundation for Infant Paralysis was founded by President Franklin D. Roosevelt in 1938
with the goal of eradicating polio in the United States. The name was later changed to the March of Dimes
Foundation (Dimes 2011).
25
Offit (2005) discusses the vaccine development process in great detail. The intense public pressure,
coupled with Salk’s inability to use his mineral oil adjuvant (which appeared to work very well but caused
side effects) and his choice in polio virus strain (an extremely virulent form) all contributed to the Cutter
laboratory crisis that followed.
26
The description of the field trial and results are all paraphrased from Offit (2005). Direct quotes are cited
specifically throughout the text.
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the NFIP turned to other companies with an enticing proposition: The NFIP would buy
27 million doses of the vaccine at a cost of 9 million dollars after the vaccine was
publicly available. The pharmaceutical companies would have to pay for all costs of trial
vaccination. Even if the vaccine did not work and could not be sold, the NFIP would still
pay the company. As Offit (2005:45) explains, the NFIP had “taken the risk out of
vaccine research and development”. Four companies agreed to produce the vaccine.
Removing the economic risk of research and development led to widespread interest in
the vaccine industry. In later years, a different type of risk would drive most of the
pharmaceutical companies out of the vaccine industry.
In 1954 Salk got permission to test his vaccine on U.S. children. It is worth
describing the magnitude of the field trial as well as the public response because it might
be the only time in recent U.S. history that a vaccination trial or vaccine has held so much
hope or captured so much interest from the American public. Beginning in April of
1954, and supported by the NFIP for Infant Paralysis, the community field trial remains
to this day, “the largest, most comprehensive test of a medical product ever performed:
twenty thousand physicians and health officers, forty thousand registered nurses, fourteen
thousand school principals, fifty thousand teachers, and two hundred thousand citizens in
forty-four states volunteered to participate” (Offit 2005:52). The trial also included an
astounding 1.8 million children who received one of three treatments.
Thomas Francis was charged with the monumental responsibility of analyzing the
trial data, which included an enormous amount of data (1.8 million children’s worth!).
The task is even more awe-inspiring when one recalls that Francis had no high-tech
computers and statistical software to aid in the analysis. Francis not only had to analyze
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an enormous data set – he had to do it as the country held a collective breath. The public
desire for a vaccine was overwhelming. A May 31, 1954 Gallup poll exemplified the
public interest: More Americans knew about the polio vaccine trials than knew the
President’s full name (Dwight David Eisenhower), likely because more Americans had
“participated in the funding, development, and testing of the polio vaccine than had
participated in the nomination and election of the president” (Offit 2005:54).
On April 8, 1955, Francis completed his report and on April 12th he presented the
results to the public. Normally, the results of scientific trials would be announced at
scientific conferences among peers, but the polio announcement was different. Francis
walked into a conference room filled with 150 press, radio, and television reporters and
16 television and news reels. Fifty-four thousand physicians packed cinemas and movie
houses around the country to witness the announcement. Francis reported that by the end
of the trial, 16 children had died of polio, none of whom had received the polio vaccine.
Thirty-six children developed severe (iron lung) polio, but only two of these children had
received the vaccine. Children without the vaccine were 3.3 times more likely to be
paralyzed from polio than those who were vaccinated. The vaccine was safe and
effective.
It is difficult for those of us who did not experience the polio epidemic to
appreciate the effect that the announcement had on the American public. Offit (2005:55)
describes the moment:
Inside the auditorium Francis finished to restrained applause. Outside the
auditorium Americans tearfully and joyfully embraced the results. By the time
Thomas Francis stepped down, church bells were ringing across the country,
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factories were observing moments of silence, synagogues and churches were
holding prayer meetings, and parents and teachers were weeping.
By the following year, Salk’s inactive polio vaccine (IPV) was mass distributed to
children around the country. Until this period, childhood immunization was relatively
inexpensive – children only received widespread vaccination against DTP and smallpox
(Hinman, et al. 2006). In order to mass produce the vaccine and ensure that all children
could access the vaccine, the government contributed federal funds. In 1955 and 1956,
Congress appropriated federal funds to ensure that all children could receive the IPV
(Hinman, et al. 2006). While the appropriations undoubtedly assured that many children
received the vaccination, the IPV coverage was unequal and incomplete (Hinman, et al.
2006). To address these inequities, the Vaccination Assistance Act (Section 317 of the
Public Health Service Act) was passed in 1962 (Orenstein, et al. 2005). The main purpose
of Section 317 was to use federal money to provide state and local health departments
with grants to support comprehensive immunization. The government negotiated prices
for vaccines with manufacturers and was able to obtain the vaccines for significantly less
than the private sector (Orenstein, et al. 2005). Few people suspected that government
vaccine coverage and price negotiations would significantly affect vaccines shortages
forty years later (a topic to which I will return shortly).
Shortly after the polio vaccine was released for general use, problems began to
develop. On April 25, 1955, an infant with paralytic poliomyelitis was admitted to a
California hospital, just nine days after receiving the vaccine (Offit 2005). Five more
cases were reported to the California Health Department in the next few days. All five
individuals became ill several days after receiving the vaccination and they all suffered
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from localized vaccination site paralysis (Link 2005). The Public Health Service traced
all six cases back to a set of vaccines distributed by Cutter Laboratories and asked Cutter
to recall all of its vaccines that had already hit the market. Cutter complied, but too late.
Two weeks after the first six cases were reported, another larger wave of polio cases
emerged. This time, however, the cases could be traced through household contacts and
social networks. An additional 454 children were infected and it was soon discovered
that the polio vaccine, which was supposed to contain an inactivated virus, actually
contained a live virus. Changes were made to the vaccine inactivation process and the
vaccine was made safe (Offit 2005). While most of the public quickly forgot about the
incident, anti-vaccination groups have not, and continue to refer to it as the man-made
polio epidemic (Offit 2005).
The next major vaccine events did not unfold for two decades. The DTP vaccine
was a combination vaccine that provided protection against three diseases: diphtheria,
tetanus, and pertussis (Baker and Katz 2004). Today, the same three diseases are
prevented using the DTaP vaccine. The difference in the two vaccines relates to
pertussis. The DTP vaccine was made from the whole-cell pertussis bacteria (rather than
a subunit), while the DTaP vaccine uses acellular pertussis. Unlike its whole-cell
counterpart, DTaP only contains a few detoxified components of the cell that elicit
immunity (NVIC 2011).
Beginning in the early 1970s, fears started to emerge about the DTP vaccine and
its association to neurological impairments. The scare led to the emergence of vaccine
litigation in the U.S. While there was a “lack of true epidemiologic, pathologic, or
physiologic evidence linking specific vaccines to specific adverse outcomes” associated
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with the DTP vaccine, the legal system nevertheless became the engine through which
claims were assessed and damages awarded (Freed, et al. 1996). It is interesting to note
that today, after thirty years of studying the effects of whole-cell pertussis, scientists still
cannot agree on the validity of DTP allegations (Ball, et al. 2001; Geier and Geier 2002;
Geier and Geier 2003; Pichichero, et al. 2002).
Regardless of the scientific validity of the claims, the economic costs (and for
some, gains) of vaccine litigation were substantial. In 1978, the average amount sought
per claim was $10 million. By 1984 the number jumped to $46 million and by the
following year “the total amount sought through litigation was $3.162 billion, an amount
more than 30 times greater than the market value of all DTP vaccine sold in the private
sector that year” (Freed, et al. 1996:1870). This new market for vaccine litigation
attracted lawyers. With the lawyers came countless advertisements that portrayed the
dangers of vaccination.
Litigation caused more than economic consequences. The 1970s litigation cases27
against vaccine manufacturers led many manufacturers to leave the industry, thus causing
vaccine shortages. Between 1974 and 1986 the number of DPT manufacturers dropped
from seven to two; oral polio manufacturers went from three to one; and manufacturers of
the measles vaccine declined from six to one (Link 2005). The media covered the DTP
shortage, but focused on the vaccine’s alleged side effects rather than the possible public
health consequences of reduced vaccination coverage (Freed, et al. 1996). Many
Americans also viewed the shortage suspiciously. The arguments of one attorney
illustrate how the DTP vaccine and the larger vaccine industry were portrayed at the time:

27

See Reyes v. Wyeth Laboratories (Link, 2005).
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“alleged DTP shortage is a ploy by drug manufacturers to avoid paying damages for a
product that the companies knew was less safe than they led the public to believe” (Freed,
et al. 1996:1871).
Litigation not only caused some companies to leave the business, it caused those
who remained in the business to proceed with caution. This precautionary principle was
evident in 1976, when the government recommended a massive immunization program
against a severe swine flu epidemic that epidemiologists predicted (Link 2005). The
immunization recommendation became integral to the presidential election, receiving
widespread attention and creating a public panic. The vaccine manufacturers were
“under tremendous pressure to create a vaccine ‘yesterday’” (Link 2005:35). Insurance
companies refused to provide liability coverage for the vaccine manufacturers and the
manufacturers in turn refused to distribute any vaccine without insurance liability
coverage.
In 1986, in an effort to relieve the economic risks placed on manufacturers,
Congress approved the National Childhood Vaccine Injury Act (NCVIA), which
established the National Vaccine Program, as well as the National Vaccine Injury
Compensation Program (VICP) (Malone and Hinman 2003). The main purpose of the
VICP was to provide no-fault insurance funds as a compensation source for “actual
vaccine-related injuries” (Freed, et al. 1996:1871). For each vaccine, the Program
established a list of conditions eligible for compensation. Many of the conditions that
were listed on the table of vaccine associated conditions had never been scientifically
tested – inclusion was based on litigation settlements, public fear, and unsubstantiated
claims of associations, not science. In the eyes of many researchers and vaccine
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advocates, including conditions on the Table that were not scientifically substantiated
reproduced and reinforced public distrust and fear of vaccines28 (Orenstein, et al. 2005).
Further, “in a legal sense, the vaccine injury Table legitimized a condition not grounded
in scientific data” (Freed, et al. 1996:1871).
While it minimized manufacturers’ risks, the VICP does not absolve
manufacturers from all liability or potential risk. If an individual believes that a vaccine
caused an injury, he must file a claim through the VICP. After going through the VICP
process, a plaintiff may either accept the decision and possible compensation offered
through the VICP, or reject the decision and take the case to the tort system. If a plaintiff
accepts the VICP offer he is prohibited from suing the manufacturer or vaccine provider.
In this regard, the VICP does offer some manufacturer protection, but only if the plaintiff
settles with the VICP. Further, the VICP legislation does not prohibit individuals from
seeking compensation for pain and suffering through the tort system, which can result in
substantial economic settlements (Orenstein, et al. 2005)
The VICP offered federal liability to manufacturers, but liability came at a price.
If the VICP was going to accept economic risks associated with vaccine production and
dissemination, then it was also in the government’s best interest to ensure that
manufacturers were subject to stringent vaccination manufacturing standards. The FDA
is charged with enforcing these standards (Orenstein, et al. 2005). Facilities that
manufacture vaccines must comply with current Good Manufacturing Practices (cGMP).
The FDA is responsible for cGMP oversight and the cGMP standards require controls

28

For example, one clause associated with the DTP vaccine stated that the vaccine “may result in
permanent impairment” (Freed et al., 1996).
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involving the production plant, the equipment, and all procedures involved in vaccine
manufacture29 (Orenstein, et al. 2005). The FDA also approves the labeling for vaccines
and has the authority to recall vaccines if there are safety or efficacy concerns.
Stricter FDA requirements for facilities caused vaccine manufacturing to decrease
(Jacobson, et al. 2006a). The cost of bringing facilities up to new codes was not
economically beneficial to many companies, causing several to leave the pediatric
vaccine business. As one example, Warner Lambert (now Pfizer) ceased production of
the influenza vaccine, Fluogen, due to financial losses and regulatory constraints.
Warner Lambert sold the factory to King Pharmaceuticals, who subsequently ceased
production altogether when it determined that bringing the factory up to governmental
codes would be too costly (Stern and Markel 2005).
FDA requirements also oversee pre-marketing regulations, which include
extensive clinical trials to measure the safety and efficacy of drugs. These requirements
have led, in part, to waning vaccine research and development (Riddiough and Willems
1980). While these regulations undoubtedly help in protecting the public’s health, they
also contribute to pharmaceutical disinterest in vaccine development because complying
with pre-marketing regulations can be incredibly time consuming and costly. In 2000, it
was estimated to cost between $110 million to $802 million dollars to bring a new drug to
licensure (Orenstein, et al. 2005). A review of five vaccines, conducted by the NVAC,
found that it took between 2 and 21 years from Phase I trials to licensure (Orenstein, et al.
2005). Without measurable economic gains it is easy to understand why the
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The cGMP standards include measures of safety and quality for each stage of vaccine production:
“protein content, viral infectivity, bacterial contamination, and endotoxin content” (Orenstein, et al.
2005:603).

178

pharmaceutical companies, which are profit driven, have largely fled the vaccine
business.
The decrease in pharmaceutical interest in the vaccine industry is directly
associated with federal regulatory policies, public fear and litigation, and recent vaccine
shortages. Over the past few decades, many companies have abandoned the vaccine
business to pursue research and development in the chronic disease field. Unlike the
chronic disease industry, the vaccine industry is not economically lucrative. Many
companies believe that the cost of complying with vaccine regulations outweighs the
economic benefit of vaccine production (Stern and Markel 2005).
The exodus from vaccine research and development occurred gradually, not only
as a result of the VICP, but also due to changes in vaccine financing and public fears of
autism. In the early 1990s, a number of pharmaceutical companies were still involved in
vaccine development, and the cost of vaccines was increasing dramatically. The
increasing prices primarily resulted from new vaccination developments that required
expensive technologies and procedures (Hinman, et al. 2006). Rising vaccination costs
led many families who normally sought treatment with private providers to seek free
immunizations from the health department (Hinman, et al. 2006). The subsequent
fragmentation of health care provision allowed some children to slip through the cracks,
contributing to a measles upsurge between 1989 and 1991 (Hinman, et al. 2006). After
investigating the epidemic, the CDC found that more than half of the children who
developed measles had not been immunized, despite that many of them had previously
seen a health care provider (Hinman, et al. 2006).
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In response to the epidemic and rising vaccine costs, Congress passed the
Omnibus Budget Reconciliation Act (OBRA) in 1993, creating the Vaccines for Children
(VFC) Program. Unlike Section 317, the VFC is an entitlement program that guarantees
vaccines free of charge to children who are on Medicaid, uninsured, or who are American
Indians or Alaska Natives (Orenstein, et al. 2005). Children who have health insurance
that does not cover immunizations can also receive free vaccines through Federally
Qualified Health Centers or Rural Health Clinics.
While the VFC ensured that more children would have access to recommended
childhood vaccines, it also further discouraged companies from manufacturing vaccines.
More companies might have been willing to update facilities and adhere to stricter FDA
requirements (described above) if the pediatric vaccine industry was more lucrative. The
decline in the pediatric vaccine business is at least in part due to the creation of the
Vaccines for Children Program. The program led the federal government to buy over
half of all pediatric vaccines that are administered in the country. Given their
prominence in the market, the government has successfully negotiated the prices of these
vaccines and is able to obtain them for significantly lower prices than can private sector
distributors (Jacobson, et al. 2006b). For example, in 2005 it cost $792.27 for a child to
receive all of her recommended vaccines (from birth through school entry) from the
private sector. In the public sector, the same vaccines cost $517.12 (Hinman, et al.
2006). As a result of the negotiated prices, the profit margins for drug companies
plummeted. Many pharmaceutical companies did not see economic benefit in pediatric
vaccine distribution and the drug shortage cycle continued.
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Recent public concerns about the safety of vaccines did little to encourage
pharmaceutical companies to remain in the vaccine industry. Interestingly, many current
vaccine fears are largely the result not of manufacturer errors, but of a series of decisions
made by the FDA, CDC, and AAP. In 1997 the FDA, in compliance with the FDA
Modernization Act, began to compile a comprehensive list of all drugs and foods that
contained “intentionally introduced mercury,” with the goal of eliminating any that could
potentially lead to harmful exposure levels (VHPB 2000:7). The results were presented
at an FDA meeting in 1999. During the meeting, members “recognized that some infants
could be exposed, as a result of vaccination . . . to cumulative mercury levels that
exceeded one of the three existing federal guidelines on exposure to (methyl)mercury”
(VHPB 2000:7). The FDA recommended that the hepatitis B vaccination schedule for
infants be modified to delay vaccination until a thimerosal-free vaccine was available
(VHPB 2000). More detailed and conservative guidelines were subsequently published
by the AAP and CDC, increasing public fears about the dangers of thimerosal.
Until this point, thimerosal had been one of the most widely used vaccine
preservatives since the 1930s without any known toxicity (Link 2005). The preservative
was so popular and used in so many vaccines because of its excellent antibacterial
properties30 (Link 2005). What was curious and controversial about the FDA
recommendation, and subsequent recommendations by the AAP and CDC, was that
thimerosal did not contain methylmercury, but ethylmercury. The FDA was trying to

30

Some researchers argue that thimerosal might have been safe when children received fewer vaccines, but
became toxic as children received a greater diversity of vaccines, many of which contained thimerosal.
There is no scientific evidence to support the position, but it’s worth exploring.
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reduce levels of a completely different type of mercury, methylmercury. The two types
of mercury have differential effects on the body and different toxicity levels. Using
methylmercury guidelines to ban a product containing ethylmercury was not scientifically
supported (Link 2005).
In addition, there had been no reports of any harmful effects caused by exposure
to mercury at the levels contained in the vaccine (VHPB 2000). Scientific studies do not
support an association either. One review of 14 published studies on the association
between thimerosal-containing vaccines (TCV) and neurodevelopmental disorders
(NDD) concluded that no statistically significant association existed between the two.
The reviewers argued that the four studies that found an association, all by the same
authors, utilized overlapping datasets that were methodologically flawed and therefore
impossible to validly interpret (Parker, et al. 2004). Another prospective cohort study of
14,541 English children found no association between TCVs and NDD (Heron, et al.
2004). Researchers in Denmark examined rates of autism diagnosed among children in
the country from 1971 to 2000. The authors found no increase in autism rates during the
years when thimerosal-containing vaccines were used (up to 1990). Moreover, the
researchers found that autism rates increased from 1991 to 2000, after thimerosal had
been removed from the DTP vaccine (Madsen, et al. 2003).
Was it appropriate for the FDA, CDC, and APA to revise vaccination guidelines
to ensure that children did not receive thimerosal-containing vaccines? Some researchers
argued that the change was appropriate even though there was no scientific evidence to
support it, because it would allay public fears about the safety of vaccines. Supporters of
this view argued that the general public would not distinguish between the different types
182

of mercury and their effects and that media would likely exacerbate fears by reporting
that childhood vaccines contained mercury without qualifying the statement, thereby
leading to mass concern among parents. Opponents of the decision argued that removing
thimerosol from vaccines only served to confirm and fuel public fears that vaccines are
unsafe. If there was not anything dangerous about the drug then why would the
government remove it from the market? Regardless of whether the ban was appropriate,
the event emphasizes the role that public fear has on vaccine regulations and
recommendations. The outcry regarding the vaccine, and the changes required to respond
to public concerns, also help to illustrate why pharmaceutical companies continued to
reassess the economic viability of vaccine development. According to the Institute of
Medicine, there are currently only four major vaccine manufacturers worldwide, and only
two in the U.S. (Medicine 2001).

Vaccine Approvals, Recommendations, and Funding
FDA Process to Approve a Vaccine
In this section I present a brief overview of the processes through which vaccines
are approved, recommended and funded. Noting this is important because many of the
public’s concerns surrounding vaccines revolve around these three processes. The FDA’s
Center for Biologics Evaluation and Research (CBER) regulates vaccine research,
approval, and monitoring in the U.S. An Investigational New Drug (IND) application
must be submitted to CBER when a sponsor wants to conduct clinical trials on a vaccine.
The IND application includes specific information about the vaccine, how it is
manufactured, tests for quality control, vaccine safety, proof of immunogenicity in
animal testing, and the proposed clinical study protocol for testing in humans (FDA
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2011). If approved, the sponsor can begin to conduct pre-licensure vaccine clinical trials,
which typically are carried out in three phases. In Phase 1 trials, a small number of
closely monitored subjects are recruited to test the safety and immunogenicity of the
vaccine. Phase 2 studies commence to determine the dose-ranging for the vaccine; these
studies can include hundreds of subjects. In the final pre-licensure phase, thousands of
subjects are typically enrolled to “provide critical documentation of effectiveness and
important additional safety data required for licensing” (FDA 2011).
A Biologics License Application (BLA) can be submitted if the vaccine
successfully advances through the three pre-licensure phases. The BLA includes efficacy
and safety data from the pre-licensure studies that will enable the FDA reviewer team to
assess the risks and benefits of the vaccine in order to approve or oppose it. During this
stage of the review process, manufacturer facilities and the actual vaccine production
process for the vaccine under review are inspected (FDA 2011).
After the FDA has reviewed the BLA, the sponsor and the FDA present findings
to the Vaccines and Related Biological Products Advisory Committee (VRBPAC). This
non-FDA expert committee comprised of scientists, physicians, biostatisticians, and a
consumer representative, advises the FDA regarding the safety and efficacy of the
vaccine for the proposed indications. Generally, the FDA follows the recommendation of
the VRBPAC. For a vaccine to be approved, it must also have sufficient, detailed
labeling so that health care providers can properly use the vaccine, assess the vaccine’s
risk and benefits, and administer it to the public (FDA 2011).
After a vaccine is licensed, the FDA continues to oversee the production process
to monitor safety. Periodic facility inspections and monitoring of the product and
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production must continuously occur throughout the duration of vaccine licensure. The
vaccine manufacturer must also provide the FDA with results from their own safety,
potency, and purity tests for each vaccine lot, and must provide, if requested, samples
from each vaccine lot for FDA testing (FDA 2011).
Despite the three phases of pre-licensure human trials, the potential adverse of a
vaccine cannot be fully anticipated until after the vaccine had been administered to the
general population. Thus, many vaccines undergo Phase 4 studies, which are formal
studies on a vaccine that occur after it is on the market. Aside from these studies, the
government relies upon the Vaccine Adverse Event Reporting System (VAERS) to
identify potential vaccine safety issues post-licensure.
The CDC Vaccine Schedule
The Childhood and Adolescent Immunization Schedule is maintained by the
CDC. Whether a vaccine is included on the Schedule, and the designation it receives,
plays a critical role in determining which vaccines will be widely manufactured, which
will be covered by federal insurance programs, and often, which will be covered by
private plans and mandated for school entry. The vaccines that are included in the
schedule, the dosing, and the timeliness of dosing are updated annually and the vaccines
included on the Schedule are approved by the Advisory Committee on Immunization
Practices (ACIP), the American Academy of Pediatrics, and the American Academy of
Family Physicians (CDC 2011b).
The role of the ACIP is particularly important in determining which vaccines
appear on the Schedule, and in what form, because the CDC almost always follows the
ACIP’s recommendations. The ACIP is a committee including 15 experts from
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immunization related fields; the experts are selected by the Secretary of the Department
of Health and Human Services “to provide advice and guidance to the Secretary, the
Assistant Secretary, the Assistant Secretary for Health, and the CDC on the most
effective means to prevent vaccine-preventable diseases” (CDC 2011a).
Pharmaceutical companies, specific vaccine advocates, and health practitioners
have a vested interest in ensuring that vaccines are recommended. The Immunization
Schedule is so important because it is federally issued and used by states, insurance
companies, schools, and parents to make important vaccination decisions. States do not
mandate any vaccines that are not listed on the vaccine Schedule. In addition, insurance
companies usually base coverage on the schedule and are less likely to cover vaccines
that are not included on the schedule. Finally, Section 317 (federal grants extending
vaccine coverage for children who don’t qualify for VFC programs) and VFC funds only
cover vaccines that are included on the schedule (Hinman and NVIP 2005; Smith 2010).
Over the past decades the specific diseases covered on the schedule have changed,
as have the vaccines’ compositions (e.g., whole cell versus acellular pertussis), the
number of doses, and the age at which immunization occur. In 1983, DTP, oral polio
virus (OPV), and MMR were the only vaccines listed on the schedule (Tempte 2007). In
1991, the ACIP added Haemophilus influenzae type B vaccination (Philadelphia 2011).
By 1994, the ACIP included universal Hepatitis B vaccination of infants on the Schedule,
along with the DTaP version diphtheria, pertussis, tetanus shot. By 2002 the varicella,
rotavirus, pneumococcal, hepatitis A, and inactive polio vaccines were added
(Philadelphia 2011). The 2007 Schedule includes twelve vaccines that are recommended
for infants and children up to eighteen years of age (CDC 2007). The vaccines prevent
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fifteen viruses: hepatitis B, rotavirus, diphtheria, tetanus, pertussis, Haemophilus
influenza type b, pneumococcal, measles, mumps, rubella, inactive poliovirus, varicella,
hepatitis A, meningococcal, and human papillomavirus (CDC 2007). Ensuring that
vaccines remain on the Schedule might actually have the largest impact on actual
vaccination practices, given the Schedule’s structuring power.

Gardasil Development and Approval
The events leading to the initial approval of the Gardasil vaccine and its later
dissemination are worth discussing in detail given the focus of this dissertation. As
Williams and colleagues (2008:817) argue, pharmaceuticals “develop lives or biographies
of their own; trajectories shaped at every stage or phase by politics.” Gardasil’s
pharmaceutical development, testing, and approval as a vaccine (initially) targeting
females highlight the gender and sexual politics of the vaccine (Casper and Carpenter
2008; Williams, et al. 2008). An examination of Gardasil’s history helps to explain why
an expensive vaccine with relatively low public health benefit is targeted to (all) young
girls and covered by private and public insurance plans. Ultimately, political decisions
following the approval of Gardasil, which were highly publicized and controversial, led
to questions regarding stakeholder motives, vaccine safety, and vaccine need.
Pharmaceutical companies like Merck play an increasingly important role in
medical decision-making processes through, among other things, the sophisticated use of
carefully constructed direct-to-consumer advertising (Williams, et al. 2008). For
instance, the behind-the-scenes work that Merck undertook prior to Gardasil approval
helped to largely frame Gardasil as a desexualized cancer vaccine. Understanding the
work carried out by Merck prior to the launch of the vaccine also explains why,
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compared to technologies such as Plan-B emergency contraception, there was relatively
little initial resistance to the vaccine, despite its introduction during the conservative
Bush-era. In sum, the story behind Gardasil’s debut has largely shaped the public’s
response to it and has had long-lasting and far-reaching effects, influencing the ways that
both providers and parents view the vaccine several years after its launch.
Research and Testing
The Gardasil vaccine is the result of three decades of research and clinical trials
(Rothman and Rothman 2009). Researchers first identified HPV infections to cellular
changes in the cervix and linked HPV-16 to pathogenesis of cervical cancer (Rothman
and Rothman 2009). In subsequent studies, other types of HPV were found to have a
causal role in the development of anogenital and cervical cancers. In the early 1990s,
independent researchers discovered that “empty virus cells” could be created without
HPV DNA encoding, providing the technological possibility to develop a preventive
vaccine (Herskovits 2007). Merck licensed the technology to make the DNA-free virus
shells in 1995 (Herskovits 2007). The technological and scientific discoveries regarding
HPV were the impetus for vaccine development and in 2002, results found that women
who received a vaccine against HPV-16 remained free of “persistent infection”
throughout the 17 month study. As their end point, investigators used persistent HPV
infection as a “reasonable surrogate” for cervical cancer due to both “ethical and
scientific” concerns (Rothman and Rothman 2009:782).
Based on promising results from the 2002 study, Merck developed a quadrivalent
vaccine designed to protect against two high-risk strains – HPV-16 and HPV-18, and two
low-risk strains (HPV-6 and HPV-11) linked with genital warts. The vaccine, when
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tested on 12,167 females ages 15 to 26 years old, protected against persistent HPV
infection among those who had not been previously infected. Although the publication
concluded that “widespread immunization of female children and adolescents may result
in a substantial decrease in HPV-16—related and HPV-18—related cervical disease,
including cervical cancer” (Rothman and Rothman 2009:782), responses from the wider
scientific community regarding the promise of an HPV vaccine were more cautious.
Studies on the cost-effectiveness of the vaccine questioned whether it was prudent use of
public health resources. Others challenged the claim that reducing incident cases of some
HPV types would actually lead to a decrease in cervical cancer rates (Aronowitz 2010).
Related to this were concerns that targeting the two most prevalent oncogenic strains
(HPV-16 and HPV-18) could create opportunities for less successful but more virulent
strains of HPV to reproduce (Aronowitz 2010). To these concerns, others added that
research regarding the duration of effectiveness or possible long-term adverse effects on
natural immunity were lacking.
Though concerns were – and continue to be – raised about the long-term
consequences of an HPV vaccine, the promise of a vaccine against cancer generally was
regarded with excitement and hope among women’s health advocates, public health
practitioners, medical providers, and the lay community. The unknown was whether
public concerns about the sexually transmitted nature of HPV would dampen public
support for the vaccine.
Preparing for FDA Approval Process
Rothman and Rothman (2009) argue that Merck’s experience with a hepatitis B
vaccine largely influenced the way it approached the Gardasil vaccine. In 1982,
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approximately 4,000 American contracted liver diseases related to hepatitis B and 800
died from hepatitis B-related liver cancer. Merck neither tried to convince the ACIP that
most Americans were at risk for developing hepatitis B, nor that the vaccine was an
anticancer product. When Merck originally requested approval for the HBV vaccine, it
agreed with the ACIP recommendation that the vaccine be narrowly targeted to include
healthcare workers who might have contact with blood or other bodily fluids, men who
have sex with men, IV drug users, prisoners and staff in custodial institutions, and
pregnant women in high-risk groups. Merck did not attempt to argue (as it would later do
with Gardasil) that because hepatitis B infections can lead to cirrhosis and liver cancer,
that all groups should be vaccinated; nor did it argue, as it later would, that HBV vaccine
was a cancer-preventing vaccine.
When the HBV vaccine originally became available, high-risk users did not get
vaccinated and rates of hepatitis B did not decline. One reason that high-risks users were
not vaccinated related to the lack of government subsidization. As one analyst explained,
“Services for junkies and gay men were not a popular line item” (Rothman and Rothman
2009:782). Disappointed in low HBV vaccine uptake, the ACIP recommended universal
HBV vaccination for infants in 1991 with the goal of preventing the disease “before the
humans who carried it had a chance to make the behavioral choices that spread it”
(Rothman and Rothman 2009:782). The recommendation was endorsed both the
American Academy of Pediatrics and the American Academy of Family Physicians.
Despite the recommendations, only two-thirds of pediatricians and one-third of family
doctors thought universal vaccination was a good idea and only half of pediatricians and
a quarter of family physicians routinely recommended the vaccine. Providers in small
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practices were not stocking the vaccine due to issues with insurance reimbursement and
high upfront costs, while many parents were against giving their children another
vaccine. Two years later, in 1994, when Congress enacted the Vaccines for Children
Program, HBV vaccine coverage sky-rocketed. By 2002, 90% of children under three
years of age had received the vaccine (Rothman and Rothman 2009).
Merck’s experience with the HBV-vaccine led to important insights about the
importance of dissociating the vaccine from high-risk behaviors or populations, gaining
professional medical association support, and securing government reimbursements and
mandates. To successfully frame the Gardasil vaccine and win political, provider, and
public support for it, Merck not only relied on past experience, but also on its role as a
titan in the pharmaceutical industry. Merck had the experience and funds to frame and
aggressively promote its drug, as well as the connections, name recognition, and
resources to lobby conservative politicians and organizations prior to the review process
to minimize controversies regarding transmission (Epstein and Huff 2010; Rothman and
Rothman 2009).
When Merck presented the HBV vaccine for FDA approval, it did not attempt to
frame it as a cancer prevention vaccine; with Gardasil, cancer was at the forefront of
vaccine framing. Years before the FDA would approve Gardasil, during the
commencement of vaccine safety and efficacy trials, both Merck and the FDA agreed that
Gardasil would primarily be developed as a cancer-prevention technology. Dr. Eliav
Barr, the Senior Director of Vaccines/Biological Clinical Research for Merck recalled
that “at the inception of the program, Merck and the FDA met and agreed that the
primary basis for licensure was to—was based on the demonstration of the prophylactic
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efficacy of Gardasil, to show that Gardasil is efficacious in preventing HPV 16 and 18
and related cervical cancer” (Thompson 2010:121).
In 2001, Merck’s clinical research team analyzed efficacy data from an interim
analysis of the HPV-16 component: the vaccine had 100 percent efficacy. Based on these
promising results, Merck hired consultants to “start thinking about the policy issues
surrounding Gardasil” (Herskovits 2007). Merck’s Executive Director of Medical
Affairs, Rick Haupt, explained that in 2001 he saw HPV “predominantly as an education
challenge” (Herskovits 2007). In thinking of how to approach the vaccine, he remarked,
“what drives the standard of care for providers is what their professional society
recommends.”
Merck sought to gain the support of professional medical associations (PMAs),
including the American College of Obstetricians and Gynecologists, the American
Society for Colposcopy and Cervical Pathology, the Society of Gynecologic Oncologists,
and the American College Health Association by providing them with funding. Rothman
and Rothman (2009) provide a thorough analysis of the funding provided to each of these
PMAs, how funds were used to gain professional support for the vaccine and raise
awareness about the dangers of cervical cancer, and the ethics of these relationships.
Here, it is sufficient to say that using Merck money and training, members of PMAs
provided direct training through workshops, speaker’s bureaus, awareness campaigns,
and webcasts about the vaccine and cervical cancer to well more than 11,000 healthcare
professionals (Rothman and Rothman 2009). With Merck funding, an HPV vaccine
toolkit was distributed to clinicians to aid them in discussing the vaccine with parents and
young women, and e-mail and postal letter templates about the vaccine were given to
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clinicians to distribute to college-aged women. Rothman and Rothman (2009) questioned
whether the materials presented to healthcare providers using Merck funds were
balanced. Pointing to an ACHA webcast, they also challenge the disclosure policies of
PMAs. Five of eleven presenters and program committee members who organized or
spoke at an ACHA-funded webcast, “HPV Vaccine Update”, offered for CME credit to
members failed to disclose that they had received expense reimbursements or had
participated in the Merck speaker’s bureau. ACHA only requested that members disclose
their relationship with Merck, stating that “it remains for the participants to determine
whether the faculty’s outside interests may reflect a possible bias” (Rothman and
Rothman 2009:785).
By framing the Gardasil vaccine in a highly biomedicalized and desexualized
way, Merck avoided some of the problems that manufacturers of other reproductive
technologies (such as Plan B) faced when trying to win conservative support and FDA
approval. That Merck side-stepped many potential issues regarding sexual transmission is
perhaps even more significant given the highly conservative political climate. As Epstein
and Huff (2010:213) explain,
In repeated cases involving sexuality policy, powerful actors within key federal
government agencies privileged a Christian Right moral agenda over the
mainstream scientific consensus. More precisely, right-wing activists both inside
and outside government sought to influence federal policies by deploying a
scientific counter expertise that aligns with conservative Christian values, using
the idiom of science to call into question the conventional scientific wisdom.
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Epstein and Huff (2010) argue that Gardasil was able to fare better than other
reproductive technologies or efforts at the time, such as condom efficacy and Plan B,
both because of drug attributes and manufacturer strategies. Long before Gardasil was
licensed, Merck met with women’s health advocates to discuss vaccine framing and how
to disassociate HPV as a sexually transmitted infection from cervical cancer prevention
(Epstein and Huff 2010). Merck also met with leading conservative groups to address
any concerns they might raise prior to approval. In particular, there were concerns
among some experts that religious conservatives would oppose offering a vaccine to
adolescents that would prevent a sexually transmitted infection (Globerson 2007).
Referred to by some as the “promiscuity vaccine”, some religious conservatives did
indeed fear that adolescents who received the vaccine would be more likely to engage in
sexual activities, or engage in those activities with a great number of partners (Colgrove
2010). By and large, however, fears of conservative opposition to the vaccine were
overblown. Prior to and during the approval process, conservative groups were largely in
support of a vaccine to prevent cancer.
Conservative leaders’ support of the vaccine can be attributed both to Merck’s
pre-licensure efforts to frame Gardasil as a cancer-preventing vaccine and to public lack
of awareness of HPV. Public fear regarding cancer might have made the vaccine more
difficult for conservative groups to oppose. In evaluating why so many conservative
organizations supported a vaccine to prevent a sexually transmitted infection, one
women’s health advocate reasoned that they “clearly made a strategic [decision] that
coming out against a vaccine that could save women from getting cancer was not a place
that they wanted to be. So they pinned their position on this idea that it shouldn’t be
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forced on anyone and that parents should always have the decision-making authority”
(Epstein and Huff 2010:216-217).
The public’s general lack of knowledge regarding the connection between sex and
HPV also helped the manufacturer sidestep many issues associated with promiscuity,
morality, and reproduction. In fact, the lack of knowledge regarding what HPV was or
how it was transmitted initially made it difficult for conservative groups to oppose the
vaccine based on promiscuity fears. Bush-era federal health advisory committee member
and former Focus on the Family consultant, physician and public health trained Reginald
Finger appeared to be the quintessential far-right spokesperson. On his personal
webpage, for example, Finger writes, “in everything I do, I seek to put Jesus Christ and
His Kingdom first” (Epstein and Huff 2010:215). Finger determined that an HPV
vaccine was unlikely to encourage sexual promiscuity because few teens understood what
HPV was or how it was transmitted. He concluded that “for disinhibition to be a factor
inhibition has to be a factor. And nobody really has evidence to show that fear of HPV is
an inhibition factor for teenagers. Certainly, HPV is not HIV and neither is it pregnancy”
(Epstein and Huff 2010:216).
While many conservative groups were generally supportive of Gardasil, there
were dissenting opinions. Two groups, the Concerned Women of America and the
Family Research Council initially opposed the vaccine, largely due to concerns that the
vaccine would promote promiscuity. By the time vaccine hearings commenced,
however, the groups were largely on board (Epstein and Huff 2010). Epstein and Huff
(2010) suggest that the groups softened their positions in light of practical considerations
and continual reminders that girls who practiced abstinence until marriage could still
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become infected by future spouses or by force. In a prepared statement for the ACIP, the
Family Research Council’s policy analyst stressed the importance of abstinence, but then
conceded, “we also recognize that HPV infection can result from sexual abuse or assault,
and that a person may marry someone still carrying the virus. These provide strong
reasons why even someone practicing abstinence and fidelity may benefit from HPV
vaccines” (Epstein and Huff 2010: 219).
The FDA Approval Process and State Legislative Activities
In December 2005, Merck & Co. requested that the FDA conduct a priority
review of the Gardasil vaccine. Merck’s previous efforts to control vaccine framing and
win support of key groups on both sides of the political spectrum might help to explain
the relative lack of opposition to the vaccine during the approval process. Unlike the
FDA and CDC hearings for Plan B, which were highly political and marred in
controversy, the Gardasil hearings were relatively uneventful. Individuals who had
attended hearings for Plan B and Gardasil commented on the general lack of resistance to
the vaccine (Colgrove 2010; Epstein and Huff 2010).
Amy Allina, director of the National Women’s Health Network, who attended the
hearings, noted a desire on all sides to frame Gardasil as a cancer-preventing vaccine
rather than a vaccine to prevent a sexually transmitted infection. “The level of tension
was just much lower, there wasn’t a feeling that there was something very controversial
or contentious being discussed. It was much more what you’d see at another advisory
committee meeting where you’re just talking about a major medical breakthrough.
Everyone was aware that there was this undercurrent of discomfort with talking about
anything that has to do with sex, which we have in this country, but by focusing on the
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cancer prevention instead of on the HPV as a sexually transmitted infection, the company
managed to shift the conversation a little bit” (Epstein and Huff 2010: 219).
In May 2006, an FDA scientific advisory committee voted unanimously (13-0)
that Gardasil was a safe and effective vaccine to administer to girls ages 9 to 26 years of
age. Discussions about age recommendations for Gardasil commenced two-and-a-half
years prior to licensure. Members of the Advisory Committee on Immunization
Practice’s (ACIP) HPV Working Group began examining a “huge amount of material” on
the virus and vaccine in order to make an age recommendation. While the vaccine was
approved for females ages 9 to 26, the ACIP ultimately followed the advice of its HPV
Working Group, recommending routine vaccination for girls between 11 and 12 years of
age with catch-up vaccination among girls ages 13 to 18 (CDC 2007).
The decision to target 11 and 12 year old girls was based on several factors: first,
at this age girls are also targeted to receive other federally recommended vaccines,
including the meningitis vaccine, the hepatitis A vaccine, and boosters for chicken pox
and tetanus/diphtheria/pertussis (Herskovits 2007). Moreover, parents take their children
for wellness checks less often during the pre-adolescent and adolescent years; offering a
vaccine during this stage encourages more frequent visits. As Dr. Janet Gilsford, Chair
of the HPV Working Group explained, “We decided to focus on 11 and 12 year olds
because there’s a strong movement afoot to establish adolescent visits [to the doctor] at a
time of life when people aren’t going to the physician for routine care” (Herskovits
2007). Secondly, since sexual contact is the primary mode of HPV transmission and the
vaccine is most beneficial when administered before sexual onset begins, it is important
to vaccinate individuals before sexual debut (Pollack, et al. 2007; SAM 2006; Siddiqui
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and Perry 2006). Finally, research has indicated that the immunologic responses to the
HPV vaccine (as well as other vaccines) is higher among pre-pubescent than postpubescent individuals (Stanley, et al. 2006).
The CDC and ACIP decision to designate Gardasil as a recommended vaccine
was crucial because the designation ensured that federal funds would be provided to
states to ensure that low-income children have access to recommended vaccines.
Moreover, because most insurance providers’ reimbursement policies are based on
ACIP/CDC recommendations, designation as a recommended vaccine more or less
guaranteed that most major insurance providers would cover the vaccine (Fisher and
Brundage 2009). Even more than other vaccines, public and private payment for
Gardasil was critical due to its high cost: completion of the three-dose series, on average,
costs $360. Within five months of ACIPs decision to recommend Gardasil, the CDC had
added Gardasil to its Vaccines for Children Contract, thus ensuring that qualified girls
between the ages of 9 and 18 would be able to receive it (Herskovits 2007). In the
subsequent months, the private sector followed suit. Ninety-five percent of plans added
Gardasil to their formularies (Herskovits 2007).
Post-licensure, conservative groups largely remained supportive of the vaccine
(Colgrove 2010). The shift in support occurred when individual states attempted to
mandate Gardasil for school entry. In September 2006, approximately three months after
FDA approval, the first bill to mandate HPV vaccination was introduced in Michigan
(Colgrove 2010). Beverly Hammerstrom, the state legislator who introduced the bill, was
also a member of Women in Government (WIG), an advocacy organization comprised of
legislators who supported bills focused on advancing women’s issues (Colgrove 2010).
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A key priority among WIG legislators was to advance HPV-related legislation to increase
funding, education, and in some states, vaccine mandates. WIG supporters argued that all
girls and women, regardless of ability to pay, should have access to preventive
technologies to protect against cervical cancer (Fisher and Brundage 2009). Fundamental
to meeting this goal, they argued, was mandating that all middle school aged girls receive
the vaccine, although parents could choose to opt-out of the program. In the coming
months, more than 30 states would initiate some form of legislation to mandate the
Gardasil vaccine. As legislation efforts increased, so did the controversy surrounding the
vaccine.
Members of the religious right expressed outrage that states would require young
girls to be vaccinated against a sexually transmitted disease (Herskovits 2007). A
representative of Focus on the Family explained her organization’s opposition to the
mandate, “We are an organization that supports parental rights . . . We believe that
parents are the medical decision-makers for their children” (Epstein and Huff 2010:220).
Conservative groups argued that the mandate was another case of “‘big government’
trampling the rights of the individual” (220) – a perspective that many people of a
libertarian persuasion found compelling.
Debates surrounding the vaccine mandate not only exposed long-standing
tensions regarding governmental and parental control, but tensions concerning the role of
the pharmaceutical industry in shaping public health policy, and the independence (or
lack thereof), between government agencies, politicians, and the pharmaceutical industry.
Attention surrounding political efforts to legislate HPV and cervical cancer prevention,
education, and screening also led to a more critical view of the vaccine itself. Many
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parents, worried about the newness of the vaccine and the unknown long-term risks and
side effects, opposed the school mandate (Herskovits 2007). Some members of the
public health and medical community agreed, arguing that there were still too many
unknowns to mandate the vaccine (Fisher and Brundage 2009). Some healthcare
professionals and public health advocates worried that mandating a new vaccine –
especially one that was meant to prevent a sexually transmitted disease – would
undermine the already diminishing public trust in immunization programs.
The controversy surrounding HPV vaccine mandates reached its climax on
February 2, 2007. Texas governor, Rick Perry – “a conservative Christian and opponent
of abortion rights and stem cell research”– issued an executive order mandating that all
girls entering the sixth grade be vaccinated against HPV (Globerson 2007:75). Normally,
vaccine mandates are enacted through a legislative process or by public health officials
who are granted rule-making authority. Justifying the unusual move, Governor Perry
compared the Gardasil vaccine to the polio vaccine, arguing that by reducing rates of
cervical cancer, the vaccine would ultimately save women’s lives, and – for the state of
Texas – money (Globerson 2007). Governor Perry’s decision to bypass the legislative
process generated a firestorm of controversy, both in the conservative state of Texas, and
nationwide. Perry’s motives for bypassing legislative procedure were questioned and it
was soon discovered that Perry’s former chief of staff was also a Merck lobbyist. During
the same period, the press released reports that Merck has made significant financial
contributions to Women In Government (Colgrove 2010). In response to public outrage
and negative publicity, Merck ceased lobbying efforts to achieve state mandates and the
Texas legislature passed a bill to prohibit any HPV school mandate (Colgrove 2010). The
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decree raised the level of resistance to the vaccine, and also questions regarding the
relationship between legislators and the pharmaceutical industry.
As Colgrove (2010:5) explains, “The revelation of this aggressive lobbying was a
public relations debacle for Merck”. Added to concerns about Merck’s lobbying tactics
were questions regarding its business ethics and drugs’ safety. Merck was already the
target of negative publicity in light of accusations that it withheld and concealed risks
associated with use of its pain medication Vioxx. Moreover, as the result of Vioxxrelated civil litigation, Merck was forced to pay billions of dollars in damages, which led
to the joke that HPV stood for “Help Pay for Vioxx” (Colgrove 2010). While criticism of
Gardasil’s hefty price tag was not new, it intensified in the wake of reports that Merck
had made donations to Women in Government.
Though experts had raised concerns about vaccine need and cost before licensure,
events post-licensure drew the attention of a larger group of critics. At an average cost of
$360, Gardasil cost significantly more than other common childhood vaccines. Some
people wanted to know whether the benefits of the vaccine were worth the costs. In
advertising Gardasil, Merck highlighted the vaccine as a cancer-prevention technology,
but it did not mention how many women develop cervical cancer or what types of women
were most at risk for HPV-related disease. In one of a series of critical reviews of the
Gardasil vaccine published by the Center for Media and Democracy, Judith Siers-Poisson
(2008) questioned whether public funding or universal immunization was necessary
given that Gardasil only protects women from some strains of HPV that can cause
cervical cancer, and moreover, when all cases of cervical cancer account for a relatively
low mortality rate and small disease burden. She argued that cervical cancer does not
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“even crack the top ten fatal cancers for women,” then provided comparisons of the
number of lives claimed from all cancers, heart disease, and Vioxx: “cancer of all types
combined kills more than 500,000 people in the United States each year, while heart
disease claims more than two million lives. An estimated 27,000 to 55,000 people have
died just from taking Merck's Vioxx.”

Gardasil Marketing and Advertising
As previously discussed, Merck sought advice from women’s health advocates,
consultants, and organizations on both sides of the political spectrum prior to seeking
vaccine licensure. These conversations, along with lessons learned from the HBVvaccine, led Merck to adopt a highly medicalized and desexualized advertising campaign
that emphasized the vaccine’s cancer-preventing benefits. Even the name “Gardasil”
was carefully considered. Until the advent of Gardasil, vaccines were named after their
creators or the diseases that they prevented. Gardasil was the first vaccine to be
identified by its trade name, which was created to elicit a connection between the vaccine
and its ability to “guard” – not against HPV, but cervical cancer (Rothman and Rothman
2009).
From 2001, Merck recognized that HPV and cervical cancer awareness were low
within the population. To successfully market the vaccine, education had to focus on the
association between HPV infection and cervical cancer, rather than the connection
between HPV infection and genital warts, for example, or any other association that
would link HPV as a sexually transmitted infection (Mamo, et al. 2010). Fortunately for
Merck, it appeared that few Americans knew much of anything about HPV. The results
of a Merck-funded study of HPV awareness, completed prior to advertising Gardasil,
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found that only five percent of women and girls surveyed knew of a connection between
HPV and cervical cancer (Herskovits 2007).
Merck wanted women and girls to have a strong association between HPV
infection and cervical cancer before Gardasil became available. In order to heighten
awareness of the connection, Merck launched a massive non-branded disease awareness
campaign on September 30, 2005, several months before obtaining FDA approval for
Gardasil. Merck partnered with DDB advertising agency and Edelman public relations
firm on both its branded and unbranded marketing campaign (Herskovitz 2010). The
non-branded DTC media campaign focused on awareness and came in various forms
from “Tell Someone”, “Make the Connection”, and “Make the Commitment” (Mamo, et
al. 2010). The first campaign, “Make the Connection” aimed to increase public
awareness regarding the connection between HPV infection and cervical cancer. Beaded
bracelets were used along with the “Make the Connection” advertisements to raise
awareness. Merck funded events throughout the country where celebrities wore “Make
the Connection” bracelets to promote cervical cancer awareness and girls could order kits
from the Internet that included materials to make bracelets and educational materials
(Herskovits 2007). The kits were so successful that Merck ran out.
In the second phase of the unbranded campaign, girls and women were
encouraged to “Tell Someone”31 about the connection between HPV and cervical cancer.
According to Bev Lybrand, Vice President and General Manager for Gardasil, the “Tell
Someone” campaign tapped into “women’s natural inclination” to talk and share

31

Ads aired during the “Tell Someone” campaign can be accessed through the following links:
http://www.youtube.com/watch?v=4yV7SpHOcrw
Elizabeth Rohm: http://www.youtube.com/watch?v=OMbvhug7CGU&feature=related
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information (Herskovits 2007). Actresses looked directly at the viewer and encouraged
women to talk about the connection between HPV and cervical cancer and share
information with mothers, daughters, sisters, friends, and peers. Girls could share
information with others online, choosing from a selection of e-cards that included the
question “Did you know that cervical cancer is caused by certain types of a common
virus?” (Herskovits 2007). Mothers were targeted through “Make the Commitment”
advertising which encouraged women to pledge to talk their daughters’ healthcare
providers about the risk of cervical cancer (Mamo, et al. 2010).
The unbranded campaigns were intended to play on cancer fears and on themes of
empowerment and protection. Lybrand explained, “Of course everyone understands
cancer and is scared of cancer,” but “we learned early on that moms really wanted to
protect their daughters—that protective insight is important. For young women, they
want to empower themselves to take control of their own destiny” (Herskovits 2007).
Messages of female empowerment and parental responsibility continued to be salient
themes within the branded advertisements.
After gaining FDA approval, Merck began its “One Less” marketing campaign 32.
Television commercials include an ethnically diverse group of girls who are individually,
or in groups, engaging in a variety of activities, including jump roping, dancing,
skateboarding, playing basketball, and playing the drums (Aronowitz 2010; Braun and
Phoun 2010; Mamo, et al. 2010). Speaking directly to the camera, while engaging in
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One-Less and I Chose ads can be viewed through the links below:
One-Less: http://www.youtube.com/watch?v=hJ8x3KR75fA
One-Less: http://www.youtube.com/watch?v=15Jk3OBm3lU&feature=related
I Chose: http://www.youtube.com/watch?v=ZHUamYNSH9c&feature=related
I Chose: http://www.youtube.com/watch?v=ehvxbEOgNEM&feature=related
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activities, girls say, “I want to be one less . . . one less statistic” (Aronowitz 2010:20). In
another commercial, girls confidently shout, “I want to be one less, one less!” An adult
woman, presumably a mother, then appears on screen and explains that “Gardasil is the
only vaccine that may help protect you against the four types of HPV that may cause 70%
of cervical cancer”. Side effects are then discussed by another, older woman (Aronowitz
2010; Mamo, et al. 2010). Print advertisements for Gardasil, appearing around the same
time, focused on evading risk, rather than becoming one less cancer statistic.
Advertisements read, “She won’t have to tell him she had HPV . . . because she doesn’t.”
(Aronowitz 2010:21).
In 2008 television spots, the words “I chose” are central to messaging. A group
of mothers say, one after the other, “I chose to get my daughter vaccinated” while young
women announce, “I chose to get vaccinated.” The spots include the tagline “You have
the power to choose” (Chesler and Kessler 2010). Fisher and Brundage (2009) draw
comparisons between the “one less” advertisements and the public awareness campaigns
created by the American Cancer Society in the 1950s. In both campaigns, the emphasis
has been placed on the individual’s role in preventing cervical cancer and by reducing
“false modesty” (Fisher and Brundage 2009:255). The Merck “One Less” campaigns
encourage both girls themselves and their mothers to avoid becoming a statistic by
talking to their providers about the vaccine. While the argument has been made that such
advertising “suggests the main obstacle to eliminating cervical cancer is ‘unjustified
prudishness’” (Fisher and Brundage 2009:255), a counter argument could be made that
the intentional decision to avoid using the words “genital warts” – rather discussing them
as “other HPV related diseases” is an effort to deny or deflect focus on the relationship
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between HPV and sexual transmission. Gardasil advertising has been examined by
several researchers (Braun and Phoun 2010; Fisher and Brundage 2009; Mamo, et al.
2010) who point to the lack of sexual related information in the advertisements. For
example, males are never depicted in advertisements, despite the fact that most females
contract HPV through heterosexual contact. Advertisements repeatedly mention cervical
warts, but genital warts are referred to as “other HPV-related diseases”, despite the fact
that the vaccine protects against two strains of HPV that cause 90% of genital warts.

Chapter Six Summary
In summarizing this chapter, it is important to remember that opposition and
support to vaccines is not static, but rather changes through time. It is important to
understand general vaccine trends, while not obscuring the heterogeneity involved with
each vaccine. Hope in technology, perhaps best exemplified in Jonas Salk’s polio
vaccine, is countered by risks associated with technology. It is worth reiterating that the
following analysis has to be understood as necessarily being greatly influenced by the
trends discussed in this chapter; throughout the remaining chapters I refer to events
described here to contextualize parent and provider perspectives. Expert, parental, and lay
perceptions do not emerge out of thin air, but stem from specific historical contexts.
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Chapter Seven – Structural Factors in the Provision of Vaccines

In the following chapter, I describe how structural factors, including vaccine cost,
administration fees, billing, and reimbursement formularies shape providers’ views
towards and practices regarding Gardasil. Specifically, I discuss providers’ knowledge
and awareness of the economics of vaccination for their practices, highlighting how
structural factors can affect which practices carry Gardasil, when they administer it, and
to whom. I also describe the role that patient vaccine costs and insurance coverage had,
or will have, on parents’ Gardasil choices, as well as the perceived role that insurance
coverage and cost have on other parents’ vaccine decisions.

Practice Level Costs and Considerations
The information presented in this section is based on comments made by a few
physicians and nurse practitioners who spoke about the economics of vaccination.
Providers who discussed the profitability of vaccines had varying perspectives, which
might relate to differences in their patient populations, office types, and strategies for
procuring vaccines (Zimet 2009). In the first section of the chapter, I rely more heavily
(but not exclusively) on the perspectives of one nurse practitioner, Ann, whose
professional responsibilities include addressing the economics of vaccination. Along with
clinical responsibilities, Ann consulted with health clinics, private practices, and other
health care institutions to develop more streamlined and cost-effective strategies to
provide vaccinations. Drawing from her own experiences working with clinics and
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practices, she was particularly helpful in explaining some nuances of vaccine cost and
reimbursement.
Most of the providers I spoke with were not sure whether vaccines were profitable
for their practice. This lack of knowledge was not surprising to Ann, who felt that most
providers knew very little about the economics of their business.
I mean a smart provider these days, even in a solo or small group practice, they
separate themselves from [the business-side of the practice]. They have someone
that tells a patient, “No, we can’t see you because you don’t have insurance, or
your co-pay today is X, Y, or Z.” The provider doesn’t want to get into that
because it taints that consulting relationship.
Providers offered information about the economics of vaccination for their
practices, but usually began with the caveat that they were fairly far-removed from the
business-side of healthcare provision. Many providers (both MDs and NPs), regardless of
whether they were aware of practice economics or not, stressed that the business-side of
healthcare was not an aspect of health provision they wanted to be involved in. Moreover,
several providers expressed discomfort with any suggestion that profitability factor into
treatment decisions; a few providers specifically cited examples in which they had
prescribed or withheld treatments knowing that in so doing, they would be costing the
practice money.
Providers, in other words, made a point of separating their own treatment
decisions from economic concerns. Jane, a nurse practitioner in Pennsylvania, provided a
typical response to questions regarding the profitability of vaccines:
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I do think we make money on vaccines but I don’t do money. So I really don’t
know. I’m one of those old idealistic people who thinks that she can just give the
right care and not care what it costs. So I’m not into making money for the office.
When they [office managers] come and say ‘We need you to do this, this, and this
because it really makes us a lot of money’ I just ignore them because I do what I
think people need and I won’t give a Gardasil because it makes money for the
office. But I think it probably does.”
Ann described some of the challenges one of her clinics faces when purchasing
vaccine doses: “We don’t buy [Gardasil] in bulk, we don’t get the lowest rate for
purchasing Gardasil and last year the lowest rate for the real bulk purchases was like
$150 per dose. But we couldn’t even buy it for that. We were buying it for like $160 or
$165 a dose.” Ann explained, “Most people charge at least $10 to $20 [as an
administration fee]. I think in our student health services we usually only charge about
$7. The health department has a really low administration fee too, but a lot of private
providers really tack on administration, record keeping expenses and stuff like that.”
Ann went on to clarify that it is possible to get better deals on the vaccines, but doing so
is often time intensive and requires legwork and resourcefulness on the part of the
practice. She recalled that the director of one student health center became so frustrated
with the high cost of the Gardasil vaccine that she confronted a Merck representative at a
professional meeting. Ann noted that while the representative was helpful, it required a
lot of effort on the director’s part to find ways to make the vaccine affordable.
While few providers knew how much their practice charged as an administrative
fee for vaccination, several providers did justify the use of a fee. Jane, who was emphatic
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about her disinterest in profit-driven healthcare, also felt that a practice should not lose
money on vaccines. For this reason she felt administrative fees were justified, given the
guesswork involved in ordering vaccines, their limited lifespan, and the costs associated
with storing them properly. “It’s fair that we charge significantly more than the vaccine
costs because our overhead costs are high and sometimes, if you get them in individual
doses they’re more expensive. And if you get them in big bottles they expire and you
may throw out some of the stuff; so you have to give enough of it so that it’s cost
effective.”
Although lack of sufficient reimbursement can lead some practices to decline
stocking all or specific vaccines in office (Keating et al. 2008), only one provider in this
study worked at an office that did not stock the Gardasil vaccine. Patients who wanted
the vaccine were written scripts, picked up the vaccine at a local pharmacy, and then
returned to the practice to have it administered.
In some cases, providers had to turn down parent requests for single-component
vaccines, not because of any clinical resistance to administering three separate vaccines,
but due to the high economic cost. Several providers mentioned that many parents
request separate vaccines in place of combination vaccines, such as the combined MMR
(measles, mumps, and rubella) and DTaP (diphtheria, tetanus, and pertussis) vaccines.
Nina, a pediatrician working in Pennsylvania, noted that while she had no clinical reason
to oppose administering separate component vaccines, the cost of doing so was
prohibitive. In reference to administering measles, mumps, and rubella as three separate
components, she explained, “We looked into this. I think it was like a thousand dollars. It
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was astronomical to get just a case of measles [vaccine] for however many come in a
box. But it was an astronomical amount and so, no, we’re not going to do that.”
Insurance reimbursement concerns sometimes altered if and when providers
would administer vaccines. Sophia, a Florida nurse practitioner, told me that she rarely
gives children vaccines during sick visits because more than half of her clients are on
Medicaid and the office is prohibited from billing Medicaid for sick and well-care
treatments on the same visit. Sophia described the policy as frustrating and recognized
that the policy not only resulted in many missed vaccine opportunities, but also burdened
parents, who had to make return visits to vaccinate their children. When I asked her if
she knew why the policy existed, she replied, “I don’t know. We’ve [she and the other
providers] brought that up at office meetings and with our billing and coding person and
she said, that’s the rule, that’s what you got to do”. Despite the fact that Medicaid would
not reimburse the office for vaccines administered during acute-care visits, the providers
sometimes gave the vaccines anyway. “Nine times out of ten your hands are tied.
Sometimes we fudge, sometimes we’ll do things and just don’t get paid for it.”
Economic concerns can also affect who administers vaccines. Only two providers
(one NP and one MD) regularly administered vaccines themselves and only one parent
said that her provider generally administered vaccines to her child. For the most part,
vaccines are administered by nursing staff or medical assistants. When I asked Elizabeth,
a Florida pediatrician, why she did not administer vaccines herself, she responded that it
was not a time (thus, cost) efficient strategy: “It’s actually built in time purposes because
drawing up the vaccine, recording it, and then administering it can take up to 10 minutes,
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so it’s not efficient in the office to have the doctor doing that part because while the nurse
is occupied with that I’ll go see the next patient.”
Only one healthcare professional reported that in her practice, physicians
routinely administered vaccines, largely because it reduces medical errors and because
parents like it. The pediatrician explained that at first, she did not feel trained to
administer vaccines. “I’m used to it now. It takes more time and it’s actually not a good
business proposition because a doctor’s hour is worth more than a nurse’s hour in pay –
we spend a lot of time pulling up the vaccines and giving the vaccines, where we could
be seeing more patients. But at the same time, the parents love it.”
In her explanation, the pediatrician argued that having nurses administer vaccines
would be more profitable. However, the reason that her colleagues opted to give
vaccines themselves can also be seen as profitable if parents interpret the practice as
unique and indicative of extra care and attention. By keeping parents happy, the practice
develops a loyal, satisfied clientele.
Just as they felt ill-equipped to talk about vaccine reimbursements, few providers
felt confident speaking to the profitability of vaccination. Sophia was confident that her
practice did not make money on vaccines. Upon further reflection, she suspected that
they sometimes actually lost money in an effort to cover all of their patients. “We have
lost [money] sometimes because if we didn’t have enough of a VFC dose in, we’ve
actually borrowed shots from our private ones that are out of the boss’ pocket to give to
our other kids. So in that case, yeah, we’ve lost money on them.”
On the other hand, Elizabeth thought that for her practice, the HPV vaccine
“definitely has been a money maker.” She attributed profitability to the newness of the
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vaccine, arguing that over the short-term, all new vaccines generated income for the
practice. “Usually the first year it’s pretty lucrative. After that it’s more of a break even
thing. So it doesn’t tend to be a long standing money maker.” Nina, also thought that her
practice profited from vaccines. She attributed profitability to the size of the practice,
good vaccine management, and their ability to sell unused vaccines to other smaller
practices. Janet, another pediatrician practicing in Pennsylvania, didn’t know exactly
how profitable vaccines were for her practice, but she knew that her practice generated at
least some income from administering vaccines, a feat she attributed to their support
staff, who are responsible for ensuring proper billing, purchasing, and management of
vaccines.
We have a clinical office manager and it’s her job to order the vaccines and figure
out the best way to get them covered. So many practices have no profit margins
on their vaccines. But if you order them correctly and you bill for them correctly,
then they get covered by insurance and you do have a fair amount of profit margin
on your vaccines. Our practice is not losing money on vaccines, we’re making it.
But it’s not a huge amount.

Patient-Level Costs and Considerations: Insurance Coverage and Patient Access
The cost of Gardasil was not a significant factor in most parents’ vaccine
decisions. Of the 17 parents who had already had at least one daughter vaccinated with
Gardasil, only six checked to see if it was covered by insurance before beginning the
series. Four of the six parents who first checked to see if the vaccine was covered were
privately insured and two were using Medicaid. All of these parents, including the two
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mothers on Medicaid, would still have had their daughters vaccinated if the vaccine were
not covered by insurance, but three of them (one on Medicaid and two privately insured)
might have waited to begin the series for financial reasons. As a mother of three
explained, “I probably would have put it off if I had to pay out of pocket simply because I
live on one income and $360 is kind of tough for just a shot. I mean yes, obviously I
thought it was a good idea and I probably would have somehow, probably later down the
road, figured out how to come up with the money to get it for them.” The other mother
thought she might have spent more time researching the vaccine and making sure it was a
sound economic investment, but still would have had it done.
The remaining parents had their daughters vaccinated without confirming
coverage, generally because they assumed their plans would cover it. After telling these
parents how much an average three-dose series cost, I asked if they would have rethought
the vaccine decision if their insurance companies had not paid for it. Most parents
believed said that they still would have had their daughters vaccinated. Several parents
explained that you could not put a price tag on a child’s health. From their perspective,
parents do – and pay – whatever it takes to protect their children. As one father said,
No, it was not really a consideration. I mean it probably should be, but I think it
doesn’t matter if I have to pay that out of my pocket. I’ve made the decision.
You’ll see that as a parent, once you’ve – whatever it takes. Give them a kidney,
that’s no big deal. When do we start? I mean, seriously. You just have to – that
was not even a part of the decision-making equation.”
It is worth noting that many parents in this study were financially secure and likely had
fewer economic concerns than many parents. Only one mother would have rethought the
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vaccine had it not been covered, explaining, “I think working as a normal consumer, I
think I would have delayed and looked into it and asked, okay, is this something that is
really necessary? What all does this really show? And what will it really help?”
Of the 9 parents who had not vaccinated any child, two were uninsured and the
rest were privately insured. Insurance coverage was not a consideration for the two
mothers who were not planning to vaccinate their daughters at any point in the future,
though one of these two women was uninsured. Six of the seven parents who would
likely vaccinate in the future, but had not yet made a definitive vaccine decision, were
covered privately. Though none of these parents knew if their insurance companies
would cover the vaccine, lack of coverage would not be reason enough for them to
decline vaccination. Two of these parents thought that they might postpone the decision
if the vaccine were not covered. One father noted that it would cost over $1,000 to have
all three of his daughters vaccinated without assistance, which would likely require that
his daughters begin the series at different points to make it financially viable. Despite the
financial burden, paying out-of-pocket would not be a “show stopper.” The other
mother thought she might delay the decision to maximize the amount of “useful”
coverage her daughter received from the vaccination. If a booster would eventually be
necessary, she wanted to ensure that she didn’t pay for “wasted” years of protection when
her daughter wasn’t nearing sexual activity. She would likely delay the vaccination until
a year before she thought her daughter was sexually active to get the most active
protection from the vaccine.
Though economics did not factor into any parent’s ultimate vaccine decision
(aside from timing for a few parents), a number of parents (n=8) perceived that cost likely
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explained why other parents did not get their own children vaccinated. However, only
one woman could think of particular individuals whom she thought would be unlikely to
vaccinate due to economic issues and lack of insurance.
Providers had mixed responses regarding the role that vaccine cost played in
vaccine decisions. A few providers (n=3) mentioned that cost was a concern when the
vaccine originally came out and fewer insurance plans were covering it; however, most
providers did not believe that cost was a significant issue for most parents of preadolescent and adolescent daughters (ages 9-17). One pediatrician said that “It’s very
rare – almost unheard of that insurance is the reason not to give it.”
Perceptions that cost is a not a general issue likely are in part related to the
populations with whom providers interact. Most providers who worked in offices where
most parents had private healthcare coverage or were wealthy enough to pay out-ofpocket did not encounter too many parents who declined the vaccine for financial
reasons. However, providers who worked in offices where they saw a larger proportion
of parents without insurance were more likely to say that cost could potentially be an
issue, but more so in terms of access and convenience (recall that uninsured and
underinsured girls are eligible for low cost or free vaccines, but must obtain them through
VFC-participating clinics, and in the case of underinsured girls, through federally
qualified community or rural health centers).
One nurse practitioner working in Florida noted that a significant portion of her
clients were covered by Medicaid or uninsured. While she thought that parents of
Medicaid enrolled children most readily accepted recommended vaccines for their
children, she noticed more variability in vaccine acceptance among uninsured parents. At
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the clinic in which she works, uninsured parents can get the vaccine through the VFC
program and are only required to pay a $10 out-of-pocket fee to cover administrative
costs. Despite the relatively low cost of the vaccine, Sophia said some parents still did
not feel they could afford it. She advised these parents to go the local health department,
where they could get the shot for free (i.e., without an administrative fee), but some
people rejected this suggestion, saying, “ ‘I’m not going to go down there and wait three
hours for a shot.’ That’s usually the excuse. ‘I don’t want to go, it takes too long to get
anything done down there’”. Another provider in Pennsylvania also noted that when cost
was an issue, it had less to do with the ability to obtain the vaccine for free, and more to
do with the inconvenience and stigma associated with getting it for free. She explained,
“[Cost is] not really a problem [for] younger girls, since they can go to [. . .] a state health
department immunization clinic. But even if they need to sometimes they won’t, they
have their own ideas about the State system, etc.”
Often times, parents were simply unaware of governmental assistance programs
that provide vaccination at low or no cost. One Pennsylvania school nurse believed that
insurance coverage and access, as much as cost itself, were primary reasons children did
not receive all of their vaccines. With the economic crisis, she noted that more parents
were losing jobs and insurance coverage and were unaware of governmental programs to
help them receive vaccines. Once parents were informed of opportunities to receive
vaccines, they generally took advantage of them. Another school nurse recalled an
experience when the only reason a girl had not been vaccinated was because her parents
did not realize there were programs in place to assist families in need: “I ran into a
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student last year whose father’s insurance company wasn’t paying for the [Gardasil]
vaccine [. . .] and then I told him about the free program and he got it.”
More providers (n=5) described cost as a significant barrier to women in their
twenties. Laura, a nurse practitioner in Florida, observed that “The ones who tend not to
get it are girls that are out in the college age – maybe in the early 20s – and they’re
thinking about it but then maybe their insurance doesn’t cover it.” For parents who had
delayed the decision due to concerns about vaccine safety and newness or their
daughters’ sexual maturity, insurance coverage sometimes became the decisive factor
compelling parents to vaccinate their daughters. As part of her Gardasil conversation
with parents and older adolescents, Jane generally stressed that “you are going to end up
not having it paid for if they don’t get this soon,” noting that this frame generally
compelled parents to initiate the series. Another provider highly encouraged parents to
initiate the series by their daughters’ seventeenth birthday. When parents expressed
ambivalence about whether they should vaccinate their daughters, she would say,
Look. If you’re wondering just because of time, if you don’t give it by the time
she’s 18, it might not be covered. And it’s [more than] 300 dollars. And then
usually – [parents say,] “Okay, give it! (laughs). Let’s squeeze it in before the
th

18 birthday.” So sometimes insurance works favorably for us; it really tips the
scales.
As these cases illustrate, when economic concerns are an issue, providers can play
an important role in helping parents find alternative means to obtain the vaccine, but
doing so requires that providers have a thorough understanding of available resources to
their patients. Providers, however, often admitted that they knew little about the
218

insurance and payment side of vaccine administration. This might be one reason why
some providers were unaware of potential resources for their patients. For example, one
Florida nurse practitioner did not think that Gardasil was covered under VFC “because if
it was it would bankrupt the whole system.” Yet, Gardasil is covered by the VFC (CDC
2011c). Another Florida provider seemed to be unaware of some of the options available
to uninsured, underinsured, and Medicaid-participating patients. She perceived cost to be
a major barrier to Medicaid and uninsured parents:
I think most [private] insurance companies are paying for it. Our public health,
the Medicaid is not paying for it. And in our community, a huge percentage of
the population definitely is not going to be able to afford to do it and will not
vaccinate if it’s not paid for. And the uninsured – I think most of the uninsured
are not going to be able to afford it and are not going to be interested.
However, as discussed previously, all children through age 18 who are Medicaid eligible,
uninsured, American Indian or Alaska Native, or underinsured are eligible to receive
vaccines, including Gardasil, through the Vaccines for Children Fund.
Ann recounted an experience where one of her nursing students was working in a
pediatric office and had to educate the provider about vaccine coverage: “A young
woman came in who was 17 and the student was recommending Gardasil and the
provider there that ran the practice had not thought of VFC for her, and of course she
would qualify for free Gardasil, which is hugely expensive.”

Vaccine Uptake: Education as a Marker of Class
Education is not necessarily itself a structural factor, but because clinicians
discuss education as a proxy for, or marker of social-class differences, I chose to include
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the discussion here. Providers sometimes pointed to the interrelated variables of
education level, income level, and insurance coverage as predictors of vaccine resistant
among parents. Several providers (n=5) felt that well-educated, middle and upper-class
parents were more resistant to vaccines. Janet, a pediatrician who worked in a large
pediatric practice serving a largely White, middle and upper-class population, compared
these parent’s reactions to Gardasil with the responses she received from parents when
she was in residency and the vaccine had just become available. During her residency
she primarily served a low-income, less educated, minority population; despite the
newness of the vaccine, she reported that during her residency she encountered far fewer
parents resistant to the vaccine. She primarily attributed the variation to patient
education. Her previous population consisted primarily of poor, younger, minority
populations. She recalled, “We gave the Gardasil at 9 [years of age] and hardly anybody
refused it, because of the population. You probably know this – the lower educated
population refuses vaccines a lot less. They kind of just do whatever the doctor tells
them to do.”
One nurse practitioner, who also thought resistance was more pronounced among
well-educated parents, drew from differences she observed at her previous low-resource
setting and in her current retail setting, Jessica explained, “I think the vast majority of
parents who oppose vaccines are highly educated. They have access to information to
make a choice. And the internet has only fueled the fire.” To Jessica, it made sense that
well-educated parents would seek perspectives and information from multiple sources
because they had the knowledge, time, and opportunity to do so. She also thought that
parents with less education might be less aware of options to abstain from vaccinating, or
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processes by which exemptions could be obtained. Jessica saw this as an educational
issue, but more so, an economic issue: “I also think [well educated parents] are more
willing to fight. For instance if the child can’t get into school unless they’ve had all these
vaccines, parents in the housing projects may not have the means or resources, or even
the wherewithal to tackle that battle.”
The settings in which vaccines are offered to parents in these populations might
also discourage them from postponing from vaccine decisions due to access issues, time
constraints, and convenience. Jessica noted that in some
Low resource settings, you will often see the well-child checks and the vaccinechecks tied in with WIC vouchers, so there’s a give and take here. It’s like,
alright I’m going to get my WIC vouchers and my food here and I got to take my
kid in so that they can get their vaccines. I mean you just don’t have that in the
private insurance, high resource settings.
Several providers (n=4) thought that most resisters they treated were privately
insured. One physician said it was uncommon for her to encounter vaccine resistors, but
then added, “This is a public clinic and most abstainers go private. Most of my kids are
on Medicaid but I do get some [private insurance] too.” She believed that in her own
clinic, the mothers who resisted Gardasil or expressed concerns about it were the
privately-insured “women in a higher social class”.
While providers attribute vaccine resistance to education and access issues,
providers also felt that parents receiving free or low cost vaccines through federal and
state-funded programs viewed medical technology differently from parents who were
privately insured. Parents who were offered vaccines through public programs saw
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medical technologies as expensive, protective technologies that they should accept if
given the opportunity. Sophia explained, “Most of our Medicaid and VFC recipients say
‘Yes, whatever it is they need, whatever is out there, give them everything’. It probably
is more of the private insurance patients, or parents, that are a bit more hesitant.”
Interestingly, several parents (n=3) also considered vaccine resistance to be a
class-based phenomena, not related to differences in education level, but the result of an
inflated sense of entitlement. They tended to see it as a privileged position adopted by
some middle and upper class Americans who, concerned about the health risks of
vaccines, rely on others to incur risks to protect their own children. One father perceived
middle class parents to be particularly likely to adopt this position.
One thing that’s kind of disturbing about the anti-inoculation campaign is that it
seems a lot of middle class parents seem to be gullible. And I do resent it in some
way as kind of a Yuppydom- like entitlement thing. Like the 0.001 possibility
that my little Johnny’s going to get mercury poisoning because it’s something that
I read in Parent magazine somehow outweighs the combined social interest in
people in eradicating this deadly virus.

Chapter Seven Summary
The healthcare providers in this study were largely unaware of the practice-side
economics of vaccination; however, the few clinicians who did speak to the profitability
of vaccines indicated that vaccines, if generating income for the practice, were not
significant sources of profit. A few providers did report that cost was a barrier to
vaccination, but primarily for young women in their late teens and early twenties, who
were no longer covered by their parents’ insurance plans and no longer qualified through
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federal and state initiatives and programs. Several providers lacked awareness of
available resources through which their under-insured and uninsured patients could
receive Gardasil. This is concerning, given that (according to three providers) some
parents would vaccinate their children if they were aware of low or no cost means by
which to do so. Several providers also observed a trend in vaccine resistance, associating
it with higher income, well-educated parents. These observations do not appear to
characterize the vaccine choices made by parents in this study.
Parents perceived that high vaccine costs and low insurance coverage accounted
for low rates of Gardasil uptake in the general population. Parents’ assumption that cost
is a major barrier to uptake is interesting, given that only one parent could think of
individuals within her community for whom cost might be an issue. The perception of
cost-as-barrier is especially interesting because no parent, regardless of socioeconomic
status or insurance coverage, identified vaccine cost as a significant barrier in their own
decision-making process. Indeed, in most cases, parents did not even verify that their
insurance companies would cover the cost of the vaccine before having their daughters
vaccinated. Even among parents who would, or had checked on coverage, the prospect
of paying full cost never viewed, in and of itself, as sufficient reason to reject the vaccine.
The findings suggest that, at least for this group of parents, economic issues are of minor,
peripheral, or no important in vaccine decision-making. In order to understand which
factors are of key importance to parents, it is first necessary to describe how parents
generally perceive the benefits and risks of vaccination, for many of these broader
perceptions directly and indirectly shape the ways in which parents understand the
Gardasil vaccine. In order to understand how knowledge is conceptualized or how it
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factors into parent-provider conversations, it is necessary to discuss some of the patterns
providers observed in parental vaccine hesitation or resistance to vaccines.
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Chapter Eight – Benefits and Risks in the Context of Risk Communication

Although I am specifically concerned with how parents make Gardasil vaccine
decisions, particular vaccine decisions are not isolated events. It is important to have a
composite picture of parents’ general and specific views on vaccination because these
views – developed over many years and in the context of vast cultural, social, and
individual experiences – inform the ways in which parents perceive the Gardasil vaccine.
Parents’ wider, more general perceptions about vaccines shape, to some extent, the ways
in which they regard specific vaccines.
Therefore, I begin this chapter by describing parents’ general vaccine practices
and perceptions, discussing first the benefits they typically associate with vaccination,
following by a discussion of common vaccine risks. In the latter half of the chapter, I
focus specifically on the benefits and risks that parents associate with HPV-infection and
vaccination. I conclude with a discussion of the ways in which particular risks and
benefits are negotiated through parent-provider interactions.

General Vaccine Benefits -- Individual and Collective Benefits and Responsibilities
All of the parents that I interviewed expressed general support for immunization.
With the exception of one mother who refused to vaccinate her children against chicken
pox, every parent reported that his or her children had received all school-mandated
vaccines. Every parent recognized at least some benefits to vaccination, most often in
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preventing disease states in their own children and in the general population. Several
parents saw the absence of specific diseases in their own or other children as proof that
vaccines were successfully protecting the population from illness. Barb, a mother of
three, is a staunch supporter of vaccines, pointing to her own daughters’ excellent health
as proof of vaccines’ benefits:
I mean, I do firmly believe in the vaccinations simply because my kids have never
ever been sick. They’ve obviously worked. And they’ve done what they were
supposed to do, because like I said they’ve never got the chicken pox. They’ve
never got the measles or the mumps. I mean they’ve never had any type of
childhood disease . . . Ever. Which I would imagine is solely because they’ve had
the immunizations for those childhood diseases.
Parents, especially those who remembered contracting diseases that are now
vaccine-preventable, saw the eradication or decreased incidence of a disease as a
significant benefit of vaccination. In particular, parents were grateful that their own
children would not have to suffer the pain, discomfort, or lasting scars associated with
diseases that they themselves had experienced. For example, Natalie, also a mother of
three, was relieved that her children would avoid many of the vaccine-preventable
diseases that she contracted as a child: “I had every childhood disease under the sun. I
had German measles, measles, mumps, chicken pox. We all had it. I’m glad that my
kids didn’t have to go through the whole mumps and German measles thing. So I think
there’s a purpose for them, especially when it comes to population outbreaks.”
As Natalie’s comment suggests, many parents recognized the benefits of vaccines
not only to protect the health of their own children, but to minimize or prevent disease
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outbreaks. Parents (n=11) who discussed the societal benefits of vaccination viewed
immunization as both a parental and social responsibility – necessary to protect the health
of their own child but also to protect the health and well-being of the larger community.
Victoria, a mother of two, pointed to the eradication of diseases that had, in the
past, killed children, as benefit enough to support immunization. “Statistically [vaccines]
have virtually eliminated some of the diseases that commonly killed children. If we think
of all the diseases that have virtually been wiped off the earth because of vaccines, I think
that the benefits far outweigh the risk.” Courtney, who has three daughters, expressed
similar support for vaccines, especially when she considered past epidemics and their
effects on society: “I understand the need for vaccines. As a society to think that all
humans are not going to be vaccinated is a very scary thought. We have gone through
that and it doesn’t end well.”
Included in these narratives was recognition that enough individuals had to do
their part in getting their children vaccinated in order to ensure that large-scale epidemics
would not occur. Mark criticized well publicized anti-vaccine movements because
members of these movements not only put their own four children, but the larger
population at risk: “A really trendy thing to do in Hollywood is not to [vaccinate], but
what they don’t understand is if all of them buy into this then all those kids are going to
be at risk. The reason that [there aren’t] epidemics is because people are all vaccinated
and so we are all protected.” Mike, a father of one daughter, was also critical of parents
who abstained from vaccinating their children because he saw it as a form of selfishness.
“I feel like it’s too much libertarianism. It’s like those gun nuts who insist on their rights
to bring their rifles into a McDonalds.” In this case, Mike felt that people’s insistence on
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expressing their right to abstain from vaccinating (or bear arms at McDonalds) reflected a
wholly individualistic worldview; he saw people as either unable or unwilling to consider
the risks that self-interested actions posed to others.
That some parents viewed immunization as a collective responsibility for the
societal good is not to say that they saw vaccination as risk free; all parents associated at
least some risks with vaccination, especially to the wellbeing of their own children.
Rather, these parents generally saw the risks associated with vaccines as acceptably low,
given the social benefits. From their perspective, all parents had to be willing to accept
the minute chance that their own children would experience complications from a vaccine
in order to mitigate the much larger possibility that many children would develop a
disease if individual parents did not act.
Parents valuing this perspective were likely to support vaccine mandates and view
as selfish parents who sought philosophical and religious exemptions– willing to benefit
individually from the sacrifices of others. Mike was skeptical of parents’ motives for
refusing vaccines, dismissing claims that there is any scientific evidence to support nonmedical exemptions. He explained, “Like this sort of distrust of public health campaigns.
I don’t see that it’s really scientifically-based and it just seems a case of self-interest
trumping civic responsibility.” One mother’s perspective towards the collective benefits
of vaccination exemplified the thoughts of many parents. Faith, who has one son and one
daughter, recognized that there are diverse and complex reasons that parents do not have
their children vaccinated, but ultimately concluded that, “If it’s for the good of the
majority . . . then it’s kind of like, you need to toe the line. I mean you don’t want kids
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coming down with childhood diseases. . . Certain things we just have to do for the good
of everyone”
Most often resistant parents were perceived as shirking both societal and parental
responsibilities. Christina a mother of two, for example, had difficulty understanding
how parents could refuse vaccines for their own children, asking, “How many kids have
to die from a disease that we could have wiped out, or that could be nearly wiped out,
before you understand? It could be yours. We’re not gonna do that to our kids.” Patty, a
mother of three, was bothered that her own sister had not had her children vaccinated.
“I think it’s really dumb. It really bugs me. Drives me absolutely crazy. It’s their
choice, but you know . . . I just think they’re kind of relying on all the rest of us to get
vaccinated so their kids don’t have to. And I think it’s dangerous for the kids. If
anything should happen they would be in real trouble.”
While parents generally supported vaccination as both an individual and
community responsibility, some of their own practices and comments suggest that their
commitment to collective social responsibility in vaccination was stronger in principle
than in practice. One father, for example, strongly valued the collectivist sentiments
underlying public health and was a staunch supporter of mass vaccination campaigns.
Criticizing parents who reap the benefits of herd immunity without themselves having
their children vaccinated, he admonished, “Come on! Be a team player”. I asked him
how he would feel if the Gardasil vaccine were available to young men. He responded,
“As the father of a daughter and no boys, I’m definitely in support that all the boys
should get it (laughs).” I asked him whether he would feel differently if he had a boy.
He replied, “It’s not like the inoculation comes with risky side effects or something like
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that. It should just be a matter of course. It’s available, you get it.” Although the father
was supportive of male vaccination against a disease that he primarily associated with
causing harm in females, he opposed efforts to vaccinate healthy children and adults
against the flu in order to protect “babies and old people”. In the case of HPV, the father
was willing to support secondary vaccination of males to protect females, but in the case
of flu, he was unwilling to support immunizing his daughter against the flu to protect the
health of infants, elderly, and other at-risk populations.
Victoria also expressed values regarding collective responsibility that seemed to
conflict with individual practices. She could not receive the flu vaccine because of an
egg allergy, but actively encouraged others to get the vaccine so that she was protected.
She explained,” I tell everyone else, ‘now ya’all get your vaccine so that the germs aren’t
around for me to get.’” I then asked her if her own daughter got the flu vaccine and she
responded, “No. She’s not one of the people at risk.” In this example, the mother used
individualistic criteria in assessing whether to vaccinate her daughter, but expected those
around her to get the flu vaccine so that she would enjoy protection from the herd.
These two examples serve as reminders that individuals stated values and beliefs
do not necessarily translate into specific or predictable action. To assume a one-to-one
connection between values or morals and action would be misleading.

General Vaccine Risks
While parents acknowledged both individual and collective benefits to
vaccinating their children, they also recognized that vaccines are not without risks. Every
parent with whom I spoke perceived at least some risk associated with receipt of a
vaccine. The most commonly expressed concerns related to disease severity, short and
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long-term adverse effects, vaccine components, duration of protection, and vaccine
overload. Some of the risks discussed here pertain to all vaccines, while others are
associated with specific vaccines. Although parents described Gardasil-specific vaccine
risks, these concerns are described separately to highlight both overlapping and unique
risk perceptions.
While some parents wanted their children to receive all available, recommended
vaccines, other parents preferred to consider each vaccine individually. At least to some
extent, perceptions of disease severity, and thus, vaccine need, shaped parental decisions.
Natalie did not question the need for vaccines in general, but rather, “the need for all of
them – I think that unfortunately we don’t need all of them, of what they give.”
Skepticism and concern regarding the need for vaccines was often discussed in
relation to the flu and chicken pox vaccines. Just as parents recalled some of their own
illness experiences when touting the benefits of vaccines, they pointed to other
experiences to question the need for all vaccines. Many parents contracted chicken pox as
children and had few complications from the disease. Given their own mild experiences
with the disease, some parents felt that the vaccine was unnecessary. Theresa, a mother
of two, argued that in fighting chicken pox, “You’re trying to basically obliterate a
benign issue. Chicken pox is not a horrible dreaded disease.” Mike agreed, “[If my
daughter] hadn’t gotten the chicken pox I probably wouldn’t have had her vaccinated
because I don’t see it as severe. It’s more like the flu. I had it. I see it as unavoidable.”
Several providers also reported that it was not uncommon for parents of pre-adolescent
and adolescent girls to question the need for the chicken pox vaccine. A few providers
(n=2) themselves questioned whether the chicken pox vaccine was necessary. Laura, a
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nurse practitioner, acknowledged “[Vaccines] have great benefits but I don’t think all the
time that the risks or possibilities of some of the problems always outweigh. For
instance, the chicken pox vaccination. I mean, come on. We can’t get the chicken pox
anymore? I think we’ve gone too far.”
Similarly, some parents (n=6) simply felt that a flu vaccine was needless and that
the possible risks of the vaccine outweighed the risks of contracting the flu. Marie, who
has a son and daughter, did not vaccinate her children against the flu, reasoning that even
if they caught the flu, it was unlikely that they would have severe consequences from it.
In explaining her rationale, she associated severity with need: “It’s one less vaccine I feel
they have to have right now.” Though Mike believed that the flu vaccine was an
important technology for some segments of the population who could suffer severe
consequences of infection, he did not believe that “a healthy 13 year old is seriously
vulnerable to the flu”. He explained, “It seems frivolous and a waste of time and
resources for me. I mean, fine, for infants and old people, yeah. But I’m not going to run
around getting vaccines for myself or my school kids. It just doesn’t seem appropriate.”
Mike’s rationale is contingent upon a connection he draws between disease severity and
perceived susceptibility.
Parental decisions regarding the chicken pox vaccine perhaps most clearly
illustrate the relationship between vaccine risk, perceived disease severity and
susceptibility. In the case of chicken pox, age became a key variable tied to assessments
of susceptibility. A few parents (n=3), who originally avoided the chicken pox vaccine
when their children were young, reconsidered the vaccine years later, when they felt that
chicken pox infection could pose much more serious health risks to their (now older)
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children. For example, Marie resisted vaccinating her children up to a certain age, but
then decided that given her daughter’s age, the risks of the disease outweighed the risks
of the vaccine. “As [my children] got older I felt that they were too old to be dealing
with chicken pox. I think they were 12 and 14. I felt that the chicken pox were [sic]
more damaging to them than the actual vaccine.”
Individual health profiles were important in some parents’ assessments of whether
vaccines were safe for their children. Most often (n=6), children’s specific health
conditions were cited as reasons to vaccinate – especially against flu. Alice had all four
of her children vaccinated because they suffer from asthma and Jill, a mother of three,
always has her sons vaccinated, but normally does not vaccinate her daughter.
In contrast to the flu and chicken pox vaccines, which were generally viewed by
parents as benign illnesses (with individual and age-related exceptions), the meningitis
vaccine was seen as invaluable because meningitis, though rare, was perceived as lifethreatening. As one mother succinctly put it, “meningitis is just plain scary.” Parents
whose children had not yet been vaccinated indicated that future vaccination was
imminent.
Elizabeth, a pediatrician, agreed that when it comes to vaccine coverage, “Tetanus
is the easiest. Meningitis is probably second. Those are the easiest, top two. Hands
down.” Other providers agreed that parents generally and readily accepted the meningitis
vaccine. Several providers (n=4) attributed parental interest in the vaccine to media
coverage documenting local deaths caused by meningitis. Sophia recalled a recent case
in which a local university student died of meningitis. The case received wide media
coverage. “That completely changed [how parents felt about the meningitis vaccine] and
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people were coming in droves to get it, after the news.” Elizabeth referred to the same
incident in explaining why so few of the parents in her practice refuse the vaccine.
“[Parents] know meningitis is bad. They know people die from it. And it’s news stories
like that – they die from an illness that is preventable with a vaccine. Those parents are
on board. It’s a very well accepted vaccine in my practice.”
Along with vaccine need, some parents questioned the safety of specific vaccines;
again, the flu and chicken pox vaccines were commonly mentioned. In the case of the
seasonal flu vaccine, the fact that a different vaccine is manufactured each year led some
parents to feel that the vaccine can never be tested for long-term safety. In the case of the
H1N1 vaccine, its rapid emergence onto the market led others to doubt its safety. Natalie
was unwilling to have herself or her children vaccinated against H1N1 because in her
opinion “there’s not enough research done on it, it was put out too fast”.
The newness of a vaccine was associated with concerns about its long-term
safety. Especially when it originally came out, parents expressed fears about the newness
and necessity of a chicken pox vaccine. Several parents (n=3) delayed having their
children vaccinated as long and possible in order to assess the safety of the vaccine; in
order to avoid making a decision altogether, three parents actively sought to expose their
children naturally. Marie explained, “I did hold off on the chicken pox, just because I
thought it was too new at the time. So I waited until the very last minute that they could
still get it and then I decided that I probably should. I usually like to wait on them until I
get some of the feedback from the vaccines.”
Along with disease severity, parents also expressed concerns about the
effectiveness of vaccines, especially new ones. Many parents (n=12) worried that
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vaccines would either cause or fail to protect their children from the diseases they were
intended to prevent. A few parents (n=4) were concerned about a vaccine’s ability to
provide long-term immunity from a disease. Especially in the case of the chicken pox
vaccine, parents worried that immunity would wear off when their children were older
and were more likely to suffer severe consequences from the illness. For example,
Theresa, whose children had received all of their recommended childhood vaccines, did
not want to vaccinate them against chicken pox. She was relieved when both of her
children naturally acquired the infection. Explaining her hesitation, she recalled, “[When
it came out] all I kept thinking is: you’re taking a disease that’s an inconvenience for
working parents to stay home for a week with their child, and you are making it an adult
disease where it does become dangerous as an adult.” Sarah, a mother of three who
described herself as pro-vaccine, expressed similar fears. “What happens if it wears off
and my daughter is at a child-bearing age and she gets exposed to someone with
chickenpox?” After failed attempts to have her daughter naturally acquire the disease,
she eventually acquiesced and had her vaccinated.
While some parents questioned the long-term immunogenicity of vaccines,
parents also questioned whether some vaccines worked at all (n=4). Questions about the
effectiveness of the chicken pox vaccine caused Faith to delay making a vaccine
decision: “There are kids who have gotten [the vaccine] but have still gotten chicken pox,
although a lot milder. So then you’re just questioning does it really work?” Coupled
with concerns regarding the efficacy of specific vaccines were fears that some vaccines
could cause the very diseases they were supposed to prevent (n=6). One mother pointed
to the polio vaccine and another mother to the measles vaccine when referring to this risk.
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Most commonly, however, parents (n=4) implicated the flu vaccine as the prime
example of a vaccine that can cause the disease it is supposed to prevent. Tony, the father
of one daughter, now gets the flu vaccine but thought for many years that “The flu
vaccine gives you the flu. I believed that for years and never got the flu vaccine.”
Although some parents did think that children could develop diseases from vaccines,
several thought that the disease would be less severe; from this perspective, the failure of
the vaccine to completely prevent disease was less important than the vaccine’s ability to
lessen its severity. Alice expressed this viewpoint when explaining why she felt that a
vaccine-induced illness would be less severe than a naturally-acquired strain of the
disease: “The main thing people think of, and I think of too, is sometimes getting what
they’re trying to vaccinate you against. You hear about those live vaccines. Like the one
with the flu. [But] a little bit of [flu] is better than having a full blown case of it. If it’ll
help me build up what I need to not get it, then I’d rather have that.”
When considering vaccine risks in general, parents expressed anxiety that certain
vaccines could cause Guillain-Barre syndrome, autism, or developmental impairments,
although they were unsure which specific vaccines were associated with these perceived
risks. Four parents worried that vaccines could cause Guillain-Barre syndrome, and
several providers (n=5) reported that this was concern among their own parent
populations.
The long-term adverse consequence that parents most often associated with
vaccination was autism. Healthcare providers (n=8) also reported that autism was a
significant concern among parents in their practices. While many parents (n=12)
considered autism to be a possible vaccine risk, only two parents altered vaccine
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decisions because of this fear. Autism concerns were key to one couple’s decision to
postpone giving their daughter any vaccines until immediately before she entered
kindergarten (with their subsequent three children, they followed the recommended
schedule) and Rachel, a mother of two, was unsure whether her 12-year old daughter
would receive her MMR booster because she was particularly concerned about autism.
Autism, in particular, was a risk associated with vaccines administered during the
first few years of life. Some parents (n=4) recalled anxiety when making past vaccine
decisions for their older children or current vaccine decisions for their younger children.
In recalling some of her earlier vaccine decisions, Evelyn, who has one daughter, shared,
“I did have an autism concern, you worry about whether your baby is healthy, and you
don’t want to harm your baby. So yeah, I was concerned but I still felt that positives
outweighed the negatives. I know that it’s now a huge question for a lot of vaccines.”
Many of the parents (n=6) who mentioned a possible link between autism and
vaccines did not themselves believe this was a concern; rather, they attributed this fear to
other parents or as a common risk publicized in the media. Both parents and providers
pointed to the media role in publicizing and increasing public attention and fear regarding
vaccine-related autism. As one mother explained, “I used to not worry about vaccines at
all, but now that you hear so much about how they cause, can cause autism – like they
think that there’s a connection with the autism, I’m more cautious.”
The actress Jenny McCarthy has been vocal in insisting that vaccines cause
autism and are responsible for causing her own son’s autism. McCarthy has become a
leader in the anti-vaccine and vaccine safety movements, making radio, print, and
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television appearances to advocate for “greener” vaccines. Her name was mentioned by
both providers (n=6) and parents (n=4) when discussing autism-related vaccine fears.
The role of media in disseminating vaccine information (and at least in the following
example, shaping parents’ risk perceptions), is clearly illustrated by one father’s
reflections on vaccine safety. Mark and his wife had delayed vaccinating their first
daughter due to safety concerns that were intensified through popular media coverage
about vaccine risks at the time. He explained that news reports “saying they’re putting
mercury into your kids” are hard to ignore. He noted that he and his wife “would still
have been on the McCarthy campaign bandwagon” if they hadn’t “pushed to find the
other side of the story”. Interestingly, Mark got the other side of the story from another
actress, Amanda Peet. The father largely accepted McCarthy’s claims until he heard a
radio show in which prominent vaccine expert, Dr. Paul Offett, and Peet were discussing
the benefits and importance of vaccines.
Sometimes parental concerns about vaccine-related risks were more general. A
few parents felt anxious about aspects of vaccination of which they knew relatively little.
One mother asked of vaccines in general, “What are the long term effects? Do they cause
other things? How do they attack your body? Are they stored in our liver? Do they
become toxic – do they cause toxicity in your liver? Do our bodies totally absorb them?
How do we deal with antibodies?”
A few of the parents (n=4) in the study expressed fears regarding the number of
vaccines administered in one visit and the age at which children receive vaccinations.
Along with the number of vaccines that children received, concerns were raised by three
parents about the chemicals contained within them. Natalie had heard that the flu shot has
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mercury in it, which led her to question why the government would encourage its citizens
to be injected with a mercury-containing vaccine when “we know there’s a possible link
between mercury, autism, and Alzheimer’s”. Natalie originally feared the contents of a
specific vaccine, but that fear led her to develop a more generalized concern about
governmental safety and regulatory procedures and to question who benefitted from
public health immunization campaigns.
That there lacks factual and scientific evidence to support beliefs that, for
example, the flu vaccine contains mercury33 or that vaccines cause autism is largely
irrelevant, because such beliefs exist and flourish irrespective of published studies and
reports to suggest otherwise. More relevant is to understand not only how risk
perceptions affect decisions to accept, defer, or refuse vaccinations, but also how such
perceptions are both shaped by, and can shape, the ways in which parents perceive public
health institutions, governmental interests, and clinical practitioners. The example
illustrates, once again, that specific vaccine decisions (e.g., Gardasil) are not isolated,
discrete events; rather, they are part of a much wider, contextually-located and
experientially informed constellation.

HPV Vaccine Benefits
All but one parent discussed at least some benefits associated with the HPV
vaccine. “Protection” was most commonly cited as a benefit of the vaccine, though the
thing from which the vaccine provided protection varied. For a few parents, protection
itself was a benefit without a necessary object. That a child was protected against
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The flu vaccine does not contain (methyl) mercury
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something, regardless of what that something was – was central to some parents’
descriptions of why they chose Gardasil. Protection, in some ways, became a form of
reassurance, both that parents were “guarding” their daughters’ long-term health and that
they were doing everything they could as parents for their daughters. Alice, for example,
did not know what HPV stood for or what the Gardasil vaccine protected against when
her provider recommended it. She had her daughter vaccinated that same visit,
explaining, “[I got it for her] to prevent disease. This is what we do for our kids. My
daughter had this because it seems like it will prevent future heartache or disease, so
that’s kind of why I did it.” Another woman, when explaining why she would support an
HPV school mandate, said, “I just feel if it’s protecting your daughter, why wouldn’t you
want to do it?”
Some parents described the vaccine as protecting their daughters against more
specific diseases, but these specific forms of protection were secondary to the larger goal
of making decisions that were generally protective. As one mother said it, “And of
course I want to protect [my daughters] in any way that I can. So that’s why I wanted
them to get the shot.” Another mother identified protection from HPV, genital warts, and
cervical cancer as benefits of the vaccination, but for her, the Gardasil vaccine was really
about protection writ large. This mother was battling breast cancer and worried that she
might not be around to protect her daughter in the future. Any protection she could
provide for her daughter was reason enough for her: “I just want to protect her. And
that’s the whole thing about the Gardasil, is I get protection”.
Overall, parents saw cancer prevention as the primary (and sometimes exclusive)
benefit of Gardasil. When describing the benefits of Gardasil, two parents thought that
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the vaccine protected against some types of cancer, though they were not sure which
ones. For these parents, the specific type of cancer-protection afforded was largely
irrelevant because any reduction in the risk of developing cancer was beneficial in itself.
As one mother put it, “My thought is, if it can prevent cancer or a worry of cancer, I’m
there.” More than half of parents (n=16) identified prevention of cervical cancer as the
primary benefit of vaccination. The fact that the vaccine could protect their daughters
from the possibility of cervical cancer was a major benefit to getting the vaccine (though
recognizing cervical cancer protection as a major benefit did not always lead to
vaccination). Eleven of these parents had at least begun the three-dose Gardasil series.
Slightly more than a third of parents (n=10) understood that the vaccine would not
protect their daughters from every type of HPV that can cause cervical cancer, but most
of these parents (with the exception of one) saw any reduction in risk as a potential
benefit of vaccination. As Theresa explained, “It’s good to know in my eyes that, yes,
she has [been vaccinated] and no, it’s not going to prevent [cervical cancer] completely.
and it’s not like you still don’t have to get exams done, but to know that she’s protected is
a good thing.” Despite its limited ability to protect against all forms of cervical cancer,
Gardasil provided parents with the reassurance that they had taken advantage of an
available technology to protect their daughters’ health.
Only five parents knew that the vaccine protected against genital warts and all
five of these parents listed prevention of warts as a benefit to vaccination. After learning
through the course of the interview that the vaccine protected against genital warts,
parents saw it as a significant added benefit of vaccination. One mother, who had already
vaccinated two of her daughters without knowing that Gardasil protected against 90% of
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genital warts was sure that her provider never mentioned the benefit to her, because if he
had, she would have remembered. While she was not upset that her provider had left out
this detail, she would not have minded if he had mentioned it because it would have been
“one more good reason to get them vaccinated.” Another mother, whose experience was
similar, described as “fantastic” the fact that her daughters were also protected against
some types of genital warts.
Nearly half of the parents with whom I spoke mentioned that they or someone
close to them had experienced complications due to HPV infection. All of the
information that parents provided about their own or other’s experiences with HPV
infection were self-reported; I did not ask parents whether they or people they knew had
any HPV-related illnesses. That so many parents volunteered this type of information
suggests that personal, family, and peer experiences with these diseases help parents to
frame issues surrounding vaccination.
Eleven parents described their own or other’s experiences with cancer in general,
cervical cancer, hysterectomies, cryosurgery, abnormal pap smears, HPV-related
infertility, or genital warts. Ten34 of these parents specifically pointed to these
experiences as a reason to consider the HPV vaccine. Along with the physical effects
associated with HPV infection, parents did not want their daughters to experience the
uncertainty, trauma, and fear that are associated with abnormal pap smears, biopsies, and
treatments for HPV-associated infections. One mother recounted the psychological
trauma that she experienced when she found out that she had abnormal cervical call
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One woman, whose mother had a hysterectomy due to cervical cancer, was not convinced that the
vaccine could prevent cervical cancer, and therefore did not see the vaccine as beneficial in this way.
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growth. She would never wish that any woman, especially her own girls, feel the same
sense of fear she felt throughout the diagnosis and treatment process. “I had two spots on
my cervix that were removed. It was very scary. Very, very scary. [Here I was] in my
mid-thirties with three small children and I would not want that to happen to my girls.
They did a biopsy first and then a cone . . . I was lucky, I think, to be able to have what is
a simple procedure. It could have been devastating.” In vaccinating his daughter, one
father hoped to spare her the anxiety of receiving abnormal pap results. He explained that
he would consider the vaccine a success if it could save his daughter from “Getting the
news of an abnormal pap and not knowing what it means. If I can help her not have a
couple of those phone calls then it’s worth it.”
Several parents knew of women who had developed cervical cancer or other
forms of cancer. Parents did not want their daughters to fall victim to similar diagnoses if
it could be prevented. One mother pointed to her own family’s history of reproductive
cancer as part of the reason she chose to have her daughter vaccinated. “I have a cousin
who had cervical cancer and I thought about that. . . Plus my mom died of breast cancer
pretty young. So anything I can do to help my daughter, prevent her from having any
serious illness.”
Several providers (n=3) also reported that parents sometimes want the vaccine
because they think cervical cancer is hereditary. “I’ve had some of the parents tell me,
here is what they say: HPV runs in the family. So there’s a bit of a learning issue with
that. But they think it’s something a little bit more genetic and that that’s their risk
factor. . . I’ve heard ‘It runs in the family’ a lot.” Another provider heard similar
statements at her office. “I’ll have people say, ‘Oh, we definitely want her to get
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[Gardasil] because cancer runs in our family.’ I hear that a lot. And then I explain to
them that this isn’t something that would run in the family, but I hear that fairly
frequently. Yes, we want her to get that because cancer runs in our family.”

Times of Risk: Vaccine Innovation, Safety, and Immunogenicity
The newness of the Gardasil vaccine was central to many parents’ concerns; the
fear of “unknown risks” was unquestionably the most commonly associated fear with the
vaccine. Twenty-four parents worried that there could be negative long-term health
effects associated with the vaccine that had not yet been discovered or documented.
Parents did not always specify particular types of long-term health risks that they feared,
but rather spoke of the unknown consequences as anxiety-inducing. Complicating or
contributing to the risk of unknown adverse effects and vaccine safety were concerns
about pharmaceutical company motives and the relationships between government
agencies, vaccine manufacturers, and providers; these particular concerns are discussed
thoroughly in Chapter Ten.
When explaining why some parents in her practice are hesitant to have their
daughters receive the HPV vaccine, Robyn, a Florida nurse practitioner, concluded,
“They don’t usually have anything specific in mind. Just that it might be dangerous, and
it’s all very amorphous. They don’t come in with specific dangers in mind, they just say
that their kid’s a guinea pig.”
Helen, the mother of a nine year old daughter, was concerned about the newness
of the vaccine, but could not pinpoint exactly what she needed to know about the vaccine
to make her feel comfortable enough to give it to her daughter. “I mean, I’m leaning
towards getting it for her, but I have to – I want to reassure myself to look into those,
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because I just have vague questions about whether or not this vaccine is safe and how
long it’s been tested and what are the side effects”. Wendy, who has a son and two
daughters, also wanted to know more about the long-term effects and attributed some of
her own anxiety about the vaccine to her own lack of initiative in seeking out more
information about the vaccine. In describing her hesitations, she asked, “How much
research is out there that shows long term statistics? I’m nervous because I didn’t do my
homework on this, that’s probably why. That’s how I’d do it first. I just don’t know
much about it yet. I don’t.”
Parents who did discuss specific long-term risks most often worried about
detrimental effects to their daughters’ future fertility or general reproductive health. It is
unclear from where these concerns arise. It might be that reproductive and fertility fears
relate to the fact that the vaccine is associated with diseases affecting the reproductive
tract. It also could be that parents assume that the initial cohorts of pre-adolescent and
adolescent recipients of the vaccine have not yet reproduced, thereby limiting our
knowledge of whether issues with fertility and pregnancy exist. Several parents also
mentioned thalidomide in particular; it could be that parents recall this particular drug
effect, which happened to result in high rates of miscarriages and birth defects.
Courtney took her two eldest daughters to receive the vaccine and plans to take
her younger daughter to be vaccinated in the future. Reflecting upon her own concerns
regarding the vaccine, she explained, “It’s something new and with anything new it’s a
natural fear of what’s going to happen to my daughter thirty years from now. That was a
lot of my questioning. She is still growing at 16, what’s going to happen if she wants to

245

become a mother some day? Are we going to see any side effects that would hinder that
possibility? And not even related to that, what about the liver, kidneys?”
Natalie questioned whether the vaccine had been studied long enough for
researchers to state that there were no long-term safety effects. “Tell me what, you know,
ten years down the line here. Is that long enough to study a drug? I don’t know. I went
to school with kids that had a short limb because their mothers took thalidomide. I went
to school with kids whose mothers took tetracycline when they were in the womb and
their teeth were all completely gray. And they didn’t find that out until how many years
later? Twenty years later. So how long do you have to go?”
Marie, who was leaning towards vaccinating her 16-year old daughter, explained
similar misgivings. “There isn’t this long history of HPV. And I wonder, what are the
risks if someone takes this vaccine now, twenty years [later], is it going to mean
something not so good for [my daughter]?”
Four providers noted that at least some mothers express specific concerns about
Gardasil’s long-term reproductive effects. When I asked two providers to describe some
of the common questions and concerns their parents expressed when discussing Gardasil,
both mentioned long-term reproductive effects as a common issue. One Florida provider
explained,
[Parents say,] “It might be good now but in two years they’re going to tell me that
it causes sterility.” Oh! That’s a big one. That my child won’t be able to have
babies because of the Gardasil. I think those are the major ones that they come
with . . . I’ve had quite a number of them think that that’s going to be a problem.
Or just because the research isn’t out that, you know, that . . . either they’ve heard
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that it does [cause long-term reproductive problems] or what if it does? What if in
20 years she can’t have a baby because of Gardasil?
A Pennsylvania provider also self-identified long-term reproductive consequences
as a common concern among parents in her practice as well.
Here’s the big one: They say that they’re afraid that it’s going to make them
infertile. I hear that a lot. A whole lot. And I always tell them, “Well cervical
cancer can do that to you, but there have been no reports at all about infertility
with the Gardasil”. But that’s a big one. I don’t know where that comes from. I
don’t know if it’s just like an urban myth that’s been spread out there or if there’s
something on the internet, but there’s no, you know, logical basis for it. Then I’ll
say to them, “Well where did you hear that from?” and they’ll say, “Well
somebody else told me that” or they’ll say something like “My friend is a nurse
and she said that you have to watch out for stuff like that. They might become
infertile.” It’s just bizarre to me, I don’t know where it comes from. But I’ve
heard it. I’ve definitely heard it a lot.
As this provider notes, cervical cancer (as well as pre-cancerous HPV-infection) can lead
to infertility, yet only one parent viewed prevention of infertility as a benefit of
vaccination. It was much more common for parents to see the vaccine, rather than HPV,
as a threat to their daughters’ future fertility.
Questions regarding the duration of vaccine protection – if and when a booster
would be required – also factored into some parents’ (n=7) vaccine decisions. Parents
were unclear regarding the length of immunity provided by Gardasil and felt that having
such information would help them decide when to vaccinate their daughters. Theresa
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wanted to know “how long down the line do they know when they’ll need a booster shot?
Or will they need a booster on it?” Mark asked similar questions, “Is it a one vaccination
for a life type of thing? Or is it something that she’ll have to get – like suppose ten years
down the road they find that those first batch of girls are no longer protected?”
Duration of immunity was especially important to four parents who did not think
their daughters would become sexually active in the near future. Parents wanted to
maximize “productive” use of the vaccine. One mother thought carefully about when to
vaccinate her daughter given the lack of information she had about a booster. When she
discussed Gardasil with her daughter’s provider she focused on vaccine coverage:
One of the biggest questions I had – and I don’t know that she gave me a
straightforward answer or not – was how long they expect that vaccine to last.
And I think she said five years. And I was thinking in my head, well, she’s 15
now. If it’s only five years, she’s going to be 20. Is she going to have to need
another vaccine? Should I wait? Should I do it now?”
The same mother had postponed the decision several years due to concerns about
vaccine timing.

She felt one had to consider “how old she is and how long the vaccine

was going to last. And I just think nine, ten, eleven, that’s way too young. And even
thirteen. I was like, wow! She’s only going to be 18 by the time that it’s not going to be
as effective.” She felt that the gap between the time when the vaccine was administered
and the time a girl would likely become sexually active was too great – by the time the
vaccine could protect her daughter from exposure it would already be losing
effectiveness.
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Booster concerns were part of the reason another mother had deferred making the
decision to vaccinate her ten year old daughter. Jill wanted to ensure that her daughter
benefited as much as possible from the vaccine, but she also did not want to wait so long
to vaccinate her that her daughter made the decision without her input.
I think in my mind, if I gave it to her when she was ten and she’d have to get
boosted again when she was 17. Hopefully – I say hopefully because I know the
statistics prove otherwise – but I would hope by 17 that she wouldn’t have
(whispers) had sex. Hopefully. But then at – when she’s 17 I think it’d be more
her choice to have another one or not. So I don’t know, maybe if we did it when
she was 14 or 15 then – that seven year window would be when she’d be more in
college? (laughs) Where I wouldn’t know what she’s doing unfortunately
(laughs).”
She continued, “I don’t know, maybe I have the wrong idea of it, but if you get it when
you’re ten does it provide – like, what’s the immunity that it provides? You know what I
mean? Like, would you have to get a booster later on or is it better to get it later on when
you think you might be entering that realm of exposing yourself to that.”
These parents considered two dimensions of time when considering Gardasil.
Like other parents, who were concerned with safety, parents wanted to delay vaccine
initiation as long as possible, but while their daughters were still virgins. The difference
is that concern regarding vaccine duration rather than vaccine safety led them to delay
initiating the series. Vaccinating too early might then leave the child unprotected when
she would much more likely be in need of protection. One mother reasoned that if she
vaccinated her daughter at age 9, she might become vulnerable to HPV again at age 19.
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Since the mother hoped her daughter would not become sexually active until at least
fifteen or sixteen years of age, she thought it made more sense to vaccinate at 14 and
ensure her daughter was covered through her mid-twenties.
Parents thus had to evaluate how long to defer a vaccine decision in order to
maximize coverage before their daughters became sexually active. For a few parents,
insurance coverage and personal control also factored into the timing/booster element. If
daughters were in need to booster shots at ages 19 or 20, they probably would not be
covered by the parents; insurance plan and the parents’ could not ensure that their
daughter’s would actually get the booster shots.
Finally, some parents (n=8) described what they perceived to be minor risks
associated with Gardasil, but emphasized that these same risks. Commonly cited risks
included pain and swelling at the injection site and fever. Only a few parents (n=3)
described fainting as a Gardasil specific risk.

Provider Assessments of Vaccine Safety
Parents looking for provider guidance in determining a timeframe for establishing
vaccine safety would likely not receive uniform responses. In this study, the physicians
and some nurse practitioners were confident that Gardasil was safe and had been studied
for a sufficient length of time. The chiropractor and five nurse practitioners, however,
were less sure of the long-term safety of the vaccine. While most of these nurse
practitioners felt confident enough in the vaccine’s safety to recommend it, they were
also much more willing to respect and appreciate parental concerns regarding long-term
safety.
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Several nurse practitioners raised concerns about long-term immunity provided by
Gardasil. One nurse practitioner worried, “We don’t know how long it confers immunity.
There’s just too much unknown about it.” Another NP echoed her concerns, “Exactly
how effective is [the Gardasil vaccine] doing what it says it’s going to do? And how long
is it good for?” A third nurse practitioner said, “We don’t know how it’s going to affect
people in 15 years. The one thing we do know, pretty much about all vaccines now, is
that they don’t last forever. And so when are you going to need to have that vaccine
repeated? We have no idea yet.” Lydia, a school nurse, did not have any concerns about
the vaccine other than the newness of it. When I asked Lydia what constituted newness –
at what point the vaccine would no longer be new – she responded, “You know, that’s
really hard to answer. I would like to say – and this I’m pulling out of my brain, but to me
it seems like after five years [post-licensure] maybe you’re starting to get a pretty good
comfort level. But again, that’s probably a real poor number because who knows?”
Lydia’s question of “who knows” is at the heart of safety disagreements between
some providers and parents. Distrust and doubt can arise when parents are unsure that
anyone can know when a vaccine is safe and providers believe that they, or
epidemiologists and biostatisticians, or vaccine experts, or the FDA and CDC can know –
and do know – that the vaccine is safe.
Different views about what constituted safety and how much time was required
before something could be deemed reasonably safe led to very different assessments of
vaccine safety. Physicians, and most nurse practitioners, believed that the criteria
established by the FDA for establishing vaccine safety were sufficient and therefore felt
confident in the safety of the vaccine. Parents, and a few nurse practitioners, were
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doubtful that enough time had lapsed or enough girls had been vaccinated to confidently
know whether the vaccine was safe.
Most providers felt that the pre-licensure studies provided sufficient evidence of
the vaccines long-term safety and efficacy. However, parents sometimes made
comments to suggest that vaccine safety had to be assessed post-licensure. The test
subjects who would ultimately determine whether there were serious adverse effects were
the cohorts of girls across the country who received the vaccine after it was marketed to
the general public. One mother, who had not yet vaccinated her daughter, explained, “I
haven’t done enough research on long-term effects or anything like that. I don’t know if
that’s out yet.” Another mother had her daughter vaccinated, but originally described
herself as feeling “leery of something that I feel is fairly new and untested” These
comments reflect a belief that even after vaccine approval, long-term safety information
is not available and that girls who are vaccinated post-approval are part of the research.
Providers evaluate safety based on population-level probabilities of risk, while
parents are concerned about their child’s individual risk. Providers often trust in the
vaccine review and approval process. Often times, their own assessments of safety are
based on the fact that a vaccine has been vetted and approved by the government. When a
vaccine has been studied for a specific period of time and on an adequate number of
people deemed sufficient to detect in sufficient quantity the common and rare short and
long-term effects, assessments of safety are made by biostatisticians, medical doctors,
vaccine experts, and epidemiologists. A vaccine is deemed safe and appropriate for
public use not when vaccine risks are eliminated, but when the vaccine’s risks are
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deemed sufficiently low, and its benefits sufficiently high (Hoskins 2010; Rodricks and
Tardiff 1984).
However, what might be deemed as an acceptably low risk for the population
might be too high a risk for an individual child. Parents are not worried about populationlevel risks of vaccines, but rather, about the direct risks to their children. When it came
to one’s own child, parents wanted to know how much time was really need to evaluate
the safety of a vaccine. Natalie questioned, “Is ten years long enough to know?” Parents’
inability to confidently answer this question often led them to delay making a decision
about the vaccine.
Lack of consensus among providers about the amount of time required to evaluate
the safety of Gardasil increased some parents’ conviction that the vaccine was too new
and that too many questions remained unanswered. The different standards applied by
healthcare providers to evaluate the safety of a vaccine could solidify parent doubts that
current safety standards are sufficient. One mother emphasized the need to use her own
intuition when making healthcare decisions because “so many doctors, they’re just not on
the same page. One believes this way and one believes that way, so you just have to go
with your gut feeling. And that’s what I try to do. With the information that I have I try
to make the best decision.”
Among the providers (primarily physicians) who had strong faith in the rigorous
governmental process for evaluating the safety and efficacy of vaccines, the amount of
time needed to evaluate the safety of a vaccine was the number of years the vaccine was
studied prior to its FDA approval. Some providers, who felt that the current long-term
safety data were satisfactory, took time to explain the process through which HPV safety
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data were obtained, in hopes of allaying parent’s fears regarding the long-term safety of
the vaccine. While providers reported that such explanations sometimes addressed
parents’ concerns, in other cases, the most complete and accurate description of the
vaccine research served not to allay fears, but rather solidified them.
Parents who expected that decades of vaccine safety and efficacy testing be
completed before considering the vaccine safe and effective for use (in the general
population or for their child’s use), tended to dismiss the existing HPV safety studies as
incomplete. In these cases, providers’ attempts to provide the specific details of the
safety studies backfired. While providers might deem the information to be proof of a
lengthy and rigorous process, parents might consider the exact same information to be
inadequate and premature. The ability to differentially interpret the same scientific facts
should once again remind us to question the tenuous assertion that individuals are more
likely to “comply” or “adhere” to public health and provider recommendations if they
have more biomedical knowledge regarding a technology, disease, or process. In this
case, the opposite seems to be true.
The following three quotations reveal some of the conflicting views that providers
and parents have about vaccine safety and how much time must pass before a vaccine can
generally be considered safe. In responding to parent concerns regarding the newness of
the Gardasil vaccine, two pediatricians, the first from Pennsylvania and the second from
Florida, explain:
“A common misperception that people have is they don’t think [Gardasil has]
been studied well enough, that it’s too new. That we don’t know the side effects
of it. They definitely think that.”
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“They just don’t believe the – I’m sure they just don’t understand how stringent
the process is to get something approved like this.”

“I first tell [parents] that even though it’s only been used in the US for about two
years they were using it in other countries – particularly in Europe . . . for years –
seven years even, before we even brought it over.”

The latter pediatrician clearly felt that nine years of research and use was sufficient
evidence of the vaccine’s safety, but she further explained that many parents think nine
years is insufficient. When parents say this, she asks them “Well how much research is
enough for you? And I had one dad tell me (laughs) twenty years! I was like, okay sir,
there’s just no helping you.”
The pediatricians’ responses not only highlight variations in the ways that they
and parents evaluative the length of time necessary to conclude that a vaccine is safe, but
also that the pediatrician’s view – that the government’s vaccine vetting process is
stringent, thus assuring ample time was spent collecting and reviewing safety data – was
the ‘correct’ view. The first provider used the word “misperceptions” to refer to the time
criterion used by some parents to assess vaccine safety. In the latter case, the provider
dismisses the parent’s concerns as beyond help (or, perhaps, persuasion). While
differences in the ways in which providers and parents collect and evaluate knowledge
are specifically discussed in the next chapter, competing knowledge claims, as expressed
through provider narratives, are evident throughout the dissertation.
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Risky Relations: Promiscuity and Sexual Behaviors
Another commonly cited risk associated with Gardasil had to do with the effects
of vaccination on girls’ sexual behaviors and beliefs. Early research on anticipated
acceptance of an HPV vaccine suggested that parental concerns regarding the effects of
vaccination on sexual behavior might lead to low acceptance rates (Brabin, et al. 2006;
Davis, et al. 2004a; Liddon, et al. 2005; Olshen, et al. 2005). Central to concerns
regarding sexual behavior were fears that vaccinated girls might believe that they were
protected from all sexually transmitted diseases and would therefore engage in
unprotected sex or have sex with a greater number of partners. Another fear is that
receipt of the vaccine would be viewed by girls a license to become sexually active or be
interpreted as, if nothing else, parental indifference to their sexual behavior. Concerns
about promiscuity, while commonly mentioned by parents, seldom played a significant
role in their vaccine decisions.
Concerns regarding promiscuity were mentioned by many parents (n=17), though
often when discussing fears that other parents had regarding the vaccine. When asked
why other parents might not want to give their daughters the Gardasil vaccine, more than
half of parents (n=18) suggested that sex-related fears would play a role. For example,
Tony had no concerns that vaccinating his daughter would give her a false sense of
security or be interpreted as a license to have sex; however, he observed that among his
friends, he held the minority view. “[For] my evangelical Christian friends it’s more
about the topics surrounding premarital sex. And they tend to equate disease with
premarital sex. Disease with promiscuity.” Melissa, who has one sixteen year old
daughter, felt that much of the resistance to the vaccine related to promiscuity, though she
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had not spoken to anyone who actually held this view: “It seems to me that there are a lot
of people that have sort of negative thoughts about the HPV vaccine, but a lot of it seems
to be, ‘Well if you get the vaccine then your kid’s going to be sexually active,’ and I just
think that’s a ridiculous argument.”
Several parents likened HPV vaccine decisions to decisions regarding birth
control, where parents feared that accepting either technology sends a message to the
daughter that sexual activity is permitted or even encouraged. “I almost questioned why
they offered [the HPV vaccine] so young. Why would you do that? Like, I almost think
that it maybe puts in the kid’s mind – I mean, at nine years old, I don’t know. But I think
almost that’s one of those things that might put, like, that false sense of safety in their
head. Like, well, if I get the shot then I’m prevented against all these things. Not just
HPV.” Several other parents (n=4) also similarly questioned the age at which girls
received the vaccine and whether it was too young.
Most parents (n=10), however, generally dismissed concerns that helping their
daughters obtain either the Gardasil vaccine or birth control pills would actually
encourage them to become sexually active. As Helen put it, “There are lots of parents
that think if their children are offered birth control that it will make them more
promiscuous. You know, I can understand that in a way. But if kids are gonna have sex,
they’re gonna have sex.” Victoria had heard similar concerns: “That the girls will think
because they have this vaccine that they can be more promiscuous because they’re
protected [. . .] I know that’s why parents don’t want their girls to be on birth control.
Because they’re morons (laughs). They think that that’s gonna make a difference.” These
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parents reasoned that adolescents, who wanted to have sex, would have sex, regardless of
whether they benefited from the protection of birth control pills or a vaccine.
A few parents (n=6) did worry about the effects the Gardasil vaccine might have
on their daughters’ sexual behavior, though none of these parents reported that their fears
were sufficient to keep, or have kept them from vaccinating their daughters. Jill, who had
not yet vaccinated her daughter but was fairly sure that she would eventually, shared
some of the concerns that she and her friends had recently discussed.
[The vaccine] might put that false sense of safety in their head. Like, “Well, if I
get the shot then I’m prevented against all these things.” Not just HPV. If they
think that they’re now protected against something then maybe they won’t think
twice. You don’t want to encourage – I guess that’s the sense of false protection,
if they’re thinking, “Oh I had the shot and I’m good”.
Even though the majority of parents did not strongly believe that promiscuity or a
false sense of security would result from giving their daughters the Gardasil vaccine, such
concerns influenced several parents’ (n=6) decisions to alter when they had their
daughters vaccinated and/or the content of vaccine conversations. Bill, the father of two
girls, explained that he and his elder daughter,
[. . .] had discussions about sex and really basically why she’s not ready for it.
And she didn’t disagree at all. And with respect to this, there’s the knowledge on
her part that this [vaccine] does not give you license to have unprotected sex. Not
at all. And I mean, she already knows [that] HPV is one of the STIs that you may
get, and maybe not the worst one, you know what I mean? Yes, HPV could cause
cervical cancer, or uterine cancer, or whatever, but it doesn’t have to, and it might
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not. But HIV, you know. And obviously pregnancy too, unwanted pregnancy too.
So that’s been specifically addressed, that this is not a license to have unprotected
sex.
For two parents who were not planning to vaccinate their daughters, concerns
regarding sexual morality and responsibility did enter into their rational for rejecting the
vaccine. For Rachel, abstinence until marriage was the morally correct choice and she
saw it as her responsibility to teach her daughter about the consequences of making
immoral or unhealthy decisions. Rachel was against the vaccine because she saw it as a
sign of permissiveness or societal leniency towards behaviors that she considered
irresponsible. “When you give her the [HPV] vaccination you are basically saying, well
this is just in case you choose to have sex. Let’s take away one of the consequences”
To condone the vaccine would contradict her philosophy that people accept the
consequences of their actions. One of the own core lessons that she constantly imparts to
her children is that all behaviors have consequences. She believed that people should
think about the consequences of specific actions before taking them and then be prepared
to accept those consequences responsibly. The vaccine, in her mind, took away one of
the consequences of having sex.
Natalie’s views were similar: “I think it’s more my job to teach [her] about not
having multiple partners. Not being promiscuous – not going to parties and getting drunk
and losing your inhibitions and going home with somebody you don’t know. I think
that’s more my job to let her know what the consequences can be if she does that.” Both
women framed their opposition to the vaccine in terms of individual responsibility, but
what they defined as encompassing individual responsibility varied. Rachel’s resistance
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to the vaccine was rooted in religious beliefs regarding sexuality. For Natalie, individual
responsibility had to do with more than one’s sexual behaviors, but how one chooses to
live life. Aside from concerns about the safety and efficacy of the Gardasil vaccine, she
felt that the vaccine was largely unnecessary if individuals made healthy lifestyle choices
(such as eating a balanced diet, taking supplements, and exercising) to boost their
immune system and practiced safe sex with monogamous partners.
While all parents hoped their children would practice safe sex, and many parents
hoped that they would remain abstinent until marriage, only Rachel and Natalie saw the
Gardasil vaccine as contradictory to these goals. In other words, no other parent saw the
vaccine and education as mutually exclusive interventions.
Promiscuity also was mentioned when parents questioned the need for the
vaccine, revealing their own assumptions about risk, and what types of girls constituted
the true “high risk”, target population. A few parents (n=4) questioned whether girls who
did not have sex with multiple partners needed the vaccine, suggesting that moral
calculations factored into some parents’ assessments of their own daughters’ need.
Theresa, whose daughter was vaccinated, still questioned whether the vaccine was really
necessary for her daughter. “I think there’s a need for [Gardasil] but maybe it’s more
necessary if you have a promiscuous child . . . [Is it] necessary for someone who’s going
to have a monogamous relationship? Is it something that’s really a benefit down the line
for – I don’t want to say a normal kid because you wonder if that is the norm anymore.”
Theresa’s question about normalcy speaks to a broader concern that several
parents had about the societal context in which their children were growing up. Parents
were particularly concerned about the perceived changes in societal sexual norms. Faith
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was disturbed by sheer volume of information that children had largely unfettered access
to, “I see some of these on YouTube and I kind of go online sometimes to see what’s out
there. What kids have access to. And I’m sickened by it, quite frankly. And it’s normal
behavior for these kids to hop from place to place, it seems like.” Another mother was
convinced that children were having sex at younger and younger ages. “There are some
fifth grade girls that should get in now. I mean that’s scary to say, it’s scary.”
Parents contrast these images with accounts of their own adolescent years, hoping
that their children will follow a path similar to their own and not what they might be
exposed to through the media, their peers, or larger society. One mother stressed the
importance of “self-respect” to her daughter and hoped the message resonated, but also
worried whether her own expectations and experiences were too out-dated to be realistic.
“Granted, yes, I am 53 and things are different, but in high school I would have never
even thought of having sex with anybody, no matter where I was. In fact, I broke up with
a guy I was dating because of that, because he was pressuring me. And I was like, okay,
forget it, we’re done.”
Providers’ Experiences Discussing Sexuality with Parents
Nearly all providers (n=14) reported hearing concerns about promiscuity from
parents, but the frequency with which they heard these fears varied considerably. Jessica
reported hearing this concern often, noting that “there is definitely a perception among a
lot of parents that my child will become promiscuous if she has this vaccine.” Another
Florida provider agreed that many of the concerns she heard had to do with parent fears
that the vaccine condoned sex. Comparing Gardasil to hormonal contraceptives, she
explained, “There’s a reluctance to get it because [. . .] some people seem to equate it to
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putting their 12 year old on birth control pills. And it’s like, doing a vaccine is not the
same thing as you know, saying go have sex. But I think there’s an awful lot of people
who view it that way.”
Several providers saw similarities in the way that parents responded to Gardasil
and their reactions to the use of hormonal contraceptives for the regulation of
menstruation or other non-sex related reasons. Recalling typical responses she hears from
parents about Gardasil, Amelia, a nurse practitioner, said, “I would say the stigma. It’s
like giving your 12 year old birth control pills to regulate the period. Do I give her the
HPV vaccine which gives her the freedom to go out and have sex? I have heard that.
They feel like they’re maybe promoting sexuality, promiscuity in their child.” Three
providers recounted cases in which the association between reproductive technologies
(such as Gardasil or hormonal contraceptives) and sexual permissiveness was so strong
that some parents would not consent to therapies even if they knew their children were
already sexually active because of the message consent would convey. One provider
shared an example to illustrate this point. She had asked a young woman if she was
sexually active and the girl said that she was. Upon hearing this
The grandma flipped out. I asked the girl what she was using for birth control and
the girl said nothing because her grandma wouldn’t let her go to Planned
Parenthood. The grandma responded that she didn’t want to take her to get birth
control because she felt that by taking her then she was giving her granddaughter
permission to be sexually active.
While many providers did hear concerns that the vaccine would lead to
promiscuity or send a message that sex was permissible, most providers were surprised at
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how infrequently parents raised this concern. One provider said that among her clients,
there were only a few “that actually say ‘Well, if I give her that then she’s going to think
it’s okay to have sex. So I can’t give her the vaccine.’” Nor do providers typically hear
parents say that their daughters do not need Gardasil because they will remain abstinent
until marriage. Jane said, “I’ve been surprised, I’ve [only] heard about a mother who
thought that if you have a firm belief in abstinence only until marriage, then you really
don’t need the HPV shot. . . Like I said, I get very little of what I expected, which has to
do with sexual behaviors generally.” Other providers (n=4) heard this argument more
often, but still far less frequently than they originally expected.
More commonly, providers heard parents say that the Gardasil vaccine is
unnecessary because their daughters are not sexually active. In fact, all providers
reported that this was a common response among parents, especially those with younger
daughters. Janet explained, “I don’t get a lot of, ‘Well, then she’s just going to think it’s
okay to have sex,’ which I thought I might get a lot of, but I hardly ever hear that. It’s
more, ‘I just don’t think she’s going to be exposed, so she doesn’t need it.’”
Providers commonly responded to parents’ doubts about their children’s risk of
acquiring HPV at a certain age. Many parents in Sophia’s practice wanted to know
whether Gardasil was really necessary at a young age and “how much of a risk their child
is truly at. A lot of it is a perception that it’s not something the child needs until she’s
older and maybe, you know, dating or thinking about, later on, becoming sexually active.
I think a lot of parents are just, just don’t think it’s a necessary thing until that point.”
Most providers were more understanding of parental decisions to delay an HPV
vaccine decision for a younger girl than they were for older girls. Few providers felt that
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sexual debut at age 10 or 11 was likely for the majority of their female patients, but
providers also worried that parents would delay the decision too long. Providers
questioned whether some parents would actually know whether their daughters were
sexually active, and doubted whether most parents could accurately gauge the lead-up to
onset precisely enough to ensure a sufficient window for the vaccine to be administered
prior to sexual onset. Moreover, providers worried that some parents would assume that
their children would practice abstinence simply because that is what the parents
advocated.
One pediatrician often heard parents say that their children didn’t need to get
Gardasil at such a young age. They say,
“Oh, she’s not going to be exposed at this age.” And you know, it’s funny
because for some of them, I think they’re probably right. Like if we’re talking to
a 10 or 11 year old child. But some [parents] feel like that and they’re like “Oh,
we preach abstinence in our house.” And the girl’s like 16! And you’re like,
yeah. Okay. So [the mode of transmission] does play a factor because . . . they
just don’t think their daughters are going to be exposed yet.
As the above quote suggests, providers were generally less sympathetic to
parental concerns about vaccine need when daughters were in their mid or late teen years,
or when parents preached abstinence until marriage. Some providers found it difficult to
respond to parents who insisted that the vaccine was unnecessary because their children
were not going to be sexually active until marriage. One provider explained, “[Some]
people just believe that their children are not going to be sexually active until they’re
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married so they do not have to worry about this [. . .] They’ll say, I don’t even want to
hear about it. So what do you say to that, you know? Alright.”
Another provider expressed similar frustration in responding to parents who were
convinced that their daughters would not have sex until marriage, and therefore did not
even need to discuss the vaccine.
The problem with these parents is they’ve already closed the doors. You’re not
going to open them because they can’t see their child in any other way, which is
just a whole problem with how they’re raising their child and the communication,
doing all that. So I know that there’s nothing that I’m going to say that’s going to
deter them.
Providers generally viewed the belief that their daughters would remain abstinent
until marriage as “parent denial”. When parents refused to discuss the vaccine for this
reason, many providers responded by presenting statistics that indicate most young
women become sexually active during their teen years. One provider would respond, “I
mean hopefully they won’t [be active until marriage]. And if that’s your belief system
that’s fine but 50% of fifteen year olds are having sex so . . .” Despite these efforts,
statistics were not often effective at persuading parents because no matter how large the
percentage of girls having premarital sex, their daughters would always be in the
percentage that were not . Another pediatrician related how the typical conversation
played out:
[I say,] “Eighty-percent of teenagers – or whatever, high school students – will
have sex by the time they graduate.” [And the parent responds] “Well, mine is in
the 20 percent [that won’t].”’ And you know, 99% of college students are having
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sex. [And the parent responds], ‘Well, mine is the one percent.’ They know that
their child is the one that is not going to have sex before they’re married, and
that’s just the way it is.
Rather than challenging parents regarding the accuracy of their knowledge
regarding their children’s sexual activity, providers most often emphasized the
prophylactic nature of the vaccine and the importance of immunization prior to sexual
debut. In stressing that the vaccine is intended to be given prior to the onset of sexual
activity, providers often try to appeal to common ground with parents by implicitly
affirming the virginal status of the daughter and framing the vaccine as a benefit of
choosing abstinence.
One provider, who receives many refusals because of a child’s age, always
responds by explaining the rationale behind targeting young girls. “I explain the reason
that we give it so young is so we catch everyone. That we don’t necessarily think that
your ten year old daughter is going to be exposed to it this year, but we want her to be
protected before she ever has a chance to be exposed. Still a lot of people want to wait.”
Another common response among providers was to emphasize the limited effects of the
vaccine after sexual debut. In these discourses, risk is associated not with refusing the
vaccine outright, but failing to vaccinate in time to take full advantage of its benefits. A
nurse practitioner generally told parents who preferred to defer the decision that Gardasil
covers four strains of HPV. “If you want to wait until she’s 18 and maybe she’s just had
that one special guy and she was already exposed to one, that means your shot is now
only good for three. I just try to tell [parents], you want to get it done before she even
thinks about having sex.”
266

A pediatrician coupled this perspective with research indicating that younger girls mount
a better immune response,
I just say, some studies have actually found that the earlier they get it the better
efficacy, the amount of better immune response to it. I talk about that. And I do
tell them, I know you don’t want to think about that, that your child is just a little
girl right now. But you know, 50% of fifteen year olds are having sex. So we
have to think about it. And the most important thing is that they get this vaccine
before they’re sexually active because it’s not going to treat HPV if they get it.
As will be further discussed in Chapter Twelve, both parents and providers
sometimes tried to minimize the focus on individual responsibility in managing HPV risk
by displacing the immorality linked with the vaccine from the daughter onto others,
including future partners and rapists. When parents said their daughters would be
abstinence until marriage, Elizabeth responds, “‘Well, what if [your daughter’s future
husband] has been with a lot of partners, don’t you think she could get that from her
husband?’ And then they go ‘Oh. Well I guess that’s possible, but she’ll have to deal
with that later.’” Sue, a Florida pediatrician,found that mothers were much more likely to
feel comfortable accepting the Gardasil vaccine for their daughters if she put “some of
the burden on the boys” by reminding mothers that daughters could have sex with one
man in their lives and still develop cervical cancer if he was not as responsible.
Another provider shared her own sister’s experience with HPV when parents were
uncomfortable addressing their own daughters’ sexuality: “[My sister is] as straight as
they come. You know, a straight-laced person who’s now in her mid-40s, was married for
over 20 years and only ever had sex with 2 guys and one of them gave her HPV. And
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that kind of really is an eye-opener for a lot of moms.” The provider found that sharing
her sister’s experience helped many parents reframe the vaccine. “Out of the ones that I
need to pull that story out on, I will say three-fourths of them get the vaccine. I think it
really helps – and of course it’s an honest story too.”

When parents brought up concerns that Gardasil would encourage their girls to be
promiscuous or engage in unsafe sex, providers often responded by stressing to girls that
the vaccine would not protect them against pregnancy or most diseases that are sexually
transmitted. One provider would say, after presenting the risks and benefits of the
vaccine, that getting Gardasil, “doesn’t mean it’s okay for her to go out and you know,
sleep with the football team.”

Communicating Risk
Providers noted that parents tended to focus on vaccine-related risks, no matter
how small, while sometimes disregarding what providers perceived to be more
substantial risks associated with HPV-infection. Providers tried to educate parents about
HPV and Gardasil risks using population-level risk statistics. As one provider explained,
the provider’s role was to help parents and young women understand, “what is your
actual risk, what is your risk of disease or side effects of the vaccine, and things like
that.” From the provider perspective, risks can be weighed in calculated ways to arrive at
decisions. But as discussed in Chapter Two, and as will be further discussed in the
following chapters, parents tend to conceptualize risk in more complex ways that are
based on information provided from diverse sources of knowledge, considerations of
trust, and temporal and contextual factors.
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Providers never tried to completely discount the risks associated with vaccines.
They always acknowledged that Gardasil came with risks. Some providers (n=9) tried to
juxtapose vaccine risks against the risks associated with HPV infection. Robyn
encourages anxious parents to go to the CDC website and read the studies describing in
detail the safety and efficacy of the vaccine. She also tells parents, “I understand that you
have concerns. Nothing in life is without some risk. But when you look at the rates of
cervical cancer and HPV against the risk the vaccine poses, for the most part the benefits
way outweigh the risks. And we certainly have big numbers. Lots and lots of women
have been vaccinated.” Robyn, like other providers, did not dismiss parents’ safety
concerns. She validated their legitimacy, but then framed them against other risks that
she felt, based on population-level indicators, were more substantial.
Other providers tried to allay parents’ fears by reminding them that of course
Gardasil was not risk free, but that Gardasil was not unique either. There were risks
associated with Gardasil, just as there were risks associated with any vaccine, any
medical technology, and any aspect of life. Over-analyzing some risks could cause
parents not only to lose perspective about counter risks (e.g., associated with HPV
infection), but also become crippling.
Some providers tried to allay parents’ fears by explaining that risk analyses would
completely paralyze us if we considered every risk we could possibly encountering when
making any decision in life. Lydia would explain to parents that there was certainly the
possibility of unknown, long-term risks associated with Gardasil that might not become
known for decades. She would explain that while she did not think it was likely that we
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would discover adverse effects from Gardasil forty years down the road, it was a risk that
could not be discounted. She then added,
But obviously that could happen from other exposures, from other things in life.
It takes a lot of years to really truly know what consequences anything has. I
mean, you can just sit and worry about drinking out of your water bottle,
especially if it’s been in a warm car. And maybe you should worry about it, but I
don’t worry about that stuff too much because it can just really get you down if
you worry about everything. I’ve been talking on my cell phone for 45 minutes
and I’ve probably increased my risk of brain cancer, but that study was
inconclusive. And again, the Gardasil is doing some very positive things that
should impact society in a very positive way, so I would not have a lot of
concerns about it.”
As this provider suggests when mentioning aspirin, the most basic, taken-forgranted medical decisions also come with risks. Risk, they emphasize, is an inherent part
of everyday life and all decisions require that we accept a certain degree of risk. Several
providers felt that technological innovations and improvements in screening, diagnosis,
and treatment had led parents to expect risk-free health care. One NP found it
particularly disturbing that parents were unwilling to accept even the smallest risks
associated with healthcare treatments, especially when they tended to ignore the risks of
failing to treat: She explained,
Medicine is not without risk. When you subject yourself to a treatment, I don’t
care if it’s an aspirin tablet –heck, you can get a GI bleed from an aspirin. People
have to understand that everything is not risk free and that’s a huge problem in
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our society now. We’re becoming so much more entitlement oriented. The
expectation that every delivery result in a perfect baby, you know? These are very
dangerous and inappropriate and expensive assumptions to make. And we have
to educate people regardless of the immunization about [the risks], that these are
your choices.”
Laura stressed the uncertainty of risk calculations, and the need to make decisions
based on the incomplete, available information. Providers made recommendations based
on uncertain risk calculations and patients had to do the same. It was always possible
emerging data could lead experts to reconsider the safety or benefits of a technology that
had previously been deemed safe and effective. She described how she responded to one
young woman’s concerns about the vaccine, “Just the other day I said to a girl, ‘Look,
margarine or butter? Margarine used to be bad and butter was good. Now it’s the
opposite. At this time, with the type of information that we’re given, this is what we
have. I’ll review [the information] to the best that I can.”
While well intentioned, it is unlikely that many of the risk communication
strategies employed by providers will be meaningful and significant to parents if they do
not account for, and seriously consider, competing knowledge frames, which are
discussed in the next chapter.

Chapter Eight Summary
This chapter began with a description of the general benefits and risks that parents
in this study associate with vaccines and the diseases they prevent. Parents saw both
individual and collective benefits to vaccination. Parents agreed that for the majority of
vaccines, the individual and societal risks of failing to vaccinate outweighed any risks
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associated with vaccines. They framed vaccination as a parental and social duty
necessary to protect the health of their own children and the wider community.
While all but one parent had given their children all vaccines required for school
entry, perspectives regarding the chicken pox vaccine (a mandated vaccine) and nonmandated vaccines were more variable. Perspectives towards and uptake of the chicken
pox and flu (both seasonal and H1N1) vaccines were most varied. Doubt regarding the
severity of the diseases, coupled with concerns about the safety of the vaccines to prevent
them, led several parents to postpone or refuse these vaccines. It was not uncommon for
parents to vaccinate one or more of their vaccine-eligible children against the flu, while
leaving one or more of their other children unvaccinated. These findings illustrate that
“gradations of acceptance” (Streefland, et al. 1999:1710) exist not only in terms of
variation in parents’ vaccination strategies for their own children, but are vaccinespecific.
As passive acceptors (as defined in the LVC approach) of the chicken pox
vaccine, several parents were compelled to accept the vaccination not because they were
supportive of the chicken pox vaccine, but because their children could not enter school
without it. As Mike explained, “They require [the chicken pox vaccine] for the school
system so it’s sort of out of my hands. If it were up to me, I probably wouldn’t bother.
So I mean I did it because it was required. I definitely choose my battles as far as
bucking the system goes.”
The list of risks associated with vaccines was lengthier, including both
generalized risks, and risks associated with specific vaccines, such as the flu and chicken
pox vaccines. Parents drew upon their perceptions of disease severity, vaccine need
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(susceptibility), and vaccine safety (e.g., newness, efficacy, contents of a vaccine) when
describing vaccine-related risks.
Parents overwhelmingly listed cervical cancer prevention as a key benefit to
Gardasil vaccination, though the idea of any type of protection was important to some
parents. Parents who had themselves experienced complications of HPV-infection or
knew someone who had, were generally more likely to see Gardasil as protective against
a host of complications associated with HPV-infection.
Like with vaccines in general, the risks associated with Gardasil were more
diverse. Similar to fears regarding the chicken pox and flu vaccines, parents expressed
concerns about the newness of the Gardasil vaccine and the possibility of long-term
consequences. The unknown risks associated with a new technology were
unquestionably the most often cited (n=24), and in many cases, most significant fear that
parents had about Gardasil. They also questioned whether their daughters needed a
vaccine that they associated with, if nothing else, the onset of sexual activity, which no
parent thought had commenced. Less commonly expressed fears were that daughters
might misconstrue the vaccine as a license to engage in promiscuous or unsafe sex, or
that daughters would think their parents condoned sexual behavior by giving them the
vaccine.
Providers often tried to address parental safety concerns by explaining the
processes through which vaccines are tested and evaluated and by encouraging parents to
view vaccine risks in light of other medical risks. In response to parents’ doubts about
the need for the vaccine, providers often stressed the prophylactic nature of the vaccine or
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presented statistics suggesting many girls become sexually active before one might
expect.
In the following chapter, I describe some of the predominant sources through
which parents and providers obtain vaccine relevant information and how differences in
the ways that they view this information can lead to challenges in communication.
Unlike providers, parents make risk calculations based on information that comes not
only from scientific sources, but from personal experience, religious beliefs, notions
regarding sexuality, trust (discussed in Chapter Ten) and assessments of their daughters’
personal risk profiles.
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Chapter Nine – Sources and Types of HPV-Related Knowledge and HPV-Related
Risks and Benefits

The risks and benefits that parents associate with vaccines, including Gardasil, are
shaped by past experiences, broader attitudes towards vaccines, and the types of
information that parents obtain (and differentially validate) from various sources. This
chapter begins with a description of the sources through which parents learn about
vaccines; particular attention is paid to sources of information regarding HPV-related
infections and the Gardasil vaccine and the types of information acquired from different
sources. Specifically, I begin with a description of the roles that the media, vaccine
manufacturer, and family, friends, and other parents play as sources of particular types of
information. I then discuss the central role that parental knowledge and action plays in
understanding the need for Gardasil. Subsequently, I provide a detailed consideration of
the healthcare provider’s role as a potential source of vaccine information. Positioned at
the service-delivery interface, the clinician is a potentially important source of vaccine
information. Given the providers’ important role in vaccine decision-making, I present
their own perspectives regarding the Gardasil vaccine. I describe the strategies used by
providers to present particular types of information to parents. I then describe parents’
accounts of HPV discussions with providers, highlighting the types of information that
parents recall providers sharing with them. Finally, I conclude by comparing the sources
through which parents and providers obtain and evaluate vaccine relevant information,
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highlighting tensions that can arise when different sources present conflicting
information.

Media Sources of Information
The media play an important role in disseminating information, especially about
vaccine risks, to parents. Several parents and providers noted that their concerns about
the severity of meningitis – and subsequently, their support for the meningitis vaccine –
largely resulted from media reports publicizing deaths of young people from the disease.
Most often, however, parents were particularly likely to associate their own (or general
parental) fears of vaccine overload and vaccine-caused autism and deafness to reports or
stories they heard through the media. Parents (n=6) and providers (n=6) were especially
likely to mention Oprah and Jenny McCarthy as vaccine-related media figures.
The media were sources of Gardasil-related information as well. Three parents
had read or heard media reports describing Governor Rick Perry’s attempt to mandate the
vaccine and concerns that the vaccine would lead to promiscuity. Three women had read
informational pieces in a local newspapers or magazines describing the vaccine, what it
prevented, who was eligible to receive it, and how much it might cost. One woman had
heard about the vaccine on the radio, and another woman saw an episode of a popular
medical-drama that dealt with HPV. Tony had seen an MSNBC health report that
described the prevalence of HPV in the general population, which was one reason he
ultimately opted to vaccinate this own daughter. The report summarized findings from a
study in which “They found [HPV] on little kids’ hands. There are strains of HPV cause
warts on your hands. It’s so common.” Only a few parents (n=3) in this study had read
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news reports linking the Gardasil vaccine to increased risk of fainting or death. However,
providers reported that parents in their own practice sometimes brought up these risks.
Parents actively sought information about the vaccine using online resources. Ten
parents had visited, or planned to visit online sites in order to learn more about the
Gardasil vaccine. When parents said that they had or would obtain information about the
vaccine online, I asked them which types of sites they would visit, how they would find
them, and how they would evaluate the quality of the information presented on each site.
Some parents had narrow conceptions of what constituted a legitimate and reliable online
information source, while other parents had less defined processes for evaluating online
material. A few parents (n=3) were unsure of their online research techniques, beyond
the use of specific search engines. Wendy was unsure how she would proceed with an
online search, other than to say, “I would Google it first”.
Some parents were not exactly sure which sites they would visit, but stressed that
the types of information that would be available online would be partial. Natalie
commented, “We always go online for anything. But we’re not getting the whole big
picture online. We’re getting bits and pieces of information.” Mark tried to provide a
more detailed strategy for evaluating websites, but found it difficult. “I’d go to Google,
type in HPV and see the most popular [results]. I mean something, obviously if it’s
Wikipedia you take that with a grain of salt. But, I know there’s WebMD and then . . .
it’s just the quickest.”
When selecting reliable sources of health information, some parents have go-to
sites that they trust. A few parents (n=3) went, or would go, to university or governmentaffiliated websites to gather what they considered reliable information about the vaccine.
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Bill explained, “I’ve gone to certain websites, like the Mayo Clinic website and other
kinds of – you know, not the Gardasil website. More independent medical specialization
websites.” In excluding the Gardasil website from his search, Bill suggests that the
information contained on manufacturers’ websites is partial and biased. Helen thought
she would eventually read the FDA website to learn more about the vaccine and Tony
described the CDC website as his go-to source for reliable and trustworthy information,
but also conducted Google key-word searches to learn more about Gardasil. In
describing the problems he perceives of assessing the reliability of online sources, he also
articulated his own process for evaluating knowledge claims.
The hardest thing is separating . . . . what is the phrase? The chafe from the
wheat? Separating the junk – the pseudo-science, the anecdotal information –
from the truth. A lot of websites that end in “org” might as well be ‘junk.org’
because they’re funded by people who have ulterior motives. When Gardasil
[came out], I Googled it. And then all the sudden you get all this stuff and you
start looking through everything and it’s like, whoa! How come what this says
over here doesn’t match with what this says over here? And it isn’t until you look
at the cdc.gov [website], for example and you go okay, this and this make sense.
This is the CDC, I know who they are. It’s the government, I know who they are.
Let me find out who these [other] people are. And then you find out it’s the
Committee for the Advancement of Family Values. And then you find out what
their mission statement is and you go, I get it. And then it all clicks and you’re
like okay, this I can discard. I’ll read it. I’ll read it. But when the BS meter goes
off I’m like okay, I got it.
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Only two parents had or would visit the Merck website for vaccine-related
information. Evelyn visited the site after seeing the “One Less” commercials. “I went
online to the Merck website to read up on it . . . the website has a reminder email system
for the second and third shots.” Gretchen, a mother of two, received a Merck-sponsored
Gardasil pamphlet at a health fair and subsequently went to the Merck website to gather
additional information. On the other hand, some parents (n=4), like Bill specifically
noted that they would not visit the Merck website, because they did not believe they
could obtain unbiased vaccine information from the manufacturer, again speaking to
issues of trust, which are discussed in Chapter Ten.
Despite the fact that Merck was not always deemed a reliable or credible source
of HPV-related information, Merck was unquestionably the most pervasive source of
information about Gardasil. As described in Chapter Six Merck’s campaign to advertise
the link between HPV and cervical cancer, and the vaccine itself, was unprecedented.
The advertising campaign clearly reached parents in this study, who overwhelmingly
(n=24) referred to Merck or Merck-related advertisements as a source of information
about HPV and the vaccine.
The advertisements resonated strongly with many parents, who could in some
cases describe the Gardasil commercials months or even years later. More than half of
the parents with whom I spoke mentioned the “One Less” slogan during the interview
and the “One Less” commercials were often the first time that parents had heard about
HPV itself, or a vaccine to prevent it. A few parents could only recall the “One Less”
slogan from the commercials, but most parents associated the slogan with other facts or
sentiments.
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Many parents found the commercials catchy and appealing. Perhaps most vocal
in her praise of the commercials was Lucy, who has one daughter. The specific images
and values presented in the commercial particularly resonated with her. When asked
where she had first heard about HPV, she responded, “The commercial. The ‘One Less’.
Oh my God, have you seen it? The commercial was snappy as hell. I wish I could get a tshirt.” Describing the commercial for me she began snapping her fingers and singing,
“’One less, one less, I’m gonna be one less!’ The girl is skipping rope and I’m like
‘Okay!’” Lucy was so moved by the commercials that she began referring to her
daughter as ‘one less’. “I’ll call her up, ‘Hey darling – oh hey one-less, how you doing?’
And that’s her new nickname. One-less.” The images of mothers and daughters making
the decision together was especially appealing to Lucy: “Whether they were real mothers
and daughters [depicted in the commercials] or not, they kind of looked alike. You could
almost think that they were. But that commercial, it hit home for me. It made the home
run.”
The themes of empowerment and protection were appealing to other parents too,
who specifically liked the commercials because they touched on these themes. In
reference to the “One Less’ campaign, Melissa commented,
I thought it was an interesting campaign and you could really see the imagery
playing with mother and daughter. I’m protecting my daughter. But sort of also
the daughter being empowered – I want to be one less daughter, or sister, or
whatever. I want to be one less. So that’s probably the first time I heard it.
Jean, who has one daughter, appreciated that the advertisements included
daughters and sent the message that young women can and should be a part of making
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this vaccine decision. “I see all of the commercials on TV – one less. Which I think are
very clever. I just think that they appeal to the younger generation and I think it’s
important that the girls know the importance of the vaccine, what it’s supposed to do.”
Jean was able to recall specific dynamics portrayed in the commercial, and she
appreciated that both the mothers and the daughters played (unequal) roles in the decision
to get the vaccine.
Yeah, I think if I remember the mother talks about what HPV viruses are, and
usually the mother and daughter are sitting in a situation together. And the
mother talks about how it’s important to protect against the virus because it can
potentially cause cervical cancer at a later time. And then the daughters come
into the conversation and they talk about how it’s important to be one-less.
Apart from empowerment, the “One Less” slogan also appealed to parents’
desires to protect their daughters, but from what? For many parents, the “one less”
slogan was understood exclusively in relation to cancer – not genital warts or HPV
infection. Merck’s marketing strategy to frame Gardasil as a cervical cancer prevention
technology paid off. In recalling what types of information were presented during the
commercial, most parents exclusively conceptualized “one less” in terms of cervical
cancer. Like many parents, Lucy recollected, more than anything else, that the
commercial was about “Cancer. They kept saying cervical cancer over and over. I don’t
even remember them saying warts on the commercial. But it just kept saying cervical
cancer and over it – subliminally or whatever, but it was cervical cancer.”
The commercials evoked parental fear about cancer and for them, “one less” was
not about one less daughter with genital warts or HPV, but one less daughter (presumably
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their own) at risk of developing cervical cancer. According to Victoria, “the commercial
works. One less. I want [my daughter] to be one less. If this will help [her] not have
cervical – or have a better chance not to have cervical cancer then I’m all for it.”
Other parents acknowledged the powerful message captured by the simple slogan.
Theresa recalled the message, “I’m gonna be one less. That’s the one that sticks out more
in my mind. And it grabs your attention. It makes you think about it.”
Most parents responded positively to the cervical cancer association suggested
through the advertisements, but Natalie thought the ads were deceiving because the
vaccine did not protect against all strains that cause cervical cancer: “One less. My
daughter’s gonna be one less. I’m like, one less what?” When I asked her what she
thought “one less” referred to, she replied, “One less woman whose gonna die of cervical
cancer. How do you know that? That’s what I want to say to these moms. How do you
know she’s gonna be one less? How do you know that the vaccine is going to protect her
against that one strain that she might get anyway?” Natalie acknowledged that at some
point a narrator mentions that the vaccine cannot protect against some strains of HPV that
can lead to cervical cancer, but she believed this fact was deliberately under-emphasized
and was inserted at the end of the commercial, after audience attention had waned
If it doesn’t catch our attention we’re already on the phone, doing other stuff. So
that’s why they keep repeating – this girl and this girl. One less, one less, one
less. At some point in time you’re gonna walk back in the room and you’re going
to hear one less. And that’s the whole point, is that people are sucked in to that
and then they’re already out of the room by the end of that commercial. Do they
hear that this isn’t going to protect against [some strains of HPV that cause
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cervical cancer] - the little man that is at the end of the commercial that’s talking
really fast, that we don’t hear anyway, that we tend to block out? No.
Aside from the connection between the vaccine and cervical cancer, few parents
remembered gathering additional information from the commercials. Evelyn recalled
that the ads, “asked if I wanted to protect my daughter from a disease she couldn’t detect
on her own.” Barb understood that the vaccine protected against HPV, not cervical cancer
itself. “It’s just the virus that can cause cervical cancer, it’s not actually the cervical
cancer itself.” The incomplete ability of the vaccine to protect girls from all cancer
causing HPV strains was mentioned by Patty, who understood from the commercials that
the vaccine was best administered as a prophylactic, and that it only protected against
certain HPV strains that can lead to cervical cancer, though she (inaccurately) understood
that all four strains included in the Gardasil vaccine were cervical cancer causing.
Finally, Rachel honed in on the sexually transmitted nature of the virus, and could recall
nothing else from the commercials: “I remember the ones . . . where it’s just one – or one
less? One less who will get it – I believe it’s a sexually transmitted disease.”
Merck-sponsored advertisements were, unquestionably, the most common source
of Gardasil information obtained through the media, but parents also learned about the
vaccine through other media sources.

Friends, Family, Colleagues, and Daughters
Some parents (n=7) had not discussed the vaccine with their friends, family
members, or peers prior to having their daughters vaccinated (or in one case, deciding
against it), but three of these parents did have subsequent conversations about the
vaccine. More typical, however, was for parents (n=16) to indicate that they had or
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would talk to friends, family members, and colleagues about the Gardasil vaccine. In
most cases, at least some of the conversations parents had about the vaccine with others
occurred before parents made decisions for their own daughters, though three parents
only discussed the vaccine with others after having their own daughters vaccinated.
Some parents actively sought the opinions and perspectives of others, but most
conversations about the vaccine came up during a child’s band rehearsal, a sports
practice, a school event, or at the park, when parents were already gathered together.
While many parents who had already vaccinated their daughters did discuss the
vaccine with other parents before getting it, none described these conversations as
significantly factoring into their decision. However, it is worth noting that few of these
parents had spoken with parents who reported serious consequences from the vaccine or
serious resistance to it, so it is difficult to gauge whether parental perspectives would
have factored more heavily into the decision had they been negative.
For most parents, the main purpose of discussing the vaccine with other parents
was to learn of any potentially serious side-effects that might be associated with
vaccination. The lack of adverse events experienced by individuals within their close
social network reassured parents of the vaccine’s safety and might have helped to boost
their overall confidence in the vaccine. Five of the seven parents who had not yet made a
definitive vaccine decision had, and/or planned to talk to other parents about the vaccine.
Two of these mothers knew that many of their peers had already vaccinated their
daughters and wanted to know whether their friends’ daughters had experienced any
complications from the vaccine before making a final decision.
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For other parents, it is unclear from their own accounts whether discussions with
peers, parents, and family members influenced their decision in any significant way. For
example, Jill, who thought she would have her daughter vaccinated in a few years, had
spoken with other mothers about the vaccine. Like her, they had some concerns about
how to explain the vaccine to their young daughters, who were between 9 and 11 years of
age. They also expressed some minor concerns about promiscuity. Through these
conversations, Jill’s own anxieties were validated, yet these discussions did not
significantly influence her perspective on the vaccine, which was that eventually, it
would be something beneficial for her daughter to have. As these examples illustrate,
while parents are interested in knowing how other parents perceive the vaccine and
whether they have vaccinated their own daughters, they do not always feel compelled to
adopt similar practices.
It is possible that in conversing with others about the vaccine, parents selectively
“hear” or focus upon information aligned with their pre-existing perspective, while
filtering out contradictory information. The two parents who were generally against the
vaccine recounted discussions with family and friends that highlighted negative
experiences with the vaccine, but it is unclear whether these accounts led to concerns, or
more likely, were seen as evidence to support already existing concerns about the
vaccine.
Parents who were supportive of the vaccine tended to highlight the lack of
reported problems when discussing Gardasil or their friends’ support of it. Two parents
who were leaning towards vaccinating their daughter(s), or had already done so, did
mention that some of their friends were against the vaccine, but either dismissed outright
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these concerns or attributed them to specific characteristics that made these concerns
individualistic and non-generalizable.
For example, Helen became more certain of her desire to eventually vaccinate her
daughter after talking to a friend who was not planning to give her daughter the vaccine.
In this case, hearing her friend’s reasons for opposing the vaccine, and reflecting on her
own reactions to these reasons, helped to solidify her own confidence in choosing to
vaccinate in a few years.
Several parents reported that their daughters provided them with information
about the Gardasil vaccine, mostly by relaying conversations that they and their own
friends have about it. Five parents said that their daughters talk about the vaccine with
their friends and generally know who has and has not been vaccinated (four of the five
girls were 13 years of age or older). Courtney explained that her daughter,
knows out of her group of friends who’s gotten [Gardasil] and who hasn’t. They
share that with each other. I’ve heard them in their youth club saying, “Well next
week I have to go for my last injection,” and then they’ll say, “Oh yeah, I’ve done
that. I got mine last year.” So they talk about it as a group: "Well I know suchand-such hasn’t done it yet because she’s afraid of needles”. So they’re very
aware, much more so than I realized.
Melissa, whose daughter talks to her friends about the vaccine had not yet made a
final decision to vaccinate her daughter, but felt reassured that so many girls seem to have
safely received it (yet another example of the role social norms can play in allaying fears
regarding vaccine safety). Two parents said that their daughters learned about the
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vaccine in health class (ages 15 and 16), and two daughters conducted some of their own
research on the vaccine prior to receiving it (both 15 years of age).

Parental Knowledge: Sex Education, Sexual Readiness, and Knowing
Parents themselves become important sources of knowledge in assessing their
daughter’s need for Gardasil. Important to decisions about if and when their daughters
needed the HPV vaccine were evaluations of their daughters’ sexual maturity. In
evaluating their daughters’ sexual development and readiness, parents relied on sexrelated discussions they had had with their children, their children’s responses to these
conversations, and information on their activities derived through parental monitoring.
To a large extent, however, parents’ assessments of their daughters’ sexual maturity were
based on faith – both in their abilities as parents to ‘know’ when their daughters were
thinking of becoming sexually active, and faith that their daughters were being honest
with them about their level of readiness. In this section I discuss the different strategies,
or sources of knowledge, that parents deployed to evaluate their daughters’ risks of
coming in contact with HPV in the near or distant future.
None of the parents with whom I spoke thought that their daughters were
currently sexually active or had been sexually active in the past. Most parents did not
foresee sexual debut occurring for a significant period of time, though a few parents with
older daughters (ages 15 and 16) suspected that sexual debut would occur in the nearer
future. Even these parents, however, then provided counter information that made them
think their daughters might not become sexually active “any flipping day now,”
suggesting that assessing and weighing indicators of sexual debut is challenging.
Because timing was a key issue in many parents’ vaccine decision, having a sense of
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when their child would become sexually active was critical. I asked parents whether they
thought they would know when their child became sexually active and if so, how they
would know.
Many parents relied on discussions they had with their daughters about sexuality
as tools to gauge their daughters’ sexual maturity levels. Often times, parents referred to
their own experiences of learning about sexuality to explain their own rationale for
approaching sexual education in a particular way. Some parents made a point of
discussing sex with their daughters because they did not receive sex education from their
own parents. Rachel made a concerted effort to be open and honest with her own
daughter about sex because her own mother had not had those conversations with her. As
a result, Rachel felt “clueless” about a lot of things, reflecting “I’m still learning a lot of
things because there’s a lot of things my mom never told me.” Faith explained that her
mother was a very private person who never discussed sex with her. She thought that
“maybe it’s because she was so not sharing that I want to be, because I’ve had questions
that are unanswered”.
Other parents strived to be open and honest with their daughters about sex
because they valued the open and honest relationship that their own mothers fostered
with them. One mother explained that when she was growing up, she knew that she
could safely approach her mom with any sexual health question and she wanted her girls
to feel the same level of comfort with her.
Of course, hoping that children feel comfortable talking to their parents about
sexuality does not imply that parents feel comfortable talking to their children about these
topics. Parents found talks uncomfortable for several reasons. At the societal level, sex
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has a dual role. While sexual themes are commonplace in the media and sex is often
openly discussed among peers, intergenerational discussions about sexuality and sexual
health issues are often perceived as awkward and uncommon. The fact that sex education
is a politically contentious and emotive issue, suggests that sex is seen as a private, and
sometimes shameful act that is not to be discussed. A sexually conservative cultural
environment hardly fosters a sense of comfort or ease in discussing sex-related issues.
While parents might feel comfortable discussing sex with their partners or friends,
it was clear that some parents felt less comfortable broaching the subject with me.
Parents who shared with ease their family medical histories and religious views, found it
difficult to speak directly to sexual health issues, sometimes alluding to sexual topics and
themes without directly speaking to them, or speaking in a whisper when talking about
sexual intercourse, genital warts, or sexually transmitted diseases. When it came to
initiating sexual health conversations with their own children, additional factors led them
to feel discomfort. Many parents felt that they lacked the experiential knowledge or
training to fluidly engage in these types of conversations.
Moreover, because parents associated sexuality with adulthood, talking about the
subject with children seemed contradictory, inappropriate, and awkward. Parent-child
conversations about sex threatened both intergenerational and role boundaries,
challenging the distinct roles separating parents from children and adults from non-adults.
Discussing sexuality with children tested parents’ conceptions of their children as
innocent, asexual beings. Educating children about sex required acknowledgement from
parents that while their children will always be their children, they will not always
remain innocent or childlike.
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Nearly all parents expressed discomfort, anxiety, or dread when describing past or
future conversations about sexuality with their daughters, but they also felt it was part of
a parent’s responsibility to have these discussions, no matter how difficult. Tony’s
evaluation of sex education encapsulated the sentiments of many parents:
People are so uncomfortable talking about sex. Especially sex and their
daughters. I am too. I haven’t had that talk yet but I will. Yugh. I’m just as
uncomfortable as the next parent. But you got to do it. You suck it up. I [think]
it’s a poet that says at a certain point in life it’s time to put away the toys. And
certain things in your life you gotta do. It’s time to put the toys away and be a
grown-up. . . Talking to your daughter – she’s the only one I got. I’m trying to
do it right this time ‘cause I don’t have another child, you know? That’s it.
Some parents found sex education talks with daughters to be especially difficult
because they perceived the physical, social, and emotional risks associated with sex to be
graver for girls. Pregnancy was at the forefront of parents’ physical concerns, but they
also thought that their daughters were more likely to experience long-term reproductive
health problems from engaging in risky sexual activity. Parents were not only worried
about sex-specific diseases, such as cervical cancer, but also perceived that females were
more likely than males to experience infertility as a result of engaging in sexual activity.
Regardless of the challenges involved, parents wanted their daughters to feel
comfortable approaching them about sex. Fostering this trust required parents to convey
to their children openness and ease discussing sex, regardless of whether such openness
or comfort came naturally. To maintain open communication channels with their
daughters, parents often had to respond carefully and calmly when their children talked
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about sexual norms among their peers. Lucy routinely struggled to preserve the open
relationship that she had with her daughter, whose accounts of peer activities horrified
her. She provided one such example where her daughter might tell her, “‘Oh, Suzy gave
such-and-such a blow job in the girl’s bathroom today.’ And you have to be careful
because you can’t go ‘What the fuck!?!’ You have to go, ‘Oh, okay’ (laughs nervously).”
The importance that parents ascribed to sex education surmounted any
awkwardness of discomfort they personally felt. Most parents described their
relationships with their daughters as abnormal, in that they perceived they were more
likely than other parents to talk openly to their children about sex. Often times, parents
also expressed confidence that their children would be more protected or prepared to
respond to sexual issues due to these discussions or a sense of openness that parents felt
they had with their children. Gretchen felt confident that her 17-year old daughter would
make healthy sexual decision for herself, not only because she was mature, but because
she had access to parents who were supportive and open to discuss these issues with her.
Of her daughter, who was a freshman at the time, she remarked, “I think she’s pretty
much . . . ahead of the game . . . I’d say most of her friends are pretty knowledgeable but
they probably aren’t as free to talk to their parents about things like we are.”
Rachel, who was not going to vaccinate her 12-year old daughter, felt confident
that her strategy for preparing her daughter for the world would protect her more
effectively than a vaccine: “I know that there are a lot of kids that are sexually active at
this age, but I also know that in teaching my daughter I am doing something that
everyone seems to leave out, and that’s preparation. I’m preparing my daughter and my
son for, as they get older, the things that are set before them and what can happen.
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Children’s reactions to sexual health discussions often provided parents with an
indication of their maturity level and readiness to become sexual active. Parents
sometimes provided examples of their daughters’ responses to sexual topics as
indications that they were not yet interested in romance or sexual relationships. Several
parents (n=6) pointed to the “eww” or “ick” factor as an indicator that (at least one of)
their children were not yet sexually active and unlikely to contemplate it in the near
future. As Barb put it, two of her girls (ages 9 and 11) were “still like ‘Ewww! Boys!
Yuck!” Parents provided recent, specific examples of interactions they had with their
daughters that led them to believe their children were not approaching sexual maturity.
Sarah pointed to her 14-year old daughter’s recent reaction to materials covered in health
class: “She came home a couple of weeks ago and was like (gasps) ‘Oh, this is so
disgusting, why do I need to know this?’ And I said, ‘What are you studying about?’
[And she responds] (whispering) “the male reproductive system.” (laughs).” Mark was
also confident that it would be many years before any of his daughters, the oldest of
whom is 11 years of age, considered engaging in sexual activities, remarking that his
eldest daughter still, “gets grossed out when [my wife] and I are kissing in the kitchen”
Some parents (n=5) of older daughters (ages 15 and older) trusted that their
daughters told them the truth when they assured their parents that they were not yet
having sex. These parents talked to their daughters about health and sexuality frequently
and generally described their relationships as close, honest, and open. For these reasons,
parents felt fairly confident that their daughters’ reassurances that they were not yet
sexually active were accurate and honest.

292

Aside from conversations about sexuality, parents relied on observations,
monitoring, and control of their daughters to gauge their sexual maturity. For example,
two parents drew upon their daughters’ inability to recognize (and failure to respond to)
flirtatious behavior as an indication that they weren’t interested in sex quite yet. One
mother explained that while she knew her daughter would likely become sexually active
in the near future, she was confident that her daughter was not yet active, partially
because of her daughter’s obliviousness to boys’ flirtations. She recalled a recent
exchange when they were ordering food.
The little boy was flirting with her so desperately I had to walk away because I
was about ready to laugh. And it just went over her head. He goes, “Oh, I’ll give
you these three really big nuggets.” She’s like, “Yeah.” She’s looking around,
you know? He goes, “Okay, well you want some soda with that?” And she goes,
“No!” He was doing everything he could to get her attention and nothing worked.
Four parents with older daughters described their involvement in their daughters’
lives as a key reason they did not yet think they were sexually active. One mother simply
said she knew her girls were not sexual active “because they’re not out of my sight long
enough.” Another mother recognized that her daughter might not be completely honest
when she plans to become sexually active, but felt confident her daughter had not reached
that point yet because her schedule did not allow for it. “I can look at it and say, okay,
activity wise, I pretty much know where she is at every given point in time, just because
of her activities and what she’s doing.”
Many parents had to evaluate competing evidence to assess sexual debut, which
made it difficult for them to express confidence in their sense of “knowing”. In
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evaluating her own daughter’s sexual maturity, Melissa considered her daughter’s age,
her daughter’s reassurance and general discomfort with the topic, and her own history.
She began by stressing, “She’s 16, she could be sexually active any flipping day now!” At
the same time, her conversations with her daughter led her to think her daughter might
not be at a stage to consider sex yet. Recounting their last conversation, she said, “She
seems to still have this ick factor about sex, just in our general conversations, and we’re
pretty open talking to each other. And she’s like, just the whole idea of male-female sex
is disgusting to me.” However, Melissa also noted that a disinterest in heterosexual sex
did not necessarily mean her daughter was not interested in sex. She noted that on her
social networking page, her daughter identifies herself as bisexual, “and she’s dated a girl
for two weeks and she said they never kissed or anything. And she’s like, in my mind I
want to date girls, but with my body I can’t quite do it yet.”
Parents use different criteria and a variety of strategies to assess their children’s
sexual maturity and sexual activity. Despite these strategies, and the hope that their
daughters would come to them before becoming sexual active, some parents recognized
that these expectations might be unrealistic. Deborah, a mother of three, worried that
despite the very open dialogue she maintained with her two daughters about sex, they
might still have difficulty approaching her to talk about it, “When I was a teenager my
mom was very open and I could talk to her about anything, but I know I wouldn’t have
gone to her [before I had sex]. I think it’s harder for them than for me.” Theresa
expressed similar concerns, also based on her relationship with her own mother, and her
own sexual health choices: “For myself, I would look at it and hope that [my daughter]
would tell me [when she is thinking of having sex]. Which is being in La-La Land.
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Because I’m thinking, did I tell my own mother? No.” Victoria echoed the same
concerns, arguing that “if kids are going to have sex, they’re going to have sex. And
they’re not going to talk to their parents about it ahead of time. I mean I didn’t talk to my
parents at first.”
Like these mothers, some providers worried that parents would misjudge their
daughters’ sexual debut, thereby missing an opportunity to provide maximum benefits
from the vaccine. Sophia felt that most parents did not know when their children became
sexually active, and often spoke to adolescents privately about sexual matters of which
their parents were unaware. Ann felt that there was a “huge gap” between what
adolescents are actually doing and what parents think they are doing. “It’s just very
difficult for most families to have a dialogue about those things. Money and sex in our
society are kind of taboo, even within families. So sure, I think that adolescents are
having sex at a younger age a lot of times than their parents suspect.”
Parents partially relied on their own sex education efforts and beliefs that sex
education would translate into certain behaviors to evaluate their daughters’ sexual risk
levels. They also hoped that by establishing open and honest communication channels
with their daughters that daughters would speak honestly with them about their sexual
intentions. Despite varied strategies to evaluate daughters’ sexual readiness, both parents
and providers acknowledged that in many cases, parents simply would not know when
their daughters first became sexually active.
Providers’ Sources of Information
In this study, twenty-four parents had or planned to discuss the Gardasil vaccine
with their daughters’ healthcare providers. While parents solicited vaccine-related
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information from their healthcare providers, they also obtained information from family
members, other parents, and media sources. Parents collect information from diverse
sources, but do not grant equal relevance or importance to it. As will be discussed in the
following chapter, the credibility of a source can largely affect the weight parents assign
to information from it.
Providers, while hearing about Gardasil through multiple sources, overwhelming
used a scientific, epidemiological model to assess the credibility of information that they
received. Providers tended to value knowledge generated from their own training and
expertise, as well as from bench scientists, vaccine experts, public health officials, and to
a less extent, their peer providers and vaccine manufacturers. Data published in or
supported by peer-reviewed academic journals, the CDC, and professional medical
associations.

Providers as Sources of Vaccine Information
Despite differences in the ways that they evaluate the relevance and weight of
vaccine information, providers are a fundamental source of disease and vaccine-related
information for most parents. In this study, twenty-four parents had or planned to discuss
the Gardasil vaccine with their daughters’ healthcare providers. Given the central role
that providers hold as sources of information, it is important to understand what types of
HPV-related information healthcare providers actually share with parents and under what
conditions. In the following sections I describe provider reports of typically Gardasil
interactions – including if, when, and how providers approach the conversation. I then
present parents’ reports of their own HPV-related interactions with healthcare providers,
highlighting important areas for future research.
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Provider Reports of Interactions
When and how providers choose to discuss the vaccine depends on several
factors, including the needs and characteristics of the practice population, the age of the
child, the assessment of the individual child, and sometimes, the response of the parent to
other information covered during the visit. Seven providers reported that they always
tried to bring Gardasil up at visits after girls reached a certain age. Jessica always tried to
have sexual health conversations while both the parent and daughter were present, but if
she saw strong resistance on the parent’s part, she would sometimes make a note in the
chart to resume the conversation at the next visit during one-on-one time with the
daughter. In knowing whether to have an in-depth talk about sexuality with adolescents,
she explained, “You just kind of feel it out. You get a sense. It’s a vibe. They either
look you in the eye or they don’t. I mean, I don’t know, maybe I do it wrong every time
for that matter, but you just get a sense about whether or not this is something that’s
appropriate.”
Five other providers usually brought the vaccine up with parents, but reported that
they usually did not use acute care visits as Gardasil opportunities, primarily because they
perceived a lack of interest among parents in having their children vaccinated while they
were ill and felt Gardasil could usually wait. One provider did not herself bring up the
Gardasil vaccine because of her own misgivings (discussed in the subsequent section)
about it. If parents asked her about the vaccine she would provide them with objective
information, but preferred not to encourage vaccination by introducing the topic herself.
Another provider knew that some of her colleagues never initiated conversations about
Gardasil, but would discuss it if parents brought it up. “I think the practitioner has a
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significant influence – usually the provider has to bring it up. It depends on whether they
choose to talk about it or not. I’ve seen physician after physician just walk in and out. . .
If the practitioner clearly is against the vaccination or associates it with promiscuity then
they will never bring it up.”
The school nurses and chiropractor did not initiate conversations with parents, but
would discuss Gardasil if parents asked them about it. One of the school nurses who
worked with the high school population did frequently talk to girls about the vaccine,
especially if they were thinking about becoming or already were sexually active. In these
cases, she included Gardasil among safer sex strategies and encouraged girls to talk to
their parents about their sexual health.
Many providers reported that they were less likely to bring the Gardasil vaccine
up with the youngest eligible age groups, and if they did bring it up, were less likely to
explain mode of transmission or other specific information about the vaccine. Unless a
parent brings it up, one doctor does not begin to have discussions about Gardasil until
daughters are eleven years old, because she felt that nine year olds were too young to
understand why Gardasil would be important. She also felt, in most cases, that there was
little danger in delaying vaccination from ages nine to eleven, saying, “Maybe this is all
our naiveté, but God help us if our 11 year olds are having sex. I mean that’s just really
bad.” She also explained that discussions with parents of eleven year olds were difficult
enough, “it’s hard enough to push Gardasil that I don’t need to stress myself out and
spend the time trying to push it to a 9 year old. I just try pushing it at 11.” At the eleven
and twelve year old visits, Elizabeth does not generally mention anything about the link
between Gardasil and sex when introducing it to parents. With her teenage population,
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however, she does explain how HPV is transmitted and what the vaccine will and will not
protect against.
Another provider said that she was the only doctor in her practice that routinely
discussed Gardasil with eleven year olds. The other providers in her practice – who were
all male – told her that they infrequently or never introduced Gardasil to parents of girls
that young.
Some providers felt it was important to initiate Gardasil conversations from a
young age, even if few parents would immediately get the vaccine, so that parents had
time to think about the vaccine for the future. For example, two parents who planned to
have their daughters vaccinated, said that their providers initiated conversations about
Gardasil as a recommendation for the future, not for the present.
Several providers approached Gardasil like they would any other vaccines. They
would refer to the medical chart and list the vaccines (sometimes only Gardasil) for
which a girl was eligible to receive. Nina described how she would approach the vaccine
with a 13 year old and her mother:
I’d say, ‘These are the vaccines that she needs today. I would highly recommend
the Gardasil that protects us girls from HPV. It protects us from 70% of cervical
cancer, 90% of genital warts.’ And then I say, ‘the most important thing – I know
it’s not something you really want to think about, your little girl having sex. But
it’s something that will protect her from possibly getting cervical cancer in the
future so you have to think about it before she becomes sexually active, so now is
the time to think about it, to bring it up
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Nina, in recommending the vaccine, frames it collectively, as something “us girls”
need. In doing so, she emphasizes the shared connection between herself, the mother,
and the daughter, speaking to them not only as a physician, but as a woman.
In describing routine conversations they have with parents and patients about Gardasil,
all providers reported that they typically explain that the vaccine can prevent cervical
cancer. In describing typical Gardasil conversations, some providers (n=4) explained that
the vaccine did not protect against all types of HPV that can cause cervical cancer. The
other providers simply described Gardasil as a vaccine that was developed to protect girls
from developing cervical cancer. It is unclear whether providers, in actual conversations
with clients, do stress the limited protection.
Two providers always included in their conversations that the vaccine prevented
the two strains of HPV that caused 90% of genital warts. Four providers mentioned
genital warts protection only with older girls (usually 15 years of age or older). Nina
explained that parents of younger girls “don’t seem to like the genital warts so much. I
don’t usually mention that unless they’re a little older. Usually if they’re 15 and up I’ll
mention it. If they’re younger than that I usually just say cervical cancer.” Robyn
brought it up with older adolescents and their mothers at the teen clinic. She explained
that while protection against genital warts was not the most important information to
share about Gardasil, girls found the information particularly important in assessing the
benefits of the vaccine. “I’ll tell you who it really resonates with more than the parents,
it’s the kids. Because the idea of having warts is just so creepy to kids. For parents it’s
usually the severe health consequences, for kids it’s the gross warts stuff. It just creeps
them out.”
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Four providers seldom, if ever, mentioned genital warts because they conceived
the major benefit of the vaccine to be in the prevention of cancer and therefore did not
think it was as important to mention warts. They also noted that parents received a
pamphlet that contained information about warts. Jane did not view protection against
genital warts as a significant benefit of the vaccine. “Why I don’t bring it up as much?
[Parents] don’t seem to know as much about it. It doesn’t seem to have as much
importance to them, and I guess it’s true that it isn’t really as important to me. You
know, I think, (sighs) it’s more important that people don’t get cervical cancer than that
they don’t get genital warts.” It is interesting that part of the reason Jane does not discuss
genital warts is that parents do not seem to have a previous awareness that the vaccine
protects against them. Of course, parents cannot evaluate whether genital warts
protection is an important benefit of the vaccine if they are unaware that the protection
exists. Parents in this study rarely knew that Gardasil offered protection against genital
warts but upon learning this information found it to be a significant benefit to
vaccination.
Jane, who worked both in a family practice and in a non-profit teen clinic, saw
many girls who she diagnosed with genital warts. In further reflecting on why she
typically does not mention genital warts protection when discussing Gardasil she asked,
“I don’t know, do you think we should? I see so many warts and I see so much hysteria
about the warts that I get tired of . . . I don’t like it brought up a lot because it just –
people have it blown way out of proportion and then when they get it you would think I
told them that were dying of something. You know?” Jane’s experiences diagnosing and
treating warts led her to exclude wart protection from her Gardasil conversations, which
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is interesting given that the stigma associated with the benign forms of HPV would likely
lead some parents and young women to view Gardasil protection against genital warts as
an additional reason to vaccinate their daughters.
It is possible that a few providers did not mention genital warts when presenting
Gardasil information to parents because they were misinformed about Gardasil’s
protective benefits against warts. One provider, when asked why she did not mentioned
genital warts, replied, “I don’t because it’s my understanding that it does not protect
against the physical genital warts. Am I wrong about that?” After I explained the
relationship between strains 6 and 11 with genital warts, the provider felt that she still
would not mention this protection to clients unless they specifically mentioned it. She
replied, “I think in some ways, knowing the population of young girls, they don’t even
want to think about the sexual activity aspect of it. [The genital warts] might be bringing
it a little more in their face than they want to acknowledge.”
Another provider admitted that she rarely mentioned that the vaccine protected
against genital warts. She explained, “I guess I think that the main thing that we’re trying
to prevent is the cancer and the other thing is, it doesn’t prevent –this vaccine doesn’t
prevent all genital warts. It prevents the ones that cause cervical cancer.” Like the other
provider, this practitioner did not view genital wart protection as a key benefit of
Gardasil, but also, she seemed to believe that the vaccine only prevented HPV strains that
led to cervical cancer, not the more benign, external warts.
A few providers did not discuss sexual transmission every time that they
presented Gardasil information; rather they chose to exclude, mention, or stress the
sexual aspect after assessing the knowledge and needs of the parent and daughter. Ten
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providers reported that they always included in their conversation that HPV was sexually
transmitted, but three of these providers only included the transmission route in all
conversations with older girls (depending on the provider, beginning at age 12 or 13).
Some providers, such as Nina (quoted above) and Maggie (a nurse practitioner) brought
sexuality to the forefront of the conversation in hopes of providing parents with an
alternative way to conceptualize the vaccine to defuse anticipated parental concerns.
Maggie, for example, tried to turn abstinence into a selling point for the vaccine. She
immediately tells mothers and daughters that HPV is sexually transmitted, but uses that
information to discuss the importance of abstinence and why abstinent girls can benefit
the most from the vaccine. She explained,
I try to bring it to the forefront as quickly as possible. You have a window of
opportunity, which is sexual exposure. If you can put your hand on the Bible and
say that you have never had sexual activity then this is a critical window. It’s just
like never putting a cigarette in your mouth – a great thing that we want to
commend you for, and want you to continue not doing. But with the HPV
vaccine you have an opportunity because you haven’t had sex.
In this pitch, the provider approaches the daughter’s proclaimed abstinence not
with a challenge, or reminder that she will eventually become sexually active, but as a
commendable decision that makes her eligible to receive a vaccine that other girls (who
presumably made less commendable decisions) cannot. Along with Maggie and Nina,
two other providers also routinely emphasized that Gardasil was a prophylactic vaccine.
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Provider Vaccine Recommendations
The providers with whom I spoke were well aware of the influence their Gardasil
recommendation could have on parental vaccine decisions. One provider believed that
within her own practice, the provider made a huge difference in determining whether
adolescent girls walked out of the office having received Gardasil or not. “I think if you
walk in and the same family either gets to talk to me or talks to somebody who says,
‘Well it’s really your choice. If your daughter’s not sexually active then there’s not really
a real need to get it,’ then they’re not going to get it. Apparently any kind of skepticism
of the medical community is going to make them not get it.”
Janet recognized the important role she played in parents’ Gardasil vaccine
decisions. “I think a huge deal is the provider and patient conversation. Many times
they’ll ask me what I think about it, and many times they end up getting it because [. . .] I
stress how important I think it is.” Other providers also reported that parents typically
wanted to know how they felt about the Gardasil vaccine and whether they would
recommend it. Jane explained that many of her parents ask her whether she “believes” in
the vaccine or not and Laura stressed that the most common questions parents ask her is,
“What do you think?”
Most of the providers (n=12) highly recommended Gardasil to parents and young
women and strongly endorsed it regardless of whether their endorsements were
specifically requested. One pediatrician noted that parents frequently asked her for her
opinion on Gardasil. She replied, “I mean, I’m not sure what they think I’m going to say.
I mean of course I’m going to say that I think they should have it, that I think it’s a
wonderful vaccine, [that] I think it’s wonderful that we have something that can help
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prevent cancer, and I think it would be silly to not protect yourself against that given the
opportunity.”
The pediatrician’s surprise that parents felt they had to ask if she endorsed the
vaccine revealed her own expectation that parents should know that she, a very vocal
advocate of vaccines, would obviously recommend Gardasil. At a more latent level, her
comment suggests an assumption that all providers would endorse the vaccine. This
provider worked in a large practice; it was not uncommon for her to see new adolescent
patients. That the provider was equally surprised when their parents asked for her
Gardasil opinion suggests that she assumes all providers are supportive of Gardasil and
recommend it. While it is true that all of the providers I interviewed were generally
supportive of vaccines, and that all of the pediatricians endorsed Gardasil, it is not the
case that all providers recommended Gardasil.
Four providers – three nurse practitioners and the chiropractor – were less
comfortable recommending the vaccine. These providers attributed their discomfort to
their aspects of their nursing or chiropractic model of care, and to their perspectives
regarding vaccines in general and Gardasil in particular.
The chiropractor and nurse practitioners emphasized the importance of patient
participation in healthcare decision-making, especially when they perceived treatments to
be optional or less necessary to ensure the health and safety of individuals or
communities. These four individuals strongly emphasized the importance of including
girls and parents in the healthcare experience by empowering them to learn about their
bodies, educating them about healthcare options, and encouraging them to participate in
healthcare decision-making. These providers tried to provide accurate medical
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information about the vaccine, but preferred not to be put in a position where they felt the
parent would accept or reject a vaccine based on their recommendation.
All four providers noted that they felt more comfortable recommending other
vaccines to their clients. A key difference between Gardasil and other vaccines was that
providers did not consider Gardasil to be a necessary vaccine. They did not perceive all
girls to be at equal risk of being exposed to HPV, nor did they perceive that girls who
developed HPV were at equal risk for developing cervical cancer.
Like the nurse practitioners, the chiropractor was not opposed to vaccination in
general; rather, he felt that Gardasil was a less necessary vaccine due to most individuals’
ability to clear infections naturally and because of public health screening programs. One
NP agreed, arguing that Gardasil should be presented as a choice that parents need to
make themselves. She stressed that the practitioners’ role should be to equip parents with
information so that they can make informed decisions for themselves.
We have to educate people about their choices. There’s over 100 types of HPV.
This protects you against 4. And, furthermore, the vast, vast majority of people
who are caught with HPV will clear it with their own immune system. And so
what are the percentage of people that we’re really protecting from death with
these vaccines? You know you do have to take these things with a grain of salt
and so it should be a choice that’s presented to people. It shouldn’t be a high
pressure situation, I don’t think. That’s where I’m coming from anyway.
One of the nurse practitioners additionally worried that adverse reactions to the
vaccine could make it more difficult to convince parents to accept vaccines that she felt
were far more important. She would not initiate Gardasil conversations and preferred
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neither to recommend parents to accept or refuse the vaccine. She did not view Gardasil
as a necessity and worried that adverse events associated with Gardasil could make
parents leery of accepting other vaccines that she felt were critical to ensuring public and
individual health. She explained that Gardasil is
not necessarily a life-saver, if you will, the way that whooping cough vaccine has
been or things that have really been these hallmarks of public health and
infectious disease. HPV is a vaccine that could sort of tip public perception of the
value of vaccines. Because when adverse events occur, it just becomes something
that is not necessarily needed.
Jessica’s concerns about the necessity, safety, and cost of the vaccine, coupled with the
fact that Gardasil was stocked on-site, led her to avoid initiating conversations about the
vaccine. She explained,
In my current setting I don’t bring [Gardasil] up unless asked, even though I
should bring it up more because I have it sitting right there in my refrigerator.
But I mean, it’s funny, I was almost more likely to talk about it in my previous
setting where I didn’t have it sitting in the refrigerator because it was more of –
I’ve done the counseling piece, they can absorb the information, and if they want
it we can work on getting it. But I have my bias against it.
She further clarified, “I sort of feel like people should be informed before they
make the decision and I think informing them and then ten minutes later giving them the
injection isn’t being truly informed. I’d like them to sort of digest the information and
then come back.” When I asked Jessica if her philosophy towards time and informed
consent was true of all vaccine decision-making, she replied,
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No, it’s specific. And that’s my bias. It’s interesting, the thought just popped in
my head . . . I don’t agree with pharmacists that won’t dispense contraceptives or
whatever based on moral/religious grounds. I feel like maybe that’s how I am
about the HPV vaccine. But it’s not on moral or religious grounds, it’s just on a
show me the evidence ground.
The provider’s ambivalence highlights some of the ethical issues that practitioners
grapple with in the provision of healthcare. The provider found herself struggling to
disentangle her personal and professional vaccine concerns and questioned how these
concerns related to her responsibilities as a practitioner to protect patient health and
inform patients of available preventive technologies. She was not comfortable enough
with the safety of the Gardasil vaccine to initiate conversations about it, because she
feared that parents would interpret initiation of conversations as a vaccine
recommendation. At the same time, she was uncomfortable with the implications of
being inactive in initiating conversations and the reasons underlying her inaction.
In describing the strategies they use to initiate, discuss, and recommend the
Gardasil vaccine, it becomes clear that there is a high degree of variability in the types of
information parents likely receive from providers. For example, few providers mention
to parents, especially to those with younger girls, the protective benefits of Gardasil at
preventing genital warts. Of more concern is that during recounts of typical discussions
with parents, only four providers mentioned that Gardasil only protects against certain
types of HPV that can cause cervical cancer. If in practice, providers are touting Gardasil
as a cervical-cancer prevention vaccine without also stressing its limited protective
abilities, both parents and girls could mistakenly believe that pap smears are no longer
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necessary. On a more subtle level, failing to stress the limited benefits of the vaccine
could lead individuals who later develop HPV-related infections to lose faith in the
efficacy of vaccines.

The Parent-Provider Interface: Parent Reports of Interactions
I asked parents to recall, to the best of their ability, the first time that they had
discussed Gardasil with a healthcare provider, who initiated the conversation, what types
of information were discussed and by whom, and how materials were presented. All but
four parents had discussed the Gardasil vaccine with at least one of their children’s
healthcare providers. Some parents, who had originally spoken to providers about the
vaccine years ago, had difficulty recalling specific details of visits. Other parents, who
had recently made Gardasil decisions, recounted greater details. Some parents had seen
healthcare providers several times before making a decision to vaccinate their daughter.
Other parents who continued to defer making a Gardasil decision had spoken once or
more to their providers. Parents with more than one daughter in the eligible age range
sometimes had not talked to their provider about Gardasil for all of their daughters.
Four parents reported that neither they nor their providers had initiated a
conversation about the vaccine. The mother of a sixteen year old daughter attributed this
to the fact that her daughter did not currently have a regular healthcare provider and thus
only saw providers, usually at walk-in clinics, when she was sick. Wendy, whose
daughters were 12 and 15 years of age, had a regular provider, but only took her children
to the doctor for acute care visits and sports exams. The last time the girls went for sports
physicals their grandmother took them, and while Wendy knew from talking to her
mother that the provider had mentioned Gardasil, she knew nothing of the actual
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interaction. The other three parents had daughters between 10 and 11 years of age. The
mother of an eleven year old was not interested in having her daughter vaccinated, and
therefore did not bring the vaccine up at her daughter’s most recent visits; her provider
did not mention Gardasil either. One father had not heard of the vaccine until recently
and thus had not thought to ask his ten year old daughter’s pediatrician about it. Jill had
thought about mentioning the vaccine during her daughter’s ten year physical, but was
uncomfortable initiating the conversation, hoping instead that her pediatrician would.
I thought about asking about the vaccine at her last visit but then something came
into my mind that it’s kind of linked with, I don’t know, what we think of as
(whispering) sexual activity. So I was like “Oh my God! She’s ten! I’m not
talking about that!’ (laughs). . . I think most people probably have the same
[reaction as me]
She continued, “I almost think that if something was initiated with a professional,
not just me talking to her, it would probably be better. For me anyway.” If Jill’s
hesitation to initiate the conversation itself is shared, it is possible that some parents who
are interested in the vaccine will not discuss it if the provider does not take the initiative.
In the previous cases described, it is possible that the provider will discuss the vaccine
with these parents during future visits, when daughters are slightly older and perhaps,
when providers perceive that the conversation will be received more openly. As
providers in this study and national studies (Daley et al. 2010) confirmed, many
practitioners do not begin recommending the vaccine until girls turn 11 or 12 years of age
or enter their teen years.
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Twenty-two parents had spoken at least once to a provider about the Gardasil
vaccine. Fifteen parents reported that the provider initially brought up Gardasil. While
parents did not always recall exactly how providers initiated the Gardasil conversation,
several parents explained that the provider mentioned Gardasil as one of several vaccines
for which their daughters were due. In other cases, providers discussed the Gardasil
vaccine as a separate vaccine that, unlike other vaccines, was not required for school
entry.
In recalling HPV conversations initiated by providers, parents reported that
providers always presented some information about the vaccine to parents verbally. Eight
parents also remembered receiving some type of flyer or pamphlet that contained
information about the vaccine. Three parents could not remember any specific details of
their conversations with providers. One mother heard the provider say the word
“Gardasil” and interjected that she had no interest in the vaccine. The provider replied by
handing her a pamphlet and telling her that she recommended the vaccine.
Slightly more than half (n=8) of the fifteen parents who reported a providerinitiated Gardasil conversation believed that the provider explained that the HPV vaccine
prevented, or could prevent, cervical cancer. According to parents, three providers stated
that the vaccine would also protect against genital warts. Four providers discussed that
HPV is sexually transmitted and three emphasized that the vaccine was only effective as
a prophylactic. Two providers explained that the vaccine only provided protection
against some strains of HPV and one provider mentioned that abstinence was the only
sure way to protect oneself against sexually transmitted infections. One provider urged
that the parent verify that Gardasil was covered by her insurance company and another
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provider emphasized that the vaccine was not school mandated and did not need to be
administered immediately. Five parents reported that the provider included the daughter
in the conversation.
After discussing the vaccine with providers, nine parents (out of the 15 who
reported provider-initiated conversations) agreed to begin the vaccine series during the
same office visit. The other six parents did not have their children vaccinated after the
initial conversation and one of these mothers had no plans to vaccinate her daughter in
the future. Among the other five mothers, two mothers eventually initiated the series,
while the other three planned to begin the series at some point in the future. The two
mothers that eventually initiated the series had planned to begin the series immediately,
but one provider recommended she first make sure that her insurance would cover the
series and the other mother wanted her daughter to actively consent to the vaccine, which
she was unwilling to do at the time. Eventually, both mothers had their daughters
vaccinated. Among the three women who continued to delay beginning the series, two
mothers, with nine and eleven year old daughters, said that their providers initiated
conversations about future vaccination. Both providers recommended that the girls
receive the vaccine, but in a few years. Finally, one mother was still concerned about the
newness of the vaccine, but was leaning towards initiating the series when her daughter
turned seventeen.
Two of the six mothers who did not initially have their daughters vaccinated
reported that providers initiated follow-up conversations regarding the vaccine at future
appointments. Marie, who had deferred the decision for more than three years, recalled
that her pediatrician, since retired, had brought up the vaccine at every visit. The other
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woman, Lucy, recollected that the pediatrician initially introduced the vaccine during her
daughter’s thirteenth year wellness exam. While the mother was ready to vaccinate her
daughter after the original discussion, she wanted her daughter to take an active role in
the decision-making process and consent to receive the vaccination. Over the course of
the next two years, her daughter needed to see the doctor on six occasions, and at each
visit, the doctor reminded them of the vaccine. The mother finally had her daughter
vaccinated for her fifteenth year check-up.
In seven cases, the parent initiated the conversation about the Gardasil vaccine
with his or her child’s provider. All of the parents who asked their providers about the
vaccine ultimately had at least one of their daughters vaccinated; however, three of the
parents did not begin the series during the same visit. One mother, over the course of a
year, asked two pediatricians and her own gynecologist about the vaccine; all three
providers strongly recommended it, but she waited several more months before beginning
the series. Two fathers who conducted their own research on the vaccine asked their
daughters’ healthcare providers about the vaccine, and based on responses, delayed
vaccination.
Parents who initiated conversations with providers described the exchange in less
detail than parents who said providers began the conversation. In recalling their own
conversations with providers, three of seven parents said that upon asking their providers
about the HPV vaccine, the providers replied that they thought it was a good idea. Other
than a provider recommendation, they did not think the provider discussed more about
the vaccine. Only two parents recalled providers discussing specific information about
the vaccine or the virus it prevents. One parent asked her provider about the vaccine,
313

explaining that her mother-in-law had had cervical cancer. He responded that the vaccine
was not a cancer-preventing vaccine, but could prevent some of the causes of cervical
cancer. He also stressed that the vaccine was not required for school entry. Another
mother asked her provider if she thought the vaccine was a good idea. “She said that it
can help to prevent a certain type of cancer, I believe. And she said ‘I think it’s a good
idea. I don’t think it can hurt your daughter in any way and I think it can only help.’
Those are the things I remember for the most part.”
It is unclear why parents’ recollections of HPV vaccine discussions seem to differ
depending on who initiated the conversation. It appears from parent recollections, that
providers might share more information about HPV and Gardasil when they initiate
conversations. One pediatrician’s own account of her approach to Gardasil lends some
weight to this difference. In a routine clinical visit with patients 11 years of age and
older, Elizabeth only discusses the benefits of Gardasil, what it can and cannot protect
against, how HPV is transmitted, and the risks associated with HPV and the vaccine if
parents do not immediately consent to the vaccine. If the parent consents to have her
daughter vaccinated, Elizabeth simply moves on to the next issue. She explained, “If I
say to the mom of an 11 year old ‘okay, these are the vaccines that we’d like to give.
They’re due for the tetanus, the meningitis, and the Gardasil’ and the mom already says
‘okay, yeah,’ then I don’t actually explain Gardasil.”
Despite this one provider’s account, there is no way to know whether the
providers seeing the two groups of girls have different strategies for discussing the
vaccine. We cannot know whether parent’s recollections accurately portray the
conversations that took place in the provider setting. It could be that parents who initiate
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the conversation do so by asking pointed questions that narrowly define the discussion,
while when providers begin the discussion they have a broader scope of talking points. It
might also be that parents who initiated conversations were most interested in hearing
whether the provider recommended the vaccine, and therefore were more likely only to
recall this feature of the conversation. It is also possible that providers assumed that
parents who asked about the vaccine were either interested in receiving it or had already
done research on the vaccine, and therefore did not require additional information about
what it protects against, how it is transmitted, and so on.
Another interesting difference between parents’ descriptions of interactions had to
do with the daughter’s role during the discussion. In all but one case, daughters were
present for parent-provider conversations regarding the Gardasil vaccine. Fourteen of
fifteen parents said their daughter was present when the provider brought up the vaccine.
Five of these parents (daughters ages 13, 14, 15, and 16) specifically noted that the
provider addressed the daughter when initiating the conversation; the mother was
included in the conversation, but as a peripheral participant. Among the seven parents
who brought up the vaccine themselves, each had at least one daughter (ages 11- 16)
present at the time, and two parents had two daughters present. None of the parents who
initiated the vaccine conversation mentioned that the provider said anything specifically
to the daughter during the conversation. It is unlikely that the child’s age can explain the
difference in approaches, since in both groups at least a sub-set of daughters were of the
same ages. It might be that providers addressed parents in parent-initiated conversations
precisely because the parents started the conversation.
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As previously mentioned, there are plenty of reasons why parents’ descriptions of
HPV conversations differ. It is impossible to determine, based on the way that I collected
my own data, whether conversations actually differed, or whether parents recollect
different aspects of the interaction. It would be worthwhile in future studies to examine
the actual differences in provide-parent conversations based on who initiates the
conversation, because such differences could have effects on the breadth and scope of
information that parents receive.
If providers are indeed presenting less information to parents who initiate
conversations about the vaccine, there is a chance that parents and daughters will make
semi-informed vaccine decisions or have a less complete understanding of the complete,
but limited benefits of the vaccine. Providers might be missing important opportunities
to discuss abstinence and safe sex with girls, or opportunities to involve them directly in a
decision that affects their personal health.

Provider Sources of Information
Data from provider interviews reveals that differences in the ways that they and
parents assess the credibility and relevance of vaccine-related information can sometimes
lead to conflicts, frustration, and misunderstandings in the clinical encounter.
As discussed in Chapter Eight, providers tried to respond to anticipated and stated
concerns that parents might have about the Gardasil vaccine. Whether responding to
concerns about the newness of the vaccine, the age at which it was administered, or its
effects on sexuality, providers sometimes responded to parent HPV-related concerns by
elevating their own expertise or knowledge system over the source in question. While
well intentioned, such approaches could diminish trust or discourage parents from sharing
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concerns with providers, especially if parents feel the providers are condescending or
reproachful. Consider one provider’s account of her response to parents who ask her
about adverse vaccine effects they have heard about through the media or friends.
You know, you can’t just go by a news report or something else you hear on TV
because anything can happen within 24 hours of giving a vaccine that has nothing
to do with the vaccine. And because it was given within 24 hours it’s still
reportable. So just because someone got into a motor vehicle accident and died [it
gets reported in VAERS], because death was within 24 hours of Gardasil. Do you
really think that was the cause? The Gardasil? No! So you can’t go by just
hearsay and what’s talked about.
Moreover, risk statistics are of little help to parents if parents do not perceive that
population-level statistics are relevant to their individual case. In Chapter Eight, I
presented an example in which a provider tried to counter parent claims that the Gardasil
vaccine was unnecessary because their daughters would not be sexually active until
marriage. The practitioner commonly presented national statistics to parents that
suggested the majority of youth became sexually active before marriage. In response,
parents countered that their daughter was in the minority percentage that were not. The
strategy, based on population statistics, was of little relevance to mothers who made
assessments for individual daughters. Moreover, such responses might be interpreted by
parents as indications that providers doubt their own awareness of their daughters’ sexual
readiness or moral characters.
Conflict and misunderstanding can arise when providers try to use scientific or
medical information to “correct” a belief. This most often became an issue when parents
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held views about reproductive technologies that conflicted with their own. Providers had
particular difficulty responding to parents who felt that technologies such as birth control
(for acne or menstrual cramps) and Gardasil either directly promoted promiscuity or
conveyed a message that parents and providers passively approved of premarital sexually
activity. Maggie found it particularly difficult to respond to parental concerns about
promiscuity but saw the conflict as educational. She had knowledge, the parents did not:
The religious stuff does become an issue when the kids become adolescents. It
definitely becomes an issue of what parents think and this huge wall comes up
between me and them because of a lack of knowledge [on parent’s part]. I give
[adolescents] a vaccine, education, medications to prevent disease. This does not
equate with promiscuity.
Recall from Chapter Seven that one pediatrician drew upon her own clinical
experience to argue that education and vaccine resistance were intertwined. She
observed, “We gave the Gardasil at 9 and hardly anybody refused it, because of the
population. You probably know this – the lower educated population refuses vaccines a
lot less. They kind of just do whatever the doctor tells them to do.” Janet encountered
little Gardasil resistance in the less educated, low-income population that she treated,
despite the fact that the vaccine was brand new at the time. When it came to vaccines,
Janet preferred working with this parent population because they usually readily accepted
vaccines, which she thought were fundamental to the health and well-being of individual
children and the larger population. While Janet wanted her parents to be well-informed
and educated, her conception of what constituted information or education was narrowly
defined. Reflecting on her observation that parents with lower education levels tend to
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do whatever the doctor recommends, she replied, “It has pros and cons. I think it’s good
to be educated, I think it’s good to ask questions. But I don’t agree with refusing
vaccines, which some of the higher educated families try to do. Which seems counter
intuitive (laughs).”
Janet’s assertion that it is good to ask questions is qualified and contingent:
education was acceptable as long as it did not cause parents to make decisions that
providers felt were the wrong decisions. In this case, outside sources of information were
encouraged as long as they led parents to vaccinate. Janet recounted a recent exchange
she had with a mother who was refusing the DTaP vaccine based on a chiropractor’s
recommendation. The provider explained,
I was very angry. I was just so irritated that the chiropractor told them to refuse
[the vaccine] because it is not safe. I was like, you have got to be kidding me.
We ended up talking them into getting the tetanus by itself without the pertussis,
since that’s the problem according to the chiropractor. And I’m not against
chiropractors, but I don’t want them telling people that they shouldn’t be
vaccinated. (laughs).
Whether more frequent among highly educated parents or not, several providers
observed a trend between consumer education and vaccine resistance, where parents who
are “more likely to say “no” are the ones that have done research.” While Janet’s
examples are more illustrative than some other provider examples, most providers
expressed similar types of sentiments. Yes, providers want parents to be involved,
informed advocates for their children’s health, but at the same time, they only want
parents to seek and value certain types of knowledge.
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It was clear that many providers did not believe that some of the sources from
which parents gathered information would lead to well-informed decisions. Providers
recalled many instances in which parents chose to refuse or delay vaccine decisions
because of information they obtained through sources that providers found questionable
or downright rejected. According to many practitioners, it was not uncommon for
parents to have vaccine concerns because of something they read, saw, or heard in the
popular media. Several providers expressed frustration that parents seemed to blindly
accept unsubstantiated claims reported in non-scientific venues regarding the possible
effects of a vaccine on one individual, while challenging provider and expert knowledge
claims and ignoring the hundreds of thousands of cases in which the vaccine was
administered without incident.
Providers noted that the internet has provided parents with an overwhelming
amount of information about vaccines that parents selectively read and address during the
office visit. Sue recounted a case in which a mother sent her a newspaper article
reporting that a girl developed chronic fatigue syndrome from Gardasil. No matter what
Sue said, the mother could not be convinced that Gardasil was safe after reading the
article. Sue expressed frustration that parents seemed to put more faith in a journalistic
news report than in the public health system or a licensed physician, and that the internet
has led parents to falsely believe that they are capable of making expert decisions. “Of
course, the parent reads about one article stating an association and now that parent is a
medical expert.”
Other providers shared similar experiences. Parents hear from friends, family, or
the media that girls suffer adverse effects after being vaccinated with Gardasil and then
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question the vaccine’s safety, but without validating the claims or understand how
adverse effects are reported through the Vaccine Adverse Event Reporting System
(VAERS). Providers (n=9) frequently mentioned having to talk to parents about how
VAERS worked in response to stories they heard about adverse reactions. One provider
responded to these concerns by explaining how the VAERS worked, though sometimes
parents do not believe her: “They believe a lot of those things that they see online where
27 girls died after [getting the Gardasil vaccine]. I get that a lot. And you explain to
them that there were other conditions and it was just, oh by the way, they also had the
HPV vaccine. It wasn’t due to the HPV vaccine but [not all parents] believe that.”
Some providers understood why parents were concerned by news reports, but also
did not consider these stories to be forms of “evidence” upon which vaccine decisions
should be made. In response to parent concerns that Gardasil causes Guillain-Barre
syndrome, one provider said, “We’ve given 23 million doses [ of Gardasil] and all of the
adverse reports are entered into the VAER system. Guillain-Barre occurs in a certain
percentage of the population anyway, I don’t feel like there is an association based on the
evidence.”
Providers often had to respond to parent concerns regarding vaccine side effects,
many of which were publicized in the popular media and for which there was little or no
scientific evidence to support. Providers found it particularly frustrating when parents
put more weight on celebrity recommendations than their own. For example, Kelly, a
school nurse, was not uniformly opposed to non-medical exemptions, but was opposed to
exemptions based on certain types of knowledge. She was particularly frustrated that
several parents were resisting specific recommended childhood vaccines because Jenny
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McCarthy (a vocal Hollywood celebrity) insists that they caused her son’s – and many
other children’s - autism. Kelly recalled several recent cases in which parents sought
vaccine exemptions specifically “because Jenny McCarthy said that her son got autism
from it and that’s reason enough.” She continued,
Parents aren’t abstaining for the right reasons. They’re [abstaining] because they
see some kind of celebrity spokesperson saying “Don’t get vaccinated,” which I
think is crap. If you don’t want your kid vaccinated, you better find out why. I
understand some of that. I can see why some parents would think that and if they
do I can respect their opinion, but don’t just say you’re not getting your kid
vaccinated because Jenny McCarthy says you shouldn’t. I find that very hard to
believe that somebody would make a decision based off that, and people tell me
that, so I know they do.
For Kelly, there were clearly “right” and “wrong” motives to abstain, or
legitimate and illegitimate reasons to be wary of vaccines. Sophia described parental
resistance to the MMR vaccine as a “huge issue” in her practice. Aside from her concern
that children were being left unprotected from vaccine-preventable diseases, she was also
frustrated that parents found celebrity spokespeople more credible than their own primary
care provider. When I asked her why parents were declining the vaccine, she explained
that it was due to concerns about autism that parents heard from “news stories and Jenny
McCarthy. It’s on Oprah. And I guess Oprah’s got a lot more credibility than I do.”
Indeed, four parents that I spoke with specifically mentioned Oprah, Jenny McCarthy, or
both women, when describing sources of general and specific vaccine information.
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There was a sense of frustration among healthcare providers that parents validated
information from sources that, when pressed, they could not identify. Nearly all
providers felt that a lot of the information that was available to parents was inaccurate,
and yet, providers felt that they had to spend a lot of time in a limited visit to respond to
inaccurate information. Healthcare providers also found it ironic that parents would
discount their professional medical opinion regarding one aspect of healthcare and in the
next breath ask for their medical advice. The following example illustrates this point
well: Elizabeth was perplexed that parents would refuse to follow her recommendation to
follow the AAP vaccine schedule, which is what she recommends, and then ask her to
recommend an alternative. Thus, parents are rejecting a biomedical recommendation
because they discredit or distrust it, while simultaneously asking for biomedical expertise
on how to proceed. Describing her policy, she emphasized that parents who want to split
vaccines,
are well aware that it’s against guidelines and it’s not what I would recommend.
So I don’t allow them to tell me, “I want them split up but you need to tell me
how to do it.” I say, “No. I’m telling you get six. So if you want them split up,
you’re going to tell me how you think it’s appropriate.” And when I say that,
about fifty percent will say, give me all the vaccines.

Chapter Nine Summary
Generally, parents legitimized knowledge from a wider variety of sources than did
providers. Consistent with findings reported by Litton and colleagues (2011), the vaccine
manufacturer and healthcare professionals were leading sources from which parents
learned about Gardasil. However, parents often obtained information about vaccines
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from their own experiences, their family members, peers and colleagues, other parents,
vaccine manufacturers, biomedical and alternative healthcare providers (such as
chiropractors), news, radio and television programs, and myriad websites. Providers, on
the other hand, obtained and legitimized knowledge published in peer-reviewed academic
journals, promoted by specific member groups (e.g., ACOG, APA), or recommended by
national and international health organizations.
The Theory of Reasoned Action posits that social norms regarding vaccination
can affect parental vaccine decisions. However, it is unclear what role these
conversations and social norms actually played or could play in parents’ vaccine
decisions. Parental narratives suggest that conversations with friends, family members,
and other parents about the vaccine enabled parents to get a general sense of the safety of
the vaccine and the social norms surrounding receipt of it. In particular, parents valued
these discussions in assessing the safety of the vaccine; reassurance in the safety of the
vaccine was affirmed as a greater number of girls within their social circle received the
vaccine without incident.
The fact that vaccine-skeptical parents tended to report negative conversations
about the vaccine and vaccine-supportive parents disregarded negative reports suggests
that some parents might selectively filter out contradictory information shared by their
peers and other parents, while amplifying experiences and perspectives in line with their
own (Leask, et al. 2006; Meszaros, et al. 1996). If this is indeed the case, then it lends
support to the argument that other factors, unrelated to knowledge play a role in these
decisions.
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The two most common sources of parental HPV-related information were Merck
(through Gardasil commercials) and healthcare providers. The predominance of certain
sources in conveying vaccine information might help to explain why some types of
information, such as the relationship between cervical cancer and Gardasil, are
commonly reported, while other information, such as the association between genital
warts and Gardasil, is less known. However, it is important to remember that information
is filtered and evaluated within larger social fields and in relation to other, sometimes
competing and conflicting information.
Parents and daughters became important sources of information in assessing the
need for the vaccine. Parents seldom felt comfortable talking to their daughters about
sex, but did so anyway because they wanted their daughters to feel comfortable
approaching them with questions and concerns about sex. Sexual communication also
offered a means by which parents could assess their daughters’ sexual maturity and
anticipate sexual debut. The strategies employed by parents to gauge their daughters’
sexual readiness and maturity were largely founded on notions of trust – trust that their
educational efforts are effective, trust in the accuracy of their strategies and assessments
for evaluating sexual maturity, and trust that their daughters will come to them before
they think about having sex. In the following chapter, I will argue how parents’ notions
of trust in their daughters and in others intersect with parental conceptions regarding
Gardasil, risk, and time.
The types of information that parents obtain from providers not only has to do
with the quality of the professional relationship, but provider perceptions regarding HPV
infection, vaccine safety, efficacy, and need. Provider accounts of typical Gardasil
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conversations reveal that there are significant differences in the scope of HPV-related
information that providers share with patients and when and if providers initiate
conversations. Even within their own practices, providers shared different types of
information – and present that information in different form – depending on
characteristics of the patient. Along with other considerations, such as the type of office
visit and insurance coverage, these factors can shape the ways in which Gardasil
conversations are (or are not) initiated, by whom, and what types of information is
shared.
What constitutes knowledge, and how to negotiate different knowledge claims, is
key to the parent-provider interaction. Differences arose when parents and providers
were discussing the need for, and risks associated with the vaccine, but when neither
party was willing to accept the validity (or perhaps superiority) of the other’s knowledge
system.
What Janet (and other providers) saw as a paradoxical relationship between
advanced education and vaccine resistance was founded upon two taken-for-granted
assumptions. First, Janet and other healthcare providers assumed that individuals with
advanced education are more likely to deem as superior scientific forms of information in
making vaccine decisions and, that upon reviewing these data, parents would similarly
conclude, as she did, that Gardasil was safe, effective, and beneficial. However, not even
the providers in this study, who did rely on a shared set of scientific knowledge to
evaluate the vaccine, could agree among themselves the safety, necessity, and efficacy of
Gardasil. Four providers were unlikely to universally recommend the Gardasil vaccine.

326

What Janet’s observations and other narratives reveal are taken-for-granted
notions about the constitution of knowledge, how knowledge should be used, and who
should possess it. Parents and providers often enter into interactions with differing ideas
about what constitutes legitimate information, and subsequently, what types of
information should be used to inform vaccine decisions. Conflicts can arise when
providers and patients feel that their own criteria for evaluating and valuing knowledge
are dismissed. As will be discussed in the following chapter, such conflicts can damage
the trust that parents have in providers, and subsequently, the confidence and value that
parents place on their providers’ vaccine recommendations.
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Chapter Ten – Trust and Risk Evaluation

The risks and benefits that parents perceive regarding a disease and the vaccine it
is developed to prevent are largely shaped, as has already been discussed, by antecedent
events, decisions, and policies that frame the structural field in which parents seek
healthcare and conceive of vaccines. Moreover, parents obtain information used to assess
vaccine risks and benefits by diverse sources; however, the validity and weight granted
specific information varies. To some degree, the weight assigned to particular
information relates to the trustworthiness of the source. As will be discussed shortly, the
political efforts to mandate HPV vaccination for school entry, and subsequent revelations
that key actors spearheading these efforts were receiving funds from or were personally
connected to Merck, led both parents and providers to question specific sources of
information and the vaccine itself.
Though no interview questions contained specific references to trust, parents and
providers continually invoked notions of trust to frame vaccine decisions and engage in
risk assessments. Parental trust in the public health system, pharmaceutical companies,
healthcare providers, daughters and their future partners, other parents, and society were
central to the ways in which parents conceptualize the HPV vaccine and decisions
regarding it. The trustworthiness of a source was an important consideration for parents
who attempted to evaluate the credibility of information; the safety of the vaccine; the
motives of manufacturers, regulators, and providers; daughters’ sexual preparedness; and
the social world in which daughters interact.
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In the first section of this chapter, I present information on pharmaceutical
companies and government agencies, and historical and more contemporary events that
shape the ways in which parents’ assess not only the trustworthiness of these
stakeholders, but of the Gardasil vaccine itself. Within this section, I also present
providers’ views on the vaccine and their own trust or distrust of Merck, regulatory
oversight, and the vaccine, because, as shall be discussed, provider recommendations and
insight regarding a vaccine are highly valuable to parents. Thus, providers’ evaluations
of the trustworthiness of the vaccine can potentially affect if, how, and when providers
discuss and recommend Gardasil.
Subsequently, I discuss the ways in which trust is gained and lost through the
service-delivery interface. I rely primarily on parental narratives to describe the criteria
upon which parents assess the trustworthiness of healthcare providers, and how such
sentiments can alter the ways in which parents approach vaccination. Finally, I discuss
the role that trust plays in parents’ evaluations of their daughters’ disease risks.
It is important, when reading this chapter, to remember that trust operates on
multiple and intersecting levels that are not easily disentangled. To speak of trust solely
as it relates to singular stakeholders, such as pharmaceutical companies or providers, is
difficult and somewhat artificial, for parents sometimes evaluate the trustworthiness of
one stakeholder or entity based on the actions or trustworthiness of another (i.e., trust or
distrust by proxy) or measure trustworthiness in relative degrees (e.g., the lesser of two
evils). In the following discussion of trust, I present parental perceptions of trust as they
apply to both specific entities and relationally, acknowledging that such an attempt can
neither adequately capture the complexity of parents’ actual perceptions regarding the
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trustworthiness of any or all groups, nor explicate the subtle and nuanced ways in which
trust (or distrust) in one group can affect perceptions of the trustworthiness of other
actors.

Pharmaceutical Companies, Government, and Providers
As discussed in Chapter Six, general population distrust about the composition of
vaccines, their effects on the body, and laws regarding vaccine mandates is not new, nor
is distrust of the role or motivations of pharmaceutical companies and the government
vis-à-vis vaccination (Blume, 2006 ; Colgrove; Durbach, 2002; Fenner et al., 1986; Offit;
Spier, 2002; Sturm, Mays, & Zimet, 2005; Wolfe & Sharp, 2002). Indeed, one might
expect that distrust in either or both entities would increase with time, as history and
technology provide a cumulative, well documented, and easily accessible record of
alleged errors, mishaps, and tragedies attributed to vaccines or vaccination campaigns.
Both parents (n=6) and providers (n=5) expressed HPV vaccine safety concerns
that directly or indirectly stemmed from (or resulted in) a lack of trust in governmental or
pharmaceutical interests, relationships, or processes. Individuals pointed to the capitalist
model of healthcare practiced in the U.S., pervasive use of drug marketing and
advertising, historical cases of drug recalls, the high cost of many drugs, and the politics
of drug regulation as some reasons to feel distrustful. While some individuals’ general
distrust of providers, public health, or pharmaceutical companies led them to view the
HPV vaccine with caution, other individuals identified the sources of their distrust as
originating in processes or characteristics unique to the HPV vaccine.
Distrust in government and pharmaceutical companies often related to a general
distrust in capitalism and a perception that values and goals of the capitalist-driven
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biomedical system conflict with the values of human health.

Several individuals’

distrust was directed squarely at the pharmaceutical companies, who they perceived as
powerful, profit-driven corporations that valued profit margins far more than consumer
health and safety. As Bill, a father of two daughters put it, “One should be wary of big
pharma and their interest in all of this.”
In viewing biomedicine as a capitalist form of healthcare, some individuals cast
the net of distrust even wider to include any stakeholder, including public health
practitioners, insurance companies, politicians, lobbyists, and healthcare providers, who
could potentially profit from the use of new biomedical technologies. Laura, a nurse
practitioner, lamented that treatments seem to benefit everyone but the consumer
stakeholder. She questioned who benefited from the current recommendation that the
Hepatitis B vaccine be administered to infants, despite not knowing length of coverage:
“What about re-vaccinations? We aren’t even sure how long Hep B is going to last and
we’re doing this to newborns?” Although supportive of vaccines in principle, Laura
found that in practice she had more difficulty confidently recommending vaccines to her
patients due to her misgivings about stakeholders’ interest. Expressing concern about the
increasing number of vaccines available to the public and their questionable safety she
said
Once again, I cannot believe we’re going to add more [vaccines to the
recommended schedule]. Meningitis is questionable . . . Listen to our history in
America. We’ve given medicines and ‘Oh! – they seem to cause birth defects and
all sorts of problems for women and babies’, and ‘Oh! Now we’ll take it off the
market’. The problem I have is the way we run, and how we can get rich or make
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a profit off of healthcare in America. So people who are doing things, usually, are
– and the drugs that get put out by the FDA – is messed up. It’s all about money.
Just like the lobbyists and other things. We don’t do what’s best for Americans,
really. We do what is the loudest, noisiest, making you the most money. That’s
what gets through. Not the actual common sense portion of it. Or it’s 100% time
and face. So that always bothers me because later you’ll see there are problems.
Natalie clearly explained how far such a web of distrust can extend if one views
biomedicine as a purely capitalistic endeavor: “Pharmaceutical companies are a business.
Insurance companies are a business. So you know, they pay big bucks to those lobbyists
up there. It’s about business. It’s what’s going to be passed and what’s not going to be
passed.”
Like Natalie, several other parents were concerned about the relationship between
pharmaceutical companies and healthcare providers, either because they worried
providers would push specific brands or products to receive kickbacks, or because they
feared providers simply regurgitated vaccine safety information given to them by the
manufacturer. Mark, a father of four, felt ambivalent about going to his healthcare
provider to learn about the HPV vaccine.
I don’t know that we would necessarily go to a doctor and say ‘hey, I want to get
some information [on the HPV vaccine]. Just because I feel like a lot of the
information I’m going to get typically would come from the drug rep who’s
selling the vaccination who’s more of a marketing package. And so it has to be
more balanced. You can get that little brochure that you get at the doctor’s office
online from the pharmaceutical company.
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Several parents generally questioned whether direct-to-consumer drug marketing
was ethical. That such advertising creates a link between the pharmaceutical companies
and healthcare providers further caused some parents to mistrust the information they
receive from healthcare professionals. A general distrust in pharmaceutical drug
information, coupled with an overall increase in direct-to-consumer marketing and
advertising caused some parents and providers to view the HPV vaccine with caution.
The multi-million dollar Gardasil advertising campaign was successful in reaching most
providers and parents, but the response to the Gardasil campaign, and pharmaceutical
advertising in general, was not always positively received. Jessica, a nurse practitioner,
said, “I have a few issues with Merck and some of their advertising campaigns, not just
with Gardasil but with Zostavax, with Vioxx”
Some parents also felt that the Gardasil vaccine was marketed far more heavily
than other drugs, and therefore a particularly suspect drug. That Gardasil seemed to be
unusually well advertised, led some parents to question how much the company stood to
gain from the vaccine. Melissa, a mother, reasoned that the company would not invest
what she perceived to be an unusually large amount of money in advertising if there were
not an exceptional amount of money to be made off of the vaccine. She explained,
It seems like the Merck pamphlet is the only hard information I have, and it’s
from Merck. And it’s been such an advertising campaign, as opposed to
information through a health provider, which I would see as more legitimate. I
see their ad campaign . . . and I think, is this really something that’s good for you?
Or is this just advertising, like we just want to sell this drug? Because it was so
heavily advertised I’ve kind of stuck it in this same sort of – well, okay, here’s
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just another drug trying to sell itself. And because it’s so expensive, for me, I go,
well, that just goes to show you that they just want to make money off of it.
The cost of the vaccine raised alarm bells for other individuals as well, who saw
the high price tag associated with the vaccine as an indication that profit, rather than
public health, was the company’s bottom line. One provider generally supported the idea
of an HPV vaccine, but had misgivings about the current vaccine. “[Gardasil is] an
insanely expensive vaccine. And Merck has a history of coming up with these pretty
expensive things, like Vioxx. Getting them out there and making a whole heap of money
off them. Where’s the cost-benefit ratio analysis?” A parent asked, “If it’s so beneficial
to have that [the HPV vaccine], why is it so expensive and why can’t the price go down?”
The two quotes above illustrate two different values regarding the relationship
between the benefits and costs of technology. The provider suggests that expensive
treatments and interventions are acceptable if the benefits are vast, but does believe that
the benefits of the Gardasil vaccine are sufficient to justify the cost. The parent suggests
quite the opposite – that high-benefit interventions should be low cost. In both cases, the
cost of the vaccine led individuals to distrust the pharmaceutical company’s motives, but
based on differing sets of ideas regarding price points associated with beneficial health
technologies.
Trust is often gained and lost through experience. As I will discuss shortly, many
parents gain trust in their healthcare providers after providers have demonstrated – in
some form or another – competency and demonstrable concern for a child’s health and
safety. In the case of pharmaceutical companies and governmental regulating agencies,
trust can be lost when drugs have to be recalled due to deleterious effects. There are
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plenty of historical cases in which treatments administered to the population were only
later discovered to cause severe, and often long-term, ill-effects.
New technologies can produce anxiety-related unknown effects precisely because
they are nascent and possible long-term effects may not appear until decades later.
However, risks associated with innovative treatments are not always wrapped up with
notions of distrust. One can have the utmost trust in the researchers or agencies that
develop, test, and oversee the creation and use of a new technology and still perceive
risks associated with the technology itself. Concerns regarding the long-term
consequences of technologies can be linked to distrust if individuals perceive that such
risks can be prevented or at least minimized with greater research, monitoring, oversight,
etc. While nearly all parents (n=24) expressed at least some concern about the newness
of the HPV vaccine, only a few parents connected their concerns regarding the newness
of the vaccine with distrust in its manufacturers or regulators.
Several parents coupled concerns regarding the newness of the HPV vaccine with
references to past medication recalls to explain why they felt distrustful towards
pharmaceutical companies and regulatory oversight. Bill, a father of two, explained,
“I think [other parents] probably delayed the decision for the same reasons that I did. We
don’t know the long-term effects and there aren’t studies because it’s so new. And let’s
face it, there are all these other things that have happened with particular drugs that
parents have taken. So it’s good reason that you want to be cautious.”
One mother pointed to more recent cases of drug recalls when expressing her own
doubts about the safety of the Gardasil vaccine. She recalled,
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I know that Merck makes Gardasil. . . And it seems like – if Merck did Vioxx,
and I know that there is a recall– the drug that they developed and was approved
by the FDA caused a lot of problems. I don’t know the specific details but it’s
like, Merck, you have a habit of pushing things through and maybe not following
up. So if I have any sort of misgivings about the HPV vaccine my misgivings
would be: Okay, well it’s connected with Merck and Merck has done something
in very recent history that has been bad for people.
Distrust also arises from fears and suspicions that early recipients of approved
vaccines are essentially test subjects, or “guinea pigs”, used to determine the long-term
safety of new drugs. Explaining why some parents refuse to have their daughters
vaccinated, Isabelle, a Florida nurse practitioner said, “Some people are just nervous
about anything new that’s on the market and they’re afraid they’re being used as guinea
pigs.” Jessica, a nurse practitioner, described her own hesitation in recommending the
Gardasil vaccine to her patients,
Well I would say professionally my main criticism of [the Gardasil vaccine] is
that the safety data isn’t fully released yet and I don’t understand how something
can have FDA approval before that safety data is back. I also tend to be a
relatively conservative provider and prescriber. I generally do not prescribe a
medication that has not been on the market less than five years. I am not one to
jump and try the latest or greatest because I want to see – I mean I know that
studies only look at a couple hundred people or whatever – not a whole heap.
And I want to see what plays out among all these other guinea pigs before I
prescribe it.
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While any new vaccine can cause both providers and parents to feel some level of
anxiety regarding the unknown risks associated with the drug’s use, the manner in which
the product was introduced and marketed amplified some individuals’ distrust of the
vaccine. Marie was not about to give her daughter a vaccine simply because it was
heavily marketed – in fact, the heavy marketing gave her great pause: “Before I just jump
on the bandwagon and do Gardasil for my daughter I want to look at safety issues, or how
long it’s been in testing, or how long has this vaccine been developed. Because it just
seemed like boom! It was just there and it’s being pushed on TV.”
Tony had followed the development of the vaccine and had planned to have his
daughter vaccinated as soon as it was approved. He changed his mind after learning
about the effort to mandate the vaccine in Texas, which caused him to question the
motives of the manufacturer and the safety of the vaccine. He recalled, “And then Texas
tried to make it mandatory and [there was the] whole mess with them. I waited a year
and a half just to hear if there were adverse events. And when the CDC published that it
was nothing that they didn’t see with other vaccines, mostly site related, [then I had my
daughter vaccinated].
Ann, a nurse practitioner, felt that the immense direct-to-consumer advertising
campaign, coupled with intense and immediate efforts to mandate the vaccine, did little
to allay public or personal concerns regarding the safety and benefits of the vaccine.
I’d like to see some more studies on the shot. My big thing about Gardasil is that
it’s still very, very new. . . We just need to get more information out there, more
studies on what the outcomes are. And I think that that will reassure people and
allow people to make better decisions about the vaccine. And it will calm down
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some of the controversy because a lot of the controversy has really been – here’s
this brand new thing on the market and you’re trying to push it down our throats.
The effort to mandate the HPV vaccine so shortly after its development concerned
some providers, who felt the move was irresponsible given the newness of the vaccine, its
mode of transmission, and general controversy surrounding it. The chiropractor who
participated in the study was particularly suspicious of the push to mandate the vaccine,
given its cost:
Again, I know that it hasn’t been mandated, but I know when it came out they
were trying to mandate that everybody gets it, and again, I don’t like those
mandates that you have to do something because this vaccine, I believe, is the
most expensive one on the market. Any time I see something that tells me that
everybody has to do it, I always think money. Because it goes back to that. If it’s
the most expensive and everybody has to do it, who stands to gain the most? The
company that’s making it. If everybody has to do it. It just makes me skeptical
about it.
Several providers felt that such politicized efforts to mandate the vaccine only
served to further erode parental trust in pharmaceutical companies, the public health
system, and vaccines. Reflecting upon the mandate’s effect on her professional opinion
of the Gardasil vaccine, Ann explained,
I think the company made a bit of a mistake in letting some of that happen in
Texas, because it caused a lot of bad press. And unfortunately one of my first
exposures to Gardasil was extremely negative because of Rick Perry in Texas,
trying to politicize the vaccine when he had not made flu vaccine mandatory,
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which kills a hell of a lot more people. So things like that really will leave a bad
taste in your mouth as someone who wants to make a scientific decision about
things.
Another provider worried that there were still too many unanswered questions
regarding the vaccine, and that the effort to rush the vaccine onto the market might end
up diminishing public trust in vaccines. She argued,
There’s just too much unknown about [Gardasil]. It’s like, it’s just an experiment.
We don’t know what we’re doing. We [healthcare providers] don’t even know.
And then the risk of that is that people are going to get turned off by vaccines. So
not the risk of the actual vaccine but the roll out, if you will.
Sophia recalled that some parents become defensive when the HPV vaccine
initially came out due to fears that it would be mandated. “There was the big brouhaha in
Texas when they were trying to make [the Gardasil vaccine] a mandatory thing and
parents were saying, no, not my good girl!” The push to mandate the vaccine, she felt,
likely polarized opposition and resistance to it, making it more difficult for her to discuss
vaccine options with parents.
It is important to note that distrust in a pharmaceutical company or government
agencies safety record, motivations, or relationships does not necessarily translate into
support for or resistance against a vaccine. Several of the parents who distrusted
pharmaceutical or governmental agencies had already vaccinated or planned to vaccinate
their daughters. Similarly, providers who expressed distrust, disappointment, or
skepticism in pharmaceutical industry motivations did not wholesale reject the value or
benefits of the vaccine.
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It is also the case, however, that four of the providers (three nurse practitioners
and the chiropractor) who opposed the way in which the vaccine was marketed, its high
price tag, and the rush to mandate it given its newness and mode of transmission were
less likely to provide resounding recommendations in favor of the vaccine, or push
refusing or deferring parents to reconsider their position. The specific ways in which
provider distrust affected their discussions and willingness to recommend the vaccine are
discussed, in detail, in the following chapter.
While none of the parents or providers claimed to trust the pharmaceutical
industry, some people felt that concerns regarding industry motives or power were
exaggerated. One parent felt that some people
are just very wary of big companies, and big pharma especially. And if they say
this is good for you then they’re going to take the opposite, just because that’s
their knee-jerk political reaction. I know I identify with that but then you also
have to say, wait a minute, let’s see what’s what. But let’s face it, [some people]
will always say it’s a conspiracy.
For the majority of parents, trust in governmental agencies and healthcare
providers was associated with a conviction that these stakeholders made decisions based
on scientific evidence and a desire to protect public health, not in collusion with, or for
the benefit of the pharmaceutical industry. For some parents and providers, the fact that a
vaccine had been approved by the FDA was reason enough to trust in its safety. These
individuals had faith in the regulatory system and stringency of governmental approval
and oversight processes to have confidence in the safety of a vaccine. Monica, who has a
son and three daughters, deemed a technology safe if it had been clinically tested and,
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based on such tests, was approved by the FDA. To gain approval from the FDA was an
indication of vaccine safety: “I think if the vaccine has been tested and approved and it’s
safe, I don’t know why any parent wouldn’t want to get their daughter vaccinated”.
Other parents had faith that the government would address any issues found with
vaccines and felt that the systems in place and experts employed to guarantee the safety
of recommended vaccines were trustworthy and competent. Patty pointed to the
government’s steps to remove thimerosol from vaccines as proof that the government
would not intentionally allow harmful substances to be injected into its citizens. She also
dismissed fears that vaccines could cause development disorders, such as autism, arguing
that if links existed, researchers would have found them by now: “They took all the
mercury out of vaccinations. If there was really something to it people would have found
something by now. Because I think people are looking for, have been looking for that
link [with autism]. There’s just no scientific proof”.
Parents who trusted in governmental oversight made little effort to investigate
themselves the safety and efficacy of a vaccine, both because they felt they lacked the
expertise and training to interpret the results of large-scale clinical trial data themselves,
and because they had faith that the individuals assigned to do this job were honest. As
Mike said, “I trust our public health system and see it as the aggregate, a shared
responsibility for one another. I expect them to advise us which vaccines are required
and which are optional. The flu and HPV vaccines are optional.” Sarah expressed her
leap of faith more simply: “If the vaccine was available and recommended by their
healthcare provider, then I just have to take the faith of the system.”
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Trust in providers
The relationship parents perceive between themselves and their healthcare
providers plays a key role in healthcare decision-making. Results from other studies
indicate that provider recommendations are an important way in which parents report
making healthcare decisions. What parents in this study made clear is that the value
placed on a provider’s recommendation is contingent upon trust; not all healthcare
provider recommendations are equal.
Giddens argues that while we can make decisions to trust someone or something,
the “faith which trust implies also tends to resist such calculative decision-making”
(Giddens 1993:293). Trust implies faith, and while faith in a person or institution can be
lost or gained through singular experiences, the process is often subtler, built on
cumulative experience and largely unconscious. In this study, parents often espoused
their unwavering trust in a provider, but without explaining why the provider was worthy
of such unflinching faith. When probed to explain how providers gain or lose trust,
parents often had to pause and think, suggesting that decisions to trust are not calculated
or consciously made, but are unconsciously garnered. Many parents eventually pointed
to the fact that under a provider’s care, their children either recovered successfully from
illnesses, or never became seriously ill. However, a provider’s affect, communication
style, and concern for the individual child were also factors associated with trust. A sense
that clinicians treated children as individuals, rather than as representatives of an
aggregate was continually mentioned as proof of providers’ intentions and
trustworthiness. Though most parents expressed a strong sense of trust in their provider,
some parents shared experiences – mostly in the past – that led them to distrust specific
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providers, or providers in general. Often times, the same criteria that led to trust, could
lead to distrust.
Many parents conceptualized their provider as an intermediary who sorted and
translated abstract medical knowledge into relevant information for parents. The
provider was often seen as filter and stop gap, someone who could advise parents towards
worthwhile technologies and treatments, while cautioning them against innovations and
interventions that might not be as safe or necessary as pharmaceutical companies, the
public health system, or larger medical community might believe (or have the consumer
believe).
For most parents, trust was placed in their specific healthcare provider, not in
healthcare providers as a whole. Indeed, many parents trusted their providers because
they were seen as unique – engaging with parents and children in ways that they saw as
exceptional. Thus, while parental trust in individual providers was high, the tendency to
highlight the uniqueness of their own providers as unique suggests that their trust in the
broader healthcare provider community is more tenuous.
Some parents trusted healthcare providers with whom relating was effortless,
indicating that to some degree, trust was established through an underlying sense of
understanding and familiarity. As Christina put it, “A doctor should fit like a good pair
of jeans. It should be a comfortable experience when you go into a visit a doctor. And if
it’s not, then you’re not with the right doctor. Period.” The provider’s disposition could
itself contribute to a sense of trust. Barb concluded, in trying to explain why she trusted
her daughters’ provider, “He’s just very personable. He’s a nice guy in general.”
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Parental perceptions in the unique and exceptional skill of their specific providers
were often the result of particular experiences in which other providers had misdiagnosed
or failed to diagnose a condition that their trusted doctor found immediately, or
eventually. One mother explained, “Part of what makes me trust this particular doctor is
that my son was diagnosed with a heart defect and he caught it immediately and he told
me in ten minutes what it took the pediatric cardiologist about a month to find out. . .
This guy has just proven himself to me.”
When assessing the trustworthiness of a provider, parents often referred to their
cumulative experiences and successes with a provider. Explaining why she trusted her
doctor, Barb said, “He hasn’t steered me wrong into anything yet (laughs). I mean, every
time we go in for anything, the treatment he gives usually takes care of what the problem
was and we don’t have to repeatedly keep going back because what he does isn’t
working.” Barb’s trust in her provider is contingent – though laughing, she notes that her
provider has not failed her “yet”. At the same time, in noting that her provider’s
treatments “usually” take care of the problem, Barb seems to indicate that even with
trusted practitioners, some degree of “error” is acceptable or expected.
Another mother, who switched physicians, agreed that it was unfair to expect that
physicians could always accurately diagnose and treat illnesses on the first try, but she
did expect providers to accurately diagnose problems or refer cases that they could not
diagnose or treat. She lost faith in her previous provider’s ability to safeguard her
children’s health after he unsuccessfully prescribed her daughter a series of medicines to
treat a condition that he would not diagnose. Ultimately, Deborah questioned whether
the provider was harming her daughter’s health by prescribing medications without
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knowing what was wrong with her. She recalled “He put her on a whole bunch of
medicine, but would never say what was the matter. He just kept putting her on medicine
and putting her on medicine.”
Particularly in regards to pre-adolescent and adolescent children, parents
emphasized the relationship between the provider and child, specifically how the provider
interacted and involved the child in the healthcare visit. An important component of
establishing a trusting relationship was that providers speak honestly, clearly, and directly
to children and young adults about issues that affect their health, but without dismissing
or disrespecting the parent’s role in the making healthcare decisions.
In explaining why she trusts her daughters’ provider, Courtney recounted the way
that the doctor discussed the Gardasil vaccine with her sixteen-year-old daughter. When
the doctor described how HPV was transmitted, she “turned from me and was talking
directly to [my daughter] about it. And she’s wonderful. She’s very matter-of-fact. And
she doesn’t skirt around any issues or think ‘Oh well this conversation might make
somebody feel uncomfortable.’” Other parents also described their providers’ openness
and frankness with their daughters as a key reason they trusted them. Gretchen also
noted that the pediatrician primarily spoke to her daughter about the Gardasil vaccine.
Gretchen attributed her daughter’s active role in making healthcare decisions to the
provider’s long-term efforts to develop a trusting and empowering relationship with her
daughter.
The provider-daughter relationship was particularly important to parents of
maturing girls, who wanted to ensure that their daughters would feel comfortable sharing
personal health information with providers, even if they did not feel comfortable sharing
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the information with their parents. In other words, parents wanted their children to trust
in the provider. Thus, parents trusted providers who worked to create trusting
relationships with daughters.
When providers were not deemed skillful at relating to children, parents lost faith
in the relationship. Theresa explained what she looked for in a trustworthy provider, and
why her previous provider’s failure to meet these expectations led her to seek care
elsewhere:
[Someone with] an ability to relate to the kids. Somebody that watches what [the
kids are] doing, not just asking me what they’re doing. To be able to talk to the
kid and relate to the kid, not just the parent. Because the kid isn’t going to trust –
I can’t imagine as a teenager walking in to any doctor and saying ‘I want birth
control’, or ‘I need birth control’, when they’ve never really even talked to me as
a person. If they want a kid to have trust in the doctor then they need to relate to
and trust the kid.
Theresa continued by explaining that while her previous provider espoused the
importance of establishing a trusting relationship with her daughter, in practice he did
little to foster this trust. The provider did not direct questions to her daughter, nor appear
comfortable discussing sexual health issues, which ultimately led Theresa to find a new
healthcare provider:
Well you have to understand this [former] pediatrician. He would come in and
look at me and whispering, say, “Has she gotten her period yet?” Like,
whispering it to me. And I’m like, “She’s sitting right here, ask her.” And he
would whisper, “Has she developed breasts yet?”, and I’m like, “Well, take a look
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at her!” It doesn’t take a rocket scientist [to know whether she has breasts]. It was
almost like he was uncomfortable. It was like, if you can’t even discuss her
having her period, then it’s time for us to change doctors. After Theresa
confirmed that her daughter had begun menstruating, the pediatrician replied,
“Okay, well now it’s time for our talk. I’m no longer your doctor, I’m her doctor,
yada, yada, yada, and if she feels that she needs to discuss anything I want her to
feel free.” And I’m like, you can’t even ask her if she has her period. Do you
think she’s going to be comfortable coming to you and saying I want birth
control? You know, it was just not a good match.
Aside from including children in healthcare conversations, parents instilled trust
in providers who spent time with them. Parents generally recognized the time demands of
health practitioners, which might be one reason that parents often pointed to the length of
time providers spent with them as a key ingredient in forming a trusting relationship. It
was not only the amount of time that a provider spent with parents and children, but the
efforts taken by the provider to solicit and respond to parent and child questions and
concerns and educate and inform parents as to the basis of their recommendations and
advice.
Parents did not want to feel rushed. They wanted to feel that their providers were
fully engaged in the visit, open to their questions and concerns, and willing to answer
questions thoroughly. A rushed provider, parents felt, was less likely to detect specific
issues or conduct an exam or evaluation based on the child’s unique, individual medical
history. Faith valued her pediatrician’s “never-in-a-hurry attitude” and Courtney boasted
that her daughter’s last wellness check – when the provider also discussed the Gardasil
347

vaccine – lasted an hour. For Courtney, the amount of time the doctor spent with them
was “what made me comfortable as a mother. Where at other times with other physicians
you feel like they’re just trying to get you out the door for the next patient to come
through. You never felt you were being rushed.” Christina appreciated the time and care
her provider took to answer her questions. “He would talk over anything with you, if you
had a question it was going to be discussed until you felt comfortable. He’s an older
doctor but he’s very cool about giving you the time you needed.” Again and again,
parents equated trust with the sense that providers were engaged in the visit and willing
to take the time required to answer questions and thoroughly examine the child:
Putting the Child First
The time providers spend with parents is one of a larger constellation of trustbuilding activities or behaviors related to putting the needs of the child first. Parents
trusted providers who demonstrated a commitment to the parent and child, especially
when parents believe that these commitments were not in the provider’s own economic or
personal interests. Melissa recalled her former pediatrician, who knew the family was
uninsured, used to give her sample medications rather than writing her a prescription and
would encourage her to go the health department for vaccines so that they did not have to
pay any out-of-pocket expense.
Another mother, whose son has a rare disorder, recounted one of many
experiences that led her to trust his doctor. Concerned about some of her son’s
symptoms, she called the physician, who instructed her to meet him at the emergency
room. She felt that most doctors would have deferred the exam until the work week,
when they could examine her son in their offices. She explained, “This was that Sunday
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morning of that Miracle Network Marathon, where [the doctors are] on TV all the time.
He was dressed to be on TV and he came to meet my son in the ER.”
Developing trust in a provider also related to the prescription or non-prescription
of therapies, especially when parents’ perceived that the provider was making a
recommendation specifically based on the needs of the child, and not as standard practice
or routine. In some cases, this entailed the prescription of medications that were not
usually given to children. In other cases, it involved withholding routinely prescribed
medicines due to unique factors. Several parents pointed to cases in which they
themselves had asked providers about newer drug treatments for their children, only to be
advised that these treatments were not in the best interest of the child. In these cases,
parents respected that providers did not simply acquiesce to their own (parents’) desires
for the newest and most highly advertised technologies.
Conservative prescribing also assured some parents, especially those who were
concerned with the general over-use of medications, that their provider would not give
their children any treatment that was unnecessary. In particular, some parents interpreted
conservatism in the prescription of new medicines as a sign that providers were immune
to pharmaceutical lobbying, thus making careful and deliberate decisions based on the
safety, efficacy, and need for a treatment, rather than on heavy marketing, manufacturer
incentives, or media and consumer hype.
Melissa, who had recently moved states, worried about pharmaceutical influence
on provider recommendations; for this reason, she had found it difficult to find a new
pediatrician who she felt she could trust. Selecting a trustworthy provider was
challenging not only because it required her to know something of the factors that
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motivated him or her to practice medicine, but also because she had yet to establish close
ties to other parents in the community from whom she could seek provider
recommendations.
I worry about the sway of advertising. And I don’t know anyone down here so I
don’t know who’s a good doctor, who’s a bad doctor. Who prescribes or pushes
certain things because of the drug company? I had a friend who was in pharma
sales, so do [the providers] push certain things because they’re getting perks or
because they really believe in that medicine? Have they done recent research,
have they looked at the medical journals and then say, “Okay, yeah, this is what
we should be using”? Or are they just like, “Hey, I remember that pharmaceutical
sales woman came by and said I should use this, so I’m going to use it.”?
Like many parents, Melissa also differentiated between individual providers and
the healthcare provider community as a whole. Before moving to Florida, Melissa had a
pediatrician who she described as incredibly trustworthy. However, she also believed
that her provider was unique, or at least that he was not the only type of provider who
practiced medicine.
Trusting Mother’s Instinct
Although many parents pointed to their faith in a provider’s medical expertise as a
reason to trust him or her, some parents, especially mothers, trusted providers who trusted
the “mother’s instinct” and that took seriously the observations, concerns, and intuitions
of mothers. Just as some parents trust providers who trust daughters, mothers trust
providers who trust mothers. Several mothers pointed to specific cases in which their
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faith in providers was solidified or challenged based on providers’ willingness – or
unwillingness – to trust the mother’s instinct that something was wrong.
When providers were perceived to discount, ignore, or belittle a mother’s
knowledge, a sense of trust was lost. One mother explained that in her younger years,
she used to follow doctor’s orders without question. She reconsidered that approach
when a doctor failed to diagnose her son as asthmatic.
When I had children I took the doctors at their word. When the doctor said he
couldn’t hear the raspiness in my son’s voice, my life changed. Because I
realized that as a mother I am more in tune with my children and sometimes you
have to fight for what your child needs. Where somebody else might not
recognize it because they’re not around your child 24 hours a day, 7 days a week.
Providers as Parents
Often times (n=9) trust was associated with attributes or roles of the provider
beyond that of healthcare practitioner. Most often, parents ascribed trust to providers who
shared a dual role as parents themselves, and who could consequently understand the
anxieties, fears, and realities unique to parenthood. Parents appreciated when providers
made treatment decisions and recommendations that accommodated parents’ busy
schedules. They also found that providers with children were more understanding when
parents had difficulty adhering to all of their treatment recommendations.
Christina stopped seeing a particular physician after he refused to prescribe her
son with an antibiotic for an earache. She felt that the provider made a poor decision in
withholding medication for her son due to his specific medical history. She also felt the
provider (who did not have children of his own) discounted the physical suffering her son
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would endure if his condition worsened, the sleep she and her husband would lose if he
failed to improve, and the time and money that would be wasted if he required additional
treatment. She explained,
[The doctor] looked in the ear and the ear looked questionable, which is a term –
when and if you have children you’ll hear that a lot and want to punch somebody
because it means that you have an ear ache developing. So he’s not going to treat
it today. Nope. Your kids going to have to get sick over the next 48 hours and
you’re going to have to come back, pay another doctor’s bill – which doesn’t
grate you that much because you’re going to do what you got to do for your kid.
It’s the trip back with the sick kid when you could have prevented it.
In describing her reaction to his clinical decision, Christina highlights the importance of
treating children as individual cases, valuing the mother’s intuition, and respecting the
demands of parenthood in establishing and maintaining trusting relationships. She felt
that the provider, aside from ignoring her own instincts and her son’s medical history,
failed to appreciate the additional burdens on the family that a provider with children of
his own might understand.
Some parents worried that providers without children of their own could not
understand the fears, concerns, and anxieties that parents face when making healthcare
decisions on behalf of their own children. Deborah wanted providers to empathize with
her reality as a parent. When her pediatrician tried to allay fears she had about
vaccinating by telling her that she was worrying for nothing, she responded, “Yes, but
when you’re a mom, you worry about everything”. Parents feared that childless
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providers might make recommendations to parents based on population-based health
priorities, rather than on the characteristics and needs of individual children.
One mother described how her opinion of one pediatrician in her practice changed
considerably after the pediatrician herself became a mother:
There’s one doctor [in the practice] that I didn’t think much of and then she had
her own children and she’s a much different doctor. She’s a much better doctor.
She gets it. She understands it. You know, it’s one thing to be a doctor and to
say, ‘Well you know, you should be doing this, this, and this’. Okay. And in
reality, yes, I should be. But, the other side of that reality is that it doesn’t always
work that way. You know, and now that she has children she realizes that it’s not
just textbook. It’s, you know, yes, you should get your child to take his vitamin
every day. And you think they’re taking it every day and you find a pile
underneath the bed one day and you say, “What the heck, what’s going on here?”
You know, she’s just, you know she’s learned through first-hand experience. But
really she’s my favorite doctor now.
The common assumption woven throughout many of these trust narratives is that
parents’ providers are special, and the level of care, time, concern, and understanding
shown by their providers is rare, or at least not representative of all providers. In
differentiating their providers as unique, parents either implicitly or explicitly
communicated a lack of trust in providers as a whole. The general lack of trust parents
had in healthcare providers might actually foster an increased sense of trust, and
confidence in their individual providers. In perceiving their children’s providers as
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uniquely skilled, highly involved, well-informed, and well-intentioned, parents might be
willing to put more faith in their providers’ recommendations.

Provider Trust and Vaccine Recommendations
Provider recommendations are key to parent healthcare decisions, both regarding
vaccines, and in general. A specific recommendation for the HPV vaccine was a
significant motivator for many parents to get the vaccine, but only among parents who
also had faith in their provider. For example, one mother was originally unsure about
Gardasil, but ultimately had her daughter vaccinated. “What really swayed me was what
my pediatrician thought and he strongly recommended it. One pediatrician [who
recommended the HPV vaccine for my daughter] has been with her since birth and the
gynecologist [who also recommended it] delivered her. I trust them implicitly.”
The vote of confidence in provider recommendations was a recurring theme in
most interviews. Explaining the underlying reason she vaccinated her daughter, one
mother said, “For me it’s a trust issue. I do what my provider says.” Another mother
echoed this sentiment, “I put a lot of trust and faith in my kids’ pediatrician. And if he
recommends it . . . then I think [the vaccine is] a good thing.”
As the above quotes indicate, “trust” is key to validating the provider
recommendation. Several parents clearly emphasized the fact that their faith in a provider
recommendation was contingent upon the trust relationship that they had established with
a particular provider, meaning that an unknown provider recommendation was of little
value on its own. As one mother explained it, without trust, provider endorsements mean
little: “We do what the doctors say because we trust our medical professionals. We won’t
stay with a doctor we don’t trust. I doesn’t take but two visits to say, mmm, not gonna do
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it.” Another mother expressed similar sentiments, “It’s something that, if the doctor says
it’s good – and I trust our doctor. I mean, if it was a doctor I didn’t trust I’d probably
second guess myself, but I don’t have any qualms about [my doctor’s] decision [to
recommend Gardasil to my daughter].
In other words, the status of “healthcare practitioner” or “medical expert” carried
little weight on its own; to gain credence, trust was essential. Lest the relationship
between trust and provider recommendation be unclear, consider the following two
examples:
Even Melissa, who did not currently have a primary care physician for her
daughter, thought that she probably would have already had her own daughter vaccinated
if they still were seeing their previous provider in another state. Her indecision about the
vaccine largely related to the fact that she did not know any healthcare providers in
Florida, and therefore could not be sure that their recommendations would be
trustworthy. She explained,
I think as sort of a normal parent, I’d go to my doctor and whatever my doctor
says, I trust my doctor. So if I had a regular care physician who I had built a
relationship with, and he said, ‘I really think your daughter should get this. I feel
like the evidence shows that she’d be safe and that this would protect her.’ Then
I’d say okay, I’m on board with it. So it’d be really dependent on that relationship
with him and what he felt about it. But I don’t have a relationship with a primary
care provider here, so I don’t know.
Just as parents place trust in providers who are parents themselves, parents value
recommendations based on providers’ willingness to vaccinate their own children. If
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providers felt confident enough to give the vaccine to their own children, then surely,
parents reasoned, the providers truly believed in the benefits and safety of it.
When Alice took her 9 year old daughter for a wellness exam, she had heard of the HPV
vaccine but had not done any research regarding it.
I asked the pediatrician about the shot because I trust her and I know her. And so
I just asked her her opinion on it because she’ll tell me the truth. And she has two
daughters of her own so I said, ‘Would you get it for your daughters?’ And she’s
like, ‘Oh yeah, definitely. When my girls are old enough they’ll be getting it
too”. So when she said that it just definitely made up my mind that I would get it
for her.
For Alice, her provider’s endorsement was sufficient because she trusted her
competence and believed that her provider would never give her own children a vaccine
that she did not believe was safe and worthwhile. It is also significant that Alice
emphasized familiarity with the provider in establishing trust. Alice’s children were
Medicaid recipients and she took them to a university-affiliated teaching clinic for care.
Before her regular-care physician saw the children, they were examined by an attendant.
Alice took attendant recommendations with a grain of salt, not so much because they
were residents in training, but because she did not have a well-developed, long-term
relationship with them. They did not know her or her kids. Consequently, she felt like
they would view her children as if they were any other children. She had faith that her
primary physician would make decisions and recommendations for her children as
individuals.
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Several parents (n=4) specifically asked their providers whether they had or
would have their own daughters vaccinated; in some cases (n=3), providers mentioned
that they had vaccinated their own daughters before parents even had a chance to bring it
up. Faith asked her provider for his opinion after she read over HPV vaccine literature.
“He said, ‘I think the benefits outweigh the risk. My own daughters have had it.’ So I
mean, upon faith is what I have done with [my children’s provider].”
Two parents also delayed or refused Gardasil based on provider disclosures that
they had not, or would not, vaccinate their own daughters. In one case, a father who had
planned to have his daughter vaccinated with Gardasil deferred the decision after
discovering that his pediatrician had not yet decided whether she would vaccinate her
own daughters. A year later, when she told him that she planned to have her daughters
vaccinated, he consented to have his older daughter begin the series.

Chapter Ten Summary
Because trust is situated within larger socio-political, interactional, and relational
contexts, its nature cannot be understood by approaching vaccine decisions as singular
outcomes (Brownlie and Howson 2005). When considering vaccines, parents’
motivations to trust different actors must be seen as multi-dimensional and contextdependent, but also as processes that are situated, temporal, and child-dependent.
In assessing trust in Merck, government agencies, healthcare providers, and society as a
whole, parents spoke to the importance of institutional and systemic qualities of trust,
which parents used to position actors, define their roles, and assess the trustworthiness of
their motives. Structural relationships among pharmaceutical and insurance companies,
government agencies, and public health laws are important to examine historically,
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generally, and in relationship to specific vaccines, because, as I have argued throughout
this dissertation, these processes shape the ways that parents come to perceive vaccines as
manifestations, actions, and symbols of larger systems.
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Chapter Eleven –Decision-Makers

As previously discussed, parents gather information from diverse sources,
including vaccine manufacturers, media reports, government agencies, healthcare
providers, family members, personal experience, and other parents, peers, and colleagues
in an effort to inform themselves about the risks and benefits of Gardasil vaccine and
HPV. When it comes to making vaccine decisions, all of this information, and the sources
from which information is obtained, has to be weighed: Are sources credible? Whose
interests are various stakeholders protecting? Can providers be trusted to put the needs
of children first? Can daughters be counted on to communicate truthfully about their
sexual readiness?
Who sorts through competing and conflicting information and decides what
information is paramount to making an HPV vaccine decision? This chapter describes
the roles that parents, spouses, and daughters play in the decision-making process and
how notions of gender, maturity, and responsibility become central to defining who
participates in the decision and to what degree.
I begin by describing the role that parents, as mothers and fathers, take in
decision-making. As will be demonstrated, the expectation that one or both parents
contribute to healthcare decision-making is intrinsically connected to assumptions about
motherhood, parenthood, and parental responsibility. In the latter half of the chapter, I
address the daughters’ role, or lack thereof, in general vaccine and Gardasil-specific
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decisions and the types of information that parents think daughters should be privy to
regarding the purpose of the Gardasil vaccine.

Parental Responsibility
In general, parents identified themselves as the key decision-maker in all vaccine
decisions, including Gardasil. Fathers (n=3) were more likely to describe vaccine
decisions as an equally shared responsibility between themselves and their wives. Only
one father described himself as the sole decision-maker in his partnership. Mothers, on
the other hand, rarely described their husbands (or daughters’ fathers) as playing a key
role – if any role – in the process. Sixteen mothers said that their husband or daughter’s
father had little or no role in vaccine decisions. Five women said their partners had a
peripheral role in decision-making, and only one woman said she and her husband
equally contributed to vaccine decisions.
That the majority of women claimed sole responsibility for vaccine decisions
reveals the gendered nature of decision-making. The idea of their partners contributing to
vaccine decisions was so inconceivable and ludicrous to some women that they
responded to inquiries about their partners roles with laughter. I asked Natalie whether
her husband played a role in decisions and she responded, “No! (laughs). Absolutely not.
He pretty much goes with what I felt they should get.” Lucy was laughing so hard when
I asked her if her husband contributed to vaccine discussions she could only shake her
head no and point to herself to indicate that she was the only parent involved in the
decision. Wendy scoffed when I asked her if her husband knew which vaccines their
children had received, replying, “Oh my gosh. He’s been to one parent conference out of
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all three kids. One. For [our son], in fourth grade. It’s easier for him not to be
involved.”
Many women took it upon themselves to make these key decisions and often
times either did not mind, or appreciated that their husbands/daughters’ fathers trusted
them to make these decisions. When describing the role her husband plays in vaccine
decisions, Rachel said, “I talk, he listens (laughs)”. Faith explained that her husband had
little role in most healthcare decisions, especially vaccinations, because this was part of
her domain. “We certainly talk about medical issues, but that’s my domain. He trusts me
in that regard. I mean that’s kind of why I’m a stay-at-home mom. That’s my job. You
know, I trust him to do his job and he trusts me.”
Five women described their husbands as having at least some peripheral role in
vaccine decisions. Deborah always discussed vaccines with her husband before taking
her kids to the doctor, but stated that his interest was short-lived and largely economic:
“He discusses these things for about 20 seconds. [He might ask], Is it really expensive?
Can we afford it? What’s the long run? I mean he’s just like a couple of questions and
move on.”
The father’s limited role in vaccine decision-making could relate to the fact that
these women typically take their children to the doctor, and many parents make vaccine
decisions during the office visit. Jean noted that her husband doesn’t have a role in
vaccine decisions because “He’s usually not the one taking her. Because my schedule is
always more flexible and I was the one going back and forth to the doctor. I mean we
might talk about it but he’s actually never been in involved in the decision making
process.”
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Three of the four fathers described vaccine decision-making as a joint process
where both partners contributed to decisions. “We talk about these things and it’s a joint
decision . . . It’s not my domain or her domain in terms of the household decisionmaking.” Mark said that he and his wife “would have a big conversation” about the
Gardasil vaccine, but that he would never make a decision without her input. On a
general level, as well, most fathers (n=3) said that they would not make a vaccine
decision without first consulting their wives.
Providers noticed a similar pattern. Providers observed a significant caregiver
gender bias in their own practices. One provider estimated that at least 85 percent of the
parents that accompany children to the office are mothers. In fact, providers so strongly
associated mothers with healthcare decision-making, that all providers used the word
“mother” to indiscriminately discuss parent healthcare decision-making at least once, if
not throughout the interview. Even when fathers brought children to the office, providers
noted that mothers generally remained the decision-makers. Several providers observed
that most men who accompanied their children to the office would not make healthcare
decisions without first speaking to their wives. In three years of recommending the
Gardasil vaccine, Nina recalled only one father who consented to having his daughter
vaccinated during the visit. She recounted, “I think I’ve had one dad in the last three
years that said okay to the HPV. One dad. That’s all I can remember. All the other
dad’s say, ‘Oh, nope. Have to talk to mom about that.’ It’s one man that stands out in
my mind. He said ‘Yeah, go ahead. Do it.’”
Providers noticed this trend regardless of whether the father was the primary
caretaker or person to typically accompany children to healthcare visits.
362

In describing the gendered nature of healthcare decision-making in her family practice,
Jane observed that men tended to consult their wives not only regarding their children’s
healthcare, but their own:
The times are such that we see more and more fathers as primary care-givers – as
the person who watches the kid during the day and then works at night. We have
a number of fathers that bring their kids in. I wouldn’t say it’s the majority, but
[even in these cases] the mother makes the health decisions, even for the man.
Not just for the kids. The mother’s making the health decisions for her husband
too. That’s one of the problems when the man brings them in is they need to now
call up the wife to ask what she wants. So they’re the caregiver but they don’t
make the health decisions. I mean each case is different but I would say that’s
very common, that the dad brings the kid in but the dad doesn’t know anything
about what they want. You know, or what they’ve had. But cell phones have
solved that problem. It used to be more trouble – just call them up
Through countless clinical exams, providers begin to observe patterns in the ways
that parents respond to particular types of information. Provider expectations about
parents can shape the ways in which they choose to interact with the patient and parent
during a clinical exam. For example, Nina generally accepted that when fathers brought
daughters to see her, she would not be able to administer the Gardasil vaccine to them.
She said, “[When] I see they’re with dad I think to myself ‘Ugh, well I know they’re not
going to do any of the HPV. It’s definitely out’. I know it. Like I already know. Of
course, I broach the subject but I know it’s out because he has to talk to mom.” Although
the provider mentions that she broaches the topic with men, it is unclear whether her
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assumption that they will definitely decline it factors into the amount of information she
shares with them or how she presents material.
Parents, especially mothers, placed upon themselves the primary responsibility for
protecting their daughters and making healthcare decisions for their daughters. In
explaining why they made (or likely would make) specific HPV vaccine decisions, many
parents talked about parental responsibility to protect and prepare daughters for the
future. The two mothers who were not planning to vaccinate their daughters (Natalie and
Rachel) both referred to parent responsibility when explaining why they were against the
vaccine. These two women saw it as their responsibility to educate their daughters about
sexuality and making healthy choices, though what constituted healthy choices varied
considerably. A description of how these mothers conceptualizations were linked to
promiscuity are discussed fully in Chapter Eight. Here, I touch only upon aspects of
Natalie’s perspective that are specifically relevant to notions of parental responsibility.
Natalie saw high rates of teen pregnancy and sexually transmitted diseases as the
result of poor parenting. She remarked, “This generation knows more about birth control
than any other generation, so why is there still teenage pregnancy? I think parents need
to start doing their job.” When I asked Natalie what a parent’s job was, she replied,
Well their job is to teach – their job is to equip their children to go out into the
world and make good decisions for themselves and for their lives and for their
bodies. That’s what I think part of their job is . . . I think it’s our job, to just keep
them informed and keep them, you know, thinking critically about their decisionmaking.
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For Natalie, the best way to protect her daughter from HPV was to teach her to
treat her body well, which included, among other things, eating a balanced diet,
exercising, taking probiotics and supplements, getting annual pap smears, avoiding casual
sex, and having protected sex with mutually monogamous partners. The mother reasoned
that if her daughter followed this advice, she would likely be healthy enough to naturally
clear an HPV infection, even if she acquired it. Both of these parents saw protection and
responsibility in black and white terms: parents either educated their daughters or
vaccinated them, but not both. These mothers framed the issues of protection and
responsibility in such a way that responsible parenting precluded giving their daughters
the Gardasil vaccine. It did not cross Natalie’s mind that other parents might both
educate their daughters and vaccinate them – for her education and the vaccine were
mutually exclusive alternatives. “To me it’s like, where are the parents? Why would you
choose a vaccine for your child over educating them about what they should do?”
Natalie and Rachel’s conceptions of parental responsibility were markedly
different from other parents in that responsible behavior led them away from vaccinating
their daughters against HPV. For other parents, and some providers, responsible
parenting meant that parents provide their children with every safeguard and protection
available, including education and vaccinations. Ann felt that with time, parents were
reframing Gardasil to fit more closely with a frame that commands that responsible
parents vaccinate their children. With time, the Gardasil vaccine is “just like any other
shot. If you’re a good parent you get your child all the recommended vaccine. There’s
that big group of people that that kind of applies to. And so they’ve kind of gotten beyond
the sex thing. They can just think to give it as a vaccine now.”
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The parents that are expected to make healthcare decisions, and on whom
responsibility is both self and externally assigned, are overwhelming mothers. In many
cases “parent” is a proxy for “mother.” As previously discussed, most mothers take their
children to healthcare visits and are the sole or joint vaccine decision-maker, even when
they are not the ones accompanying children to the appointment. Many mothers
internalize the responsibility of making the best decisions for their children and see it not
only as a strategy to protect the wellbeing of their children, but as a reflection of their
parenting and an evaluation of their ability as “mothers”. Courtney’s rationale for
vaccinating as an effort to do “anything that I possibly could, as a mother, to help ward
off any type of cancer” was prototypical.
The ability to make the “right” healthcare decisions for the “right” reasons was
one way in which women assessed their own and other women’s mothering abilities.
When women spoke about non-vaccinators, critical commentary was nearly always
directed at mothers who were perceived as making irresponsible decisions. One mother
criticized mothers who refused the vaccine as arrogant and ignorant. “I’m just saying
there may be some mothers that are like (snobby voice) ‘My daughter’s not going to be
getting the disease from having sex. I’m not giving her the vaccine.’”. .
For four mothers, good mothering meant taking a more active role in vaccine
decision-making. Good mothers protected their daughters’ health, bad mothers did not.
Notions of motherly responsibility emerged when discussing the possible licensure of
Gardasil for boys. When I asked Monica whether she would vaccinate her son against
HPV, were a vaccine available, she responded, “I think that the moms of the daughters
can vaccinate their own daughters. I mean that would be kind of the selfish feeling, I
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guess. It would be nice if the mother of the boy would have the boy vaccinated so that
girls wouldn’t be harmed, potentially, whose moms didn’t take them for the vaccine.” In
Monica’s view, mothers should vaccinate their sons to protect daughters whose mothers
were irresponsible. Lucy expressed a similar sentiment when I asked her how parents
might respond to an HPV vaccine for boys. Again, she placed the onus of responsibility
specifically on mothers: “’What? You want me to protect someone else’s kid? Why
don’t they protect her? Why should I protect them? They’ve got a mom.”
Natalie was recounting a conversation that she had with her twenty-two year old
son about safe sex. She asked her son whether he was using protection, and he responded
that his partner was using birth control pills. She replied, “I’m not asking how she’s
protecting herself from being a mother. I’m asking how you are you protecting yourself
from being a father? So okay, she can take one for the team, but we’re not talking about
her. That’s her mom’s job. To talk to her about what she’s doing. With you, it’s my job
to talk to you about what you are doing with her.” Once again, mothers perceive it as
their role – or the role of other mothers – to ensure that children make responsible
decisions and protect themselves or others.
Some women saw it as their responsibility not only to protect their own children,
but the children of other, (presumably) less responsible mothers. Jill spent an entire day
discussing puberty with her daughter, “not so much for her physically, but some of her
friends. We got this book and I said, this is what’s going to happen to you and right now
it’s happening to some of your friends. And maybe their mom’s aren’t talking to them,
so I want you to be able to understand or help them if something happens.” In this case,
Jill believed not only that it was a mother’s job to prepare her daughter for developmental
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changes, but that it was the responsibility of other women (and girls) to educate daughters
when their own mothers failed.
Because all of the parents I interviewed saw themselves as the primary or joint
decision-makers regarding Gardasil, they were well positioned to speak to the role their
daughters played, or might play, in vaccine discussions and decisions. The next section
deals specifically with the daughters’ position in relation to vaccine information and
decision-making.
Daughters’ Roles in Gardasil Discussions: Sexuality and Childhood
The most significant difference between general vaccine decisions and the
Gardasil vaccine decision was the daughter’s role in the process and the types of
information parents felt compelled to share with girls about this vaccine. Most parents,
regardless of their daughters’ ages, did not typically ask their daughters how they felt
about receiving recommended immunizations. Normally, parents consented to vaccines
on behalf of their daughters without asking their daughters whether they wanted to be
vaccinated. In some cases, parents or providers explained to girls something very general
about why the vaccine was necessary, though this was not always part of the regular
vaccine routine.
The extent to which daughters played a role in the decision-making process
depended on a complex web of factors, including the parent’s comfort level discussing
sex and his or her perception of vaccine need and benefit. Along with these
considerations, parents also evaluate their daughter’s age, her level of emotional and
sexual maturity, and her ability to make careful, balanced decisions regarding her longterm health and well-being.
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Many parents perceived that their daughters were more involved with and played
a more active role in the Gardasil decision-making process that with other vaccines.
However, in a few cases, Gardasil was intentionally administered at an early age so that
parents would not feel obliged to include their daughters in the decision or explain to
them how HPV was transmitted. In other cases, Gardasil vaccine decisions were delayed
either at the request of the daughter, or so that the daughter could eventually take part in
the decision.
A central concern for many parents regarding this vaccine, and not others,
pertained to the amount and types of information a child should receive about the purpose
of the vaccine. With the exception of Gardasil, explanations of vaccine benefits, disease
risks, and mode of transmission did not routinely factor into parent-child communication
about vaccines they were going to receive. Not a single parent explained to his or her
child the purpose of the other childhood vaccines that she would receive or why the
vaccine was important. Yet many parents either intentionally wanted their daughters to
understand what the HPV vaccine protected against, and in some cases, how it was
transmitted, or explicitly wanted this information to be withheld from them. In either
case, considerations regarding HPV information sometimes led parents to delay
vaccination or vaccinate earlier than they might otherwise.
By administering the vaccine before their daughters understood the link between
HPV and sexuality, some parents (n=4) hoped to avoid grappling with questions about
the role daughters should have in choosing the vaccine or to alleviate concerns that they
would interpret the vaccine as a license to have sex (or be at a stage where they were
even interested in sex). Barb, who had her daughters vaccinated, treated Gardasil like
369

any other vaccine they receive. “I just told them it was something they had to have and
they just went with it.” When I asked her why she vaccinated her daughters’ years before
she expected them to be sexually active, she answered, “I guess just so we don’t have to
cross the bridge later. Once they do become active it’s not something that I want to have
to talk about, saying you know, just because you’re doing this, maybe you should get this
shot. Have it now and they don’t have any questions and it’s in their system (laughs).”
Victoria, who planned to have her daughter vaccinated in the next few years,
planned to tell her that Gardasil protected against cervical cancer. When I asked her if
she would explain to her how HPV was transmitted, she replied, “Probably not. I will
probably leave that little bit out.” When asked why, she explained, “Well, probably for
the same reason that (laughs) there will be parents that don’t want to give it. If she is
under the impression that it protects her more, that she could have unprotected sex, then I
don’t want her knowing that because that’s only one reason – you still shouldn’t have
unprotected sex. Period.”
Some parents questioned whether they needed to tell their daughters anything
more about this vaccine than they did about other vaccines. These parents saw no reason
why their daughters should know that the vaccine protected against a sexually transmitted
disease, and Tony argued that this was a simple way to allay fears that girls would
interpret the vaccine as a license to engage in sexual activity. He recounted several
conversations he had with friends who said thing like, “I’m never going to get that for my
daughter because that promotes sexual behavior.” When he would hear this type of
argument, he would respond,

370

You don’t have to explain what it is to her. [And they say], “Oh no, I’m real
honest with my daughter.” “Did you explain what the chicken pox vaccine was
for? No? Why?” “Because she was little.” “Well she’s too little to know what
[Gardasil] is too.” “But I – she needs, she has the right to know [what Gardasil is
for].” “No she doesn’t. No she doesn’t. How old is your daughter? Thirteen?
They don’t have the right to do anything. She has the right to do what you tell her
to do. You want to explain it to her, tell it’s for cancer? You’re not lying.”
Many parents did not, or would not consult their children when making HPV
vaccine decisions because they doubted their daughters possessed the maturity and longterm foresight necessary to make an informed decision about the HPV vaccine. In
particular, parents questioned whether their daughters had the ability to differentiate the
short-term risk of vaccination – primarily pain and fear of needles – from the long-term
benefits of the vaccine. Evelyn had hoped her daughter would recognize the benefits of
the vaccine and independently ask for it, but her daughter simply could not get past the
short-term pain associated with vaccinations: “She was focused on the negative because
she doesn’t like to get shots. But you know what, at 15 you just don’t get it. . . [Her]
whole focus was on getting the shot. She doesn’t know anyone who had cervical cancer.
At 15 you’re invincible. The idea of doing preventive stuff doesn’t hit home. For her it’s
subjecting herself to pain but without the insight about the long-term benefit.” Another
mother doubted that her daughter would be able to partake in any vaccine decision
because of her fear of needles: “I know she’d probably freak out if she knew she had to
get a shot. If there was an option to say no, she would say no.”
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Often girls became so fixated on the anticipated pain of receiving an injection that
parents and providers questioned whether they could even process the information that
was being presented about the vaccine itself. Patty tried to explain to her girls why they
were getting the Gardasil vaccine, but she wasn’t sure that the message sunk-in: “I don’t
think they really understand what cancer is or how dangerous cancer really is. They
weren’t happy because it’s three shots (laughs). One’s bad but oh my gosh, you have to
go back two more times? They were horrified”.
Providers agreed that if left to their own devices, many girls – regardless of age –
would probably refuse all vaccines for no other reason than their short-term desire to
avoid pain or their fear of needles. In most cases, mothers ended up invoking their
parental authority to ensure that the vaccines were administered. Jane described a routine
interaction she observes in her practice, “I see lots of arguing, but it’s usually the child
saying, ‘I don’t want a shot’ and the parent saying, ‘you’re taking it, I don’t care’. I see
that a lot with pre-adolescent and especially adolescent girls. They don’t want them.
And the mother says get them anyway.”
However, some parents provided their daughters with at least some role in the
vaccine decision-making process or planned to include their daughters in the decision
when they were more mature. Some parents were willing to postpone making a decision
about the Gardasil vaccine until their daughters were emotionally mature enough to have
a conversation about HPV disease transmission and balance their fear of needles with an
assessment of the risks and benefits of the vaccine. Courtney had tried discussing the
Gardasil vaccine with her twelve year old daughter, but dropped the conversation when
she became upset about the possibility of receiving shots. While she would eventually
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have her daughter vaccinated, she was unsure when they would have it done: “I’m going
to actually gauge the conversation, when it gets closer to September, with [my younger
daughter]. When we have to start talking about shots again. If she is not understanding
why we’re doing this, what in the world it’s about, I probably won’t do it. I don’t see a
negative from waiting from age 12 to let’s say 15.”
Though few parents required – or even invited – their daughters to participate in
other vaccine decisions, it was essential to some parents that daughters accept some
degree of responsibility in choosing to receive this particular vaccine, because unlike
most other vaccines that children receive, Gardasil protects against a disease that is
sexually transmitted. Thus, while most children are at relatively similar risks of
contracting other vaccine-preventable diseases, they are not at equal risk of contracting
HPV. In the case of HPV, the daughter plays a key role in determining her own level of
exposure to the virus.
One mother waited over two years to have her daughter vaccinated because she
wanted her daughter to not only understand why the vaccine was important, but want to
get the vaccine. After five visits, her daughter still did not want the vaccine. On the sixth
visit, Lucy decided that her daughter would be vaccinated, regardless of whether she was
ready. When I asked her why it was so important that her daughter participate in this
vaccine decision, she explained:
For those kinds of disease that the regular vaccines are for, she’s not really going
to be – I don’t feel she’s going to come in contact with anybody really. You
know unless she travels outside the country. But for this vaccine it was very
important for me to show her how responsible, and how sex is not a laughing
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matter. And for her to understand how easily things can get transmitted. And I
wanted her to understand where we were coming from and then be able to tell me,
‘Okay mommy, I’ll do it [. . .] I wanted her, you know what I’m saying? That sex
is a choice. The other vaccines are not a choice. You know, someone’s not going
to come up and rub you and say, ‘Here, here’s rubella’. Or you know, she doesn’t
have to think about it. But this one, you have to put more thought into it and
make her more responsibility and maybe think more before she leaves.
Mark was conflicted about whether he would involve his daughter in decisionmaking about Gardasil given that she does not have a role in other vaccine decisions. On
the other hand, because the disease was sexually transmitted, he thought it might be a
good opportunity to incorporate the vaccine into future sexual health talks.
Don’t say any of the other ones, but the other ones aren’t necessarily anything that
would be preventable by their choosing. I mean, by saying, “listen we’re getting
you vaccinated for chicken pox because there might be some day that you decide
to hang out with somebody who has chicken pox and you might get it.” So we’re
– in other words we don’t do that but it’s nothing that they would – this is
something that, in theory, they wouldn’t get except for that type of contact.
Which makes it, you know, something that could be part of the talk.
Some parents wanted their daughters to act autonomously and responsibility in
choosing the Gardasil vaccine, partially so that their daughters understood the limits of
vaccine protection, but also to reassure themselves that their daughters were capable of
making responsible choices (both regarding healthcare and in protecting their own sexual
health). Lucy stressed values of individuality, individual responsibility, and self374

protection when explaining to her daughter why she should get the vaccine, “You know,
you have to do this for yourself. Because you don’t know what other people have been
through and what they’re doing with their selves. But you need to take care of yourself.”
Parents provided a limited and contingent role in the decision-making process.
Granting power – not just consideration – to the thoughts and wishes of the daughter was
provisional and dependent upon the child making a decision that was congruous with the
desires of the parent. In other words, daughters’ vaccine desires were respected so long
as they conformed to the parents. Melissa explained that while she, her husband, and their
daughter discuss issues as a group, parents have the final say: “We joke that we’re a
democracy but my husband and I still win – are in charge. But we seriously consider all
opinions when we’re discussing anything.” Parents maintain and justify an unequal share
of power in making healthcare decisions for their daughters because they still see their
daughters as lacking the experience and wisdom to always make informed decisions.
Parents want to give their daughters the opportunity to develop these skills without giving
up the protective ability to override what they see as poor decisions. Jean put it like this:
“In my house [my daughter] gets to be involved in making decisions but she doesn’t
usually have the final say. She’s a young adult but she’s still not worldly and doesn’t
always know to make the best decisions for her.”
While parents were generally comfortable having their daughters vaccinated even
without their daughters assent, several parents would go to lengths in order to convince
their daughters to get the vaccine. Bill, for example, would have researched the vaccine
with his daughter and arranged discussions with his daughter and her provider in order to
gain her assent, though ultimately, he would have had her vaccinated either way. Lucy,
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who strongly desired that her daughter assent to receive the HPV vaccine, delayed the
decision for several years because her daughter had not wanted it. “Every time I took her
to the pediatrician he would say to me, “Are you ready to give her the Gardasil?” And
he’s been saying this for maybe a year and a half. And I said, ‘Well I’m not sure, it’s
really up to her’. And then she would say no. Only because she was afraid of a shot.”
Finally, Lucy decided that her daughter would receive the vaccination, regardless
of whether her daughter wanted it. “I said, you have to do this for me, you have to do
this for yourself. And she goes, “Okay mommy, I’ll do it, but you owe me twenty
bucks.” But this time if she had said no – we weren’t gonna walk out of there without it.
So whether I would have had to beat her or pay her off, we were gonna do it.”
Most parents of older teens were not overly concerned with giving their daughters
a role in the decision, not only because they felt comfortable overriding decisions if they
felt them to be harmful, but also because most daughters, when provided with a role in
the decision, deferred to the recommendation of their parents. One mother predicted that
her daughter, if given a choice about the vaccine, would do whatever mom said was best,
“She tends to follow exactly my opinions very closely.”
In some cases, daughters specifically asked their parents what they thought was
best (n=4), and in all cases, took that advice. Providers affirm a degree of dependence
among older teenagers on the advice and recommendations of their parents. As Sophia
explained, at ages 16, 17, and 18, adolescents are still not making the [vaccine] decision
for themselves.
For some parents (n=2), Gardasil vaccine decisions can be deferred until a
daughter’s eighteenth birthday, when they become legally emancipated adults. Several
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providers also recounted experiences where parents, either out of principle or due to
safety concerns, did not want to have their daughters vaccinated and would therefore
allow them to decide at eighteen. One provider recalled a mother who was scared to
vaccinate her own daughters because she thought her niece had become paralyzed after
receiving the Gardasil vaccine. The mother told the provider, “In theory I believe in
[Gardasil]. I think my girls should get it. But I’m going to wait until they’re older. If
they want to make their own decision when they’re 18 to vaccinate.”
The significance of the eighteen birthday results from a taken for granted notion
“that the process of maturing from child to adolescent to adult unfolds as a series of
naturally occurring stages, that there is a ‘right age’ at which children should develop
certain competencies and acquire particular freedoms and responsibilities” (Jackson and
Scott 1999:92). The age of eighteen, for some parents, marked the boundary between
childhood and adulthood, not only legally, but in a wider sense. The association between
legal emancipation at eighteen and adulthood is so widely accepted that, on one level, it
is taken as an unquestioned truth. In practice, however, many parents and providers
realize that such a clear line demarcating adulthood seldom exists.
While at age 18, young women have the legal right to make autonomous vaccine
decisions, few parents expressed a desire to delay the decision until the child turned
eighteen. Some parents and providers questioned whether the average 18-year old was
capable of making an informed, responsible, and largely independent decision. They
also doubted whether parents who took such a view were acting responsibly. For most
parents, childhood extended beyond the age of eighteen.
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Sometimes parents and providers attributed the need to remain involved in their
children’s decisions to immature brain development and an inability to think critically
about risks. From this perspective, adolescence becomes a time of danger, when poor
decisions can result from hormonal impulses or inadequate brain development. As
Natalie saw it, part of a parent’s job was to continually help children make good
decisions, regardless of their age:
They still make bad decisions when they’re 21 years old because [. . .] the risktaking and critical thinking part of their brain is still not fully developed. So they
drink and they get in the car and they drive drunk. You know, and they do things
they’re not supposed to do but they know is wrong and do anyway. I think it’s
our job to just keep them informed and keep them thinking critically about their
decision-making.
Isabelle, a nurse practitioner, doubted that adolescent girls were able to make well
informed decisions about Gardasil or other reproductive health technologies. She used
the example of Depo-Provera – an injectable form of hormonal contraception lasting
three months – to illustrate the short-sighted approach adopted by many of her young
female patients:
I’m not even sure the way that adolescent minds work, I’m not sure that they’re
even able to think about – it’s just like when I would talk to girls about Depo.
Depo is the very last thing that I recommend. There really have to be extenuating
circumstances before I give somebody Depo, and yet when I talk to the girls about
these are the reasons why – that is leaches the calcium from the bones and I worry
about them when they get a little older. They look at me like, what are you
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talking about? The idea of them ever getting older is just beyond them. They
want to know today what it’s going to do for them.
While parents thought they could take a less active role in their children’s
healthcare, they still thought they needed to provide their children with guidance and
ensure that they were making good decisions. From Jean’s perspective, “even at 17 or 18
[years of age] we have to guide our children in the right direction. Kind of like a onesided conversation. It’s stunning to me that some parents feel that when they get a child
to 17 or 18 we have done what we as parents are supposed to do”
Parents seemed to be unsure of when they could trust their children to make
responsible decisions regarding their own health. On one hand, parents recognized the
need to prepare children for adulthood by allowing them space to participate in their own
healthcare decisions, while also (perhaps) having difficulty in letting children take
responsibility for their own health. Alice recounted a recent experience with her eldest
son to explain why her mothering role did not end with legal emancipation. Her son had
turned eighteen, stopped seeing the pediatrician, and had a job with an insurance plan that
allowed him to choose his own doctor. Despite the appearance of autonomy, Alice
explained that her role of mother, “really doesn’t stop.” Alice was not sure that was a
bad thing either. She recounted that her son had recently called her to ask, “’Mom, my
temperature is 102. What do I do?’ ‘Go to the doctor, son (laughs).’ It doesn’t end.
They grow up but they never stop being your baby. As much as people say, get out of the
house, I want them out – they really don’t. Don’t believe it.”
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Providers who work with young adult populations seem to agree. Jane, who
works with college-aged students, suggested that young adults were more dependent than
ever on the guidance and support of parents:
Oh my goodness, the school – the college group is unbelievable. These kids are
on the phone with their parents in the waiting room. And okay, she’s calling me
in, I’ll call you back when she’s tell me what I have. And the minute you ask
them a question, they say let me call my mother and I’ll ask her. And I thought
geez when I went to school I thought I was . . . and I work with mother’s who
have kids in college and here they are talking to them like three or four times a
day. Call them up. How did the chemistry exam go? Call them up. Did you get
– call them up, I have one mother I work with, she calls her daughter every
morning to get her out of bed. (laughs). And they call them – what do they call
them? Helicopter pads? It’s amazing. They haven’t left home anymore. It’s not
like when you and I went off to school (laugh).

Chapter Eleven Summary
In this section I have argued that parents see themselves as the primary vaccine
decision-makers. Both from provider observations and from the ways in which parents in
my study describe decision-making, it is clear that many parents take it without question
that healthcare decision-making is the responsibility of mothers. Women, in particular,
view healthcare decision-making as their responsibility. That fathers typically will not
make healthcare decisions without their wives’ consent, yet mothers overwhelmingly
make decisions without consulting their husbands, suggests that child and adolescent
healthcare is a strongly gendered domain, even with evolving, more gender-equitable
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care-giver roles. As gendered events, women often describe vaccine choices not just as
decisions influencing the health and well-being of their children, but as assessments of
their own worth as parents and mothers.
For many parents, the typical vaccine ritual was altered – sometimes dramatically
– when it came to the Gardasil vaccine. In the case of Gardasil, some parents discussed
the vaccine beforehand with their daughters and provided more information about the
reason the vaccine was important. Some parents noted that the provider spent more time
explaining aspects of the vaccines to their daughters than was usual. And, as noted
previously, in some cases parents delayed making vaccine decisions, or intentionally
made them, in order to allow or circumvent child participation in the decision-making
process.
From interviews, it is clear that parents hold differing opinions regarding the
types of information that girls can comprehend – or should be given – regarding the
purposes and protections of vaccines, especially the Gardasil vaccine. Also differing
were perspectives on what roles girls can and should play in making their own healthcare
decisions and when they are capable of making informed decisions about interventions,
such as vaccination. In working through some of these issues, the concept of age became
significant, as did notions of childhood, sexuality, autonomy, and vulnerability.
Often the role that a daughter played, or would be permitted to play, in a possible
future HPV vaccine decision depended largely on her age and perceived level of
maturity. The daughter’s age usually factored strongly into how urgent parents felt it was
to vaccinate their daughters, what types of information parents wanted to share with their
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daughters about the vaccine, and how much of a decision-making role the daughter
should have in the decision.
It is important to recall that I did not interview adolescent girls, and therefore
cannot ascertain whether their own perceptions of vaccine participation mirror the
accounts provided by their parents. What some parents might consider a joint decision,
daughters might consider otherwise. Do daughters perceive that they truly have a choice
in the vaccine decision, or believe that they will be forced to get the vaccine even if they
refuse? In the case of the latter, can the daughter be said to have participated or simply
acquiesced to something perceived as inevitable?
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Chapter Twelve – Evaluating and Framing Risks and Benefits

In previous chapters, I described some of the salient risks and benefits framing
vaccine decisions and the sources from which some of this information is derived. I
introduced the notion of trust as a key mechanism through which competing and diverse
sets of information are evaluated and described the role that mothers, fathers, and
daughters play in assessing different types of knowledge to inform vaccine decisions.
In this chapter, I turn to the actual vaccine decisions that parents jointly or
individually make to accept, defer, or refuse the Gardasil vaccine and the ways that latent
but powerful culturally embedded values help to add additional frames through which
other historical, structural, interpersonal, temporal, and individual are understood and
positioned. As will become apparent shortly, there are no short answers to explain
Gardasil vaccine decisions, no magic bullets to describe processes that unfold in
constantly evolving temporal, social, political, and personal landscapes.
In this section, I begin with a discussion of key themes framing parental
evaluations of the risks and benefits associated with HPV and the Gardasil vaccine.
Notions of childhood, female vulnerability, and temporality emerge as salient threads
relevant to the ways that parents conceptualize HPV and Gardasil. In the latter portion of
the chapter, I further examine the temporal relationships between trust, sexuality, and
risk. I attempt to elucidate the ways in which parents’ views toward technology, cancer,
sexuality, and age intersect with multiple and competing levels of trust in different
vaccine players (e.g., pharmaceutical companies, providers, daughters, etc.) to shape the
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frames through which parents conceptualize the vaccine and make vaccine decisions. In
the final section of the chapter, I suggest that three overarching vaccine frames are
predominantly used by parents to situate the Gardasil vaccine within larger sociocultural
milieus.

Childhood, Femininity, Individuality, and Sexuality
Gardasil decisions were not simply about preventing HPV-infection or
considering the physiological risks associated with vaccination. At stake were meanings
related to notions of childhood, femininity, expectations of individual responsibility, and
morals and values associated with sexuality.
In this section, I discuss how these interrelated concepts often related to parents’
vaccine decisions. Often, notions of childhood and sexuality were coupled with concerns
about vaccine safety and trust to inform parents’ decisions to delay, but eventually accept
(or plan to accept) the Gardasil vaccine. Parents also drew upon notions of femininity
and vulnerability to justify the need to vaccinate their daughters against HPV, despite
beliefs that their daughters would not put themselves in positions of susceptibility.

Vulnerability and Victimization
Notions of childhood add an additional layer of meaning to vaccine decisions. In
the United States, children are portrayed as vulnerable, dependent, and passive beings,
but also as “active, knowing, autonomous individuals” (Jackson and Scott 1999:91) who
from very young ages are granted relative autonomy and individuality. Two conflicting
views of children thus emerge, whereby vulnerable, dependent, and passive individuals
must also be given the space and relative freedom to develop their individuality and make
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their own decisions. The contradictions inherent in this conception of childhood can
create unique dilemmas for parents who attempt to shelter and protect their children from
potential risks, while simultaneously encouraging the child’s individuality and autonomy.
Lucy explained her own struggle to find a balance between her urge to shelter and
protect her daughter and the need to expose her daughter to the dangers of the real world.
“In your mind you want your daughter to wear diapers for the rest of her life. But if
you’re going to be that kind of a mom you’re really not going to help your daughter. I
know parents [. . .] who won’t let their kids go to a party where there’s drinking for
adults. I just want her to be exposed to as much life as she can, with me watching.
When understanding how many parents make HPV vaccine decisions, the
relationship between vaccination, childhood, and sexuality cannot be overlooked. The
fact that the vaccine protects against a virus that is generally sexually transmitted
refocused the lens by which many parents assessed the need for and meaning of Gardasil.
Many parents, especially those with younger daughters, envisioned them as existing in a
state of asexual innocence. Few parents perceived their daughters as sexual beings, much
less as sexually active beings. In fact, no parent, regardless of his or her daughter’s age,
believed that his or her daughter was currently or ever had been, sexually active.
Moreover, most parents (n=23) did not expect their children to become sexually active in
the next few years, which made it difficult for those who had yet to make an HPV
vaccine decision to contemplate the need for a vaccine that prevented a sexually
transmitted virus.
It made little sense to some parents to vaccinate their sexually immature daughters
against a disease that was sexually transmitted. In conceptualizing Gardasil as a vaccine
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associated with sex, parents were led to think about vaccine need in similar terms, which
led parents to think about their children as potentially sexual beings. In conjuring up
images of sexuality, the vaccine represented to parents something adult, mature, and
decidedly not childlike. In short, the Gardasil vaccine challenged the very notion of the
child as a child, violating “[. . .] a strong cultural emphasis on marking the boundary
between childhood and adulthood – on keeping children childlike” (Scott and Jackson
1999:96). Explaining why she was not presently considering the Gardasil vaccine for her
11 year old daughter, Victoria simply stated, “Right now [my daughter] is still very much
a child.”
If parents associate receipt of Gardasil with sexuality, accepting the vaccine – and
in some cases, simply discussing it – can challenge parents’ conceptions of their children
as children. Moreover, because many parents associate the vaccine with the near onset of
sexual activity, receipt of the vaccine is sometimes seen as an indicator of their child’s
sexual and developmental status.
The association that parents make between sexual onset and the vaccine might
help to explain why parents of younger girls – and who were generally supportive of
vaccines – often appeared to be more resistant to the vaccine. Recall from Chapter Eight
that providers repeatedly expressed difficulty discussing the vaccine with parents of
young girls, whom, equating the vaccine with sexual activity saw Gardasil as a unique
and unnecessary intervention. Associations between the vaccine and sex often stifled
conversations, as Amelia observed: “Most of the moms are very uncomfortable about
that. Saying she’s not sexually active. We don’t need to talk about that. We don’t need
to worry about that.”
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Even if parents understood that the vaccine was ideally administered well before
sexual debut, some parents had a difficult time separating receipt of the vaccine from
assumptions about impending sexual debut. In the following two examples, both women
had previously described Gardasil as a prophylactic vaccine. However, in recounting
their own reactions to the vaccine, it appeared difficult for them to conceive of the
vaccine as something that could or would ideally be administered well before their
daughters reached sexual debut. Marie, who was still undecided on the vaccine, first
heard about it when her daughter was 14 years old. Recounting her early recollection of
the vaccine, she explained: “[I remember] just that it was a new vaccine they were giving
to children, you know, young girls, whatever the age was – [my daughter] was 14 at the
time. And I thought that was a little ridiculous – wanting to vaccinate girls that early. I
just thought that was just too young.” Theresa, who felt pressured into having her
daughter vaccinated at 13 years of age, even though she was sure her daughter was not
sexually active, explained her own hesitations about the vaccine: “I think if anything
some parents may look at it like I did, as you know, do we need to do this when they’re
only 13? And not sexually active? Or is it something that we can wait until they get into
a high school level?”
The reaction that providers receive from parents of younger daughters might
explain why some providers generally do not begin discussing the vaccine with parents
until daughters are a few years older. Janet observed “Most of the refusals are ‘Oh, I just
think that she’s too young. I don’t think she needs it yet.” The “yet” here is significant,
highlighting the fact that refusals to vaccinate daughters at one point in time cannot be
taken as indicative of outright opposition to the vaccine.
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Parents of early “teen” adolescents were more likely to consider the vaccine than
parents of pre-teen girls. On one hand, parents tended to view their daughters as innocent,
immature, and vulnerable and therefore often viewed the HPV vaccine as symbolic of a
transition the girls (or, perhaps, the parents) were not yet ready to face. At the same time,
parents recognized that their daughters would eventually transition out of childhood and
into the realm of adulthood, at which point the vaccine could be protective.
While most parents grudgingly acknowledge that their daughters would
eventually become sexually active, very few parents foresaw sexual debut as imminent.
Nearly all parents, even those who anticipated that their daughters would become active
in the relatively near future, often added that they hoped their daughters would remain
abstinent for extended periods of time. Such addendums served to differentiate their
moral position regarding their daughter’s sexuality from an acknowledged understanding
that such expectations were perhaps unrealistic.
As Mark explained, “My hope is that my daughters wouldn’t be sexually active
outside of the context of the man that they’re going to spend the rest of their lives within
their marriages. But I know that that doesn’t always happen.” Faith, explaining her
decision to vaccinate her daughter, added, “I’m hoping she wouldn’t go into sexual
activity thinking I’m protected, because that’s not been the message we’ve given her. We
told her, you know, that abstinence is really your only choice (laughs). And her dad
reminds her – well, you’re 35 when you get married – so we joke about that.”
Such comments, expressed seriously or through humor, speak to a resignation that
parents feel when imagining their daughters as sexual beings. Most parents did not want
to imagine their daughters sexually active, yet many also recognized that hopes of
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lifelong abstinence, abstinence until marriage, or even abstinence through high school
were unrealistic. Lucy told her daughter, “I’d like to think that you’re going to be a
virgin, but hello, I’m not that dumb to believe that it couldn’t very well happen”.
Perhaps because they saw their daughters as transitioning from childhood to
young adulthood more clearly, parents of older girls were more likely to accept the idea
of vaccinating their daughters against a disease that was sexually transmitted. From this
perspective, parents tended to view HPV – rather than the vaccine or sexual debut itself –
as the primary object of risk, often to marriage, reproduction, and overall health. Of
course, this is not to say that parents did not continue to hope that their children would
remain abstinent, at least a little bit longer. Gretchen conceded, “When I think about it,
you know, I really don’t want my daughter to be active – sexually active at sixteen but I
don’t want to be saying I wish I would have gotten that vaccine for her, if it had been
available to me.”
In making Gardasil vaccine decisions, parents often consider two or more
dimensions of time. Parents who had, or still were, deferring initiation of the series,
balanced several risks simultaneously. Trust became an important way through which
parents prioritized some risks over others in making vaccine decisions. As discussed
previously (Chapters Eight and Ten), the newness of the vaccine, especially given distrust
in Merck and the means by which the vaccine emerged onto the market, led some parents
to fear that their children might be guinea pigs in a longitudinal experiment to discover
the possible long-term effects of the vaccine. Some parents wanted to delay initiating the
series as long as possible in order to hear more about the possible long-term adverse
effects of the vaccine.
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They reasoned that over the span of several years many more girls would be
vaccinated; if there were rare or severe complications they would be more likely to
appear as more girls received Gardasil. Additionally, parents concerned that Gardasil
might lead to infertility of complications during pregnancy, believed that with the
passage of time a greater proportion of vaccinated girls would have themselves
reproduced. Again, if there were problems, it was more likely that they would be
discovered with time.
While parents wanted to hold off on initiating the series as long as possible in
order to allay their concerns regarding vaccine safety, they also recognized that they had
a finite timeframe in which to operate. Countering concerns about the safety of the
vaccine were concerns (or awareness) that their daughters would eventually become
sexually active, and that to ensure that their daughters received the maximum benefit
from the vaccine, they had to complete the series prior to sexual debut. The risk of
sexual debut had to be measured against the risks of the vaccine, requiring parents to
consider two dimensions of time simultaneously. As Figure 1 (below) illustrates,
increasing trust (and diminishing risk) are inversely related – with time, trust in the safety
of the vaccine increases (and the risk of adverse effects decrease), while trust in the
daughter’s sexual abstinence diminishes (and the risk that she will be exposed to HPV
increases).
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Figure 1. Trust in vaccine safety and daughter sexual immaturity through time and in
relation to Gardasil vaccine decision-making

Choosing the ideal time to administer the vaccine was, in some respects, a
gamble, or “leap of faith” that parents based on balancing the diminishing trust they had
in daughters with the growing trust they had in the vaccine. Parents knew that to ensure
full coverage, they needed to begin the series six months before sexual debut. Some
parents expressed anxiety and doubt that they would be able to accurately anticipate this
window, and thus saw vaccine timing itself as a risky endeavor.

Vulnerability, Victimization, and Gender
Several studies have shown an association between perceived susceptibility to
HPV and parental intentions to vaccinate (Brabin, et al. 2006; Friedman and Shepeard
2007; Marlow, et al. 2007a; Olshen, et al. 2005; Riedesel, et al. 2005; Waller, et al.
2006). Since many parents in this study vaccinated their daughters, despite strong
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assertions that their daughters would not be sexually active in the near future, one might
conclude that perceived susceptibility to HPV infection is unrelated to this sample’s
vaccine decisions. Such a conclusion would be misleading.
Susceptibility was a key factor in many parents’ decision to vaccinate their
daughters, but susceptibility was not indicative of daughters’ sexual behaviors or
morality. Rather, young, immature women were viewed as vulnerable to social pressures
and physical dangers that made them susceptible to HPV infection.
Gardasil not only hits upon cultural notions of childhood, but ideas about gender
and sexuality. The fact that Gardasil was initially only approved for use in females should
not be taken for granted. As several researchers (Mamo, et al. 2010; Prescott 2010;
Thompson 2010) have convincingly argued, the decision to exclusively target females for
vaccination is rooted in historical, assumptions about disease, responsibility, and
sexuality. While a full discussion of these arguments in beyond the scope of this
dissertation, the gist of the argument is that females have historically been burdened with
the risks and responsibilities of protecting themselves and the public from males (e.g.,
contraceptive technologies) and that heterosexism led officials to dismiss the important
benefits that Gardasil had demonstrated in the prevention of anal cancer – a disease
primarily affecting gay men. During FDA hearings to approve Gardasil, Merck officials
and key vaccine researchers recommended that the vaccine be approved for both males
and females, not only because males play a primary role in transmitting the disease, but
because of the benefits they stood to personally gain through protection (Thompson
2010).
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As discussed in Chapter Nine, many parents valued sexual communication as a
form of complimentary HPV prevention. A more latent thread underlying the heightened
sense of importance in discussing sexuality with girls spoke to the deeply rooted and
pervasive gender stereotypes. Cultural norms regarding the acceptability of premarital
sex have historically been gendered. The “boys will be boys” adage speaks to a
permissiveness – and expectation – that boys will (or should) engage in premarital sex.
Girls on the other hand, are expected to remain chaste and pure. Boys are praised and
girls stigmatized for engaging in premarital sexual activity (Crawford and Popp 2003;
Schalet 2000).
Most of the parents who perceived sex education to be more difficult and
important to communicate to daughters were mothers (n=5), four of whom had children
of both sexes. These mothers were more open with their sons about the importance of
practicing safe sex and did not (or would not) feel as comfortable having the same types
of open conversations with their daughters. When mothers explained why they
approached sex education with their sons and daughters differently, they noted that
daughters were more likely than sons to suffer adverse effects from sex.
Theresa, for example, perceived the social and emotional risks associated with sex
as being gendered and far more detrimental to girls. Theresa constantly reminded her
daughter that boys who respected her would not pressure her into having sex, because
“You’re worth more than that. You don’t want to put yourself in a position where you’re
thought less of because of your choices.” While Theresa did not encourage her son to
have sex, she was also less fearful that her son would suffer emotional consequences if he
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chose to have sex in high school. The stakes were higher for her daughter, which caused
Theresa to feel more anxiety discussing sex with her.
Bill tried to challenge gender norms with his girls, while also stressing that no
matter how unfair, the double standard would be used by others to judge their actions.
Bill explained, “I’ve taught my daughters to think for themselves, to be strong young
women. But at the same time, let’s face it. I’ve talked to [my older daughter] about
reputation and how it’s unfair that boys can [have sex] and girls can’t, but yet that’s the
real world that we live in and that’s something she needs to be aware of.”
Victoria’s approach to sex education with her son, and the strategy she planned to
adopt with her daughter, exemplify the important role that gender plays in shaping some
parents’ sex communication methods. Victoria explained that since her son was 16 she
and her husband would “always tease him not to leave home without his raincoat.”
Victoria stressed the importance of using protection, pointing out the location of condoms
to her son in the drug store. She did share with him her hope that he would have sex in
the context of a meaningful relationship, then adding, “But come on. The reality of it is
that an ounce of prevention is worth a pound of cure. And that’s my little foil wrapped
ounce of prevention.” When she sent her son off to college with a box of condoms and
joked, “Maybe you’ll get lucky and use a whole box!” When her son responded with
embarrassment, she replied, “Take them. Give them to your friends if you don’t need
them. You’re 18 years old now and for me to pretend that it’s not going to happen is
ridiculous.”
While Victoria was very proactive and comfortable discussing sex with her son,
she did not anticipate having such open and joking conversations with her daughter about
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sex at any point, even when she was going off to college. She explained, “double
standard wise, I’m sure I’ll be different with her.” Victoria knew that she would preach
the importance of having protected sex every time as soon as she felt her daughter was
“anywhere near that age,” but she also knew that she would be less “flippant” about it.
Explaining why she would take the conversations more seriously, Victoria explained,
“although an unwanted pregnancy would really change my son’s life, it would –it has
much more of a devastating impact on the girls. Let’s face it.”
As illustrated in these sexual communication examples, and through provider and
parent narratives throughout the dissertation, Gardasil risk perceptions are often tied up
not only with issues of childhood, but with notions of sexuality. Gendered notions of risk
become intertwined with neoliberal conceptions of individual risk mediation and
responsibility adds additional layers of meaning to Gardasil vaccine decisions.
The potent belief that individuals are largely responsible for protecting their own
health and well-being, and conversely, are responsible for putting themselves at risk of
developing diseases, pervades discussions of the Gardasil vaccine. Because HPV cannot
be transmitted by a child’s dirty hand, a sneeze, or a cough – but through what is often
intentional, consensual sexual activity – creates an additional layer of consideration for
the parent. Daughters themselves, rather than diseases, are perceived as the agents of
risks. Good girls, who make good decisions, are not at risk, and therefore do not need the
vaccine. Bad girls, who make immoral or irresponsible decisions, are the ones who
would benefit from the vaccine.
The notion that the individual girl bears responsibility for her own HPV risk
complicates parental decisions. Even if parents’ vaccination decisions have nothing to do
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with their beliefs regarding their daughter’s current or imminent level of risk, parents feel
compelled to explain the “real” reasons that they vaccinated, suggesting that they are
aware of other perspectives. In describing their reasons to vaccinate their daughters,
several parents went out of their way to explain that the decision did not in any way
suggest that they lacked confidence in their daughters’ abilities to make responsible
decisions regarding their own health. Similarly, some parents felt compelled to explain
that their decision to vaccinate in no way diminished the high expectations that they had
for their daughters to act responsibly, morally, and safely. In emphasizing the reasons to
vaccinate their daughters, many parents reframed risk to position it beyond the daughter,
thus protecting the daughter (and perhaps, themselves) from moral judgment.
While many parents felt uncomfortable confronting the notion of sexuality as a
reason to consider the vaccine, the concept of “vulnerability” – associated with both
childhood and femininity – was often invoked as a means to rationalize the need for the
vaccine and provide an alternative means by which parents could weigh vaccine risks and
benefits. By focusing on the child’s vulnerabilities – her inability to defend herself
against unscrupulous predators or to make mature decisions, or the physical attributes
that would make HPV infection more devastating– an alternative rational for the vaccine
was proffered that avoided challenging the virginity, virtue, or moral standards of girls.
Sometimes, parents did not specifically identify the vulnerability from which they
sought to protect their daughters. “That was my sole purpose in getting [the vaccine] for
them. In the hopes that if they do – if something did happen, God willing it doesn’t, that
they have a little bit extra protection.” Often times, however, parents and providers
invoked fears of rape and sexual molestation as key reasons to vaccinate daughters.
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One provider urged her sister-in-law to have her ten year old daughter vaccinated
immediately. When her sister-in-law asked her why she should vaccinate her now, she
replied, “Well the point is to do it before they ever become sexually active. And I don’t
think that she’s going to be [sexually active soon] but you just never know and what if
she’s molested? You still haven’t missed that window.” One father explained, “My wife
was raped when she was in high school and certainly that wasn’t planned. . .When I think
about [vaccinating my daughter] that’s what factors into my mind. You have to [do it]
before they’re sexually active. But in my wife’s case, you can’t always make that
decision [for yourself]. So there’s a certain safety net that I think is provided by doing it
at nine years old.”
While the notion of the “innocent child” is widely pervasive in parental
descriptions of their own daughters’ character and virtue, it is also commonly believed
that children – especially boys – are mischievous and unruly (Jackson and Scott 1999).
Within parental and provider narratives, assumptions about the sexual and moral
character of males are invoked to justify the need to vaccinate girls. One mother
explained why she wanted her daughter to be protected, “I just think little boys are plain
out horny. They’re horn-dogs. And from what I’ve seen of [my daughter’s] friends, you
know, they’ll go with a boy for a month and, ‘Oh, I love you!’ And then [the girls] are
giving it up and then the next month the [boy] is on to another friend and another friend
and another friend.”
Parents often explained that they vaccinated their daughters to protect them from
future partners, usually husbands, who might not have been as responsible. Tony based
much of his decision to vaccinate his daughter on a family experience. One of his
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cousins developed cervical cancer two years after she got married. He knew “for a fact”
that she was a virgin prior to getting married. As a result she had a complete
hysterectomy. “And she was 27! . . . [So with my daughter], if [her husband] doesn’t
know he has it, even if he’s her first, he’s going to give it to her! So she’s done the right
thing. She’s waited for sex for the person she plans to spend the rest of her life [with].
So she does everything right and she can get infected anyway?” For Tony, the risk of
sexual immorality or disease was external to his daughter. He did not associate HPV-risk
with his daughter’s own behavior, but with the behaviors of her future partner who could
put her at risk.
Tony was not alone in framing sexual risk externally. Both parents and providers
referred to their daughters’ future partners as risky agents from whom their girls needed
protection. Sometimes parents and providers alluded to consensual future partners, and
other times daughters needed to be protected from potential rapists.
If I can protect my daughter from a partner who isn’t –has had some bad habits in
the past, I just think she needs to . . . I mean, she’s 14 and I think she’s a pretty
sheltered 14 year old in some respects. I don’t know. I guess my fear is more that
she will make good decisions for herself but as our doctor pointed out, sometimes
unfortunate things happen. You know the trauma of a rape, I’m thinking date
rape of something like that, is hard enough. You know you wouldn’t want to live
with [HPV] consequences.
One mother explained to her daughter why she wanted her to be vaccinated, even
though her daughter was not sexually active. She explained, “this is important to your
health as a woman and even if you are not sexually active and don’t intend to be, things
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happen that you don’t always intend to have happen and you can’t protect yourself from
everything, but you should protect yourself from the things that you can.” In the
mother’s explanation, she again positions sexual risk as existing externally.
A few parents (n=4) conceived of vulnerability as an inability to make wise
decisions. As was discussed in Chapter Eleven on daughters’ roles in decision-making,
many parents argued that even after age eighteen, their daughters were not capable of
making fully informed, responsible decisions. Some parents believed that while their
daughters would try to act responsibility, their naiveté and trusting disposition might lead
them to make decisions that they would later regret. Lucy, who had recently had her 15
year old daughter vaccinated, worried that her daughter’s own insecurities might make
her vulnerable to the advances of unscrupulous boys.
I just don’t want her to make a rash decision, you know? I want to cry, but you
understand? I see her cheeks getting rosy and then on the other hand, she feels
because she’s tall, or she’s ugly, that boys don’t like her. And if a boy did happen
to be on the wrong side of the law or tracks, or whatever, and tell her ‘Oh, you’re
so beautiful!’ I don’t want her to be one of those. But if she is, I want her to be
prepared [by having been vaccinated].
Creeping into some parents’ narratives are not just concerns about the types of
images, ideas, and values their children are constantly exposed to, but also fears that their
own daughters might emulate the very behaviors and values that parents see as
problematic. As parents envision a riskier and more hostile world, they see a greater need
and responsibility to help their daughters successfully navigate it. Perceiving that fewer
schools or parents are doing their jobs, parents – and particularly mothers- increasingly
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impose upon themselves the burden of guarding and guiding their daughters. One
mother expressed these sentiments candidly, “I know the world is going to hell and you
know, people – especially here in Florida, there really aren’t any good parents anywhere.
There’s just no good parents. No parent cares about their kids. And you know, I have to
live in – I have to make [my daughter] smarter than her environment.”
The external risks confronting girls sometimes led parents to view the HPV
vaccine not primarily as a technology to protect girls from a disease, but something to
protect girls from a world beyond the control or knowledge of parents. From this
perspective, parents felt obligated to protect their daughters from HPV not because they
doubted their own daughters’ moral integrity or respectability, but their daughters’
abilities to remain unharmed and unaffected by the pressures, dangers, and immoralities
of a degrading and dangerous society. The Gardasil vaccine became a means to
counteract risks associated with society – a vaccine protecting against an immoral and
unpredictable world as much as or more than, a virus.
One mother had confidence that her daughter would make good decisions for
herself, but also worried about what types of diseases she might be exposed to given how
prevalent she perceived them to be, and how common she perceived unprotected sex to
be. She shared some of the issues she weighed when making a decision to vaccinate her
daughter, “I mean, if on one hand you say, you have kids that are abstaining. But then
you’ve got all these sexually transmitted diseases out there. I don’t know that kids are . . .
one partner doesn’t seem to be, it doesn’t seem to exist anymore.
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Providers were equally as likely to emphasize vulnerability when advocating that
children be vaccinated. Sue intentionally tried to take the focus off of daughters when
discussing the vaccine.
When parents hesitate I tell that the vaccine is very, very effective and that I really
hope she’ll [the daughter] be one of the few girls that waits until she is married.
But even then, the odds that her husband will do the same are pretty low. Putting
it this way usually takes the pressure off of the parents . . . again, I think putting
some of the burden on the boys, like I do when I talk to them, really helps.
Isabelle uses a similar approach:
I explain to them that really it doesn’t have anything to do with their sexual
activity today and what we’re trying to do is protect them so when they become
sexually active that they have immunities. And even if their daughters have, you
know, never had sex until the day they’re married, that there just is no guarantee
about the partner and how many partners [he’s] had.
In these types of discourses, two different ideas are being expressed. First,
providers generally remove any kind of responsibility from the daughter by affirming
parents’ assertions that their daughters will remain abstinent indefinitely. At the same
time, providers emphasize the vulnerability of girls, creating a scenario in which parents
might view the vaccine as a safeguard against the immorality of others (while leaving
unchallenged the assumed morality of the girl and good parenting of the adult).
The desire to frame the need for the vaccine around notions of vulnerability was
most pronounced among providers and parents who were making vaccine decisions for
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younger girls. As girls approached the early and later teen years, discourses surrounding
the need for the vaccine diversified.
In reframing HPV risk away from daughters, parents avoid questioning their own
daughters’ virtue and perceive threats to her virtue existing not in her own sexual
development or maturation, but in the abilities of others to forcibly or coercively take
advantage of her. There are several ways in which this repositioning can be understood.
In viewing the vaccine as a means to protect girls from others, parents be seen as
portraying their daughters as physically and emotionally vulnerable. Even when girls
might engage in consensual sexual relations with boys, they are exempt from moral
judgment or responsibility. They are seen as being the dupes of insincere boys who take
advantage of the innocence, naïveté, and purity of girls. In this conceptualization,
daughters remain the objects childhood and feminine virtue, whose purity and innocence
make them vulnerable to threats. Boys are seen as immoral, unscrupulous, and cunning,
willing to lie, coerce, and deceive in their dogged and singular attempts to deflower girls.
One provider expressed this belief when explaining why boys should receive Gardasil:
“Boys can get warts. I mean, what fun is that? (laughs). And they’re probably just as
irresponsible, if not more so than girls. ‘Oh yeah, I’m using a condom.’ Yeah right. ‘Oh,
I left it home.’ Or whatever. They definitely could use the protection.” These images
portray girls as ignorant and powerless, incapable of being active, empowered, and
informed sexual beings. At the same time, the script depicts boys as emotionless, onedimensional, hormone-driven automatons incapable of intimacy or genuine feelings
towards their partners.
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In seeing risk as external to their daughters, parents simultaneously express trust
and distrust in their daughters. The frame leaves unchallenged the belief that their
daughters will make responsible decisions regarding their own sexual health. At the
same time, in viewing their daughters as vulnerable to persuasion due to innocence or
desires to fit in, parents also express a lack of trust in their daughters’ abilities to judge
and evaluate situations and others carefully.
Notions regarding childhood, neoliberal individual risk mediation, and gender
work in tandem to provide layers of meanings to Gardasil vaccine decisions. As children
become young adults, the trust in their lack of sexuality diminishes at the same time that
faith in the safety of the vaccine (over the course of years) increases. In another way,
discourses of vulnerability alleviate discomfort with the meaning of vaccination in a
world where individuals are expected to manage their own risk

Vaccine Frames
In evaluating risks and benefits, parents consider Gardasil’s cancer preventing
properties, the newness of the vaccine, notions of sexuality, time, and trust. Three
overarching vaccine frames appear to shape the ways in which parents prioritize different
issues, negotiate diverse trust relationships, and frame their vaccine decisions. These
frames are not intended to be limiting or constraining. For example, it is absolutely the
case that parents adopting the cancer frame expressed concerns about the newness of the
vaccine and discussed sexuality issues during the interview. However, these concerns
were peripheral to the major focus of their decision, which was to protect their daughters
against a disease that could cause cervical cancer and that they trusted was sufficiently
safe. In presenting vaccine frames or orientation, I try to explain some of the
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commonalities interwoven throughout diverse and varying parental accounts, while
highlighting where key differences exist.
The “Cancer Frame”
As was discussed in Chapter Eight, parents often viewed cancer prevention as a
key benefit of the Gardasil vaccine. For some parents (n=7), the specter of cancer was so
pronounced that few vaccine risks could be seen as significant enough to outweigh the
benefits of reducing a child’s risk of cancer. When cancer was seen as a significant and
severe risk of HPV disease, parents tended to downplay the possible risks associated with
the vaccine.
Evidence that some parents were unalarmed by the newness of the vaccine or
possible risks associated with it is exemplified by some parents’ inability to recollect any
vaccine-related risks. One mother could not recall the specific risks associated with
Gardasil, but was sure they could not outweigh the benefits of cervical cancer prevention.
“I know for sure – I know that there wasn’t any risk that alarmed me. The benefits
outweighed any risk that I obviously must have read and the benefits of it are long term
prevention of cervical cancer. It was a no-brainer for me.” Another father took little time
deciding that he wanted his daughter to receive the Gardasil vaccine: “Why risk getting
an incurable disease when there’s no downside?” Another woman could not understand
why any mother would not have her daughter vaccinated. “It’s not going to hurt her and
it’s only going to help her, so why not?”
A strong sense of trust in the regulatory processes overseeing vaccine safety, and
particularly in providers and their recommendations, contributed to the view that Gardasil
was a “no brainer”. These parents did little research on the reported risks associated with
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Gardasil, but deemed the risks to be minute or non-existent. They reasoned that an
unsafe vaccine would not be available, and more importantly, that their providers would
never recommend a vaccine that they did not believe to be safe. These parents often
equated a provider recommendation with vaccine safety.
Parents who gravitated towards the “cancer frame” tended to view Gardasil in
highly biomedical terms. They tended to view Gardasil, first and foremost, as a vaccine
that, like all other vaccines, protects and safeguards children from contracting
preventable diseases. From this position, parents focus on cervical cancer, not HPV, as
the disease worth preventing. The cancer frame should sound familiar. It is the vaccine
frame that Merck actively sought to convey to consumers through advertising.. By
touting Gardasil as a cancer-preventing vaccine (specifically, a vaccine to prevent
cervical cancer and one originally only approved for use in females), Merck attempted to
deflect attention from the fact that HPV is sexually transmitted and that HPV risks are not
equal among all children.
The fear of cancer was so pronounced and central to some parents’
conceptualization of the vaccine that they seldom saw downsides to vaccinating their
daughters. While many of these parents knew that HPV was sexually transmitted, they
were unlikely to focus on the sexual aspects of the disease or implications that mode of
transmission might have on vaccine need. Parents who gravitated towards this
perspective shared a common trust not only in their individual healthcare providers, but
in the benefits of vaccines and the processes by which vaccines are vetted, approved, and
regulated. Perhaps as a result of their strong confidence in regulatory oversight processes
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and the benefits of vaccines, these parents were early-adapters who expressed few
hesitations about the newness of the vaccine.
Parents fitting within this frame still emphasized that their decision to vaccinate
daughters was not in response to concerns about their daughter’s own sexual activity.
Rather, parents underscored the protective benefits of the vaccine, viewing it as one way
to provide their daughters with long-term protection against a disease they might be
exposed to in the (usually) distant future: “I went out and got the vaccines for my
daughters even though I’m hoping that they won’t be sexually active for quite some time.
I just wanted to have them protected.” Tony, who had his daughter vaccinated, often had
to explain to friends and colleagues that he did not think his daughter was sexually active.
“I vaccinated my daughter not for what’s going to happen today, God forbid. But for
what’s going to happen when she’s 26 or 27, or whenever it happens.” A nurse
practitioner recounted an experience from a conference she attended where the guest
speaker said, “My daughter just got her Gardasil shot – of course, she won’t be having
sex until after 30. I’m just doing this to protect her”
In evaluating safety concerns and vaccine need, trust plays an important role.
Parents who expressed high trust in the independence of governmental agencies and
healthcare providers from pharmaceutical companies were more likely to have faith in the
safety of the vaccine. Parents who doubted the motives of governmental agencies or
healthcare providers, suspecting collusion with pharmaceutical companies, were less
likely to see FDA approval as a sign of safety.
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The “Sex Frame”
In the previous section “Vulnerability and Victimization,” I argued that parents
often shifted their focus from daughters, and their individual sexual behaviors, to external
sources of risk that could threaten the sexual health of their daughters. Regardless of
which vaccine frame parents gravitated towards, most parents expressed sentiments that
suggested they saw their daughters as vulnerable. The ways that sexuality and
vulnerability were positioned in relation to Gardasil decisions, however, varied. Parents
who adopted a sex frame (n=11) also tended to highlight the cancer-preventing aspects of
the vaccine, but in the context of sexuality. The frame led parents to adopt one of three
strategies.
One group of parents adopting a sex frame chose to have their daughters
vaccinated, but re-conceptualized risk so that the vaccine decision was not associated
with their daughters own moral character or sexual maturity. These parents recognized
the benefits of the vaccine, but felt less comfortable with the thought that others might
interpret their decision to vaccinate negatively. Parents stressed that they had high moral
standards for their daughters, who they hoped and expected would not become sexually
active in the near future. The vaccine, they often argued, was to protect their daughters
from rape, or future partners who might not have been as sexually responsible as their
own daughters. In deflecting blame from their daughters and onto others, parents
position themselves as their daughters’ protectors, safeguarding their daughters from
future threats beyond their daughters’ control. In shifting blame to external threats,
parents also reaffirm their daughters as responsible and moral, yet vulnerable. This set of
parents also highly valued provider recommendations and tended to trust in the vaccine’s
407

safety. While parents might have acknowledged some vaccine risks, concerns regarding
the safety of the vaccine were not central to their decision if their healthcare practitioner
recommended the vaccine.
The other group of parents adopting the sex frame simply deferred the decision
until a later time when they thought their daughters might be approaching a stage when
they were contemplating sexual activity. Unlike parents approaching the vaccine from
the “safety frame” (discussed below), concerns with the vaccine’s safety were not
paramount to their deferral decision. Providers note that many parents fall within this
category. Providers expressed repeatedly that many parents expressed the view that
Gardasil is “not something that the child needs until she’s older and maybe dating or
thinking about, later on, becoming sexually active. I think a lot of parents just don’t think
it’s a necessary thing until that point.”
A third frame focuses on sexuality, where beliefs about sexuality and need lead
the parent to refuse the vaccine altogether. Unlike parents who simply defer the decision
for a few years, this third group of parents refuse the vaccine and have no plans to revisit
the decision in the future because they are adamant that their daughters will not be at risk
for HPV before their eighteenth birthday. Rachel is the only parent who fits this profile
among parents that I interviewed, but several providers described parents within their
practice that also would fit into this category.
The “Safety” Frame
Parents who had not yet made a vaccine decision often weighed concerns about
the newness of the vaccine and its possible long-term consequences against the risks
associated with cancer. Among several undecided parents, the prospect of protecting their
408

daughters from cervical cancer was used to counterbalance fears they had about the
vaccine itself. One mother did not want her daughter to experience any harm from the
vaccine, but also did not want to leave her exposed to something she could prevent. She
explained why she had not gotten her daughter vaccinated yet, but planned to in the
future, “So I think that’s also part of my being leery of something that I feel is fairly new
and untested, but you know, I just want to make sure that I’m not doing anything bad to
her. But I want to help her as well. If it can prevent cervical cancer then I certainly want
her to have that opportunity to not have that.”
Parents (n=8) who adopted this frame focused on the newness and cancerpreventing aspects of the vaccine. The section on “Childhood, Femininity, Individuality,
and Sexuality” (Chapter Twelve) includes a discussion of issues most salient to this
group. These parents tended to highly value the cancer-preventing benefits of Gardasil,
but also were not overly trusting of vaccine manufacturers, regulatory oversight, or the
safety of the vaccine. A trusted provider’s recommendation was critical to their decisions
to eventually initiate the series, but would not on its own compel parents to act. Parents
in this category were seldom early-adopters of innovative technologies. They took
conservative approaches towards new treatments, developing confidence in the safety of
a treatment over time. They reasoned that the longer a treatment was administered to the
general population without incident, the more likely the treatment was safe. For these
parents, sexuality also became a consideration, but in relation to vaccine timing. Parents
wanted their daughters to receive Gardasil before they became sexually active, but also
wanted to postpone initiating the series as long as possible in order to assess the safety of
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the vaccine. Parents had to balance their trust in the vaccine with trust in their daughters’
sexual abstinence.
One parent explained this relationship, “it’s a new vaccine, has it been out long
enough to really show if there are side-effects or risks? You know, and the longer it’s out
the more comfortable you feel with that.” Marie had postponed the vaccine for more than
a year and still felt she had some time assess the vaccine’s safety. “It’s still just too new
as far as I’m concerned. I don’t feel my daughter is sexually active, I really don’t. So I
just don’t think I want her to have it right now until I know more about the vaccine.”
Melissa, who was extremely distrustful of Merck and no longer had a trusting
relationship with a healthcare provider, was finally considering the vaccine because of
the amount of time the vaccine had been available and her concern that her daughter
would soon become sexually active. In explaining why she was thinking about getting the
vaccine, despite her safety concerns, she said, “Just the fact that if I vaccinate her before
she’s sexually active I might be able to prevent cervical cancer for her.”
Another father had doubts about the safety and newness of the vaccine. He
postponed initiating the series because of those concerns, and a lack of concern about his
daughter’s sexual readiness. After a year, he felt more comfortable with the vaccine’s
safety, and less confident that his daughter would delay sexual activity. In explaining
why he was finally beginning the series he said, “I don’t anticipate [my daughter] having
sex tomorrow. I just don’t think she has the opportunities right now. If I did, I would
have gotten the vaccine sooner. That’s why I’m starting now, because it takes a few
shots, a few months, to get it all there. So it’s time to start now.”
In explaining why he had postponed the decision, he recollected,
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I was trying to wait and see if there were any [new] studies [on the HPV vaccine],
and then try to balance that with, okay, well, I have to try and be realistic because
she’s going to be sixteen in a few months. And in the next few years after that I
would anticipate that she’ll engage in sexual activity of some sort . . . but you
never know when they’ll start. . .
If she could do it over again, Theresa would have waited to vaccinate her
daughter. She did not feel comfortable with the newness of the vaccine when she had her
daughter vaccinated, but also felt pressured into getting it before she was really ready. In
recalling that decision, she said, “That’s where I could kind of bop myself because I felt
like I was a little railroaded into it. Because when [the pediatrician] was talking about it,
it was so new and I still was not sure research wise if I felt comfortable saying yes, go
ahead and give this.” Shortly after this visit, Theresa switched providers.
Many providers (n=9) reported that parents often weighed safety concerns against
sexual onset when delaying vaccine decisions. One physician estimated that “If I could
even give you a percentage, maybe, 80% [of parents of 11 and 12 year old girls] want to
hold off, they want to wait until the child’s older and the vaccine has been around
longer.”
Providers sometimes recommend to parents of younger patients that they
postpone initiating the series for similar reasons. Victoria’s doctor advised that she wait
until her eleven year old daughter was a little older to assess safety. “He said let’s just
wait and see what happens. He won’t wait forever. But he said, at 11 we have plenty of
time. But I wouldn’t want to wait much later than 15. You know . . . they have to get it
before they’re sexually active.”
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Chapter Twelve Summary
In this chapter, I described how latent but powerful culturally embedded values
help to add additional frames through which other historical, structural, interpersonal,
temporal, and individual factors relevant to vaccine decisions are understood and
positioned. Notions of childhood, trust, and female vulnerability are recurrent themes
that thread their way through parental conceptualizations of HPV disease and Gardasil.
The temporal relationships between trust, sexuality, and risk are crucial to vaccine
decision-making. Time can be seen as a modifier of other important themes; to a greater
extent than other factors, time is heavily dependent upon other factors in order to gain its
saliency. This might be an obvious observation, as time is nothing but a frame through
which we conceptualize the relationship between other events.
Parents’ views towards technology, cancer, sexuality, and age are fused with
notions of trust that operate at multiple and competing levels to focus the lens through
which parents conceptualize the vaccine and make vaccine decisions. In suggesting that
three lenses focusing on cancer prevention, sexuality, and safety help to frame vaccine
decisions, I by no means imply that decisions can be understood solely through these
frames. As I hope has been made clear throughout this dissertation, fears of cancer,
desires to protect, issues of morality, and notions surrounding gender, morality, and trust
imbue vaccine decisions with meaning and relevance. Furthermore, as these themes and
frames gain or lose importance based on a temporal dimension (estimated time of sexual
debut of daughter; number of years the vaccine has been out; number of years that
vaccine study participants have been tracked), it is important not to hypostatize these
frames as existing on their own, separate from peoples’ lives, actions and concerns.
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Chapter Thirteen – Discussion

In Chapter Seven, I began this analysis by describing the historical, political, and
cultural vaccine landscape, arguing that many of the tensions surrounding the HPV
vaccine apply broadly to all vaccines, and at least partially stem from historical events
and developments. The processes through which the Gardasil vaccine was approved and
marketed both stymied and generated criticism about the vaccine and, as discussed in
Chapter Ten, had significant effects on some parents’ perceptions of the vaccine’s safety.
The events surrounding the development of Gardasil and subsequent public backlash
exemplify the costs of institutional and industry interconnectivity: missteps taken by
Merck and legislators left some parents with a diminished sense of trust in governmental
agencies, public health campaigns, and healthcare providers, who they suspected to be in
collusion with Merck. These findings mirror results reported by other anthropologists
who have found that suspicious regarding government and pharmaceutical collusion lead
to a sense of distrust in vaccines themselves (Casiday 2007; Cassell, et al. 2006; Poltorak,
et al. 2005).
Despite initial concerns among women’s advocacy groups, public health officials,
and health economists that the high cost of Gardasil would only serve to widen the
disparity in cervical cancer rates, cost was not a significant factor motivating parent
vaccine decisions in this study. Regardless of whether their children were publically,
privately, or uninsured, parents agreed that cost alone would not deter them from
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considering the vaccine, although in a few cases, paying out-of-pocket for the vaccine
might influence when they gave their daughter the vaccine. Consistent with findings
from several studies (Gerend, et al. 2007; Litton, et al. 2010), economic issues were of
peripheral or no importance to parents’ vaccine decisions. However, few generalizations
can be made regarding the role that insurance coverage and household income have on
Gardasil vaccine decisions based on these dissertation findings given the lack of
socioeconomic diversity among parents in the sample.
In explaining what factors were central to parents’ Gardasil vaccine decisions,
there are no easy answers, no neat and clean conclusions to be drawn. The contextual
landscapes that frame parental vaccine decisions are not painted in black and white, but
splattered with shades of gray. Moreover, the landscapes within which decisions are
made are constantly evolving. Time does not stand still. Daughters do not remain
children forever; vaccines do not remain new indefinitely. The criteria upon which
decisions are made exist not in isolation, but relationally and temporally. Changes
regarding some aspects deemed pertinent to vaccine decisions require a reexamination of
other potentially important considerations. Even though some deeply rooted culturally
shared values regarding femininity, sexuality, and childhood are themselves pervasive,
taken-for-granted, and largely unquestioned, the relative importance of these values both
to parents in assessing their applicability to their own children, and to the vaccine
decision, evolve with the passage of time.
Moreover, the trustworthiness of sources is contingent and tenuous. The sources
of information deemed trustworthy one day, might be suspicious the next. Tony, for
example, who planned to vaccinate his daughter as soon as Gardasil was available,
414

deferred the decision for a year after hearing about the political efforts to mandate the
vaccine. A risk deemed unacceptably high two years ago, such as vaccine safety, might
now be considered tolerable in light of other emerging or shifting risks, such as the
likelihood of girls become sexually active in the near future. The findings presented here
reflect the messiness, contradictions, and complexities of lives imbued with cultural,
social, and personal meaning; similarly, these ambiguous manifestations can themselves
be seen as evidence of shifting material and structural landscapes, or at least, of peoples’
perceptions of them.
To admit that vaccine decisions are complex is not suggest that efforts to
understand them are futile or pointless. Quite the opposite – the complexity of such
decisions requires complex research and complex analyses that provide perhaps
incomplete, but realistic, assessments of decision-making that can meaningfully
contribute to theory and practice. Despite the messiness of life, patterns – even if
sometimes contradictory – emerge that shed light on the process through which people
act in a world of uncertainty. In this chapter, I delineate some of these patterns in an
attempt to flush out some of the key issues surrounding Gardasil uptake. I discuss the
contributions and relevancy of this literature to anthropology and public health, while
also noting the study’s limitations and areas for future research. Table 2 includes a
summary of key findings, study strengths and limitations, practical recommendations,
and directions for future research.
Well-designed contextualized research on HPV vaccine acceptance is needed,
especially given the vaccine’s availability to boys (FDA approved in 2009) and the more
recent (October 25, 2011) ACIP recommendation that all boys 11 and 12 years of age be
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vaccinated. It is my hope that findings and implications described in this study can
contribute to the development of more nuanced studies of HPV vaccine acceptance in the
future.
Table 2. Summary of Key Findings, Limitations, and Recommendations
The Nurse Practitioner (NP) Perspective
Strengths
One of few studies to include nurse practitioners in healthcare provider sample
Findings
Possible differences in NP and pediatricians’ views on, discussions of, and recommendations for
Gardasil
Limitations
Small sample size makes it difficult to assess whether differences are significant
Recommendations
Future research that includes NP perspectives and compares potential pedagogical, structural,
and ideological differences between NP and other healthcare providers’ clinical practices
regarding the HPV vaccine
The Patient-Provider Interaction
Strengths
Qualitative methods and focus on service delivery provide valuable information on the providerparent conversations that is largely absent from the current literature
Findings
Providers employ different strategies to discuss the vaccine, depending on child/parent
characteristics, visit type, and other factors
Parental initiation of conversations could possibly alter the amount of information providers
share about the vaccine
Limitations
Analysis of communication differences is based upon provider and parent recollections (subject
to multiple biases) and not on observations of actual clinical visits
Future Research
Shadow healthcare providers and observe actual clinical visits for extended periods of time to
document actual interactions and typical exchanges; consider alternative strategies to explore the
service-delivery interface (e.g., conducting interviews directly following appointments) to
minimize recall bias
Practical Implications
Parents who initiate Gardasil conversations may not receive as much information about the
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vaccine as parents whose doctors initiate conversations; this might alter the role that daughters
play in the conversation (though future research is required to confirm whether this relationship
with initiation actually exists)
Vaccine Frames
Strengths
The use of an open-ended, qualitative research design provided an opportunity to explore
connections in parental decision-making processes that would be difficult to discover using
more traditional models (e.g., The Health Belief Model and Theory of Reasoned Action)
Findings
While many parents shared similar views regarding risks and benefits of the vaccine, parents
framed these risks and benefits differently. Three predominant frames were identified: the
cancer frame, the sex frame, and the safety frame. These frames helped parents focus on specific
attributes of the vaccine decision. Parents within the cancer frame tended to view Gardasil
primarily in terms of its cancer-preventing benefits. For those using a sex frame, the sexual
route of transmission was key in decision-making and framing. Parents using a safety frame
focused on the temporal risks associated with the newness of the vaccine and sexual maturation.
Limitations
Identifying frames is time-intensive; not all parents easily fit within a single frame; the same
parent might use a different frame depending on the individual child, point in time, etc.
Future Research
Attempt to operationalize variables relevant to the three proposed frames (and sub-frames) and
conduct research to determine whether quantitative instruments can correctly classify parents
into the same frames that they were assigned to based on qualitative analysis
Practical Implications
Understanding the different ways in which parents conceptualize the vaccine can help providers
communicate with parents in relevant and meaningful ways.
The Local Vaccine Culture (LVC) Approach
Strengths
Allows for a nuanced, multi-level, holistic examination of healthcare decision-making; calls for
examination of the service-delivery interface, which provides space to assess both structural and
ideational factors through supply, demand, and delivery interfaces
Limitations
The LVC requirement to examine the patient-provider interface presents challenges in the
United States given the structure of clinical visits (e.g., small examination rooms, presence of
three individuals in the room during a typical visit, the problems of obtaining informed
consent/assent from all parties involved, etc.)
Data collection and analysis are time consuming
The “Local” in the Local Vaccine Culture Approach requires definition
Recommendations
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Rethinking the “Local” as the “Contextual” may more aptly describe the approach and require
researchers to clearly articulate diversity within sample populations
Encourage wider use of the LVC (or Contextual Vaccine Culture) approach to examine
variations in vaccine acceptance
Issues of Trust
Strengths
One of few vaccine studies to examine the dynamic interaction between trust and risk, or to
explore the role of trust itself in vaccine decision-making
Findings
Trust worked at multiple and sometimes competing levels to help parents assess and compare
risks and make temporally-situated vaccine decisions
The significance of a provider’s vaccine recommendation is contingent upon the trustworthiness
parents ascribe to the individual provider; Trust in providers has as much to do with affect as it
does with medical competency
Parents expressed distrust towards the pharmaceutical industry. Similarly, healthcare providers
held differing views regarding the trustworthiness of Merck, the Gardasil vaccine, and FDA
oversight. NPs were more critical of the pharmaceutical industry and less likely to widely
recommend Gardasil to patients.
Recommendations
More detailed and in-depth studies of trust to better understand the relationship between risk,
trust, and decision-making;
Theoretical advancement to explain the multilayered and competing ways in which trust can
affect healthcare decision-making; this requires a reassessment of current models (e.g.,
HBM/TRA) that narrowly define risk
Practical Implications
Public health practitioners and healthcare providers need to be aware of the perception some
parents have regarding the relationship between pharmaceutical companies, public health
campaigns, and provider recommendations
Medical and nursing schools should stress the importance of interpersonal skills, empathy, and
compassion in developing patient bonds and encouraging patient trust
Providers can foster a sense of trust with patients if they can relate to parents using shared roles
(e.g., as women, as parents, etc.) and are comfortable sharing their own healthcare decisions
with parents
Adolescent Role in Decision-Making
Findings
Few parents felt their daughters would be capable of making a fully informed, autonomous
vaccine decision, even after age 18
It was important to some parents that their daughters take an active role in making an HPV
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vaccine decision, despite the fact that parents did not typically involve daughters in vaccine
decisions
A few parents preferred to vaccinate against HPV at early ages to avoid discussions about
HPV’s mode of transmission
Most parents appreciated when providers included daughters in HPV vaccine discussions;
parents appreciated when providers invited daughters to participate in the healthcare visit
Limitation
Reports of daughters’ participation were based on parental and provider perceptions. Daughters
might have different views on the role they played, or would like to play in such decisions
Future Research
Pre-adolescents and adolescents have the potential to participate in health care decisions, but it
is unclear if, when, and to what extent they actually contribute to their own healthcare
experiences. There continues to be a dearth of theoretical and empirical literature on the role of
adolescents in healthcare decisions; to fill this gap, adolescents must be included in qualitative
studies to understand their perceptions.
Development of theories on healthcare decision-making and participation as a triad that includes
the provider, parent, and adolescent; Establishment of shared working definition of autonomy
within the healthcare and adolescent literature so that cross study comparisons can be
undertaken
Assessments of adolescent vaccine decision-making to understand the ethical dimensions of
informed consent (e.g., can girls understand the short and long-term risks and benefits of
HPV/Gardasil?)
Timing of Decisions
Strengths
By approaching vaccine decisions as processes, rather than dichotomous outcomes (e.g.,
accepted/refused), the importance of temporal factors emerged.
Findings
Parents’ HPV vaccine decisions often unfold through time. Factors associated with the vaccine
(e.g., newness, safety), the daughter (e.g., individual health profile, age, sexual maturation), and
the larger sociocultural context (e.g., debates to mandate the vaccine) can all influence parental
choices. Some decisions to delay vaccine initiation relate to concerns about the long-term
efficacy of the vaccine and desires to maximize protection
Implications
Healthcare providers who begin discussing the vaccine with parents of younger girls should not
consider a refusal at one point of time to be indicative of long-term resistance to the vaccine.
Future Research
Vaccine acceptance should be viewed as a process. Methods and instruments must be designed
not only to assess vaccine outcomes, but to account for temporal changes in times and variations
in decisions for individual children. Development of longitudinal study designs to better
understand decision-making process among parents who defer and delay making a decision

419

Risk Communication
Strengths
Qualitative approach allowed for exploration of multiple communicative strategies used by
providers to respond to specific parent concerns
Findings
Some approaches can potentially damage the parent-provider relationship by challenging the
validity of parental knowledge claims, such as the validity and relevance of a mother’s instinct.
Limitations
Lack of observational data to validate parent and provider accounts of how risk communication
unfolds
Susceptibility
Findings
Some parents deferred making HPV decisions until their daughters were more sexually mature
and thus, more susceptible to HPV. However, susceptibility was often seen as the effect of
external threats(e.g., rape, male persuasion) rather than a daughters own lifestyle choice;
Future Research
Studies using aspects of the Health Belief Model that measure perceived susceptibility need to
account for different sources of susceptibility (e.g., daughter’s sexual behavior,
rape/molestation, peer pressure)
Monetary Concerns
Strengths
Using a qualitative approach allowed parents to explain if, and under what conditions, financial
issues might influence vaccine decision-making
Findings
Cost was not a significant barrier or deterrent to vaccination, although it is important to note that
the majority of parents interviewed in this study were middle class and privately insured. A few
parents would defer decision-making if the vaccine were not covered by insurance, either in
order to save sufficient money to pay for the vaccine or to maximize the number of years of
active coverage (i.e., delaying vaccination until a few months before their daughters became
sexually active)
Some providers were unaware of governmental vaccine programs available to Medicaid insured,
under insured, and uninsured youth
Recommendations
Expand qualitative approach to include a more diverse parent sample to determine whether
socioeconomic status and insurance type influence views on vaccine cost
Implications
Provide healthcare providers with county-level information on the Vaccines for Children
program and vaccine availability to adolescents who are publically insured, under insured, or
uninsured.
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The Importance of Timing
Study findings underscore the fact that Gardasil vaccine decision cannot be
understood outside of their temporal dimension. In keeping with calls to situate analyses
of meaning with the unfolding of peoples’ lives (Ortner 1984); that is, in analyzing
meaning attribution and the processes through which meanings gain significance, it is
essential to understand the impact that temporal distance of a series of events
(vaccination, insurance coverage, sexual debut) may have on the saliency of the meanings
under discussion.
In the clearest example of why time matters, consider some parental concerns
regarding long-term vaccine efficacy. Several parents were supportive of Gardasil, but
suspected that future booster shots would be needed to help protect their daughters.
Parents balanced concerns regarding the limited duration of vaccine coverage with other
factors, including insurance coverage, parental authority, and HPV susceptibility. These
parents – two of whom were (or had been) nurses – chose to defer vaccination for several
years, not because of vaccine safety concerns, but because they wanted to maximize the
protective benefits of the vaccine and ensure that their daughters were protected from
HPV at the period in life when they were most likely to be exposed to it. These parents
recognized that after age eighteen, their daughters would be able to make their own
vaccine decisions and might not consent to vaccination, so immunizing before this age
was important. At the same time, parents doubted that their daughters would become
sexually active at age thirteen or fourteen, and therefore saw no reason to waste valuable
years of protection,
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In this study, as in others (Brownlie and Howson 2005:228; Casiday 2007),
parents described that the ability to “bracket out uncertainties fluctuates over time”. This
fluctuation characterized parents subscribing to the “safety” vaccine frame. Parents’
distrust in medical systems, pharmaceutical motives, and vaccine safety compelled them
to delay initiating the vaccine series, despite their general support for vaccines and desire
to protect their children from cancer. Over the course of time, however, (and in the
absence of information to cause parents to question the safety of the vaccine further),
trust in the vaccine’s safety increased, what at the same time, trust in their daughters’
insusceptibility diminished.
Few parents with whom I spoke were against their daughters ever receiving the
vaccine. Rather, parents were hesitant to have their daughters vaccinated before it was
necessary. And “necessary”, for most parents, was when daughters become interested in
dating or sex, or when they turn a certain age. These findings suggest that short-term or
snapshot studies of HPV vaccine uptake that only account for dichotomous decision
outcomes likely overestimate the actual percentage of vaccine refusals and uptake. It is
likely that the same parents who were classified as vaccine resistant at one point in time,
might actively demand the vaccine in the future.
These findings have important implications for the ways in which vaccine
acceptance is measured. Recall that Nichter (1996c:330) originally saw active demand as
“adherence to vaccination programs by an informed public which perceives the benefits
of and need for specific vaccinations” while passive acceptance denotes compliance by a
“public which yields to the recommendations and social pressure, if not prodding, of
health workers and community leaders.” Streefland and colleagues (1999), in developing
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the Local Vaccines Culture approach, questioned the sensitivity of Nichter’s original
concepts of active demand and passive acceptance to assess actual vaccine behavior.
They argued that acceptance was best seen in gradations, pointing to cases in which a
parent might fully vaccinate one child, partially vaccinate another, and choose not to
vaccinate a third. In response, they proposed the concept of “social demand” to account
for vaccine demand that is associated with general vaccine benefits or general trust in
biomedicine, rather than the vaccine’s biomedically-defined therapeutic effects.
In conceptualizing acceptance in gradations, it is necessary to emphasize that
parental vaccine acceptance must be understood as processual, contingent, and ongoing.
Again, parents classified as “non acceptors” of Gardasil one visit may very well, even at
the same visit, be planning to “actively demand” the vaccine in four years’ time.

Trust and Knowledge
Earlier, in my review of risk theories (Chapter Two), I posed the question, “Does
risk matter?” Based on an analysis of parental narratives in this study, the answer is yes.
While parent risk evaluations are unquestionably critical to parents’ Gardasil vaccine
decisions, to suggest that risk defined Gardasil decisions would be inaccurate. Further,
the concept of “risk” needs to be unpacked in order to avoid reifying it as a static,
universal category; as mentioned previously, risk cannot be understood outside of a
temporal dimension. Adding further variation to this issue is the fact that risk
assessments used by parents were “construed differently from the probabilistic
framework of epidemiological risk” that was used by many providers in this study to
evaluate risk (Casiday 2007:1061).
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Although it is true that parental concerns regarding the relevance and weight of
some risks, such as the risks of sexual debut, promiscuity, cervical cancer, and vaccine
side effects, were central to the ways that parents understood Gardasil, decisions were as
much informed by ways that parents chose to frame and interpret specific “unknown”
risks through trust. Thus, while risk does matter, its role in vaccine decision-making
cannot be understood separate from trust. As I have tried to demonstrate throughout this
dissertation, trust is central to the ways in which parents conceptualized the Gardasil
vaccine, evaluated risks related to vaccines, sexuality, and HPV-infection, and ultimately
made vaccine decisions. These findings are consistent with those reported by Brownlie
and Howson (2005). In their study, parents, rather than focusing on risk, turned their
attention to questioning “the trustworthiness of the institutions in charge” (2005:224).
Based on these results, the authors suggest that vaccine decisions are best understood by
examining how parents deal (i.e., trust) with “unknowns” (i.e., risks). To understand
risks one must study trust, for as Misztal argued, “To trust is to believe despite
uncertainty” (Brownlie and Howson 2005:223). Trust and risk, rather than existing
separately, form a conceptual whole that must be viewed as such.
In Chapter Two, I provided an outline of Giddens’ main argument regarding the
trust-risk relationship; here I discuss how his argument can be applied to make sense of
some of the ways in which vaccine narratives are situated. Central to my analysis is
Giddens’ argument that social relationships are positioned within abstract, expert medical
systems through which knowledge is legitimized and validated irrespective of the
particular healthcare clinicians or patients who rely upon it. Giddens (1993:292) argues
that because the knowledge contained in the system exists beyond any one individual,
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trust – “a leap of commitment, a quality of ‘faith’ which is irreducible’” – is required for
the system to function.
Vaccines like Gardasil are highly technical innovations developed based on expert
knowledge contributed by biochemists, virologists, biostatisticians, and medical doctors.
Parents are so far removed from these expert systems that affirmation in their safety and
efficacy largely has to be taken on faith. Some parents had little trouble taking a leap of
faith, vaccinating their daughters without questioning the safety or efficacy of the
vaccine. Sarah had her daughter vaccinated without much consideration because in her
words, “I don’t have time to worry about it. I just have to take the faith of the system.”
While Sarah and several other parents felt comfortable taking a leap of faith, other
parents, who eventually also had their daughters vaccinated, had less faith in expert
systems – expressing a degree of distrust in governmental vaccine oversight, in
biomedicine as a capitalist system, and in the separation between healthcare providers
and pharmaceutical companies (see Chapter Ten).
Trust in expert systems is largely unconscious and taken-for-granted; when expert
systems work the results generally go unnoticed. In the case of vaccines, which prevent
disease, no news is good news. The lack of trust in expert systems occurs when these
systems fail and as a result, harm befalls the public (Giddens 1993).
Parental trust in expert systems is built upon ever-changing and cumulative
experience, illustrating, once again, the relevance of time and context to decision-making.
This also suggests the importance of shifting perceptions of relationality: between parents
and children; between medical consumers and the public health establishment; between
relations of governmental oversight and pharmaceutical lobbying. Parents in this study
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who doubted the safety of Gardasil, pointed to past cases in which regulatory oversights
failed; as a result of those failures, children died from vaccines (e.g., polio) and mothers
gave birth to stillborn or severely deformed children (e.g., thalidomide). Both parents
and providers recalled the recent recall on Vioxx in describing their distrust of Merck,
and in the ability of expert agencies such as the FDA to protect the public. I argue that
the attempted efforts of legislators, in alleged collusion with Merck, to mandate Gardasil
for school entry were interpreted by some parents as ethical failure of expert systems to
prohibit that a mandate be issued for a brand new vaccine.
Decisions to trust are not made in isolation, but within relationships and networks.
Fundamental to the Local Vaccines Culture approach is the service-delivery interface,
which is characterized by provider-patient interactions. Such interactions play a pivotal
role in vaccine decisions because it is through these institutional relationships, in which
providers are positioned both as symbols of medical expertise and as individuals, that
trust in expert systems is largely defined. At the same time, the parent-provider
interaction is located within other relationships – “including those between health
professionals, those within the organizational context of the health provider and those
between parents, professionals, health systems and society in general” (Brownlie and
Howson 2005:225). The role of providers, and their positionality vis-à-vis parents, other
healthcare providers, and expert systems, is significant, especially in times of expert
failure.
As Lupton (1999) and Taylor-Gooby and Zinn (2006) note, when expert systems
fail, people turn to face-to-face relationships in an effort to re-establish trust, and turn
away from the unseen, unknown, and abstract entities (i.e., expert systems) to obtain
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knowledge. In response to failures, individuals also increasingly associate
trustworthiness with likeness. Parents, for example, feel a strong sense of collective
interest, common identity, mutual understanding, and trust with one another based on
their shared roles as parents. Conversely, trust becomes more difficult to establish
between people of different social groups, such as parents and providers.
Both of these responses can be seen in the ways that parents explained provider
trust relationships. As was described extensively in Chapter Ten, parents did not express
a high degree of trust in healthcare professionals as an expert group of practitioners; to
the contrary, parents tended to view the average healthcare professional with skepticism
or ambivalence. While trust in providers as an expert group was low, trust in individual
healthcare providers was exceptionally high. In explaining why they trusted individual
providers, parents emphasized exceptionality. The behaviors, approaches, and
characteristics that made the provider trustworthy were also perceived to be unique.
When parents described the qualities, characteristics, or behaviors that led them to
strongly trust (or distrust) their providers, they often emphasized the provider’s attributes
as personable, kind, and caring human being. It is worth noting that none of these
characteristics are directly associated with provider knowledge, skill, or competency to
practice medicine (though one could argue that an unkind, uncaring, or impersonal affect
could make it difficult for a patient to feel comfortable sharing health concerns, which
could then affect treatment). These qualities were important not because they were signs
of medical competence, but because they were signs of social competence or a sense of
shared humanity. Kind and personable providers were the types of people that parents
could relate to, who they might be friends with, who they could trust. They were not
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unknown representatives of an abstract system, but friends and confidants who would
treat their children as individuals and not cases.
Parents also granted a high degree of validity to provider recommendations when
the providers were themselves parents. When providers had children, parents felt more
confident that providers would make careful, thoughtful, individualized decisions, rather
than approach treatment from a removed, depersonalized, and objectified position.
Parents, who approached healthcare as a highly involved, highly personalized, highly
subjective experience, felt comfort and communalism knowing that their child’s
healthcare clinician also took on that role with his or her own children. Providers who
establish personal, kind, and caring relationships with parents – whether it is as parents
themselves, by valuing parental knowledge, or by sharing personal vaccine decisions –
can foster a sense of trust that strengthens parental confidence in provider expertise and
professional recommendations.

Childhood, Sexuality, and Risk
Like trust, notions of gender and childhood are largely absent from theoretical
discussions of risk and risk anxiety; moreover, theoretical discussions have largely been
devoid of ethnographic grounding. Jackson and Scott (1999) argue that risk management
may in fact be central to our understanding of childhood. Risk anxieties directed at
children are viewed as unique, and thus are central to the concept of childhood as a
demarcated phase of life imbued with specific characteristics, expectations, and
vulnerabilities. The cultural expectations regarding the management of risk during this
phase of life are equally relevant to the construction of childhood. So strongly engrained
are our cultural notions regarding the vulnerability and innocence of children that few
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would argue the ‘rightness’ or obvious need to ‘protect’ children. At the same time,
competing cultural values compel parents to cultivate a sense of individuality within their
children, which is associated with a degree of child autonomy and agency.
Parents’ efforts to balance child autonomy and parental surveillance are informed by
notions of vulnerability, maturity (or lack thereof), and assessments of a child’s ability to
think and act competently.
In this study, deeply held cultural assumptions regarding childhood and
adolescence were expressed in parent and provider perspectives of adolescent autonomy
and decision-making. In describing whether adolescents can and should take part in
Gardasil decision, both parent and providers questioned their ability to make informed
healthcare decisions – even after age eighteen. If in fact young adults are indeed
incapable of making fully informed healthcare decisions (a question well beyond the
scope of this study), their incompetence might itself be the result of the cultural notions
of childhood that assume an inability to make well informed decisions. If not permitted
to participate in healthcare decisions during childhood and adolescence, then it should not
be so surprising that such competencies are not fully developed by adulthood – as marked
by the eighteenth birthday.
Adolescents are largely perceived as being incapable of making informed and
responsible healthcare decisions, and yet, adolescents – especially boys – have a fair
degree of sexual freedom. Adolescents exist in a space of contradictions. On one hand,
they have a tremendous degree of physical freedom to engage in the physical act of sex.
On the other hand, the act itself is culturally taboo to speak of (intergenerationally) and
many adolescents are actively discouraged from becoming informed about reproductive
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health. In other words, adolescents are largely free to engage in sex, while being largely
misinformed, under informed, or uninformed about the risks and responsibilities of
having sex.
There is an interesting contradiction at play in vaccine decision-making when
adolescents, who generally have little autonomy in healthcare decision-making, are
simultaneously asked to participate in one specific vaccine decision because of their
perceived autonomy in another area of life. For other parents, a perceived lack of control
in limiting their children’s sexual behavior – and the belief that children are incapable of
making informed and responsible sexual health decisions – compels parents to exercise
control in an area where they still have it: vaccine decision-making.
The socially constructed period of childhood becomes a locus of risk. As
vulnerable, inexperienced, fragile beings, children need to be protected from external
risks. Risks threaten not only children, but childhood. Just as children must be protected,
so must the stage of childhood be preserved. The familiar idiom, “to be robbed of one’s
childhood” assumes that there are specific qualities or markers (e.g., vulnerability, sexual
naiveté, and innocence) of childhood that must be protected (Jackson and Scott 1999).
Risk anxiety directed at children, and responses to it, simultaneously serve to “construct
childhood and maintain its boundaries – the specific risks from which children must be
protected help to define the characteristics of childhood and the ‘nature’ of children
themselves” (86-87). Jackson and Scott (1999) argue that there is perhaps no other area
of life in which childhood risk anxiety is more pronounced than when considering
sexuality.
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When considered together, childhood and sexuality are viewed as mutually
exclusive categories. Sexuality is seen as antithetical to the state of innocence that is a
defining cultural characteristic of the “normal” child (Jackson and Scott 1999:87). There
are countless examples of the symbolic, temporal, and spatial boundaries used to separate
childhood from sexuality, from providing warning labels about a television show’s
sexually-explicit content, to limiting soft pornography to late night, to prohibiting
individuals under 18 years of age from purchasing pornography, to the use of euphemistic
terms to refer to genitalia (and critical reactions and protest when parents refuse to use
such euphemisms). Recent controversies regarding the availability of thong underwear in
pre-teen sizes and the acceptability of childhood beauty pageants (Jackson and Scott
1999) were controversial because these actions transgressed an invisible boundary
demarcating childhood and protecting the phase from becoming sexualized.
Sexual or otherwise, it is the parent’s role to protect children from danger.
Jackson and Scott (1999:97) argue that there is a strong cultural emphasis on delineating
the boundaries between childhood and adulthood. The state of childhood itself is seen as
vulnerable and in need of protection from pressures towards early sexual maturity and
precocious sexuality. Simultaneously, childhood is seen as a natural state but also a state
of being perpetually threatened. As a result, “constant vigilance is required in order to
protect, preserve and manage childhood for the sake of the children” (Jackson and Scott
(1990:97). The strong cultural focus on individual responsibility in the management of
health risk, coupled with the sexual mode by which HPV is transmitted, forces parents to
confront issues that may challenge their own conceptions of their children as children.
Jackson and Scott (1999:90) argue that “Increasing anxiety about risk has been
431

superimposed upon an older ‘protective discourse’ within which children are located as
vulnerable innocents to be shielded from the dangers of the wider social (implicitly adult)
world.”
The fusion of risk anxiety with protectiveness engenders a preoccupation with
prevention, a need for constant vigilance in order to anticipate and guard against potential
threats to children’s wellbeing.” As I argued in Chapter Twelve, one way in which
parents deflect risk away from their daughters, and simultaneously maintain their image
of their daughters as children, is through reference to social disorder and external threat.
From this perspective, a girls’ sexual wellbeing is in need of protection, not from HPVinfection itself, but the people who might expose their daughters to it. Daughters are
repositioned as vulnerable innocents; Gardasil emerges as a means to protect them from
“all-pervasive, global social ‘ills,’” sexual predators, and immoral peers (Jackson and
Scott 1999:88).
While parents are responsible for protecting their children from risk, they are also
criticized if they are overly protective and too sheltering. Jackson and Scott (1999:103)
argue that “Parental risk anxiety is heightened by particular discursive constructions of
responsibility. Parents are not only responsible for the care of their children, they are
also held responsible for their children’s wellbeing and conduct.” Parents are expected to
manage their children’s transition to sexual awareness, but only once they have been
deemed to have reached some undefined but socially appropriate age of awareness. Until
that transition is completed, parents also need to keep young children free from the “taint
of sexuality” (103) that could threaten their innocence.
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Such concerns help to explain why parents stress the importance of sex education
and shared vaccine decision-making, while simultaneously expressing anxiety about how
much information to share with daughters, how much autonomy to grant them, and at
what stages in their maturation process. Moreover, parents’ responsibilities to
simultaneously protect their children from sexuality, while preparing them for it,
illuminate ambivalence in explaining to their daughters the role of Gardasil vaccine.
Parents wanted their children to understand the individual responsibility they had in
protecting themselves from HPV, but did not want to have that conversation (or
vaccinate) until they felt their daughters were at an age to have a conversation about
sexual responsibility.
Parents, especially mothers, internalized vaccine responsibility and healthcare
decision-making. As has been found in other studies (Flanagan-Klygis et al. 2005; Leask
et al. 2006), parents not only internalized vaccine responsibility, but cast moral judgment
upon other women (and themselves) based on Gardasil vaccine decisions. The two
women who would not vaccinate their daughters with Gardasil saw their own decisions
as reflections of their desire to protect their daughters and fulfill their own duties as
responsible mothers. Mothers who did (or would eventually) vaccinate also saw their
decisions as reflections of their desires to protect daughters and act responsibly,
describing non-vaccinating mothers as ignorant, oblivious, irresponsible, or selfish.

Limitations
Like all studies, this study is not without limitations. Although the purpose of this
study was not to draw sweeping or widely generalizable conclusions about vaccine
acceptance and decision-making, I still attempted to obtain vaccine perspectives from a
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diverse group of parents. Despite efforts to do so, the majority of parents with whom I
spoke self-identified as White, were privately insured, and reported household incomes
above state averages (by household size). Only two of the parents that I interviewed were
uninsured and only two parents had children enrolled in publically-funded programs. It is
unclear how significant ethnic, socioeconomic, and insurance variations might have been
in this study.
The same limitations apply to the provider sample. As previously discussed, only
one male healthcare provider (chiropractor) participated in the study, despite the fact that
a greater percentage of total research fliers were sent to males. While several large
studies of healthcare provider practices and attitudes vis-à-vis HPV vaccination failed to
show an association between provider sex and vaccination practices (Roberto et al. 2011;
Vadaparampil et al. in press), another national study reported that female providers were
more likely than male providers to report administering the vaccine in their offices
(Daley et al. 2010). Even if one supposes that there are no gender differences in the
likelihood that providers will recommend the HPV vaccine, there could be variations in
the ways that they approach the topic, the information they share or withhold, to whom
they direct conversations, and the level of comfort they feel when discussing the vaccine.
For example, Burd and colleagues (2006) reported that both male and female
physicians felt significantly higher levels of discomfort when recording sexual health
histories of patients of the opposite sex. In a study of physician gender and patientcentered communication, Roter and Hall (2004) found that female primary care
physicians tended to spend more time with their patients and engage in more patientcentered forms of communication. On the other hand, Miller and colleagues (2008)
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found no gender differences in the practices through which pediatricians provided
guidance to parents about sexual risk reduction. Research using qualitative methods can
meaningfully contribute by exploring some of the potential variations in vaccine
communication by gender.
While the Local Vaccine Culture (LVC) approach provides an integrated and
dynamic approach to explore vaccine acceptance that connects individual practices to
larger community processes, the term “local” in the Local Vaccine Culture approach
requires unpacking. How is “localness” defined? The LVC approach was developed
with an overarching international lens in mind. From my reading of the literature, it
appears that the term “local” was used to emphasize the importance of local – or perhaps
more aptly, “contextual” landscapes and the relevant laws, policies, politics, and cultural
beliefs that shape vaccine uptake and decision-making in a particular place. If the
essence of the approach is to capture contextual factors relevant to vaccine decisionmaking, then what is “local” will vary not only geographically, but temporally.
Although I cannot speak for the main proponents of the approach, my own sense
is that from a global health perspective, “local” can be narrowly or broadly defined
depending on the specific field site. Many authors using the approach appear to use the
term “local” to describe regional or national-level vaccine program. Of course, defining
“local” at either such level can easily be problematized. In the U.S., there are clear and
pronounced differences in vaccine uptake (e.g., Colorado vs. Connecticut). Thus, despite
the varied uses of the term “local”, my decision to include parents from two regionally
distinct areas of the U.S. within the sample necessitates some level of explanation.
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Pennsylvania and Florida are different in important ways (see Chapter Five). At
the same time, there are a broad set of share cultural values regarding individual
autonomy, governmental regulation, choice, and sexuality that are generally shared
among individuals across the U.S. I contend that Pennsylvania and Florida do share
dome defining features that are markedly different from features defining vaccine uptake
in, for example, the U.K., the Netherlands, Cameroon, or China. The term "local" thus,
(again, from my reading), can be flexibly defined.
To describe the landscapes in which Floridians and Pennsylvanians make vaccine
decisions, I attempted to couch state-level differences in rates of vaccine uptake,
coverage, and laws within a larger historical discussion of shared cultural values related
to vaccine decision-making (Chapters Five and Six). Throughout the analysis process, I
actively looked for regional variations in vaccine decision-making. The absence of
regional variation suggests that, at least among this small sample of participants, there is
a unifying level of "sameness" that the term "local" might not adequately convey, but that
was adequately captured by using the LVC approach.
From my perspective, ambiguity that can arise in trying to create limits or
boundaries on “localness” arises from the usage of the term “local”, rather than the
approach itself. Based upon my own reading of studies using the approach, the
framework could more accurately be called the “Contextualized Vaccine Culture”
approach. The need to provide a contextualized, rather than local, description of vaccine
decision-making more precisely captures, in my mind, the essences, benefits, and "point"
of the approach.

436

Public Health and Clinical Practice Implications
Results from this study reveal the important role of healthcare providers as
sources of HPV-related information and Gardasil recommendations. These results are
consistent with past studies reporting the importance of provider recommendations on
Gardasil uptake (Kahn, et al. 2005; Klein and Wilson 2002 ; Mays and Zimet 2004;
Millstein, et al. 1996; Raley 2004; Riedesel, et al. 2005; Sussman, et al. 2007; Torkko, et
al. 2000). However, parents in this study also made it clear that the value, impact, and
credibility of provider recommendations is typically provider-specific. A specific
recommendation for the HPV vaccine was a significant motivator for many parents to get
the vaccine, but only among parents who also had faith in their provider.
This study can help public health professionals and clinicians better understand
how to cultivate and maintain trusting relationships with parents. While most parents
trusted their children’s healthcare providers, parents did not always express trust in
providers as sources of information. Consistent with other findings (Evans et al. 2001;
Smailbegovic; Sporton and Francis 2001), some parents questioned the objectivity of
information presented by healthcare professionals. In order to foster a sense of trust with
patients, it is important that providers communicate the benefits and risks of Gardasil
with parents, including its association with genital warts.
Most parents I spoke with had not known that Gardasil would provide their
daughters with protection against genital warts. While most parents were not angry that
their providers had not shared this information with them, they did feel that having
known about the additional protections would have furthered their support for the
vaccine. One mother, however, was upset that her provider did not disclose this
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relationship, interpreting it as a sign that providers did not present objective information
or trust parents to make informed decision when presented with sensitive information.
Aside from the ethical obligations providers have to fully inform parents of the
benefits and risks associated with vaccination, one recent study suggests that equipping
parents with information increases vaccine rates. Litton and colleagues (2011) found that
caregivers who received HPV-related information from a healthcare professional were
more likely to intend to vaccinate their daughters against HPV in the next six months
compared with caregivers who did not report this source of information.
Another way clinicians can foster trust is through risk communication. For some
parents, trust in expert systems has much to do with a sense of reciprocal trust from
experts. Parents trust providers who recognize and value parental abilities to notice slight
variations in children as signs of illness or health. Most importantly, parents have
confidence in providers who acknowledge and understand that making healthcare
decisions for one’s own child is a qualitatively different experience than making
decisions for populations. Parents seek providers who respect their efforts to make
careful, responsible, and informed decisions about their children’s healthcare.
As has been discussed in various sections of the dissertation, and has been
reported in other studies (Casiday 2007; LeBlanc 2007; Leask 2002), providers and
parents use different sets of criteria to evaluate the trustworthiness and validity of
knowledge. Providers tend to rely upon a narrower set of criteria in exclusively (or
primarily) legitimating scientific knowledge, while parents validate more diverse ways of
knowing (e.g., motherly embodied knowledge; personal, family, and peer vaccine
experiences, etc.).
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Providers frame vaccine evaluations using a cognitive science understanding of
risk. Parents do not. Providers in this study often made implicit and explicit statements
that indicated a heightened belief in the superiority of scientific ways of knowing. While
some providers were more likely than others to recognize the validity of other ways of
knowing, many providers, especially physicians, made comments to suggest that they too
perceived some parental concerns to be irrational, selfish, or inaccurate and that they
viewed parental decisions to refuse (and in some cases, defer the decision) as based on
lack of education, awareness, or worldliness.
Clinicians often tried to respond to parental concerns using statistics derived from
scientific risk assessments. In responding to parents’ assertions that their daughters did
not need to be vaccinated because they were not sexually active, providers sometimes
presented statistics on ages of sexual debut to suggest that sexual activity might occur
earlier than parents anticipated. Parents likely do not view these statistics as relevant to
assessing their individual daughter’s risk because their daughter is not normal, she is not
a statistic, and she is not sexually active. If the provider argues that sixty percent of girls
become sexually active during high school, the parent responds that her daughter is part
of the forty percent who will not. If the provider raises the risk, arguing that ninety
percent of girls become sexually active during college, the only conclusion a parent might
draw from this is that her daughter is more exceptional in being part of the ten percent
who will not. While providers are no doubt well-intentioned in presenting these
statistics, such responses could undermine parent trust in the provider, who might be
perceived as doubting the daughter’s moral compass, or as questioning (i.e., distrusting)
the parent’s own knowledge of his or her daughter’s character.
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Some healthcare providers found paradoxical the association between increased
education and higher observed rates of vaccine refusal. As argued earlier, this
association is founded upon an assumption that educated individuals are more likely than
others to use scientific information to assess risk, and that through assessments, parents
will conclude that vaccine is the appropriate choice. However, in this study, most of the
parents who worked within the medical system or had advanced degrees themselves had
made decisions to defer vaccination
While the risk appraisal is absolutely essential to scientific, medical, and public
health understandings of the relative merits of vaccination, there is less evidence to
suggest that parents use the same process to consider the relative merits of vaccination for
their own children. In fact, studies that examine risk communication between providers
and parents indicate that the relative importance of the scientifically understood risk
appraisal has little relevance for most parents (Hobson-West 2003; Hunt, et al. 2006;
Rapp 2000). As Hunt and colleagues (2006: 193) note, parents often have to translate
providers’ general risk information into relevant data; “while clinicians discuss risk in
clinically meaningful terms, patients must translate the clinical notion of risk into
personally meaningful terms, in order to apply to their own situation”.
Casiday (2007) argues that parents and clinicians often speak different
epistemological languages of risk. Communicating across this divide requires
translation; the challenge for clinicians is to acknowledge other forms of knowledge and
take personal experiences seriously, while also interpreting epidemiological knowledge
(Casiday 2007). Expanding notions of risk communication, and what falls within the
purview of legitimate risk knowledge, can foster parent trust in providers while also
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heightening the credibility parents ascribe to provider recommendations.
Epidemiological findings and risk assessments lack the richness and meaning of
narratives presented through media stories or personal anecdotes and are therefore
sometimes more difficult for parents to appreciate. Several researchers have
recommended that clinician’s use their own narratives as bridges to imbue
epidemiological information with meaning (Casiday 2007; Fitzpatrick 2004). Some
parents and providers in this study felt it was beneficial when clinicians shared their own
vaccine decisions with parents because it established a shared identity and link between
them.
Establishing trust in providers is a process that generally takes time to build.
Recall that Alice’s daughter was publically-insured and though her daughter was initially
treated by a resident, her primary care provider always followed-up. Alice was clear that
she would not make a vaccine decision based on the recommendation of residents
because she did not have a long-term, trusting relationship with them. However, Alice’s
trust and confidence in her primary care provider’s recommendation was so resolute that
Alice had her daughter vaccinated with Gardasil without having previously heard of it or
knowing what it prevented. Melissa felt similarly. If her daughter’s previous
pediatrician (who lived in another part of the country) recommended Gardasil, Melissa
would get it, yet because Melissa did not have a trusted provider in Florida, she was
unable to know whether she could trust a random provider’s professional opinion.
These findings have implications for health policy. Several studies report
variations in vaccine uptake among girls enrolled in different types of publically
insurance programs (Staras, et al. 2010b; Staras, et al. 2010). The authors of these studies
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suggest that differences in plan policies – specifically differences in rules regarding
consistency in the provision of primary care – likely explain some of these disparities.
They noted that girls more likely to be vaccinated are also enrolled in public insurance
plans that require that preventive and primary care is consistently administered by the
same individual, which is key in developing a trusting, long-term relationship. Given the
importance that trust can have in fostering positive healthcare relationships, and in
allaying parental fears, it appears beneficial to encourage these types of long-term
relationships. Most parents in this study not only accepted when providers included their
daughters in HPV vaccine conversations and discussions of sexuality, but actually
expected that providers would comfortably engage in these types of interactions.
Several studies have compared rates of uptake among privately and publically
insured girls, but rates among under-insured and uninsured girls are less clear (Chao, et
al. 2010; Staras, et al. 2010b; Staras, et al. 2010). As described in Chapters Five and Six,
federal and state-funding programs exist to ensure that these girls have access to the
Gardasil vaccine, yet from provider narratives, it appears that neither parents nor
providers are always aware of these options. Several providers lacked awareness of
available resources through which their under-insured and uninsured patients could
receive Gardasil. This is concerning given that (according to three providers) some
parents would vaccinate their children if they were aware of low or no cost means by
which to do so. Demands placed on clinicians are already high; it would behoove
county-level public health officials to ensure that healthcare practitioners in their
communities are trained on the local vaccine options available to girls, criteria for
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seeking different options, and information about locations through which vaccines can be
obtained.
From their own clinical experiences, most healthcare providers in this study
described many parents’ HPV vaccine decisions as ongoing processes. While many
parents accepted Gardasil vaccination when it was originally recommended to them,
other parents preferred to wait – for various reasons – to make a vaccine decision. All
but two of the parents in this study had, or eventually planned to have their daughters
vaccinated. To ensure that parents have adequate time to make a vaccine decisions
without feeling pressured, providers might consider introducing the vaccine before the
eleventh and twelfth year exams, not with the intention of vaccinating girls during those
visits, but with the goal of informing parents about the vaccines potential future use.

Anthropological, Public Health, and Practice Contributions
Results from this dissertation study have practical and theoretical anthropological,
public health, and practice implications. In this section, I describe some of these key
contributions. This dissertation study is one of few anthropological studies of parental
HPV vaccine decision-making in the United States, thus providing valuable information
about the cultural, social, and experiential context in which HPV vaccine decisions take
place. It is also one of the few studies to examine both provider and parent perspectives
regarding HPV vaccine decisions with attention to the service-delivery interface. Perhaps
most importantly, it is, to my knowledge, one of only three studies (Sussman et al. 2007;
Tisset et al. 2007) to obtain clinicians’ own narrative accounts regarding their
perceptions, interactions, and delivery of the HPV vaccine. Of equal importance, it is one
of few studies to obtain perspectives of nurse practitioners’ perspectives on
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recommending vaccines against sexually transmitted infections (Mays and Zimet 2004)
and one of even fewer that explicitly seeks to understand their attitudes and perspectives
regarding the HPV vaccine (Sussman 2007).
The American Academy of Nurse Practitioners estimates that as of 2011, there are
nearly 150,000 nurse practitioners currently practicing medicine in the United States; NPs
comprise more than one-sixth of the health care workforce (AANP 2011; ACP 2009).
Approximately two-thirds (68%) of NPs practice in at least one primary care site and
88% of NPs are trained in primary care (AANP 2011). Aside from physicians, nurse
practitioners are the largest group of primary care providers, with more than 600 million
patient visits annually. NPs are more likely than physicians to provide care to younger
patients with few co-morbidities and to see patients with only acute minor illnesses
(Hooker and McCaig year). They also play a critical role in providing care to individuals
seeking care in rural communities: an estimated 18% of NPs work in rural or frontier
settings (ACP 2009; AANP 2011).
Unlike some other types of analyses of healthcare choices that focus on values,
behaviors, and beliefs as discrete units of measure, an anthropological analysis begins
with the assumption that the values, behaviors, and beliefs associated with healthcare
choices are embedded within larger cultural contexts that cannot be understood in
isolation (Helman 1990). The approach highlights the limits of using the Health Belief
Model or Theory of Reasoned Action as exclusive theoretical frameworks for
understanding vaccine acceptance. While these theories offer helpful heuristic categories
to think about factors that might be relevant to decision-making, they are also limiting.
While they can identify specific factors, such as provider recommendations or perceived
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susceptibility, associated with a vaccine outcome, they do not inform the process through
which these variables become significant, or how interplay among factors can affect
decisions.
As I have argued throughout this dissertation, parents’ vaccine decisions are
embedded within complex webs. To isolate one strand of the web as central without
explaining its interconnectedness and relationship to the whole is to largely miss the point
of the web itself. In reducing vaccine decisions to discrete variables we run the risk of
losing sight of the goal – which is to understand the processes through which vaccine
decisions gain saliency. Parental understandings of vaccine risks are embedded in an
“evolving cultural process which resists categorizations within the static abstractions of
‘grand theory’” (Wilkinson 2001:14). Attempting to explain all risk decisions according
to one grand theory requires reducing complexities to such an extent that we run the risk
of developing frameworks “so far removed from the reality of lived experience that we
are left building castles in the air” (Wilkinson 2001:14).
The Local Vaccine Culture (LVC) approach provides an excellent framework to
holistically examine the historical, political, economic, and sociocultural milieu within
which providers and parents interact and through which parents’ temporally-situated
values, beliefs, and experiences are made meaningful. Attending to the role of social
context, temporality, and experience in examining vaccine decisions helps to make sense
of variations in vaccine decisions by viewing the within – rather than apart from – the
social fabric in which they are embedded.
The use of a more open-ended, qualitative research methodology provided the
opportunity for parents to express and articulate perceptions, values, beliefs, events, and
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characteristics that they deemed important to vaccine decision-making. The approach
also allows space for decisions to be viewed as processes rather than discrete events or
outcomes, which revealed the importance of social context and temporality on decisionmaking processes. Through narratives, it became clear that some parental evaluations of
risks associated with vaccine safety and sexual debut evolve through time, leading to
different perceptions regarding the Gardasil vaccine.

Future Research
Few studies examine issues of autonomy and agency in adolescent healthcare
decision-making. Though researchers have called for more adolescent participation and
autonomy in healthcare decision-making (Dickey and Deatrick 2000), few studies have
actually examined the role that young people play in making decisions about their health.
Several small studies suggest that children and adolescents do not participate in
healthcare decision-making to the extent that they might (Runeson, et al. 2002; Runeson,
et al. 2007).
One area in need of further theoretical and ethical development relates to the
concept of childhood and adolescent autonomy and its relationship to healthcare
decision-making. In a review of existing literature on adolescent autonomy in healthcare
decision-making, Spear and Kulbok (2004) found little consensus regarding the definition
or measurement of autonomy.
Although pre-adolescent and adolescent girls have the language and cognitive
capabilities to engage in some level of discussion about vaccines, the literature tells us
little about what role, if any, girls actually play in Gardasil vaccine conversations and
decisions. McRee and colleagues (2010) asked parents to rank, using a scale of 1 to 4
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(from no involvement to high involvement), what role their daughters played in HPV
vaccination decisions and who was the primary person involved in making the decision.
Similar to this study, parents of older girls reported that their daughters were more
involved in decisions, but again, reports come from parents’ perceptions of involvement.
Mathur and colleagues (Mathur, et al. 2010)(2010) surveyed 170 Californian high
school girls about whether they, someone else, or no one was involved in the HPV
vaccine decision-making process. Because girls used their own definitions (which were
not recorded) of what participation meant, it is impossible to assess how levels of
participation might vary, or to determine whether girls made decisions along or jointly.
While the study is a good start towards understanding how girls themselves understand
participation in healthcare decision-making, more open-ended, qualitative methodologies
lend themselves to a more thorough and nuanced analysis of what participation means to
adolescents, which can subsequently contribute to a discussion of autonomy.
Although it is impossible to know whether providers described in this study
actually shared less information about HPV vaccines with parents who initiated the
conversation, the possibility deserves further exploration, especially given that parents
seem unaware of the limited protections of vaccines to protect against all types of
cervical cancer. To my knowledge, there are no studies of vaccine communication that
examine the provider-patient-adolescent triad; such studies, that incorporate the use of
observational methods to record these interactions can provide fertile ground for
theoretical development and prove helpful in parsing out the dynamics through which
information is offered, vetted, and withheld from and by parents, providers, and
adolescents.
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Studies in this area can also reveal how parents conceptualize their children’s
roles in healthcare decision-making, and how these perspectives vary according to the
types of interventions and technologies in question. It was clear from this study that
many parents who did not give their daughters any decision-making authority in relation
to other vaccines were not only willing, but insisted that their daughters take a more
active role in making a Gardasil vaccine decision. Studies can help to identify what role
parents will allow their children to play in their own healthcare, while identifying
strategies and techniques that foster greater participation and inclusion of adolescents in
making healthcare decisions.
Additionally, studies on the provider-parent-adolescent triad can also help public
health and clinical practitioners understand the ethical dimensions involved in informed
decision-making. In this study, some providers and parents doubted that adolescents
were capable of weighing short-term consequences (such as injection pain or in the case
of Depo-Provera, protection against pregnancy) with long-term benefits (e.g., protection
against some types of cervical cancer) or risks (e.g., osteoporosis). Parents in another
study of HPV vaccine acceptance also expressed similar concerns; some parents chose to
vaccinate their daughters because they questioned their daughters’ judgment (or lack
thereof) vis-à-vis sexual decision-making (Perkins et al. 2010).
One key finding from this study was that parents conceptualize susceptibility to
HPV infection in multiple ways. Few parents believed that their daughters would be
susceptible to HPV because of their own sexual decision-making; rather, parents saw
their daughters – as females, as adolescents, as youth growing up in a changing world –
as vulnerable to external threats (e.g., rape, peer pressure, unscrupulous boys) that could
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put them at risk of acquiring HPV. It is important that researchers using theories and
instrument (e.g., the Health Belief Model) to assess susceptibility account for the multiple
meanings and associations that parents hold regarding vulnerability.
Additional research is needed to understand the role that trust plays in risk
assessments and vaccine decision-making. The amorphous, abstract, and competing
ways that parents and providers described trust, and the importance of trust in shaping
broader attitudes and perceptions regarding the pharmaceutical industry, public health,
healthcare providers, their daughters, and others, need to better understood. Using mixed
method approaches to delineate such relationships will contribute to our understanding of
the processes through which trust work, at multiple levels, to inform both parents and
providers’ views toward vaccines can have important theoretical and practical
implications.
More qualitative research designs are needed to add balance and context to the
existing vaccine acceptance literature. The systematic, but flexible nature of qualitative
data analysis allows us to rework questions and methods as we go, to adjust our focus and
sharpen our view of a problem. While statistical analysis gives us a snapshot, qualitative
analysis allows us to explore other dimensions as well – to add layers and depth and
nuance to contextualize findings. Statistical analyses are of limited utility if practitioners
do not understand how specific relationships gain saliency. Unfortunately, within the
current literature, the meaningfulness of behaviors, such as vaccination, is often
overlooked or stripped down to a quantifiable essence. To strip meaning from behaviors
– to suggest that behaviors are simply guided by physical events or conditions – is to
deny the complexity of human action. The processes through which people attach
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meaning to events are not static nor mechanical, but creative, contextual, and experiencebased.
Anthropologists are well positioned to provide their own meaningful
contributions to the vaccine acceptance literature. Anthropology is not merely about
identifying patterns or associations; rather, anthropological analyses move beyond reports
of statistical correlations among variables to understand the relationships of patterns to
the complex whole. In focusing on the meaning of observations (both to individuals and
more broadly), the normality (or uniqueness) of specific behaviors and beliefs and their
relationships to other beliefs and behaviors, and in attending to the ways in which
behaviors might change if represented differently, anthropologists can provide a more
holistic and complex understanding of phenomena.
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Appendix One: Additional Tables

Table A1. Association between Demographics and Vaccine Uptake
Demographic
Variable
Parent Education
Level

Association

Study

Positive (as education
level increases,
acceptance increases)
Negative

Gust, et al. 2003; Luman, et al. 2003; Marks et
al., 1979; Mays and Zimet 2004

None

Clinic Site
(Private/Public)

Income

Public clinic attendance
associated with higher
vaccine acceptance
None
Negative Correlation
(as income level increases
vaccine acceptance decreases)
Positive
None

Family Size

Single Parent

Race/Ethnicity

Negative Correlation (as family size
increases, vaccine acceptance decreases)
Positive Correlation

Sperber, et al. 2008
Hopenhayn, et al. 2007; Salmon, et al. 2005

Davis, et al. 2004; Dombkowski, et al. 2004;
Gerend, et al. 2007
Brabin 2006; Slomovitz, et al. 2006
Dombkowski, et al. 2004; Marks et al. 1979

Positive Correlation

Casiday, et al. 2006;
Tickner et al. in press (first-time mothers
expressed less confidence in vaccines than
other mothers)
Liddon 2005

Negative Correlation

Dombkowski, et al. 2004; Luman, et al. 2003

Hispanic mothers more accepting of
vaccines than other mothers
African American parents less accepting
of vaccines than other parents

Constantine and Jerman 2007; Scarinci, et al.
2007
Constantine and Jerman 2007; Litton, et al.
2011; Luman, et al. 2003; Scarinci, et al.
2007; Fazekas, et al. in press
Liddon 2005

Non-white more willing to accept
vaccinations than white parents
No association between ethnicity and
acceptance

Parent Age

Allen 2007; Constantine and Jerman 2007;
Davis, et al. 2004; Marlow, et al. 2007;
Salmon et al. 2005
Brabin, et al. 2006; Dinh, et al. 2007; Gerend,
et al. 2007; Litton, et al. 2011; Marlow, et al.
2007; Ogilvie, et al. 2007; Slomovitz, et al.
2006
Fazekas, et al. 2008; Mays, et al. 2004;
Zimet, et al. 2005b

As age increases, acceptance decreases

Boehner, et al. 2003; Brabin 2006; Davis, et
al. 2004; Gerend, et al. 2007; Kahn, et al.
2003; Keane, et al. 2005; Marks, et al. 1979;
Marlow, et al. 2007; Mays, et al. 2004;
Ogilvie, et al. 2007; Olshen, et al. 2005;
Slomovitz, et al. 2006; Sperber, et al. in press
Hopehayn, et al. 2007; Sperber, et al. in press
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Table A2. Cognitive Biases associated with Vaccine Decision-Making

Type of Bias

Definition

Amplification

Risks are amplified depending on the type of risk. Risk perceptions are
amplified when the risk is associated with a deliberate human act, rather than
a natural, random event. Voluntary risks are more acceptable than nonvoluntary risks (Kimmel and Wolfe 2005)
 Parents are more likely to accept vaccine scenarios when the vaccine
was voluntary, but recommended, as opposed to mandatory (ibid)

Omission

The preference to accept a harmful consequence from inaction, rather than a
harmful consequence from doing something (Baron and Ritov 2004)
 Parents would rather withhold a vaccine because they believe that
taking actions are more harmful than inaction. Parents would feel
more responsible if their child died from a vaccine than from a
vaccine preventable disease (Asch, et al. 1994; Dannetun, et al. 2005;
Kimmel and Wolfe 2005; Meszaros, et al. 1996; Ritov and Baron
1990)

Control Bias

Parents are more likely to refuse a vaccine if they perceive greater control
over their own abilities to control their child’s exposure to the disease
(Kimmel and Wolfe 2005; Meszaros, et al. 1996; Sporton and Francis 2001)
 Parents thought vaccine-preventable diseases were largely determined
by environmental factors and associated with low income, poor
nutrition, and poor sanitation (Niederhauser and Markowitz 2007)
 Parents believe they have sufficient control over their child’s sexual
or moral behavior (Mays, et al. 2004)
 Parents ascribed control to God, out of anyone else’s hands
(Princeton 1988; Sporton and Francis 2000)

Compression

People over-estimate the frequency of a rare risk, such as vaccine death, and
underestimate the frequency of a more common risk, such as influenza (Ball
et al. 1998)
 Compressions biases reported in (Hilton, et al. 2006b; Smailbegovic,
et al. 2003)

Availability
Bias

Easily accessible, widely publicized, and easily imaginable risks are likely to
be over-emphasized.
 Bias particularly used to understand the role of media coverage about
adverse vaccine effects and the effect it has on parental vaccine risk
perceptions (Ball, et al. 1998; Leask 2002)
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Table A3. Selected HPV Vaccine Studies by Methods and Sample Population
Authors
Brabin et al. 2006
Brabin et al. 2007
Chan et al. 2007
Constantine and Jermain 2007
Davis et al. 2004a
Dempsey et al. 2006
Dinh et al. 2007
Friedman and Shepeard 2007
Gerend et al. 2007
Giles and Garland 2006
Hopenhayn et al. 2007
Kahn et al. 2003
Lascano-Ponce et al. 2001
Lenselink et al. in press
Marlow et al. 2007
Moraros et al. 2006
Ogilvie et al. 2007
Olshen et al. 2005
Scarinci et al. 2007
Slomovitz et al. 2006
Sperber et al. in press
Waller et al. 2006
FG – Focus groups
I – Interviews
S – Surveys
TS – Telephone surveys
V – Vignettes

Methods
S
S/I
S
TS
S
S/V
S
FG
S
S
TS
S
S
TS
S
S
TS
FG/I
FG
S
S
FG/V

Sample
Parents
Parents
Mothers
Mothers
Parents
Parents
Mothers
Males/Females
Mothers/Females
Females
Mothers/Females
Females
Mothers/Females
Parents
Mothers
Mothers
Parents
Parents
Females
Mothers
Females
Parents
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Table A4. Selected non-HPV Studies by Vaccine, Methods, and Sample Population
Vaccine
MMR
MMR
MMR
MMR
MMR
MMR
MMR
MMR
MMR
MMR
MMR
OPV
MIX
POL
RAB/HEPa
STI
VAR
VAR
5in1
GEN
GEN
GEN
GEN
GEN
GEN
GEN
GEN
GEN
GEN
GEN
GEN
GEN
GEN
GEN

Authors
Casiday 2007
Casiday et al. 2006
Guillaume and Bath 2004
Hilton et al. 2007b
Hilton et al. 2007a
McMurray et al. 2004
Petts and Niemeyer 2004
Poltorak et al. 2004
Smith et al. 2007
Raithatha 2003
Smailbegovac et al. 2003
Kishore et al. 2003
Hak et al. 2005
Yahya 2006
McCombie 1989
Mays et al. 2004
Marshall et al. 2005
Niederhauser 2001
Tickner in press
Meszaros et al. 1996
Benin et al. 2006
Fairhead et al. 2004
Fowler et al. 2007
Jegede 2005
Kamara 2005
Keane 2005
Millimouno et la. 2006
Niederhauser and Markowitz
2007
Sporton and Francis 2001
Wilson 2000
Wroe 2004
Zimet 2005
Hinds and Cameron 2004
Rosenthal 1995

A – Archival research
B – Vaccine biographies
FG – Focus groups
I – Interviews
LGT – Longitudinal

Methods
FG
ES
I
FG
FG
I
FG
PO/I/FG/B
S
I
S/I
FG/PO
S
PO/I/FG
I
I/S
TS
S
I
S/V
I(LGT)
B/I/FG/ES
I/FG
S
FG/I/PO/B
S
I/B/F/A/PO
FG

Sample
Parents
Parents
Parents
Parents
Parents
Mix
Parents
Parents/Providers
Mothers
Parents
Parents
Mix
Parents
Mix
Providers
Parents
Males/Females
Parents
Parents
Parents
Mothers
Mix
Mothers/Grandmothers
Mix
Mix
Parents
Mix
Parents

I
S/I
S(LGT)
S/V
FG
S

Parents
Mothers
Pregnant women
Parents
Parents /Adolescents
Parents /Adolescents

PO – Participant observation
S – Surveys
TS – Telephone surveys
V – Vignettes

484

Table A5. Studies of Vaccine Acceptance using Focus Group Method

Authors

Grouped By

Casiday (2007)

# of
Groups
NA

Coreil et al. (1994)

4

Fairhead et al. (2006)

13

Program sector coverage rate/child’s
immunization status
Mothers in toddler groups, by country

Fowler et al. (2007)

16

Mothers and grandmothers only

Friedman and Shepeard

35

Sex; ethnicity; rural/urban

Hilton et al. (2006a)

18

Vaccine acceptance; single
moms/dads; parents w/partner; first
time parents; non-first time parents;
income level; autistic child

Hinds and Cameron
(2004)

8

Parents; adolescents; school attended

Houseman et al. (1997)

6

Kishore et al. (2003)

NA

Leask et al. (2006)

6

Head Start; homeless shelter; WIC;
inner-city program; teen mothers
program; Navy wives group; privately
insured
Family members of a child who got
polio; community members in villages
where a child got polio; government
physicians; private doctors
Middle class; vaccine supporters only

McCormick et al. (1997)

12

Ethnicity; language; urban/rural

Millimouno et al. (2006)

NA

Unspecified

Niederhauser and
Markowitz (2007)

13

Parents whose children were not fully
immunized

Olshen et al. (2005)

6

Parents

Petts and Niemeyer
(2004)

8

By vaccine acceptance; sex;
ethnicity (Asian/White)

Scarinci et al. (2007)

8

Ethnicity

Waller et al. (2006)

4

Education

Vaccine acceptance only
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